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ABSTRACT  
This thesis is an account of a study of some aspects of the 
biological chemistry of mercury. The interactions of mercury 
compounds with both simple and naturally occurring thiols, some 
selenols, and several antidotes for mercury poisoning have been 
investigated. 
The dithiol antidotes 2,3-dimercaptosuccinic acid (DISH 4 ) and 
the sodium salt of 2,3-dimercaptopropane-l-sulfonate (Unithiol, 
Na[UH 2 ]) form isolable complexes of stoichiometry (MeHg) 2 ENSH 2 and 
Na[(MeHg) 2U]. The mercury(II) complexes Hg(DMSH 2 ).2H 20 and Na[HgU] 
have polymeric structures, (-Hg-S'S-), similar to that reported for 
the Hg(II) complex of the classic heavy metal antidote, British Anti-
Lewisite (BALH 2 ). 
The stability constants for the interaction of MeHg(II) with 
several monothiols in aqueous solution have been determined potentio-
metrically. High stability of complexes with a-mercaptocarboxylic 
acids and a-mercaptoamines (log 3 110 (1`15-17) necessitated the use of a 
titration method involving iodide competition. 2,3-Dimercaptosuccinic 
acid forms a MeHg(II) complex with log = 	similar to that 
expected for interaction of MeHg(II) with a monothiol; but BALH 2 and 
Unithiol form complexes with log fi lo 2-3 orders of magnitude higher, 
suggesting the presence of chelation. 
Implications of the results obtained from both synthetic and 
solution studies for the use of dithiols as antidotes for MeHg(II) 
poisoning are discussed. 
A computer program for the potentiometric evaluation of ligand 
hydrolysis constants has been written. The algorithm uses a rigorous 
least-squares procedure and can be applied to mixtures of multiprotic 
acids or bases. Any titration parameter can be refined. 
Complexes of 400 with selenols have been prepared and the first 
structural studies of Hg(II) selenolates obtained. Comparison of 
vibrational spectra and X-ray powder diffraction patterns for these 
complexes and their thiol analogs allows assignment of structures for 
some complexes and suggests that, for Hg(SeR) 2 , polymeric structures 
may be more common than for Hg(SR) 2 . Thus., Hg(SeR) 2 (R.Me, Et, Bu t ) 
are polymeric and Hg(SeCH 2CO2H) 2 is linear,'but for a large number Of 
analogous thiolate complexes, only Hg(SBU ) 2  is known to be polymeric. 
Single crystal X-ray diffraction studies show a polymeric structure 
for Hg(SeMe) 2 based on .distorted tetrahedral geometry for mercury with 
bridging selenolate groups . . 
The structure of [Bu tSeHgCl(py)m ]4:is similar to those previously 
reported for the sulfur analogs with pyridine.and 47methylpyridine, and 
is isomorphous with the latter. The structure is based on an eight- 
Membered ring of alternating Hg and Se atoms (-Hg-SeBu
t7 )4 having a 
centre of symmetry and two mercury environments, 'Hg(u 7SeBu t ) 2 (u-C1) 2 . 1 
and 'Hg(u-SeBu ) 2Cl(py)', with a dichloro bridge linking the former 
mercury atoms. The complex [EtSeHgC1(py)] 4 has a similar structure but 
a dichloro bridge is absent and all mercury atoms have the environment 
'Hg(U .-SeEt) 2C1(py) . . 
The first valid comparison between Hg-S and Hg-Se bond lengths 
for analogous thiolate and selenolate complexes of Hg(II) indicates 
that the Hg-Se bond lengths are slightly shorter than expected from 
comparisons of sulfur and selenium covalent radii. 
Possible synthetic routes to selenium analogs of antidotal dithiois 
are discussed. Although selenium analogs of BALH 2 and 1 .,3-dimercapto-2- 
propanol (DMPH ) could not be isolated the new compounds selenetan-3-ol, 
1a-diselenan-4-ol and 1-bromo-3-selenocyanato-2-propanol were obtained 
from their attempted syntheses. The'Hg(II) derivatives of the selenium 
analogs, Hg(SeBAL) and Hg(SeDMP), were isolated as intractable polymers. 
These polymers have tetrahedral geometry for Hg(II) in contrast to linear 
geometry for their thiol analogs, consistent with structural differences 
between simple complexes Hg(XR) (X=S,Se). The compounds 2 7 (benzylseleno)- 
fumaric.acid and 2-(benzylseleno)succinic acid have been prepared as inter-
mediates towards a projected synthesis of SeDMSH4. 
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CHAPTER ONE  
CHEMICAL ASPECTS OF MERCURY TOXICITY  
1.1 Introduction  
Mercury and its compounds are not rare in nature, yet if has not 
been demonstrated that mercury has any essential role in any metabolic 
pathway of any known species. Today's concern with mercury is due to 
its environmental impact, and its deleterious effects on human health. 
Contamination of the natural environment by mercury compounds, particularly 
methylmercury(II), has become a serious problem in many parts of the 
world. Major outbreaks of human methylmercury(II) poisoning at Minamata 
Bay (1953) and Niigata (1965) in Japan have generated international aware- 
ness of Minamata Disease. The history and general background to these 
events and the clinical and pathological features of Minamata Disease, 
which include severe, irreversible central-nervous system damage and 
congenital abnormalities, have been recently reviewed.
1
'
2 
Organo-
mercurials have been responsible for further accidental poisoning episodes 
at Guatemala (1963), 3 Alamogordo New Mexico (1969) 4 and in Iraq (1973), 5 ' 6 
due to grain treated with methyl- and phenylmercurial fungicides. 
Over 400 deaths resulted from the Iraqi poisonings alone.
4 
The Japanese Outbreaks directly attributed to industrial discharges,
1,2 
were instrumental in promoting the sudden upsurge of interest in the 
biological and environmental behaviour of mercury (and of heavy metals in 
general) seen in the early 1960's. Although organomercurials had been 
known to be lethally toxic since 1865, 7 until the large-scale outbreaks 
most toxicological research concerned with mercury had been restricted 
to elemental mercury, particularly the vapour, inorganic mercury(II) 
compounds and mercurial diuretics. Biological methylation of inorganic 
mercury by methylcorrinoid derivatives, e.g. methylcobalamin, is well 
9 
established. 
8, 
Thus, potentially more dangerous methylmercury(II) 
results from inorganic mercury(II)-contaminated environments. 
There is much evidence indicating the relevance of mercury(II) complexes 
with sulfhydryl ligands in the biotransport, metabolism, toxicity and 
microbiological transformations of mercury(II). For example, the toxic 
agent in the Minamata episodes seems to have been MeHgSMe, isolated from 
shellfish. 1 Biosynthesis of this compound may involve the complex of 
MeHg(II) with cysteine. Some cobalamin-independent organisms, e.g. 
Neurospom Crassa can methylate Hg 2+  . Homocysteine and cysteine 
complexes are implicated in the mechanism. 
10 
Several antidotes for 
mercury toxicity will be discussed in this Introduction, all of which are 
thiols. 
This thesis considers some of the chemical aspects in the solid 
state and in aqueous solution of mercury(II) coordination with thiolate 
ligands, including several with reported antidotal activity toward•
inorganic and methylmercury(II). Recent developments in the biological 
interactions between mercury and selenium are discussed, and some model 
mercury(II)-selenolates have been investigated in the solid state. 
1.2 Metabolism and toxicity of mercury(II) compounds  
The chemical features of the three oxidation states (0, 1+, 2+) 
of mercury differ markedly. For this reason it is convenient to 
consider them separately. The experimental toxicology and pharma- 
cology of mercury has been extensively reviewed
11-14 
and so 
only the salient features which distinguish the types of mercury 
compounds, are noted here. The mode of intoxication by mercury 
compounds is usually oral, or by inhalation in the case of mercury 
vapor. 
Elemental mercury, Hg  
In the liquid metallic form, mercury is not significantly toxic, 
passing through the gastrointestinal tract unabsorbed, and is fecally 
excreted.
13 
The saturation vapor pressure of mercury under normal 
3  
ambient conditions is sufficiently high (10-15 mg Hg/m ),
13 
 to pose 
a severe health threat in poorly ventilated areas. Due to its rela- 
tively high lipophilicity mercury vapor is efficiently (80%)
14 
 
transferred from alveolar air into the bloodstream. In the blood- 
2+ 
stream, Hg
o
s rapidly oxidised to Hg and although the half life of 
Hg° is only 30s, this is sufficiently long to allow a significant 
proportion of Hg° to traverse the blood-brain barrier (or the placental 
barrier) leading to a tenfold higher accumulation in the brain than for 
inorganic mercury poisoning.
15,16 
Long-term exposure to low levels 
of mercury vapor is therefore of some concern. 
Several minutes after inhalation, tissue distribution approaches 
that of Hg
2+
, except for the significantly higher proportion retained 
in the brain, particularly in the cerebral and cerebellar cortex and 
14 
certain brain nucleii. 
Mercurous mercury, Hg 2  2+ 
Disproportionation of the (1+) oxidation state is rapid and 
reversible, with thermodynamic properties as shown.
17 
Hg
2
2+ 
 + 2e  
Hg2+ + 2e Hg0 (,) 
= 0.796V 
e- 
E = 0.853V 
Because there are no commonly occurring oxidants with oxidation 
potentials between -0.796 and -0.853V, elemental mercury is always 
oxidised to Hg
2+ 
 with excess oxidant. In addition, mercury(I) salts, 
e.g. calomel, Hg 2C1 2 , generally have low aqueous and lipid solubility. 
Gastrointestinal absorption is so low that systemic intoxication is 
rare.
14 
For these reasons, the toxicology and environmental chemistry of 
inorganic mercury is primarily concerned with the (2+)oxidation state. 
Mercuric mercury, Hg2+ 
Mercuric salts have played important pharmacological roles as 
ointments, antiseptics, diuretics and laxatives for centuries and they 
are widely used in agriculture, e.g. as rodenticides and in industry. 
Ingested mercuric salts are presumably absorbed as chloro-complexes 
formed in the high acidity and chloride content of the stomach, but 
gastrointestinal absorption is fairly low ( 20%). 14 Mercuric salts, 
like mercury vapor and mercurous salts, are severely corrosive to 
mucosal membranes 18 
After entering the bloodstream, Hg
2+ 
is bound to sulfhydryl groups 
of proteins or other endogenous ligands in the plasma, and to the 
membrane and hemoglobin of erythrocytes. Nearly all (99%) of plasma 
2+ 
is bound to non-filtrable protei Hg n thiols, e.g. albumin and 
globulin.
13 
The concentrations of mercuric ion in the plasma and 
erythrocytes are approximately equal
14 
and the target organs for Hg
2+ 
are the kidneys. 13 Mercury is bound to 2 or 3 cysteinyl groups in 
19 
kidney metallothionein. Mercuric ion is gradually removed from the 
blood by passive glomerular filtration and active tubular transport 
,in the kidneys, as well as by fecal excretion from gastrointestinal 
mucosa.
14 
These two routes are of comparable importance and result 
in a half-life for Hg
2+ 
 of 1-2 months.
1 4 
 
AlkylmerCury(II) compounds  
Alkylmercurials are used widely as fungicides, and methylmercury(II) 
is the result of biomethylation of inorganic mercury residues in 
sediments.
20 
 Short chain monoalkyl mercurials, particularly MeHg(II), 
are considerably more resistant to metabolic dealkylation (to form Hg) 
than long chain analogs, although significant biotransformation of 
MeHg(II) occurs in the kidneys and the liver.
21-23 
The compounds of 
methyl - and ethylmercury(II) have been most closely studied. Because 
of its biological and environmental importance only MeHg(II) will be 
discussed here. 
The extremely high translational diffusion characteristics of 
MeHgC1 seem to be responsible for its ready absorption from the stomach 
24 
into the bloodstream, rather than lipid solubility. The distribution 
ratio from water to lipid has been recently determined to be only q,2, 
thus, MeHgC1 diffuses rapidly but does not partition well in lipid
s
.
24 
Methylmercury(II) distribution in the body differs markedly from 
that of 
Hg2+.25,26 
Preferential accumulation of MeHg(II) occurs in 
the erythrocytes, producing a characteristic erythrocyte:plasma mercury 
concentration ratio of 10:1. 14 Methylmercury(II) readily passes through 
the blood-brain and placental barriers. Up to 10% of the whole-body 
13 
burden of MeHg(II) may be found in the brain, which is the target 
organ for methylmercury(II) poisoning. Congenital Minamata disease 
tragically results from foetal accumulation of acutely toxic doses of 
MeHg(II).
1,2 
 The neurotoxicity of MeHg(II) does not seem to be due 
solely to biotransformation to Hg
2+ 
 in brain tissue.
27 
There is little doubt that the toxic influence of MeHg(II) is due 
to inactivation of specific sulfhydryl sites of cysteinyl residues of 
proteins and enzymes. 28 Although the 1:1 MeHg(II)-sulfhydryl inter-
action serves as a selective biochemical probe for SH grou
p
S
29 
the 
active cellular sites of MeHg(II) toxicity have not thus far been 
firmly established. Significant amounts of radioactively labelled 
MeHg(II) are found in mitochondria 30 and MeHg compounds directly affect 
rat liver mitochondria in vitro. 31-33 The ability of some thiols to 
reactivate MeHg(II)-inhibited enzymes of rat liver mitochondria in 
34,35 vivo 	has recently been used to evaluate possible antidotal 
thiols. 36 	MeHgC1 also interacts with unsaturated phospholipids and 
disrupts lipid membrane permeability even at mercury concentrations of 
-7 37 
10 M, consequently,lipid biomembranes have been suggested to be 
the primary targets for MeHg(II).
37-8 
Several workers have characterised intracellular MeHg(II)-sulfhydryl 
species. A glutathione complex has been identified from rat liver 
Cytosol, with 24% of mercury in the small molecular weight fraction,
39 
and metallothionein-bound MeHg(II) has been reported to account for up 
to 40% of total protein-bound MeHg(II) in the liver cytosol of rainbow 
trout.
40 
 Attempts to relate these findings to the nature of MeHg(II) 
species in vivo must be limited by the rapid redistribution of mercurial 
among the mixture of sulfhydryl ligands resulting from cell-wall 
41 
disruption. Such ligand exchange is fast on the nmr timescale and 
7 
is discussed later in this thesis (page 75 ). The methylmercury- 
thiolate species in the bile of rats has a molecular weight intermediate 
between that of the MeHg(II) complexes of cysteine and glutathione and 
is not the complex of N-acetylcysteine or homocysteine. 42 
The toxicology of methylmercury is dominated by its long biological 
half-life (3 months) and hence, its propensity for accumulation with 
continued sub-acute exposure.
13 
 High concentrations of methylmercury(II) 
are found in the liver and kidneys but normal urinary excretion is low, 
accounting for only 10% of excreted mercury.
14 
 As a result, the 
predominant pathway for excretion is via MeHg(II) species in the bile. 
Unfortunately, the high rate of gastrointestinal reabsorption of 
biliary MeHg(II) species provides an efficient route for enterohepatic 
recirculation and contributes to the long half-life in the body. 
Attempts to increase either urinary or fecal excretion of 
MeHg(II) form the basis of two possible courses for antidotal therapy 
for MeHg(II) intoxication and will be discussed in the next section. 
Dialkylmercurials such as Me 2Hg may pose higher health risks than 
monoalkylmercurials for acute exposure, as they are generally more 
volatile and lipophilic and hence, more easily absorbed. However, 
these compounds do not separately form a high environmental or bio-
logical hazard because they are readily degraded to monoalkylmercurials 
and/or mercuric ion.
13 
Alkoxyalkyl and Arylmercury(II) compounds  
Alkoxyalkylmercurials are used in agriculture and industry as 
fungicides. These compounds are rapidly degraded to Hg
2+ w
hi
c
h 
determines their toxicity and pharmacology.
43 
Arylmercurials, particularly phenylmercury(II), are widely used as 
fungicides and mould inhibitors in paints and as wood preservatives. 
• Large scale poisoning episodes e.g. in Pakistan
44 
have occurred as 
a result of ingesting treated grain. Phenylmercury(II) is rapidly 
degraded to inorganic mercury(II), eventually showing the body distri-
bution of Hg
2+
.
25 	
Disproportionation of mercaptoamino acid and 
dithiolate complexes of PhHg(II) to diphenylmercury has been shown in 
this laboratory to occur in vitro. 45  Metabolic conversion of PhHg(II) 
to diphenylmercury
46 
and to elemental mercury
47,8 
has also been 
demonstrated in some microorganisms. 
1.3 Antidotes for Mercury toxicity  
The term antidote used throughout this thesis defines a chemo-
therapeutic agent which aids the removal of toxic metal from the body 
after intoxication. Many forms of metal intoxication may be alleviated 
with therapeutic 'chelating' agents which enhance urinary excretion 
of metal. Alternatively, antidotes which enhance fecal excretion of 
metal released in the bile may be used. 
These methods will be separately discussed below in relation to 
removal of inorganic Hg
2+ 
 and methylmercury(II). 
1.3.1 Complexing agents  
The use of complexing agents for therapeutic manipulation of 
metals in the human body is now well established, and has been reviewed 
elsewher
e
.
49 	
The term 1 chelatings agent seems to have been loosely 
used in the toxicological literature. In many situations there is 
little or no evidence that the reagent is bound entirely to one metal 
atom, in the chelating sense. 17 Evidence from this laboratory indicates 
that complexes formed between mercuric ion and several antidotal dithiols 
are not chelating (Section 2.41. • 	 Similarly, the methylmercury(l+) 
cation forms unidentate complexes particularly with thiolate ligands. 
The term, complexing agent, will be used throughout this thesis, except • 
• in those situations where chelation can be established. 
Because mercury will inevitably be bound to sulfhydryl groups of 
proteins, etc. after intoxication, an effective antidotal complexing 
agent must 
(1) be of low toxicity, 
(ii)be able to bind mercury strongly enough to compete with a 
multitude of biological ligands, e.g. chloride, nitrogenous bases, 
sulfhydryl-containing proteins, etc., 
(iii)discriminate against abundant endogenous metals such as zinc 
and calcium, 
(iv) be sufficiently lipophilic to penetrate cell membranes to 
reach intracellular sites of metal deposition and 
(v) form a lipophilic complex in the body compartment where mercury 
is accumulated. 
Highly charged species are inefficient in this regard e.g. polyamine 
carboxylic acids are largely retained in the extracellular space, and rely 
on endogenous ligands to remove metals from inside the ce11. 50 If 
enhanced urinary excretion is desired, this complex should change to a 
new hydrophilic complex in the plasma, so that metal can be eliminated 
by the kidneys. While high mobility is required of the metal-antidote 
complex in this last step, redistribution into more susceptible organs, 
e.g. MeHg(II) into the brain, is undesirable. 
Mercury(II) is a typical Class B 51 or isoft 152 metal and consequ-
ently has a high affinity, for sulfur donor ligands and particularly for 
thiolates. Many compounds containing sulfhydryl groups have been 
evaluated as antidotes for various forms of mercury poisoning, and 
these will be discussed here. 
1 0 
(i) 2,3-dimercapto-l-propanol (British Anti-Lewisite, BALH ,* 
Dimercaprol)  
The efficacy of BALH 2 as a general heavy metal antidote was 
recognised during World War II. The historical development of its 
preparation and use has been recently reviewed. 
54-6 
Treatment for acute and chronic
57,8 
 poisoning by metallic mercury 
has been reported but the therapeutic effect of BALH 2 is uncertain. 26 
The life-saving effect of BALH 2 treatment for acute inorganic mercury(II) 
poisoning is well-established and has been reviewed.
26 
 There are 
conflicting reports as to the effect of BALH 2 on urinary excretion of 
mercury after inorganic mercury(II) poisoning, e.g. some workers report 
increased excretion
,59-61
n 
c
ontrast to decreased excretion by others.
62,3  
Fecal elimination of mercury is the major route for inorganic mercury 
poisoning, therefore, renal failure does not preclude metal decorpora- 
. 14 
tion. Considerable redistribution of inorganic mercury between 
organs occurs with BALH 2 treatment, which may cause an increase in the 
amount of mercury in the brain.
61-3 
 This latter effect has been 
attributed to timing of BALH 2 treatment.
61 
Although BALH 2 increases biliary excretion of MeHg(II)
64-5 
in rats, fecal elimination is not enhanced 5 9 ' 66 due to a corresponding 
increase in gastrointestinal reabsorption.
26 
 Administration of BALH 2 
increases the brain uptake rate of MeHg(II) in mice ° and increases the 
level of MeHg(II) in the brain of rats. " 
The use of BALH
2 
is lethal in cases of methoxyethylmercury(II) 
*Throughout this work, antidotal thiols will be abbreviated to indicate 
loss of thiol protons on complex formation, e.g. BALH2, PenH2, DMSH4, 
etc. Although BALH2 exists in stereoisomeric forms, only the racemic 
material has been used pharmacologically, although the optically active 
forms have been synthesised." 
poisoning, 26 but is the most effective antidote for phenylmercury(II) 
poisoned animalS. 26 
The major disadvantages of BALH 2 are related to its limited 
aqueous solubility 15 and relatively high nephrotoxicity" (Table 
1.1). A typical course of BALH 2 treatment for acute inorganic 
mercury(II) poisoning requires four-hourly deep intramuscular injections 
of BAL (3-5 mg/kg) for 2 days followed by six-hourly injections of a 
lower dose (2.5-3 mg/kg) for up to seven days.18 Many patients . suffer 
side effects from such treatment 70 and the mortality is N2%, mainly from 
secondary infections.
14 
 Consequently, more water-soluble, less toxic 
thiol antidotes have been sought. 
thiol LD50 (mg/kg) ref. 
BALH2 
90 (mice,im) 71 
 
80 (rabbit) 72 
D-Penicillamine 3725 (mice) 73 
334 (mice) 74 
2289 (mice,iv) 75 
N-Acetyl -D-peni ci 1 1 amine >1000 (rats) 74 
Unithiol r‘,2000 ( rabbi t) 76 
DMSH 4 >2730 (human?) 77 
5000 (mice) 78 
Table 1.1: Acute toxicity of antidotal thiols. 
12 
(ii) D-penicillaminet (PenH 2 ) 
In 1950 it was noted that treatment of inorganic mercury(II)- 
poisoned patients with penicillin produced increased urinary excretion 
79 
of mercury. The antidotal effect is due to the metabolite, D- 
penicillamine. However, this compound was not available commercially 
until its beneficial action in alleviating the symptoms of Wilson's 
disease (due to Cu accumulation) had been demonstrated.
80 
PenH2  is 
water-soluble and has low toxicity (Table 1.1). Although it is 
commonly administered nowadays (100 mg/kg orally) 18 subsequent to 
BALH2 
treatment of inorganic mercury poisoning, early reports of its 
efficacy in man were not encouraging
81 
 although marked reductions in 
mortality (better than BALH 2 ) among HgC1 2 and HgNO3-intoxicated rats 
was observed, 74 but only at high doses (65 mg/kg).
26 
 PenH2 is also 
used to treat sub-acute mercurialism. 
18 
D-Penicillamine does not easily penetrate erythrocyte membranes 
in vitro, 82 however, Magos et al. have recently reported decreased 
levels of mercury in the brain following PenH 2 administration to 
83 
MeHg(II) intoxicated rats. Earlier contradictory reports by other 
workers
26 
may have been due to low doses of antidote. High doses 
(220 mg/kg) removed MeHg(II) from all organs except the kidneys in 
rats but lower doses (80 mg/kg) were ineffective. 84 PenH
2  accelerates 
the urinary excretion of MeHg(II)
5,85 
 but unlike BALH 2 , does not 
84,86 
redistribute MeHg(II) into the brain. Biliary excretion of 
MeHg(II) is increased in rats treated with PenH 2 6
5,83 
but fecal 
• • The nomenclature of this stereoisomer may be confused in the literature, 
being variously denoted D- and DL-penicillamine. The racemic isomer 
(DL-) is commercially available for therapeutic use as Metcaptase(R). 
The Merck Index describes the D- isomer as naturally occurring.75 
13 
excretion is not, due to rapid reabsorption of the MeHg-pen complex 
from the gut.
26 
High doses of PenH 2 (1 g/kg) to pregnant rats 
prevented fetal morphological changes caused by MeHgCl. 
87 
• In cases of rats poisoned by methoxyethylmercury, immediate 
injection of PenH 2 has a lifesaving effect increasing urinary 
excretion of Hg, but is only marginally effective against phenyl-
mercury.
26,66 
(iii) N-Acetyl-DL-penicillamine (NAPH 21 
Acetylation of_DL-penicillamine (or cysteine or homocysteine 
increases the lipophilic character of the antidote. Thus NAPH 2 
readily penetrates erythrocyte membranes, unlike PenH 2 . 82 NAPH2 is 
even less toxic than 
Pe11H2 
(Table 1.1) and may be administered orally. . 
N-acetylation of the amino group of PenH2 and similar compounds, 
protects the molecule against the action of catabolic enzymes and 
• 
reduces tubular reabsorption in the kidney glomeruli.
88 
NAPH2 is 
more effective than PenH 2 against acute-HgC1 2 intoxication in mice 
. 14 
and increases urinaryHg excretion. Its use in sub-acute mercuri- 
alism has been recorded.
18 
Failures ofNAPH 2 to remove MeHg(II) from 
the brain in mice
14 
 and as an antidote for human MeHg(II) poisoning 
" 
(Iraq)
5 
 were due to low doses of antidote.
82 
Thus high doses (3-4 
mmol/kg) remove up to '50% of mercury in the brain 86 ' 89 and are therefore•
much more effective than PenH 2 in this regard, whereas lower doses 
(0J-0.2 mmol/kg) have no effect.
5,88-9 
•Oral NAPH2 treatment of 
MeHgC1 intoxicated micemobilised mercury from all organs and reduced 
fetal and maternal mercury levels. 5 Urinary and fecal Hg-excretion 
•  
were increased.
5 
NAPH
2 
is more effective than PenH 2' glutathione, 
cysteine, N .-atetylcysteine or N-acetyl-homOcysteine in the removal of 
MeHg(II) from an albumin complex in 
14 
2,3-dimercapto-l-propanesulfonate, sodium salt [Unithiol,
t 
Na(UTH
2 
 )] 
— 
Because of the relatively high toxicity and low aqueous solubility . 
of BALH
2'  its water-soluble sulfonate analog, Unithiol, was prepared 
in 1955. 90 ' 91 The toxicity of Unithiol is very low (Table 1.1) and 
it may be administered orally with no long term effects. Chronic 
treatment (0.6 mmol/kg) produced transitory reductions in the copper 
concentration of some orgas
92 
and increased renal excretion of copper' 
and zinc.
93 
Although only recently available commercially in Western 
Europe and America, it has been used successfully in the U.S.S.R. to 
treat inorganic mercury(II) toxicity in man.
94 
 The high water solu- 
bility contributes to its relatively low gastrointestinal absorption 
rate (30%/24 hrs
95 
 in comparison with PenH2 60%96)  and its rapid renal 
clearance (70-80%/24 hrs).
97 
Thus Unithiol facilitates excretion of 
mercuric mercury via the kidneys. 98 
Despite its low lipophilicity and hence its low membrane permea-
bility, high doses (180 mg/kg) of Unithiol seem to be more effective 
than PenH 2 (and N-acetyl-homocysteine thiolactone) in reducing the 
brain mercury level after MeHgC1 intoxication.
82 
 This effect has 
been attributed to a reduced brain uptake rather than increased removal 
of mercury. 
99
Treatment with lower doses (114 mg/kg) did not 
mobilise significant amounts of mercury from the brain in mice.
100 
Urinary MeHg(II) excretion is substantially enhanced upon Unithiol 
treatment.
99 
Fecal MeHg(II) excretion is also slightly enhanced,
99 
although this may be due to the increased flow of bile and bile-salts 
101 
caused by Unithiol. Unithiol does not remove Cd from metallothionen 
tUnithiol is marketed for therapeutic use under the name Dimaval
(R) 
by Heyl & Co. Chem.-Pharm. Fabrik, Berlin. The stereoisomeric 
nature of Unithiol does not seem to have been reported. The 
commercial product is presumably a racemic form, like BALH2. 
15 
in the bile, but BALH 2 does. 102  
(v) meso-2,3-dimercaptosuccinic acid (DMSH IX 
Introduction of carboxylate groups into a dithiol molecule 
increases its aqueous solubility. Thus the disodium salt and the 
1:1 mercury(II) complex of DMSH 4 are water-soluble. The toxicity 
of DMSH4 
is very low (Table 1.1) and like Unithiol, it may be 
administered orally with no long-term effects
103 
 although its metabolism 
DO 
is not well understood. DMSH
4 
 was first used therapeutically in 
1954 as the trypanocidal antimony complex.
104 
 The arsenic complex has 
105 106- 7 
similar activity. DMSH 2 has been used as an antidote for lead 
and arsenic
103 
 poisoning for which it is as effective as BALH 2 , and is 
better than PenH
2 
 at increasing urinary excretion of gold after 
Au-mercaptosuccinate(Myocrisin) treatment.
108 
DMSH4 is an effective antidote to acute HgC1 2 poisoninr and is 
more effective than PenH 2 at removal of Hg from the kidneys, liver and 
7 
brain of mice. 
8,107,110,111 
 
DMSH4 
seems to be a most promising antidote for MeHg(II) toxicity. 
It is five times as effective as PenH 2 for Hg excretion in mice after 
MeHgBr administration and decreases the Hg content of kidneys, liver 
11D- 1 
and particularly the brain.
78, 
Doses of 90 mg/kg/day removed two 
thirds of mercury from the brain when given to MeHgC1 intoxicated mice. 
For this purpose DMSH4 is better than PenH 2 , mercaptosuccinic acid
100 
and BALH2 
112
. Postexposure preventative treatment with DMSH 4 to rats 
after MeHgC1 injection prevents the increase of mercury levels in the 
Only this stereoisomer has been studied extensively, however the 
racemic form was reported to be better than the meso- form at 
accelerating urinary mercury elimination from rats after HgC1 
administration. 112 
2 
16 
brain.
113 
The MeHg(II) level in the brains of neonatal rats is significantly 
114 
lower than that of controls after administration of DMS to the dams. 
(vi) Other thiols  
Several N-acetylated mercaptoamino acids (other than PenH 2 ) have been 
tested as antidotes in animal experiments, particularly against MeHg(II) 
toxicity. 
N-Acetylhomocysteine is nearly as effective as PenH 2 (and better than 
homocysteine) for decorporation of MeHg(II) from mice, and is less toxic. 88 
The corresponding thiolactone produces larger increases in urinary excretion 
of mercury,
88 
 and mobilises more than MeHg(II) from the brain,
115 
but very 
high doses are required. In contrast, the non-acetylated thiolactone does 
not mobilise mercury from the brain in mice or monkeys, and is toxic to 
monkeys.
86 
Diethyldithiocarbamate and disulfuran decrease urinary and biliary 
MeHg(II) excretion and increase the mercury content of the brain in mice.
116 
Oral doses of 8-mercaptopropionylglycine (600 mg/day) produced 3- to 
6-fold increases in urinary mercury excretion for Minamata patients, and 
was better than PenH 2 
in this regard. 117 
The new tetrathioether, PTTA, was totally protective against high 
doses (30 mg/kg) of MeHgC1 in mice and is relatively non-toxic. 118 
CH(SCH CO2H) 
CH(SCH 2CO2H) 2 
Of several tested steroids containing thioacetyl groups (which are 
presumably hydrolysed in vivo), only thiocholesterol shows significant 
protective effects against MeHgC1 intoxication in mic
e
.
119 
Pretreatment 
with the similar compound thiomestrone (109 mg/kg) was as effective as 
BALH2 treatment in decreasing the whole-body burden of MeHg(II) in mice, 
but unlike BALH
2' 
 did not redistribute mercury into the brain.
120 
 This 
thiosteroid also decreases mercury retention after HgCH 2 administration.1
21 
17 
(vii) Synergistic and mixed complexing agents  
Whereas treatment with one complexing agent may not significantly 
alter the rate of metal decorporation, simultaneous addition of a 
second agent may prove effective. The second agent may alter a 
metabolic process or function which enables the complex formed between 
the metal and first agent to be more efficienty excreted, e.g. pheno- 
barbitone enhances biliary excretion but is ineffective alone as a 
mercury antidote. Fecal elimination of mercury from MeHgC1 intoxicated 
mice treated with a polythiol resin is thus enhanced by simultaneous 
122 
treatment with phenobarbitone. 
The formation of ternary or mixed complexes between the metal and 
both complexing agents has been postulated to account for enhanced 
123t 
elimination of plutonium with salicylate and DTPA treatment, although 
some of the experimental evidence for the mixed species has been 
questioned.
124 	
Mixed ligand treatment (BAL/CaEDTA) has been used 
125 
for lead and copper
126 
 toxicity but mixed complexes have not been 
identified. 
This form of treatment does not seem to have been widely used for 
treatment of mercury(II) toxicity. 
1.3.2 Extracorporeal Hemodialysis and Hemoperfusion  
Antidotal thiols such as penicillamine and N-acetylpenicillamine 
increase the fraction of non-protein bound MeHg(II) in the blood. In 
vitro studies have shown 55-60 fold increases in the low M.Wt. MeHg(II) 
- 
fraction after 10
2 
 M cysteine treatment, 44% of which is dialysable in 
a single pass.
127 In vivo, extracorporeal hemodialysis of blood from 
dogs intoxicated with MeHgC1, resulted in a 100 fold increase in MeHg 
removal rate after treatment with cysteine.
128 
 Significantly, mercury 
was removed from the brain. In contrast, clearance of Hg
2+ 
was not 
tdiethylenetriaminepentacetic acid. 
CH 3 (CH 2 ) n CH\ 
SCH CO H 2 2 
/
SCH
2
CO
2H 
n = 10,16 131 
18 
significantly increased after treatment with BALH 2 and hemodialysis. 129 
The use of thiolpolymers to remove mercury from the dialysate has been 
suggested.
129 
Perfusion of human plasma through a bed of thiolpolymer 
microspheres has recently been reported to decrease mercury levels, in 
vitro, and is cheaper than dialysis. 130 
1.3,3 Enterohepatic complexing agents  
Treatment of MeHg(II) toxicity with many thiol antidotes produces 
MeHg(II)-thiolate complexes which are excreted in the bile. However, 
the complexes are often reabsorbed in the small intestine from which 
they reenter the portal bloodstream to the liver. Antidotal agents 
may be designed to reduce the efficiency of this enterohepatic re- 
circulation.
11,131-2 
These agents may incorporate structural features 
similar to bile acids (e.g. mercaptal substituted cholic acids, I), or 
long chain fatty acids, but contain polar endgroups (II,III) resistant 
to metabolic breakdown. 
II 
CH 2CO 2H 
RS CH (CH ) 2CH 2N( 
RS CH2CO2H 
III 
I. R = CH 3CH 2 ,H 2OCCH 2 . 131 
19 
An alternative principle which disrupts enterohepatic recirculation 
employs insoluble polymers which contain many groups capable of MeHg(II) 
binding. The polymer is ingested and traps MeHg(II) in the gut from 
which it is fecally excreted without reabsorption. Powdered human 
hair treated with mercaptoacetate, 133 polystyrene polymers containing 
sulfhydryl groups,
5,122,134 
polyterephthalate polymers containing 
thioether groups,
118,135-6 
and mercaptostarch
137 
 have been used for this 
purpose. All of these agents increase the fecal elimination of mercury 
and several reduce brain mercury levels. Phenobarbitone has been used 
to increase bile blow and hence promote fecal MeHg(II) excretion from 
mice treated with polythiol resin.
122,138 
 Attempts to use the macro-
molecular polythiol, mercaptodextran, to disrupt enterohepatic recircula- 
tion have failed, presumably due to metabolic breakdown into its component, 
N-acetyl-homocysteine. 115 
1.4 Mercury-Selenium interactions  
Selenium was shown to be an essential trace element by Schwarz in 
1957
139  and the biotransformations and metabolism of selenium are now 
fairly well established and have been summarised in Figure 1.1. The 
physical properties, chemistry and roles of selenium in trace-element 
metabolism have been elucidated in two recent comprehensive texts.
0-1 
 
The most important process in the mammalian metabolism of selenite, 
Se032- , appears to be the formation of selenotrisulphides, RSSeSR 142-6 
particularly with glutathione (Table 1.1). The major selenium-binding 
components in the blood plasma of rats appears to be albumin when Se0 3 2- 
erythrocytes and plasma are incubated in vitro. 147 selenium is 
concentrated in the albumin fraction of rat plasma after the administration 
of small doses of Se032-  , primarily in association with proteins with a 
molecular weight of 77,000.
148-9 	In mice, selenite is metabolised and 
H S 0 + ATP sulfurylase 26. (mg2+ ) 
GSSe03
2- 
 + AMP 
Adenosine + PPi 
selenophosphate 
GSH 
GSH 2_ 
-Se03 	GSSG 
iv 
% ,H 2Se03 4GSH 
+ GSSG + H 20 
GSSeSG
142-6 
+ GSSG + 3H 20 
NADPH + 
GSH reductase 
NADP 
GSSeH + GSH• GSSG163 +GSSeH 
+GSH 
NADPH 
GSH reductase 
NADP 
-11 
GSSG + H 2Se 
-11 
H Se + GSH147' 165-6 
[0] 
Se° 167 
 
H 202 
selenoprotein148'1 66-8 
SAM methyl transferase 
2+ 
(CH )2 
sin 169-70 
3  
MSe (CH)Se+ 171-2 
(MSe-protein complex) 
Figure 1.1: Mammalian metabolism of selenate and selenite (from ref. 160). 
Muscle Protein 
(MW 10,000) 
Contains 4 selenium atoms
175 
in reduced selenocysteine form.
176 
Essential in 
the glucose-dependent reduction of peroxides. 
Glucose ILL_ 
G-6-P NADP 2GSH H202 (or ROOH) 
(ii) •iii) iv) 
6-PG NADPH GSSG 2H 20 (or H20 + ROH) 
Hexokinase ii, G-6-P dehydrogenase 
Glutathione reductase iv, Glutathione peroxidase 
Selenium at the active site undergoes redox changes:
177-8 
0 
Glutathione
173-4 
Peroxidase 
EC 1.11.1.9 
(MW 4 x 21,000) 
Glycine dehydrogenase 
(MW 12,000) 
EC 1.4.1.10 
Formate Dehydrogenase 
(MW high) 180  
EC 1.2.1.2. 
+ATP 
E-SeH 
ROOH 
 E Se-OH 
E-Se-SG  
ROOH • E Se-OH 
ROH
1117// 
GSH 2 
GSSG 
0 
E-Se -SG 
Contains 1 selenium atom in reduced selenocysteine form. 179 Catalyses the 
deamination of glycine in Clostridium stricklandii. 
Glycine + H20 + NADP -+ glyoxylate + NH 3 + NADPH 
Selenium content is unknown. Catalyses the oxidation of formate to CO 2 . 
Formate + NADP CO2  + NADPH 
Present in several microorganisms, including E. coli. 
Contains 1 selenium atom in an unknown form. Spectral properties are similar 
to CytC, amino-acid composition is similar to Cyt-b5. 181 Absence is associated 
with 'white-muscle' disease. 
Table 1.1: Enzymes and proteins known to contain selenium. 
22 
and bound to albumin -lipoprotein and an unidentified protein in 
the plasma. 150 
Since the initial observation (1960) •that selenite is preventative 
against the injurious effects of cadmium salts on testes in rats, 151 
and against renal and intestinal necrosis caused by inorganic mercury(II) 
salts
152 
 there has been much interest in the role of selenium as 
'Nature's antidote to heavy metal toxicities'. 153 In an even earlier 
study with BALH 2 , Tobias et al. noted that selenite protected mice 
against the otherwise lethal effects of inhaled CdC1 2 , 154  but twenty 
years elapsed until the pioneering work by Kar and co-workers. 151 
There is evidence that selenium may be involved in the detoxification 
155- 7 	 2+ 158 
of Tl, and of Ag , Pb (and perhaps Cu ). Particularly 
relevant to this work are the extensive reviews of the interactions of 
2+ 152-3,8-9 
selenium with Cd
2+ 
and Hg , including two published very 
recently (1980).
160-1 
Despite much work in this area, the mechanisms of such trace 
element interactions are not yet well understood. 162 It is intriguing 
that none of the several enzymes and proteins (summarised in Table 1.1) 
which are known to contain selenium have been implicated in any mechanism 
for heavy-metal interaction. The confirmed existence of reduced seleno- 
hydryl groups in glutathione peroxidase and glycine dehydrogenase, and 
the scarcity of fundamental chemical information on mercury(II) compounds 
containing coordinated organoselenium ligands, led to those portions of 
the present study which are concerned with Hg
2+
-selenohydryl (Chapter 4) 
and MeHg(II)-selenohydryl and diselenide (Chapter 3) interactions. 
As an introduction to these Chapters, the salient features concerned 
with the preventative effects of selenium against inorganic mercury(II) 
and alkylmercury(II) toxicity, are discussed below. 
23 
1.4.1 Selenium interactions with inorganic mercury  
Interactions between selenium and inorganic mercury(II) compounds 
182-3162, 
have recently been reviewed by several authors 
159, 	
but some 
of the more important findings are recorded here. 
There do not appear to be many reports regarding the effects of 
selenium on intoxication by elemental mercury, other than that low 
levels of dietary selenite (3.1 mg Se/kg food) do not seem to increase 
the bodily retention of mercury in rats exposed to occupational levels 
of mercury vapor. 184 
- 
Parizek has shown that dietary Se03
2 
 prevents growth depression 
due to oral administration of HgC1 2 in rats.
185 
 Groth and co-workers 
- 
report that long term dietary supplementation with selenate, Se0 4
2 
 , 
1 
reduces chronic renal tubular damage in rats administered HgC12
86 
 
Selenate has a protective effect in rats on weight loss and histo-
pathology due to HgC1 2 .
187 
 Selenite and selenomethionine provide 
complete protection against kidney and intestinal necrosis in rats 
fed lethal doses of HgC1 2 . 152 Remarkably, this effect is not due to 
improved elimination of mercury, on the contrary, the whole body 
elimination rate is decreased
188 
 as are urinary
152,189 
 and fecal
190 
excretion rates in rats, although the effect is not marked in the 
latter case. Urinary excretion of selenium in mice is also depressed 
by administration of HgC1 2 but the mercury excretion rate is dependent 
on the administered dose of selenite. 191 In lactating rats, selenite 
decreases the mercury content of fetuses, milk and sucklings, but 
increases the whole-body mercury content of the dams.
159 
Selenite152 and selenate188 increase the whole-body retention of 
mercury but dramatically change its organ diStribution. 192 Single 
doses of selenite, selenate and selenomethionine all decrease Mercury 
24 
levels in the kidney
152,193 
and increase the content of the liver.
194 
In contrast, repeated simultaneous administration of Hg
2+ 
and 
selenite is reported to increase the mercury levels in kidneys of rats 
and mice.
195 
 
Selenite removes inorganic mercury from metallothionein in vitro, 196- 7 
but does not stimulate the biosynthesis of the apoprotein. 198 
Chmielnicka and co-workers have shown that the selenite-induced trans-
location of inorganic mercury from the kidney (where it is bound 
presumably to metallothionein) to the liver,
199 
is accompanied by an 
accumulation of mercury in the liver mitochondria.
200 
 In particular, 
combined and separate exposures of rats to HgC1 2 (0.5 mg Hg/kg) and 
selenite (0.5 mg Se/kg) for 2 weeks decrease the content of mercury in 
intramitochondrial structures of the kidney and both Hg and Se accumulate 
in the inner and outer mitochondrial membranes.
201 
 Levander has also 
reported that HgC1 2 inhibits the swelling of liver mitochondria, other- 
wise induced by selenite. Yamane et al. report nine - fold increases 
in mercury content of nucleii, microsomal and mitochondrial fractions 
of rat liver homogenates after concurrent administration of HgC1 2 and 
Na 2Se04'
194 
 It is likely that these sites, where many important 
metabolic processes are catalysed, are the targets for damage by 
mercuryll and may also be the sites relevant to molecular interactions 
between selenite and inorganic mercury. 
Single injections of selenite cause a dramatic redistribution of 
inorganic mercury in the blood. Mercury is removed from the 
erythrocytes into the plasma
149189 
"
203-5 
where it is bound to high 
molecular weight protein species containing equimolar amounts of 
mercury and selenium. The magnitude of the effect can be seen in rats 
where normally 50% of mercury is bound to low molecular weight protein 
25 
fractions in plasma, but after administration of selenite, 205 or 
selenate,
194 
 this proportion is less than 1%. Selenomethionine 
causes a similar redistribution, but higher doses are needed for the 
same response and liver enzymes are essential for the effect in 
vitro, presumably to metabolise selenomethionine to selenite. 192 
Burk et al., 149  have demonstrated that mercury and selenium appear 
together in rat plasma as a macromolecular protein complex of the 
type ProtSSeHgX. A very similar complex has been identified in 
hemosylates of rabbit blood. 204 The specific complex in these cases 
has not yet been identified, but appears to be similar to the 130,000 
Dalton cadmium and selenium binding component found by Gasiewicz and 
148 165 
Smith. ' These authors have shown that H 2  Se interacts with 
Hg in plasma to yield a protein complex of molecular weight 330,000 
containing equimolar amounts of mercury and seleni um. 147 An analogous 
Cd
2+ 
protein complex of molecular weight 130,000 formed under identical 
conditions is considered to be colloidal CdSe stabilised by association 
with specific but unidentified macromolecular proteins.
147 
The forma-
tion of complexes of this type may explain changes in the biokinetics 
and toxicity of mercury but the biokinetics of Hg
2+ 
salts are also 
altered in situations of selenium deficiency.
206 
 
The occurrence of an equimolar accumulation of selenium and 
mercury in the liver and brain of seals
207 
 and in the liver cells of 
Mediterranean cetaceans
208 
has been reported. Ratios of Hg:Se of 
1-3 have been reported in the liver and brain of whales. 209 The 
protective effects of selenate on HgC1 2 toxicity has been associated 
with the formation of electron-dense particles in the kidney proximal 
tubule cells and the reticuloendothelial cell cytoplasm and the extra-
cellular space of Disse in the liver. 187 Carmichael and Fowler have 
used energy-dispersive X-ray analysis to obtain a Hg:Se ratio of 1:2 in 
26 
these particles, which is in contrast to 1:1 ratio found by Groth et 
1 aZ. 86  This apparent discrepancy may be due to translocation of Hg 
or Se during sample processing or examination. The mercury in these 
particles has been shown to be thermally labile when a critical temp-
erature under the X-ray beam is reached. 157 Interestingly, the 
- 
administration of tellurite, Te03
2 
 , prevents the formation of these 
particles and is synergistic with Se032- in the prevention of renal 
necrosis caused by chronic exposure to HgC1 2 .
149 
 In contrast to 
- - 
Se03
2 
 , administration of Te0 32 with HgC1 2 does not affect the organ 
distribution of mercury, but it does protect against acute HgC1 2 toxicity 
and increases the whole body retention of mercury.
188 
In man, elevated levels of mercury and selenium have been found in 
the brain, thyroid, pituitary and kidneys of mercury miners, 16 years 
after the cessation of exposure.
210 
 Although increased retention of 
selenium has also been reported elsewhere in persons occupationally 
exposed to inorganic mercury, 211 it is questionable whether selenite 
mitigated the effects of chronic mercury exposure in these cases. 
Parizek has warned that not all the interactions between inorganic 
mercury and selenium are beneficial, and that the concomitant presence 
of mercury and certain selenium metabolites produces a lethal syndrome 
in rats, particularly if selenite is administered before HgC12 • 152 
These toxic effects have been shown to be similar to those caused by 
large doses of dimethylselenide. 152 Parenteral pretreatment with 
HgC1 2 (10 mg/kg) decreases the excretion of volatile selenium compounds 
in female rats after administration of Na 2Se03 (0.3 mg/kg ip). 152,192 
The effect is more marked than identical pretreatment with CdC1 2 or 
ZnC1 2'  and selenomethionine acts similarly.
212 Curiously, male rats 
are much more susceptible to the toxic syndrome than females, but this 
sex-linked difference is not related to the sex-linked differences found 
27 
for dimethylselenide conversion to the excretion product,trimethyl-
selenonium ion (see Figure 1.1). Parizek has postulated that the 
toxic effect may be due to a selenium metabolite such as MeSe - , and 
that HgC1 2 may either alter the metabolic pathways and/or distribution 
of this intermediate or sensitivity of the critical organs to MeSe7 , 
etc. 
These unresolved toxic effects must, at the moment, restrict the 
use of selenium compounds in the prevention and/or therapy of mercury 
intoxication. 
1.4.2 Selenium interactions with organic mercury compounds  
The interactions of selenium with organomercurials other than 
methylmercury(II), have not been well studied. Mengel and Karlog
205 
report that selenite-induced translocation of mercury to macromolecular 
proteins in the plasma of rats treated with methoxyethylmercuric 
chloride is not observed, in contrast to previous reports.
213 
Chmielnicka et al. report that selenite suppresses the induction of rat 
kidney metallothionein due to EtHgC1 or to PhHgCl.
214 
 
The interactions of selenium with methylmercury(II) have been 
recently reviewed.
162,215 
Concentrations of MeHgC1 in excess of 5 x 
-5 
10 M completely inhibit the in vitro activity of the selenium-
containing enzyme glutathione peroxidase (Table 1.1) in rat liver 
216 
homogenates. and selenite suppresses the induction of metallothionein 
due to MeHg-cyanoguanidine.
214 
Dietary selenite has been shown to be 
protective against the toxic effects. of MeHg(II) in quail ,2
179 
chicks 
, 208,220 rats190,221-4 
and pigs. 2256 Contrariwise, MeHg(II) 
(10 mg Hg/kg) protected against selenite-induced weight loss in rats. 1. 85 
Selenium present in dietary fish may have a protective effect against 
),.217,221 
AeHg(II but the fairly minor effects may be due to changes in 
28 
dietary Protein, etc. 
Fish meal containing selenium is reported to have delayed the 
growth retardation and reversed the neurological degeneration in 
weanling rats caused by dietary MeHgCl.
221a 
As in the case of inorganic mercury, the organ distribution of 
MeHg(II) is profoundly affected by selenite, but the changes differ 
markedly from those found with Hg
2+
. 
- 
Single doses of Se03
2 
 to MeHgCl-treated rats, produce a BALH 2- 
like effect which immediately increases the mercury level of the 
brain followed by a later decrease.
222-3 	
In rats administered both 
MeHgC1 and Na2Se03 , seven-fold increases in the selenium content of 
the brain, liver and kidney have been reported.
221
'
227 
Ohi et al. 221  
report that the total mercury and inorganic mercury contents of the 
brain increase markedly when selenite is administered to MleHg(II) 
poisoned rats but in contrast, the MeHg(II) content in the brain and 
other organs is not significantly altered. 
Closer relationships appear to exist between the Se and Hg 24- 
contents of various organs than with MeHg(II) content, which may reflect 
a selenium-induced change in the biotransformation of MeHg(II) to Hg
2+ 
however dietary selenium has no effect on the rate of C-Hg bond cleavage 
of MeHg(II) in rat liver homogenates in vitro. 228 
A direct interactive mechanism between selenium and MeHg(II) may 
also be possible. Half of the methylmercury(II) incubated in whole 
blood with an equivalent quantity of selenite, is benzene extractable 
without acidification. 229 Lipid soluble MeHg(II)-selenium complexes 
such as (MeHg) 2Se (analogous to the active species in the Minamata 
episodes 192 ) may be responsible for the redistribution of MeNg(II) into 
the brain after Se0 2 administration. 
29 
In summary, the interactions of selenium with mercury compounds 
(and heavy metals in general) appear to be affected by many variables 
such as age, sex and nutritional status of the experimental animals 
and much work needs to be done in these areas before clear mechanisms 
can be elucidated. 
CHAPTER TWO  
STRUCTURAL CHEMISTRY OF 	THIOLATES  
2.1 Introduction  
Complex formation in vivo between mercury(II) compounds and endogenous 
thiols plays a major role in the biological chemistry of mercury (Chapter 
1). All of the currently used antidotes for mercury toxicity take 
advantage of the higher thermodynamic affinity
t 
of mercury for sulfhydryl 
donors than for other possible ligands such as nitrogen-containing bases, 
chloride, etc. The historically held rationale for the use of the dithiol 
BALH 2 as an antidote for mercury poisoning is based on the ability of this 
ligand to form stable chelate complexes with arsenic. 54 Curiously, 
despite the long and widespread use of BALH 2 as a heavy-metal antidote, no 
definitive evidence for chelation to any metal has been demonstrated; for 
example, no single-crystal X-ray structure of any BALH 2 complex (or of any 
closely related vicinal dithiol except the recent complex of MeHg(II) with 
trans-1,2-dimercaptocyclohexanedithio1 23° , page 42) has been reported. 
This situation is almost cetainly due to the intractable nature of BALH 2 
complexes which are often very poorly soluble in most solvents, making 
crystal growth very difficult. As will be discussed later, it has been 
shown by vibrational spectroscopy in this laboratory that the mercury(II) 
complex, HgBAL, is not a chelate, but rather has a polymeric structure, 
with linear 'SHgS' bonding 
.231 
Although chelating structures for HgBAL 
are chemically implausible considering the strong disposition of Hg(II) 
for linear sp or tetrahedral sp B coordination , such structures are 
tDespite the unquestionable high stability of inorganic mercury(II) 
thiolates, the formation constants of Hg(SR) 2 complexes are very poorly 
established.232 
30 
31 
still found in recent toxicological discussions. 233 
This study was derived from the reports that two water-soluble 
vicinal dithiols : meso-2,3-dimercaptosuccinic acid, DMSH 4 and the sodium 
salt of 2,3-dimercapto-1-propane sulfonic acid, Unithiol are promising 
antidotes for inorganic- and methylmercury(II) poisoning (Chapter 1, 
pages 14-15), yet the relevant Hg 2+ complexes such as HgDMSH 2 and 
Na[HgUl] had not previously been characterised. 	These complexes have 
been prepared in this work and shown here by vibrational spectroscopy to 
be polymeric, like HgBAL. 
In addition to the formation of bisthiolato complexes of the type 
Hg(SR) 2 , the ready availability of alternate donor ligands at the in vivo 
target site(s) for Hg binding has prompted much interest in the nature of 
monothiolato mercury(n) complexes of the type RSHgX where X is some 
neutral or anionic ligand such as chloride, acetate, etc.234 ,235 	Several. 
model compounds of this type have been characterised in this laboratory 
and elsewhere and their structural chemistry will be briefly reviewed. 
Although the use of thiol antidotes for MeHg(II) toxicity is 
widespread and the X-ray crystal structures of three important mercapto-
aminoacid complexes with MeHg(II) have be reported, 236 ' 237 the interactions 
with vicinal dithiol ligands is less well established. 	The complex 
(MeHg) 2BAL has been previously investigated in this laboratory by vibrational 
spectroscopy and shown to have the expected linear 'SHgMe' geometry. 238 
The previously unreported analogous compounds (MeHg) 2 DMSH 2 and Na[(MeHg) 2 UT] 
have been examined in this study, together with complexes of several 
monothiolates (including the new cationic complexes with thiocholine 
perchlorate and N-methyl-4-mercaptopiperidinium nitrate. 	The aqeuous 
solution chemistry and MeHg(II) formation constants of these complexes 
will be elucidated in Chapter 3. 
2.2 Structural features of MeHg(II) thiolates  
The solid-state structural features of alkyl- and arylmercury(II) 
thiolates of the type RHgSR' are dominated by two-coordinate mercury in 
the strongly bound, linear 'C-Hg-S' moiety. Single-crystal X-ray cryst- 
allographic structures of six monothiolatomethylmercury(II) species, 
MeHgSR, and one dithiolatobis[methylmercury(II)] species, have been 
published to date. The important Hg-S and Hg-C bonding distances and 
C-Hg-S bonding angle of each of these complexes are recorded in Table 
2.1. 
The mercury-sulfur distances lie within the narrow range 2.32 - 2.39A 
as do those for the few other known thiolato-structures, RHgSR' (RtMe) 
PhHg (dithizone) [2.372(2)], 239 PhCH2HgSC(Ph) 3 [2.363] 240 and PhHgSC6H4- 
2,6-diMe L2.33(1)].
241 
 The carbon-mercury bonding distances are also 
relatively constant: 2.04 - 2.12A. The structures of the complexes in 
Table 2.1 serve to characterise MeHg(II)-thiolate binding. The MeHg-S 
bond is always nearly linear, reflecting the predominantly sp character 
of the mercury atom even in thosesituations where intramolecular bonding 
may be present, e.g. the cytosine derivatives, which all have Hg-N distances 
less than the sum of the van der Waal's radii of Hg and N (3.00A 242-3 ). 
This demonstrates the very weak residual Lewis acidity of a sulfhydryl-bound 
MeHg(II) group. 
In the dithiolato complex, direct evidence of chelation of one 
MeHg(II) group is reflected in the increased distortion of the MeHg-S bond 
angle (167.8°) from linearity,due to simultaneous weaker intramolecular 
binding to the alternate, already complexed, sulfhydryl group. The 
secondary, Hg-S', bonding distance, 2.857(3)A is still considerably less 
than the sum of the van der Waal's radii (3.35A 242-3 ), generating'effective' 
three-coordination at one mercury atom. 
32 
Complex 
[MeNgSCH2CH(AH3 )C 2-].H 20 b 
LMeHgSC(Me) 2CH(41-1 3)CO2- ] 2 .H 20 
[MeHgSC(Me) 2CH(AH 2HgMe)CO2- J a 
NH 2 
,N 
)1, unmo h 
Oe N 
• JL, HgMe 
S-- 
N 
Me 
SHgMe 
.Hg-S/A C-Hg/A C-Hg-S/ ° Ref 
• 2.352(1) 2.10(4) 177.6(9) 236 
2.38(1),2.36(1) 2.07(6),2.09(5) 175(2),175(2) 237 
2.35(1) 2.04(4),2.07(4) 176(1) • 237 
2.39(2) 2.13(6) 174 244 
2.393(4) 2.09(1) 178.6(4) 245 
2.390(6) 2.09(2) 178.6(9) 245 
2.363(4),2.367(4) 2.08(2),2.12(2) 167.8(5),117.1(5) 230 
f 
Table 2.1: Mercury bonding distances and angles from the published crystal structures of MeHgSR complexes. 
0( H 
Footnotes to Table 2.1 
the mercaptoamino acid complexes have been reviewed by Carty 246 
Figure 2.1 
Figure 2.2. Two independent molecules in the unit cell 
preliminary structrue in ref. 247 
Figure 2.3. Bonding distance Hg-N 2.13(3)A. 
preliminary structure in ref. 248 
weak bonding distance Hg...N 2.83(3)A 
weak bonding distance Hg...N 2.80(2)A 
0 
weak bonding distance Hg...N 2.95(2)A 
weak bonding distance Hg...S' 2.857(3) 
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Figure 2. : Molecular structure of Vethyl-L-cysteinatomercury(II) 
from reference 236. 
C( b) 
(a) 
Finure 2.2: . Molecular structure of. methyl T HL-peniCii . laminatomertury(II) monohydrate from 
rci'erence 237 showing weak inti:roctinns . around Hg in the two crystallographically 
independent nnlecules in the unit cell: 
s 
3.36 1 
s 
C( 
2.88 Ash v4P 
I g 
175 Is 
"3.35 
(9 s(b.) 
2.33 
S(a) 
176 
0( 1 ) 
• 2.85 
170 
C(2) 
I i (lure 	Mol ecul a r s tructure of H - DL - peflitil1aminato - bis[methyl mercury( )] from reference 237 
showing clw-ie con. tacL of the two Hg atoms. 
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Chelation of MeHg(II) by nitrogen donors is now well established in 
solution and in the solid-state (see reference 249 for a recent review). 
Three coordinate mercury involving a sulfur donor is also found in the 
solid-state structure of one isomer of the dithizone complex: 239 
One (or both) MeHg(JI) groups of the 2:1 complexes with vicinal dithiols 
BALH 2'  DMSH4  and Unithiol may be chelated in aqueous solution (Section 
3.3.3, page136). 
Several MeHg(II) complexes of mOnothiolate and dithiolate ligands 
have been prepared in this study by the metathetic reaction of MeHgNO 3 . 
(or MeHg0H) with the thiol or dithiol in aqueous solution. The non-polar 
complexes MeHgBu t and MeHgSCH2Ph were extracted into hexane and 
recovered by evaporation of this solvent. These complexes have been 
isolated previOusly250.and were not analysed. The other complexes were 
precipitated as crystalline solids, either immediately or upon slow 
evaporation of the aqueous solution to low volume. The microanalyses 
of these previously uncharacterised complexes are recorded in Table 2.2. 
The vibrational spectra of the complexes were obtained in order to 
assist characterisation of the previously unstudied vicinal dithiol 
complexes of DMSH 4 and UnithioL The pertinent Hg-S, Hg-C and C-S 
stretching frequencies for the new complexes are recorded in Table 2.3, 
together with previously assigned values for MeHgSR complexes reported 
elsewhere. These frequencies are coincident inthe infrared and Raman 
Complex 
MeHgSCH 2CO2H 
[MeHgSCH CH 2NMe 3]C104 
[MeHgSC 5H 10NHMe]NO3 a 
MeHgSCH(CO2H)CH 2CO 2H 
MeHgSCHCO2H 
1 
MeHgSCHCO 2H 
MeNgSCH 2 
1 
MeHgSCHCH SO Na 
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required % found % 
Ng H. Hg 
11.8 1.97 65.4 10.5 11.6 2.01 65.1 10.1 
16.6 3.71 46.2 7.4 16.7 3.76 45.9 7.6 
20.6 3.94 49.1 7.8 20.6 3.91 49.0 7.6 
16.5 2.21 55.0 8.8 16.8 2.43 55.1 8.7 
11.8 1.65 65.6 10.5 12.0 1.74 65.5 10.2 
9.4 1.73 62.7 15.0 9.4 1.87 1.48 62.4 
Table 2.2: Previously uncharacterised MeNg(II) thiolates and dithiolates 
a monothiol is 4-mercapto-N-methylpiperidine 
spectra, consistent with the absence of a centre-of-symmetry in these 
molecular solids. The most readily assigned vibrational band is due to 
v(HgC) and is very sharp and intense in the Raman spectra, and almost 
invariant in frequency for these complexes (528-555 cm -1 ) and other 
methylmercury(II) complexest , e.g. Me 2Ng (v s 515, vas550) 255 ; MeHgX, 
X=F (561-573), 256 Cl  (539-558) 257-63 , Br(538-545)257-8 ,262-4,  1(526- 
538 )257-8,260-3 ; MeHgC(SiMe3 ) 3 (523-528) 265 ; MeHgCN(559-565) 266 and 
MeHgSCN(543-562) 267-8 . 
The expected mercury-sulfur coordination is confirmed by the absence 
of vSH near 2500 cm. This vibration is weak in the infrared spectra 
but very intense and characteristic in the Raman spectra of the thiol 
The values in parenteses represent the range reported by various authors 
in both i.r. and Raman spectra and are often solvent and phase dependent. 
Complex 
rm-1 • vHgC/' vcsicm-1 Ref. 
monothiolate ligands 
MeHgSMe 333m [329vs] 533 [537] 692 [700] 251 
329m [327w] 522 [533] 698 [697]. 252 
MeHgSBu t 383w [390m] 534m. [536vs] 582m [586s] 
MeHgSPh 382m [382m] 536m[547vs] 692 [698] 253 
MeHgSCH 2P 346m[342t] 538m [540vs] / 700s [702w] .'680W 1684m] 
MeHgSCH 2 C H 
(334m 
'318msh [329s] 
1 550vw,br 
'529w [538vs] 
654m [676m]. 
627m . 
[MeHgSCH 2CH(h13 )CO2-]H20 325m [326vs] 538m [538vs] not reported 236 
[MeHgSC(Me) 2CH(hH 3)CO2- ] 2H 20 322vw,sh [322m] 555m [555m] not reported 254 
[MeHgSCH 2CH 2 iMe3]C104- 329s [331s] 542m [542s] 621vs [621w] 
MeHgSCH(CO2H)CH262H 
f 361m [362m) 539m [550vs] 673m [677w] 
371 [373m] 543w 719w1718W] 
[MeHgSC 5 11 10hHMe]NO3 348 [353m] 533m [539s] 748w [750sj 
(Table 2.3 continued over.. 
dithiolate ligands  
3,4-di(MeHgS)C6 H 3-Me 
MeNgSCH 2 
MeHgSCHCH OH, (MeHg) 2BAL 
MeHgSCHCO 2H 
MeHgSCH 2CO2H, (MeHg) DMSH 2 
MeNgSCH 2 
MeHgSCHCH SO3Na 
MeHgSCH, 
I 
CH(OH) 
MeNgS-CH 2 
354w [370&357m]g 549w [553vw,sh] 
335w [338m] 528w 1.526vsj 
328m.br [328s,br] 530m [537vs] 
537m [535vw,sh] 
352s [358m] 550w,sh [550s] 
526m [531s] 
341s t342vs] 543s [537vs] 
685w.[690m 
662vW [656vw,sh] 238 
686m 1675m] 
660w 1655vw] 
586m [585vw] 
684m [687w] 238 
MeHg) 2DMP 
, Na[(M0Hg)2UT] 
333w,br [329m,br] 
Table 2.3: Hg-S, Hg-C and C-S stretching frequencies for MONg(II) thiolates and dithiolatesa 
athis work unless otherwise stated. Raman values are shown in parentheses. btoluene-3,4-dithiol 
cN-methy1-4-mercaptopiperidine d1,3-dimercapto-2-propanol e in D20 (PD5.6)vHgS [342m], v cHg[546s] 
fin 020 pD=5.6 vHgs [365m] vHgc[547vs] gligand has 364w hpoor quality far infrared spectrum. 
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ligands. The mercury-sulfur stretching frequencies of the monothiolato 
complexes shown in :Fable 2.3 also fall within a fairly narrow range, 
329-390 cm-1 . The band due to this vibration is absent in the spectra 
of the thiol ligands but is usually of medium to strong intensity in 
both i.r. and Raman spectra of the complexes. The centrosymmetric 
sulfide compex (MeHg) 2S also has1 vHgs near this range [v as 344, vs 300]. 269 
The carbon-sulfur stretching frequency is more difficult to assign 
in these complexes, as there are usually several weak to medium intensity 
ligand vibrations in the region 600-700 cm -1 . The values of "es  reported 
in Table 2.2 have been assigned by comparison with previously published 
values and are probably moderately coupled to other ligand vibrations, 
giving rise to variable intensities. 
The vibrational features of the. 2:1 MeRg(II) complexes with 
•dithiolate ligands are also shown in Table 2.3 and can be readily 
compared with those of monothiolato complexes. In the previously 
reported 2:1 complexes of vicinal BALH 2 and its non-vicinal analog DMPH 2 , 
values for vHgc , vHgs and vcs are all consistent with simple linear 
'C-HgS' coordination. 238 The 2:1 complex with toluene-3,4-dithiol has 
• been previously prepared 230 in conjunction with that of the chelating 
dithiol, trans-1,2-dimercaptocyclohexane (Figure 2.4), but no spectroscopic 
details are available. The vibrational features of the toluene-3,4-dithiol 
complex and those of the complexes with antidotal DMSH4 and Unithiol are 
also consistent with simple linear 'C-Hg-S' coordination to form structures 
of the type: 
H 3C 
H 3C 
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Finure 2. _ holecular structure of trans-1,2-dimercaptoCyclohexanebjs 
[methylmertury(II)] from reference 2 -30, 
It is not possible to say whether the slight (15-20 cm -1 ) splitting seen 
in Ihec-Hg vibrational band of the toluene-3,4-dithiol and DrISH 4 complexes, 
is due to two different C4in environments, vin, one chelated MeH(L 
Although Such Splittinc is also seen in the Mercaptoacetate and 4-mercapto-
N-methylpiperidine monothiolate complexes, it is evident only in the i.r. 
spectra in these cases. The complex with confirmed chelated MeHg(II) 
was not available for this study, but its vibrational spectra would seem 
to warrant some attention. 
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2.3 Structural features of complexes of the type, Hg(SR) 2 
The very high stability of the C-Hg and Hg-S bonds in MeHgSR species 
and the very low residual Lewis acidity of the MeHgS- group, always leads 
•to dominant linear 2-coordination about mercury, with occasional weaker 
interactions with nearby donors to yield higher 'effective' 243 
coordination numbers. In contrast, the mercury atom in a complex of the 
type Hg(SR) 2 has somewhat more freedom to assume alternate sp (linear) 
or sp
3 
 (tetrahedral) coordination geometries, and in fact both situations 
arise in the few published single-crystal X-ray crystallographic studies of 
such complexes. 
Preliminary crystallographic work carried out by Wells 270 in 1937, 
suggested that the complexes Hg[S(CH 2 ) nCH 3] n = 1,2,4,5,6 were isomorphous, 
linear, molecular solids. The n-butyl (n=3) and n-octyl (n=7) members of 
this homologous series were apparently anomolous, e.g. crystals of these 
compounds were tetragonal and triclinic respectively, in contrast to 
monoclinic for the other members. Intriguingly, the anomolous n-butyl 
compound is also found in the trend for melting points and solid-state 
densities of this series (Figure 2.5). 
The molecular structure of the methyl homolog (not studies by Wells) 
was unambiguously determined by Bradley and Kunchur 271 , and is shown in 
Figure 2.6. The structure clearly contains linear molecules, Hg(SMe) 2 , 
but secondary weak intramolecular Hg-S interactions produce a three-
dimensional polymeric structure, consistent with the high melting point 
• and density in the solid state (Figure 2.6). Figure 2.7 shows the 
structure of Hg(SEt) 2 subsequently determined by these workers 274 , in 
which intermolecular interactions between the linear molecules are essentially 
nonexistent (Hg-S 3.53 and 3.56R compared with the sum of the van der Waal's 
radii, 
3.354 242-3)• 
11'175Bu tt) 4. 157 3.5 
-3 
g cm 
mp o 
130 
110 
90 
70 
50 
5 6 7 
no. C atoms 
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234 
Figure 2.5: Comparison of melting point and solid-state density of 
bis(alkylthiolato)mercury(II) complexes. 
*taken from reference 270 for the n-alkyl homologues 0 ref. 271 
0 ref. 272 t-butyl sublimes at 135° (ref. 273) 
Particularly interesting in this series is the structure of the 
tert-butyl analog (not studied by Wells) which was also determined by 
Bradley. 273 Figure 2.8 shows the polymeric nature of Hg(SBu t ) 2 
(consistent with its high sublimation temperature and low density) in 
which the mercury atom is now clearly tetrahedrally coordinated to 
doubly-bridging sulfur atoms. 
The transition from linear to tetrahedral geometry in the tert- 
butyl analog is probably a reflection of the relatively high Lewis basicity, 
45 
0 c 
Os 
• Hg 
Figure 2.6: Molecular structure of Hg(SMe) 2 from reference 271 
Figure 2.7: Molecular structure of Hg(SEt) 2 from reference 274 
Figure 2.8: Molecular structure of Hg(SBu t ) 2 from reference 273 
163 S 
r":0.32 
S'<33 N \ 
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hence high bridging ability, of the tert-butyl sulfur, but may also be 
influenced by steric effects. The complex of Hg
2+ 
with 8-mercapto- 
quinoline (Figure 2.9) apparently has nearly linear 'HgS 2 ' geometry 
with strong Hg-N interactions. 275 
Figure 2.9: Molecular structure of bis(8-mercaptoquinolinato)mercury(II) 
Details of the structure are unavailable in Tasmania and one abstracted 
distance, 275 Hg-N 1.36-1.50A is surely incorrect (the covalent radii of 
digonal and tetrahedral Hg(II) are 1.30A and 1.48A. respectively243 ). 
Dichlorobis(6-mercaptopurine)mercury(II) consists of discrete 
monomeric molecules with distorted tetrahedral 'HgS 2C1 2 geometry about 
mercury
276 
(Figure 2.10). 
Interestingly, chelation of Hg by S and N 7 is not observed due to 
the "preference (of Hg) for chlorine over nitrogen donors." 276 Although 
formally a thiol, the ligand has appreciable thione character which must 
assist in increasing the residual Lewis acidity of the 'HgS 2 ' moiety and 
thus favour tetrahedral over linear coordination. 
• Figure 2.10: Molecular structure of dichlorobis 6-mercaptopurine) 
mercury(II), from reference 276. 
The C-S bond retains an appreciable double-bond character in the 
complex but this is not directly reflected in the Hg-S bond distance 
0 
(2.48A), e.g. Hg(SMe) 2 has Hg-S 2.36A but Hg(SEt) 2 has Hg-S 2.454. 
The only other crystallographically studied bisthiolato[mercury(II)] 
complexes, of which this author is aware, are those formed between HgC1 2 
and the biologically important thiols, L-cysteine 277 ' 246 and DL-penicill-
amine278 ' 246. 	The complex Hg[SCH 2CH(NH3 )CO23[SCH 2CH(NH 3 )CO2H]Cl.k.H 20 has 
nearly linear 'HgS 2 ' geometry and ionic chloride (Figure 2.11). As Carty 
points out,
246 
this species has only one extra proton than "mercury 
cysteinate", Hg[SCH 2CN(NH3 ) 02] 2 , which is a metabolic product of certain 
mercurial diuretics. 234 	 • 
The closely related penicillamine complex Hg{[SC(Me) 2CH(N11 3 )CO 2H] 2C1} 
Cl.H 2 
 0 contains one additional proton (and hence one additional chloride for 
electroneutrality) and has a similar structure, but the linear molecules are 
47 
Figure 2.11: Molecular structure of Hg[SCH 2CH(NH 2 )CO2][SCH 2CH(NH3 )CO 2H] 
ClAH20, from reference 277. 	The penicillamine complex 
is similar, but the chloride shown here bridges two 
molecules (Hg-C1 2.85A) 278 
linked into spirals by the new (bridging) chloride. 
The complex Hg(SCH 2CO 2H) 2 , I, was precipitated as glistening plates 
by the addition of HgC1 2 or Hg(CN) 2 to two equivalents of mercaptoacetic 
acid (thioglycolic acid) in water. 
HgX 2 + 2HSCH2CO2H Hg(SCH 2CO2H) 2 2HX 
Although this compound has been known for many years, 278 it does not seem 
to have been characterised in the solid state, and so its microanalysis 
is recorded below (Table 2.4). It is of interest in this study as a 
model for the complex with DMSH 4 , and also for the bis(selenolato)mercury(II) 
analog ( page 186). 
Dissolution of I in two equivalents of aqueous KOH and evaportion of 
the solution under nitrogen, produced K2[Hg(5CH2CO2 ) 2] as a white powder. 
48 
This compound decomposes significantly (turning yellow) unless kept 
refrigerated in amber glass, but gives a satisfactory analysis under 
these conditions (Table 2.4). 
Complex C 
required % 
H Hg S C 
found % 
H Hg S 
Hg(SCH 2CO 2H) 2 12.5 1.58 52.4 16.8 12.4 1.63 52.5 17.0 
K2 [Hg(SCH 2CO2 ) 2] 10.5 0.88 43.7 14.0 10.3 0.98 43.9 14.0 
HgDMSH 2 .2H 20
a 
11.5 1.93 48.1 15.4 11.9 1.85 48.4 15.5 
Table 2.4: Analysis of previously uncharacteristed Hg(II) thiolates 
and dithiolates.b 
aprepared elsewhere (Br. Pat. 716,647) 280 
bThe complex with Unithiol was not obtained in sufficient purity to 
warrant microanalysis, but has been prepared elsewhere (page 
53 ) 281 
 
Two homologs of I, Hg(SCH 2CH2CO2H) 2 282 and Hg[SCH(Me)CO2H] 2283 have been 
prepared elsewhere, but only microanalysis and very little infrared data 
(vC=0,vC-0,vC-S) were used to 'characterise' them. 
It was expected that the monothiol analog of DMSH 4 ,2-mercapto-
succinic acid, would also form an Hg(SR) 2 complex, but it could not be 
isolated in this study (page343). The 1:1 complex 
Hg[SCH(CO 2H)CH 2CO2H] has been prepared elsewhere, but was only 
characterised on the basis of the infrared vibrations of the carboxylate 
group, and by differential thermal analysis. 
49 
Due to the varied coordination possibilities in Hg(SR) 2 complexes, 
interpretation of the solid-state vibrational spectra is considerably 
50 
more difficult than for MeHgSR species. The mercury-sulfur stretching 
frequency is the most characteristic for assignment of structure. It has 
been clearly demonstrated231 that v(Hg-S) decreases as coordination 
number increases for related model compounds. Thus two coordinate 
Hg(SR) 2 R=Me, Et231 have v as (SHgS) 337, 407 cm v s (SHgS) 297, 268 
cm-1 , higher than four coordinate Hg(SBu t ) 2231 with vas (SHgS) 172 and 
vs(SHgS) 186 Cm-1 . Similar trends hold for chloromercury(II) complexes, 
e.g. two coordinate PhHgC1 285 has v(HgC1) 331 cm contrast to four 
coordinate [R4N] 2 [HgC1 4], R=Me, 286 Et287 With Vas (C1HgC1) 225, 228 cm71 
and v 5 (C1HgC1) 264, 268 cm. 
The assigned mercury-sulfur stretching frequencies of several 
bis(alkylthiolato)mercury(II) Complexes, prepared in this work as models 
for dithiolate and selenolate complexation, are recorded in Table 2.5. 
Several previously prepared and spectroscopically characterised complexes 
have been included for comparison. 
Hg(SMe) .2 2 7 1 and Hg(SE02 274 are known to have linear two-coordinate 
HgS 2 ' geometry from crystallographic studies (page 45). 
The complexes Hg(SR) 2 R=Prn,Ph,CH2Ph,CH 2CO2H (and corresponding di-
potassium salt) have therefore also been assigned two-coordinate 'HgS 2 . 1 
-1 
geometry with v as (SHgS) in the range 330-410 cm, and vs (SHgS) in the 
range 290-390 cm -1 . the 'symmetric Hg-S band is usually intense in the 
Raman spectrum and weak in lhe infrared spectrum of these complexes. 
The converse is true for vas (SHgS). The linear structures in the solid- 
state are consistent with the monomeric behaviour of Hg(SR) 2 in pyridine 
(R=Et,Prn ,Pr i ,Bu n ,Bu i ,Bu t ) 272 and chloroform (R=Et,Bu t ,Ph) 238 solutions. 
The Raman spectrum of K2[Hg(SCH 2CO2) 2] in aqueous solution at pli ,k,7 
has an intense, strongly polarised, band at 347 cm  can be unambig- 
uously assigned to v s (SHgS). In the solid state, this complex has the 
sate intense band at 328 cm - . The Spectra of this complex and of the 
51 
Complex 
 
v  s (SHgS) 
 
vs (SHgS) 
 
Ref .b 
     
monothiolates  
Hg(SMe) 2 
Hg(SEt) 2 d 
Hg(SPrn ) 2 
Hg(SPr 1 ) 2 f 
Hg(SBu r1 ) 2 g 
Hg(SBu 1 ) 2 h 
Hg(SBu t. ) 2 
Hg(SPh) 2 , 
'Hg(SCH 2Ph) 2 
Hg(SCH 2CO 2H) 2 
K 2[Hg(SCH 2CO2 ) 2] 
338vs [338w] 298w [298m] 272 
337vs [338vw] 296m [297vs] 231 
405s,b [394vs] 231 
408vs [412w] 392sh [395vs] 272 
assignment uncertain 272 
assignment uncertain 272 
assignment uncertain 272 
172vs,b [188vs] 231 
365s,br [344s] 238 
381s [385vw,sh] 352w [356s] 
379s [370w,sh] 351w L350s] k 
355s [360vv] 321w [328vs] 
dithiolates  
HgBAL 
HgDMP 
HgDMSH 2 .2H20 
Na[HglIT] 
,1,348m,vbr 
353m,b 
389m 
,v360w,sh 
[298s,vb] 
[325vs] 
306w 
[316s,bj 
238 
238 
Table 2.5: Mercury-sulfur stretching frequenciesa for mercury(II) 
thiolate and dithiolate complexes. 
Footnotes to Table 2.5  
aRaman bands are shown in parentheses [ ]. 
Abbreviations: v, very; s, strong; m, medium; w, weak; b, broad; sh, 
shoulder; p, polarised. 
this work unless otherwise indicated. Assignments for R=Pr
n
, Pr
i
, 
Bun, Bui have been made from the spectral bands recorded in ref. 272 
and often differ from those made by Biscarini et al. 
cin pyridinju v s 355vs; v
as
[ 318vs(P)] 
din pyridine 272 v s 330s; v as [304vs(p)] 
Biscarini assigns v s 268s; vas 246s in the solid state and the bands 
-1 near 400 cm to “CCS) and notes the possibility of coexistence of 
rotattonal isomers. 
e 
 i
- 
n pyridine
272 
 v
s 
359vs; v
as 
1.329vs(P).1 
41scarini assigns v s 256m; vas [232vs] in the solid-state, however 
v
s 
388vs; v
as 
[380m] is also possible. 
in pyridine: v s 
352m, 260m; v
as 
[323m,p, 237vs,p] 
272 
gBiscarini assigns v s 252vs; v as [218vs] in the solid-state 
but vs 361vs, vas (325vs,p) in pyridine 272 
Biscarini •assigns v
s 
277vs; vas 
[250vs] in the solid-state 
but vs 366vs; vas [323vs,p] in pyridine 272 
iBiscarini assigns v 33•vs but no v
as 
in the solid-state 
and vs 246s; vas [233vs,p] in pyridine 272 
° this band not been by Biscarini (>180 am-1 
k
v
as 
[347s,p] in KOH solution, pH7. 
gives unusable Raman spectrum 
m
very poor quality for i.r. spectrum see text. 
protonated analog have been particularly valuable for the assignment of 
linear 'HgSe2 ' geometry to Hg(SeCH 2CO2H) 2 (Chapter 4, page 220). 
Mercury-sulfur vibrations due to the tetrahedral 'HgS 4 ' moiety in 
-1 
Hg(SBu t ) 2 lie at much lower wavenumbers, v s 170 cm-1 and vas 190 cm 
and this complex is also of importance in the assignment of tetrahedral 
'HgSe4 ' geometry to several Hg(SeR) 2 complexes (Chapter 4). 
52 
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2.4 Structural features of'Hg(II)Aithiolate complexes  
The 1:1 dithiolato complex of DMSH4 is a dihydrate and the infrared 
spectrum of this complex shows a broad absorption due to hydrogen bonded 
OH (3200-3600 m,br). The complex with Unithiol was isolated as the 
sodium salt from acidic solution. This product was consistently 
produced as a somewhat sticky solid which could not be dried (even by 
high vacuum pumping or storage over P 205 ) to an adequate state to warrant 
microanalysis. The near infrared spectrum of this product also showed 
broad OH absorption (3200-3600 w) and was generally of poorer quality than 
the other complexes studied. Both dithiolate complexes have very broad, 
low intensity, far infrared spectra (600-200 cm -1 ). Only two bands are 
discernible in the far i.r. spectra of HgDMSH 2 .2H 20 : 389m, 306w and 
these absorptions do not appear in the spectrum of the ligand and have 
thus been assigned as v as (SHgS) and v s (SHgS) respectively. 
All attempts to obtain a usable Raman spectrum from this solid were 
fruitless, even under conditions of low energy (red dye) laser excitation 
which did not seem to lead to sample decomposition. HgBAL has been 
shown to be amorphous and also gives relatively poor quality, diffuse 
spectra. 231 
The Unithiol complex Na[Hg(UT)].2H 20 
gives a poor quality far infrared spectrum, with a very broad medium 
intensity absorption [600-250 cm] containing poorly resolved features 
at 580m, 540w, 360w,sh [v as (SHgS)]. The Raman spectrum of this complex 
is featureless in the range 600-100 cm -1 except for a strong, broad band 
at 316 cm
-1 assigned to v s (SHgS). 
The infrared spectrum of HgDMSH 2 .2H20 and the infrared and Raman 
spectra of Na[Hg(UT)] are consistent with the linear polymeric structure 
postulated for HgBAL:231 
—2 
HO OH 
   
S—Hg— S S — Hg — S S—Hg—S 
although the poor quality of the spectra cannot preclude regions of the 
polymer with higher coordination numbers for mercury. 
It has been known for some time that intractable HgBAL will dissolve 
in excess dithiol ligand to give a conducting solution ,288  presumed to 
contain Hg(BAL) 2
2- 
anions in which Hg is tetrahedrally coordinated. 
The equilibrium constant for this reaction has been established and is 
quite high: 232 
HgBAL + BAL 2- 	 Hg(BAL) 2 2- K = 108 ' 6 
The conductivity of a solution containing two equivalents of BAL 2- per 
mercuric ion, is much high than that of the analogous non-vicinal dithiolate, 
DMP 2- 288 which may reflect the preference for 5-membered over 6-membered 
chelate rings, 
S 	/S 
/19 
S SOH 
i .e. 
Similar. 1:2 bis(dithiolato)mercury(II) complexes have been isolated 
with toluene-3,4-dithiol and 1-chlorobenzene-3,4-dithiol, as the 
dipotassium and bis(quinine) salts respectively. 
—2- 
S\ 
1-19 
/ • 
Interestingly, these compounds are molecularly disymmetric, but have not 
been characterised in the solid state. 
2.5 Structural features of RSHgX species  
Many bis(alkylthiolato)mercury(II) complexes will dissolve in 
solutions of HgX 2 , X=C1,Br,I, acetate to form complexes of the type 
RSHgX via the equilibria 
Hg(SR) 2 + HgX2  , 2RSHgX 
The equilibria for R = CF3 ; X=C1,Br,I, have been followed by vibrational 
spectroscopy
290. 
Such species may be of considerable importance in the 
-biological context, since many endogenous ligands, e.g. nitrogen containing 
bases, chloride etc. will be present at the Hg-sulfhydryl binding site(s) 
in vivo. 	Most 1:1 Hg(II) thiolates which could act as models for the 
biological interaction of RSHg(II) with non-thiol ligands, are insoluble 
in water and common organic solvents, but several dissolve in coordinating 
solvents such as pyridiA9e34 imidazole 291 to form adducts, some of which 
have also been crystallographically characterised. 
MeSHg02CMe is uniquely water-soluble and has been shown by Raman 
spectroscopy to form a diner in solution near pH6 292 . 
Although no new RSHgX species have been prepared in this study, the 
first RSeHgX analogs to be characterised by single-crystal X-ray diffraction 
are described in Chapter 4. For this reason, a brief review of the 
structural features of RSHgX complexes is included here. 
All RSHg02CMe complexes studied crystallographically to date (R=Me; 293 
Pro , Bun. 
294 
 ) consist of polymeric (-Hg-SR) n parallel chains which are 
linked by acetate groups to form wrinkled sheets. The structure of the 
methyl analog is identical to that of isomorphous MeSeHg0 2CMe shown in 
Figure 2.12. In the N-base adducts RSHg0 2CMe(py) R=Me
293
,Et
295 and 
MeSHg02CMe(4Mepy)
295
, coordination of pyridine or 4-methylpyridtne results 
in displacement of bridging acetate groups to give isolated chains with 
55 
R 
S 
0 // 
I 
0 
56 
s 'Hg 	Hg /1 
Figure 2.12: Schematic structure of polymeric RSHg0 2CMe; 
R=Me 293 , Prn and Bun 291 
PY 	S 
00 
Hg 
\O 
SR 	PY 
SR 
Figure 2.13: Schematic structure of the pyridine adducts of 
RSHg02CMe; R=Me
293
, Et
295 
and the 4-methylpyridine 
adduct of MeSHg0 2CMe 295 . 
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N-base and bidentate acetate coordination at each mercury atom. 
. 
The complexes MeSHgX (X=C1
, 296Br295
) are isostructural and are 
based on (Hg-SMe) n chains linked by triply bridging halogen atoms 
(coordinated to two mercury atoms in one chain and one mercury atom in 
an adjacent chain) to form wrinkled sheets. 
I 	I 	1 1 I 	v 1 
S 	I 	' \ : 	S I 'M H /MeHg' 1 gNle,, Hg 	
7 
_ / : 
	
N X / 1 	S I 1 	1
X 	
X 
N , Hg Me / Hg 
1 
1 N 
	
Hg Mez 1 
x S 	1 1 1 
Figure 2.14: Schematic structure of MeSHgX (X=C1, 296 Br295 ) taken 
from reference 297. 
Other crystallographically characterised RSHgX (X=halide) complexes 
which contain (-Hg-SR) n chains are those formed between HgC1 2and cysteine 277 
or penicillamine ; 278 and between HgB 2 and the thiosteroid spiroxazone 298 . 
The molecular structure of HgC1 2[SCH 2CH(NH3 )CO 2H] is shown in 
Figure 2.15a, and consists of chains of -(-Hg-SCys) n groups in which 
the Hg atom is tetrahedrally coordinated with 'Hg(p-SCys)C1 2 1 geometry. 
The penicillamine complex, (HgC1 2 ) 2 [SC(Me) 2 CH(NH 3 )CO 2H.J.2H 20 has a more 
complex structure (Figure 2.15b) in which the sulfhydryl donor asymmetrically 
bridges two mercury atoms. The mercury atoms have distorted tetrahedral 
geometry of the types 'Hg(u-SPen)C1 3 1 and 'Hg(p-SPen)C1(C1 1 ) 2 1 . In the 
Br 
zgrN /S N 
Hg 	H 
.13.rr° 
SR 
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latter case, two intermolecular Hg-C1' contacts complete the coordination 
sphere. 
CE 	c i c t 	C E 	1 CL 	Cl \ / \/ ' 	I 	CI% I 
	
Hg 	Hg 	- -C 1..F.i g -Hg--CI \ 7 N ,7- 
CIV 57 S 	S 	S 
I ysH2 	1 l'enH2 
Figure 2.15: Schematic structures of a) HgC1 2 (11-SCysH 2 ) and 
b) HgC1 2 (p-SPenH 2 ).2H 20, from reference 246. 
Figure 2.16: Schematic structure of the thiosteroid complex, 
(SNX)SHgBR (SNX-SH = spiroxazone) 298 
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The isostructural complexes [Bu tSHgCl(py) 0.51943 and [Bu tSHgC1(4-Mepy) 0.5 ] 4  
differ from the other RSHgX complexes reported inasmuch as the tetratheric 
molecules are based on ,eight-membered -(-Hg-SBu t ) 4 rings, rather than 
infinite Chains_
293 
 There are two mercury environments, 'Hg(p-SBu
t
) 2C1N' 
and Hg(1.-SBut )(p-C1) 2 '. A new RSeHgX compound, [ButSeHgCl(py) 0. 0 4 has 
been shown in this study to be isomorphoUs with the 4 7Mepy adduct of the 
sulfur analog, and the crystal structures of these compounds are discussed 
in more detail in Chapter 4 of this thesis. 
The vibrational spectra of polymeric RSHgX complexes are difficult to 
interpret. Canty has recently noted that assignment of structure .based 
cn simple point group approaches to the spectra of these molecules, may be 
misleading. 297 For example, the spectra of MeSHgC1 were interpreted in - 
terms Of a monomeric, dimeric or polymeric structure based on 
'Hg(p-SMe) 2Hg' or 'Hg(p-C1) 2Hg' bridging units,2 99 however the previously 
described single-crystal X-ray determination 29 (page 57 ) is not 
consistent with this interpretation. 
Assignment of mercury-ligand vibrational frequencies is not straight-
forward for the RSHg(halides) as mercury-sulfur and mercury-halogen 
vibrations occur at similar frequencies in related complexes, e.g. HgC1 2 : 
1 300 
'as 375 85-368 300 , vs 330-310 cm_ ', linear Hg(SR)2: vas 
 330-410, v s 
, 290-390 cm  51 ), and BU tSHgCl: i.r. 359m, 273s, 236m; Raman 391m, 
384m,.359m; 330m, 274vs•, 223vs, 201Vs cm71 .3o1 
2.6 Conclusions  
The known crystallographic structures of MeHg(II)-thiolates have been 
reviewed and several MeNgSR complexes characterised by vibrational 
spectroscopy in the solid state. Coincident infrared and Raman bands 
in the range 320-390 cm  been assigned as Hg-S stretching modes, 
60 
-1 
and bands in the range 520-560 cm to Hg-C modes, consistent with the 
expected linear 'MeHgS' geometry. MeHg(II) dithiolates have similar 
vibrational spectroscopic and structural features. 
Bis(thiolato)mercury(II) compounds, Hg(SR) 2 have vibrational spectra 
consistent with normally linear 'HgS 2 ' geometry 
[vas(SHgS) 330-410 cm 
 vs (SHgS) 290-390 cm-l j , 
except for Hg(SBu ) 2 which is known to have tetrahedrally coordinate 
mercury [v s (SHgS) '070 cm  vas (SHgS) r190 cm-1 ]. 
All Hg(II)-dithiolates studied by vibrational spectroscopy to date 
seem to have polymeric, linear structures. 
Monothiolatomercury(II) species, MeSHgX, have complex polymeric 
structures based on (-Hg-SR) n infinite chains or eight-membered rings. 
Interpretation of the vibrational spectra of these polymeric molecules 
cannot readily be achieved usfng simple point-group approaches. 
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CHAPTER THREE  
SOLUTION CHEMISTRY OF METHYLMERCURY(II) THIOLATES AND SELENOLATES  
3.1 Introduction  
Methylmercury has a high affinity for 'soft' sulfhydryl ligands, 
consistent with the 'soft' acid nature of the metal and it is generally 
considered that many of the toxicological properties of MeHg(II) are 
12 
due to bonding to sulfhydryl groups of peptides and proteins in vivo. 
It is therefore somewhat surprising that only a small amount of detailed 
stability constant information for methylmercury thiolates is available, 
and that this includes some serious discrepancies in the magnitude of the 
formation constants for MeHg(II) with several monothiols. 'Since 
solution equilibrium constants may be of some significance in the 
understanding of the effectiveness of antidotal thiols for removal of 
MeHg(II) from body tissues, this study has involved redetermination of 
the MeHg(II) formation constants with the biologically important mono-
thiols cysteine and glutathione, and the simple monothiols mercapto-
ethanol, mercaptoacetic acid, mercaptosuccinic acid, thiocholine and 
4-mercapto-N-methylpiperidine. In addition, the complexation equilibria 
with antidotal thiols penicillamine and N-acetylpenicillamine and vicinal 
dithiols BALH 2 , Unithiol and DM51-I 4 have been investigated. 
When this work was near completion, Reid and Rabenstein published 
the results of their 1 11 nmr evaluations of MeHg(II) formation constants 
with many of the monothiols mentioned above. 302 These workers have 
apparently determined the formation constants with glutathione, but the 
results were unpublished; 3°, 3 however, the formation constant of 
MeHg(II) with the biological Monothiol homOcysteine was reported. 
Attempts to investigate homocysteine in this study were unfortunately 
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frustrated by low purity of the commercially available product and rapid 
decomposition in solution. 
A brief report of part of the work described in this Chapter of the 
thesis was presented at a conference prior to publication of the work by 
Reid and Rabenstein (Appendix 1). Publication of their work produced 
a unique opportunity to compare the results obtained from two widely 
different techniques and firmly establish stability constants for the 
MeHg(II) thiolate interaction. 
The important features of the nmr technique, which has been used 
elsewhere for studies of MeHg(II) equilibria with many non-thiolate 
ligands, will be discussed below. The potentiometric method, used to 
evaluate the stability constants in this study, will be described in 
detail in Chapter 6 of this thesis, but the stability constants them-
selves will be discussed below. 
The reported antagonistic effects of some selenium compounds against 
methylmercury toxicity and the existence of reduced selenohydryl groups 
in some selenoproteins (Chapter 1) has generated considerable interest 
in methylmercury selenolate interactions in solution. Several nmr 
studies have indicated that MeHg(II)-selenolate binding may be thermo-
dynamically more favorable than analogous thiolate binding, but no 
stability constant data have been recorded. Attempts to study the 
methylmercury-selenoacetate system potentiometrically in this work have 
been frustrated by failure to obtain the free ligand in solution for 
accurate evaluation of its hydrolysis constants. 
3.2 The Aqueous Solution Chemistry of Methylmercury(II)  
3.2.1 Coordination of MeHg(II) in aqueous solution  
The solution chemistry of MeHg(II) has been recently reviewed, 41 
and is dominated by the tendency of mercury toward linear two-coordination. 
63 
However, some residual Lewis acidity is evident from the formation of 
complexes with chelating ligands in which higher coordination numbers 
for MeHg(II) of three or four for mercury have been found. The 
chemistry of MeHg(II) with these ligands has been reviewed elsewhere.
249,304 
 
In addition to polydentate ligands, some simple unidentate ligands also 
305 305 
permit higher coordination, e.g. iodide, cyanide and thi 
268 
ocyanate. 
The possibility of higher coordination with sulfur donors was considered 
for the interaction of MeHg(II) with thiols used In this study, parti-
cularly the antidotal vicinal dithiols BALH 2 , Unithiol, and DMSH4 . 
Previous work in this laboratory has not indicated any definitive 
evidence for chelation in the complex (MeHg) 2BAL in the solid state, but 
a recent simple crystal X-ray structure
230 
 of the complex trans-(l,2- 
cyclohexanedithiolato)bis[methylmercury(II)] shows S-chelated methyl-
mercury (page 42 ). In solution, Schwarzenbach and Schellenberg
305 
have shown that mercaptoethanol will interact with MeHg(II) to form a 
complex of the type MeHg(SR) 2- , as well as the highly stable monothiolate. 
MeHgSCH 2CH 2OH + -SCH 2CH2OH MeHg(SCH 2CH 2OH) 2- K io627  
The aqueous solution chemistry of MeHg(II) is also dominated by 
the self-association and hydrolysis reactions: 
MeHg(OH 2 ) 4- + MeHIPH + H
2
0 
MeHig. (OH 2 ) + + MeHg) 20H+ + H 20 K2 - 
[MeHg(OH 2 ) 41[MeHg0H] 
[(MeHg) 0 4.] 
[(MeHg) 20H / ]NeHg0H] 
The first two hydrolysis equilibria were proposed by Schwarzenbach and 
Schellenbere 5 from equilibrium constant measurements, 305 and have been 
_ [MeHg0Hj  
N i 
[MeHg(OH)
2
+
][OH1  
[(MeHg) 20H + ] 
(MeHg) 20H+ + MeHg0H H 20 
64 
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supported by Raman 
306 
and 1 H nmr306 ' 309 spectral data. 
Equilibrium constants for these equilibria have been measured here under the 
conditions used for methylmercury-thiolate and thiol hydrolysis equilibria 
(0.1 M KNO 3 , 25°). Several acidic (HNO 3) solutions of methylmercuric 
ion were titrated with 0.1 M KOH, and the composite data (186 titration 
points) treated by MINIQUAD81 (page 326) to generate equilibrium 
constants P. 10-1  and p. 20-1  for the equilibria:
t 
a [MeHg0H]  
MeHg
+ 
+ H 20 .-=--- MeHg0H + H
+ 
10-1 
[MeHg+][e] -1 
[(MeHg) 0H+ ] 
2MeHe + H 20c (MeHg) 20H 11 + _ + + 2  
20-1 
[MeHg+]2[H+]-1 
The actual titration data are shown in Figure 3.1, fitted by curves 
calculated using these values of10-1  and - 201 ' A comparison of P' B -
these constants from this work, and those obtained elsewhere, is shown 
 
c + 
in Table 3.1. It should be noted that, unless values for IS 01 = [H ][0H - ] 
are accurately known under actual experimental conditions used to 
determine 1310-1 and  13,20-1'  these constants must be expressed in terms of 
[W] and not [OH - ]. 
The trinuclear cation (MeHg) 30
+ 
has been shown by 
1
H nmr spectros-
copy to be a very minor component in dilute solutions, since its 
equilibrium constant for formation is small, 0.7±0.3.P °6 The trinuclear 
cation has been isolated as perchlorate 310 or nitrate 311 salts from 
concentrated neutral aqueous solutions, and single crystal X-ray 
structures of these salts have been determined. In the dilute solutions 
used in this study, [MeHg] l0 3M, (MeHg) 30+ constitutes, at most, 0.01% 
of the total MeHg(II) concentration, hence the corresponding equilibrium 
constant for its formation, 30 _ 2 , was unobtainable. 
tFor brevity MeHg will be used subsequently to represent MeHg(OH 2 ) 
The computer program MIMQUAD81 will be discussed in Chapter 6. 
9.2 - 
7.6 
6.0 
4.4 
2.8.- 
pH 
a 16/1/80 
initial mmoles 
KOH/M 
0.1085 
vol./mL 
59.96 
MeHg(II) 
0.1540 
H+ 
0.04164 
b 27/2/80 0.1549 0.04246 0.1089 59.96 
c 8/1/80 0.1537 0.0408 0.1085 59.96 
d 8/1/80 0.1542 0.5399 0.1085 64.98 
e 11/10/79 0.8653 0.1706 0.09898 49.96 
f 11/10/79 0.8656 0.6888 0.09898 54.96 
g 12/10/79 0.1722 0.03340 0.09898 59.96 
h 12/10/79 0.1728 0.5436 0.09898 64.95 
65 
-1.5 0 mMoles'e/mmoles MeHg(II) 1.5 
Figure 3.1: Methylmercury(II) hydrolysis data. 
The solid curves were calculated by COMIXH for the experimental conditions 
shown, with log= -4.607 and log B 1310-1 . 20-1 = - 2.234. 
  
[MeHg0H] 
 
[(MeHg) 20H+] 
[MeHg 4 ] 2 [H 4 ] -1 
 
[MeHg0H] 
[MeHg+][0H - ] 
 
[(MeHg) 20H+ ] 
  
log 
 
1 log log 
 
method conditions ref. 
   
 
MeHg+][e] -/ [MeHg0H][MeHg 
      
         
-4.607(9) b -2.234(18)b 9.25(3) d 2.37(4) d gl. h 25°[0.1 	KNO 3 ] A513.86(3) 	this 
v" work 
-2.22d 
-4.59c -2.536 
9.370 2.37c gl.j 20°[0.1 	KNO 3 ] p<=13.96 	305 
9.30c 2.37° 
-4.70e -2.33e 9.36(5)f 2.87(7)f nmrgij 25°[0.19 MeHg(II)] 309 
9.29° 2.31 c nmrg' i 25°[0•3 MeHg(II)] 306 
-4.56±0.05 gl.h 25°[0.1 	KNO3 ] 312 
-4.686(15) c -1.725(30) c 9.624(15)d 2.961(16) d gl. h 25°[0.1 	NaNO 3] p<=13.95 	313 
-4.67(3) c' k gl. 25°[0.1 	KNO3] 	 314 
-4.50e gl. 24-5° 315 
-4.40(2) c 9.55(7) d di str.h 25°[1.0 NaNO3/C1/PO4] 	316 
9.33±0.12c 2.78±0.18c nmrg33 25 ° [ 0.1 NaNO3] 317 
cconstant actually reported in original reference. . d
formation constant (page 63 ) calculated using the values of K w recorded in the original reference. c e 
Auoted in references 313,316 
'recalculated in reference 317 
gl, not given. electrodes. calibrate in .terms of.[H 47]. - h el ectrodes calibrated by [11 +] =10-pH . i  
electrode calibration unspecified. iyii+ calculated using the Davies equation 318 and used to correct 
mixed constants. 
Table 3.1: Methylmercury(II) hydrolysis constants. a 
aestimated standard deviations of the last digit are recorded in parentheses. b
weighted geometric means of eight values calculated by MINIQUAD81 from data shown in Figure 3.1. 
[(MeHg) 20H+ ] 
630-2 -  
[MeH49 4 ]2 [H4 ] - 
[MeHg0H]  
 
1 • 
[MeHe][0] -1 [(MeHg) 2OH I ][MeHg0H] 
[(MeHg) 30 -1 ] 
67 
[(MeHg) 301 ] 
3MeHg
+ 
+ H 20 (MeHg) 30
+ 
+ 2H
+ 
630-2 -  
[MeHg+ ] 3 [e] -2 
This species was neglected in subsequent evaluations of MeHg(II) 
equilibrium constants. A distribution diagram for the methylmercury(II) 
-3 
hydrolysis species is shown in Figure 3.2, calculated by COMIX for 10 M 
[MeHg] total using the constants 10-1  and B .20-1 obtained in this study. 
The constant 630 _ 2 was calculated from the published values of K 3 for 
306 
formation of (MeHg) 30 in concentrated solutions (page 64 ) since 
K3  = (320-1 
From the logarithmic t concentration scale of Figure 3.2, it can clearly 
be seen that the trinuclear species is negligible. 
A similar series of complexes, MeHgS - , (MeHg) 2S and (MeHg) 3S+ is 
formed from sulfide, S
2-
, with formation constants several orders of 
magnitude higher than the hydroxo and oxo species. 305 The crystal 
structure of [(MeHg) 3S]C104 has been reported. 310  
A comprehensive list of MeHg(II) formation constants with ligands 
containing various donor atoms (0, N P, S, Se, C and halogens) is 
shown in Table 3.2, together with values for the protonation constants 
of the ligands and 1 2,1( 1 H- 199Hg)1 (page 75 ) for the MeHg(II) complexes 
where available. The clear preference of MeHg(II), compared with H -1. , 
for 'soft' donors (C, S, Se) can be seen from a comparison of stability 
constants in Table 3.2. 
In a hypothetical system containing MeHg(II) and several competing 
ligands, some of which may participate in protolytic equilibria, the 
tAll other species distribution diagrams in this thesis have linear 
concentration scales. 
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ligand log Kfa pKad 
0-donors 
319 
q,12 
319 
9.25-9.5 
6.46 323 
320 
•■,25 319 
q,20 
15.7 
8.24 
02- 
CH3Hg0- 
OH - 
Se03
2- 
(CH34)20 ,1,6 319 mo 319 
CO32- 6.10 323 9.57 
tropolonate 5•43 319 'm 6.70 319,m 
phenolate 5.48,319 4.6.5 324 9.62 
HPO 42- 
, 
HP03 4- 
5.03, 3° 9 4.74 316 
4.67 305 
6.79 
6.3 
4-NO2-phenolate 3.80 319 7.15 
(CH3 ) 3C.0O2- 3.50 309 4.95 
CH32CO2 - 3 . 39 309 4.80 
CH3CO2- 3 . 18 , 309 ,„3 . 5 , 324 3 . 55 , 328 3.193°9 4.65 
+NH3 (CH 2 ) 7CO2- 3.15 331 4.56 
+NH 3 (CH 2 ) 5CO2 - 3.10 331 4.46 
+NH 3 (CH 2 ) 4CO2- 3.0 331 4.33 
+NH 3 (CH 2 ) 3CO2 - 2.7 331 4.12 
Se03H - 2.70 323 
(CH 3 ) 2CHCH(NH 3 )CO2- 2.7 331 2.29 
CH 3CONHCH 2CO2 - acetyl- 
glycine 
2.68 309 3.40 
HCO2- 
313 2.67, 3°9 2.68 3.55 
+NH3 (CH 2 ) 2CO2 - 13-alanine 2.52 331 3.61 
CH3Hg0H 2.31-2.96f 4.40-4.701 
C1CH CO - 2 +2 2.19 309 2.75 
(CH3 ) 3NCH 2CO2- 1.71 3 °9 1.87 
Cl 2CHCO2 - 1.14 309 1.00 
Se04
2- 
so42- 
1.12 323 
0.94 323 
1.8 
1.36 
H 20 -1.7g -1.7g 
H 2PO4 -1.74 
N-donors 
11.79 319 14.3 319 imidazolate 
EDTA
4- 
uridine(N-3) 
9.263 333 
9.0 334 
10.0 
9.2 334 
tryptophan 8.85 335 9.39 335 
8-hydroxyquinoline 8.8 312 9.63 
bAstidine(NH2) 8 . 8 324 9.1 
tryptamine 8.47 335 10.2 339 
4-hydroxyquinoline-2-CO2H 8.4 312 11.0 
8-hydroxyquinoline-5-0 3 - 8.3 312 8.37 
NH 2CH 2 (CH 2 C6H 5 )CO2- 8.29 331 9.16 
L-2-phenylalanine 
NH 2CH 2CH 2NH 2 8.25 10.05 
CH3H9-imidazole 8.18 319 9.65 319 
L-tyrosine(NH2) 8 . 12 337,1 9.11 337 
guanosine(N-1) n,8.1 334 9.2 	334 
7-iodo-8-hydroxyquinoline- 8.1 312 7.10 
5-503- 
321 
158(C6H6 ) 
203.0, 3°9 204.0(C6H6 ), 214.2(pyr) 322 
223.5 323 
221.4 323 
208.5(CDC1 3), 325 207(pyr) 326-7 
206(CHC1 3 ) 327 
211.5(CDC13) 325 
214.3(C 6H6 ), 220.8(pyr), 233.4(D20), 322 
212.4(CDC1 3 ), 329 213.5(CDC1 3 ), 325 
232, 220 (diox), 33° 233.3 3°9 
230 .4 3 31 
230.2 331 
290 .031 
237.9 3°9 
230.5
331 
232.5
309 
219.0(C0C1 3 ), 325 217.9(CHC1 3 ) 329 
233.0(CDC1 3 ), 329 222.8(CHC1 3 ), 329 
245.8 3°9 
248.5 323 
251.4 323 
260, 33° 259.8(C6H6), 322 
251.8(CD300) 332 
213.1 335 
213.6 336 
216.5 336 
1 2J 1 H.. 199Hol e 
Table 3.2: 
 
Formation constants of MeHg( II) a and Protona' b complexes of various ligands, a and 2J( 1 H- 199Hg) for the 
MeHg(II) complexes. 
NH2CH 2CO2- glycine 
NH2 (CH2 ) 5 CO2 - 
NH2 (CH2 ) 4 CO2- 
Fe(CN) 64- 
CH
3
CH
2
NH
2 	• 
NH2 (CH 2 ) 7 CO2 - 
NH 3 
CH3NH2 
NH 2 (CH 2 ) 2CO2- 6-alanine 
(CH3 ) 2 CHNH 2 
NH2 (CH 2 ) 3CO2- 
(CH3 ) 3CNH 2 
NH2CH(CO2- )CH3 a-alanine 
CH3SCHCH 2 (CO2- )NH 2 methionine 
(CH3 ) 2 CHCH(CO2- )NH 2 valine 
1,10-phenanthroline 
imidazole 
[Fe(GN) 6 -HgCH3 ]3- 
N-Me-imidazole 
(CH3 ) 2 NH 2 
histidine(Im-N) 
2,2',2"-terpyridyl 
HEDTA3- 
L-tyrosine,Et ester 
2,2'-bipyridyl 
guinoline-2-CO2H 
pyridine-2-azo-p-
dimethylaniline(2-pada) 
benzimidazole 
4-Me-pyridine 
(CH3 ) 3N 
pyridine-4-azo-p-
dimethylaniline(4-pada) 
pyridine 
3-Me-pyridine 
cytidine(N-3) 
2-Me-pyridine 
Co(CN) 6 3- 
Fe(CN) 63- 
guinoline 
[Fe(CN) 6 -HgCH 3 ] 2- 
[Co(CN) 6 -HgCH 3) 2.- 
[2,2',.2."-terpACH3Hg+ 
(CH 3 ) 3N(CH 2 ) 2N(CH3 ) 2 
adenosine(N-1) 
4-NH 2C6H4S03
- 
Halogens 
7.88,331 7,55313 
7.83 331 
7.75 331 
7.66 319m 
7.64 331 
7.60 331 
7 . 50 ,305 7 . 25 , 331 8 . 4324 
7.57 331 
7.56 331 
331 7.56 
7.54 331 
7.52 331 
331 7.52 
338 7.5 
7.41 331 
7.05,339 7 . 15312 
324 
	
7.14,319 	7.3 
7.12,319 
6.96 	41 
6.76 331 
6.4 	324 
6.35 339 
6.2 	324 
6.09 3371 
5•93,339 	5.86 312 
5.75 312 
5.75 339 
5.27 335 
5.03 319m 
N.5.05 331 
4.76 339 
4.72 324 
4.69 319m 
4.6 334 
4.35 319m 
4.15 395 
4.13 31" 
4.05 312 
3.76 119m 
3.50 3°5 
3.25 339 
3.03 319m 
,3 334 
2.60 3°5 
1.50 305 
4.90-5.64h 
6.62 ,305 	5 . 2742 	6. 98 314 
6.70 315 
9.69 
10.84 
10.81 
4.17 
10.82 
10.89 
9.32 
10.81 
10.25 
10.76 
10.48 
10.81 
9.74 
9.81 
4.92 
7.10 
7.18 
11.02 
6.1 
4.69 
7.33 337 
4.44 
4.7 
4.50 
4.34 335 
6.12 
10.05 
5.60 
5.29 
5.80 
4.2 	334 
6.08 
<0 	305 
<1 
4.97 
<0 
6.07 319m 
3 . 5 	334 
3.06 3° 5 
2.85 
Cl - 	 • 
Br- 
8.60P5 8.50'1 , 8.7 315 
69 
2..58 331 216.0 331 
211.2 331 
211.0 331 
214.1 331 
211.5 331 
213.9 331 
209.0 331 
211.9 331 
210.2 331 
218.8,41 	219.5(0300) 249 
216.6 331 
243.0(CO30D) 249 
238.8(CD30D) 332 
218.4 335 
227.8(CO300) 332 
229.6(CD300332 
228.2(CD300332 
227.9(CO300)332 
212(Me0H),340 215.2(pyr), 322 
); 30 203.6(CDC1 211(diox 	 3),341 
221.5(DMSO)341 
207(Me0H );4° 212.0(pyr),322 
221.5(DMS0), 214.5(pyr), 343 
207(diox );39 196.9(CDC1 3),341 
217.7(DMSO-d6 
)341 
200.0(pyr )322  184(CDC1 3 );41 N-9.5 
208(DMSO-d6 pc. 
Table 3.2: 	Formation constants of MeHg( In a and Protona' h complexes of various ligands,c and 2J( 1 H- 199Hg) for the 
(cont.) 	MeHg(II) complexes. 
P-donors  
P(CH 2CH 3 ) 3 
(CH 3CH 2 ) 2PCH 2CH 2OH 
(C5H 5 ) 2PC5H4-3-S03- 
Se-donors  
SeCN- 
S-donorsi 
S2- 
CH 3HgS 
5203- 
1-methyl-
quinaldine-
thione 
Me2 
70 
15 3os k 
8.8 
305 
14.6 3°5 
	
8.12 3°5 
9.15 3° 5 ,x0 305 
6.79 323 <1 200.4 323 
21.2 305 q,14 146323 
16.34 305 156.6(pyr)22 156(pyr) 323 
10.90;°5 11.05 178(PY0 26 191.0 309 
9.66 319 	'0.1 319 
8.28 395 2 305 
Michler's thioketone 
1-methylpyridine-2-thione 
.S03
2- 
(CH 3H0 2S 
(NH2 ) 2C=S 
HOCH 2CH 2SHgCH 3 
NCS - 
(HOCH 2CH2S) 2 (CH 2 ) 2 
S(CH 2CH 2CO2 - ) 2 
(HOCH 2CH 2S) 2 (CH 2 ) 5 
(HOCH 2CH 2S) 2 (CH 2 ) 3 
(HOCH 2CH 2S) 2CH 2 
(HOCH 2CH2S) 2 (CH 2 ) 5H9CH 3 
Co(NH 3 ) 5NCS + 
HOCH 2SH 2SCH2CH 2OH  
8.15 319 
8.11, 3°5 7.96 323 
,1,7 305 
6.92 319 
6.27 3° 5 
6.06, 305 6.1 324 
4.27 319 
4.20 319 
4.13 319 
3.80 319 
3.38 319 
3.24 319 
3.20 305 
3.14 319 
1-1.6 344 
6.79 
0 
-1.2 318 
0 
<0 345 
<0 319 
<0 319 
<0 319 
<0 319 
<0 319 
<0 319 
<0 305 
319 
172.4 323 
202 323 
205.6(Me0H );68 208.0(pyr) 22 
203 323 
s4L„ 5 
(HOCH 2CH 2S)(CH 2 ) 3HgCH 3 
(HOCH 2CH 2S) 2 (CH 2 ) 2HgCH 3 
CH 3SCH 2CH 2CH(CO2 - )NH 3+ methionine 
S(CH 2CH 2503- ) 
CH 3HgSCN 
CH 3SCH 3 
C-donors  
3.07 305k o 305k 
2.86 318 
2.84 318 
1.94 338 
' 1.91 319 
1.65 305 
-1.4 34" 
=CH N(CH3 ) 2 
<0 
<0 
223 3 38 
0 319 
0 305 239.9(Me0H) 250 
',-CH3- n.,37 n 
C6H 5- 1.21 n CH- 14.0, 3°5 14.2 324 
malononitrile 10.4 349 
diethylmalonate <8.6 349 
[Cu([13]dieneN4 )] 2+ <6.5 349 
acetylacetone 5 . 9 349 
	
,t46 101(CHC1 3 ), 341 101-109 (var.) 347 
105.1(DMS0 )1 41 101(neat), 325 
104.3(pyr), 322 100.6(C012 ),322 
101.5(neat)1 49 
 
1.30 109.0(CDC1 3 ) 9 34° 140(C06 ),321 
9.14 177.6(pyr), 343 178.0(pyr), 322 
176.0(C5H5  )122 175(di0x), 330 
188(D20) 330  
11.39 
13.3 
9.95 
9.0 350 
Table 3.2: 
 
Formation constants of MeHg(II) a and Protona' b complexes of various ligands,c 2 and J( 1  H- 199  Hg) for the 
(cont•) MeHg(II) complexes. 
[Ni([14]dieneN4 )] 2+ 
2-acetylcyclopentanone 
2-methyl-1,3-indandione 
Meldrum's Acid 
dimedone . 
1,3-dimethylbarbituric acid 
1 ,3-cyclopentenedione 
CH(CN) 3 
5.46 349 
<4.3 349 
<4 349 
3.72 349 
3.70 349 
3.60 349 
2.1 349 
<2 349 
6.28 
7.88 
6.18 
4 . 83 351 
5.25 352 
4.45 
4.25 
-5.1 
71 
Table 3.2: Formation constants of MeHg(II) a and Protonc6b complexes of various ligands, ° and 2J( 1 H- 199H9) for the 
(cont.) MeHg(II) complexes. 
afor the equilibrium MeHg + + L - =.*MeHgL. 
b
experimental conditions are not included here, but equilibrium constants are in aqueous solution unless otherwise 
stated. 
°this Table and Tables 3.1 (hydroxide), 3.3 (chloride), 3.4 (monothiolates - previous work), 3.6 (monothiolates - 
this' work) and 3.11 (dithiolates - this work) form a comprehensive list of MeHg(II) stability constants to date 
(1981), and updates the unpublished compilation of Erni (1977). 319 
d
for polyprotic ligands. pK
a refers to the MeHg(II)-coordinating group, reference 353, unless otherwise stated. 
d
for MeHg(II) complexes in aqueous solution unless otherwise indicated. This Table is not a comprehensive list 
of coupling constants. Only values of 2J of complexes for which the MeHg(II) formation constant is known, have 
been included. 
fsee Table 3.1, page 
gwith [H 20] = 55M by definition. 
h
see Table 3.3, page 81 . 
'this work. 
s not including monothiolates (Tables 3.4 and 3.6) and dithiolates (Table 3.11). 
k20% Et0H. 
l constants of the form MeHg0H + HL-7=MeHgL + H 20 have been converted using log 13 (MeHg0H) = -4.60 and pK a (HL) in 
the reference shown. 
mtheses by various authors (Em ZUrich) in reference 319. 
calculated from thermodynamic data in reference 319. 
°with MeHg02CMe in CH2C12. 
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Figure 3.2: Species distribution calculated 
by COMIX for the hydrolysis 
of 0.001M MeHg(II), using the equilibrium constants: log (3 10-1 = -
4.607 
and log B 20-1 30-2 = = -2.234 (this work), and log B 	7.0 (page 
). 
. .  
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nature of the dominant MeHg(II) complex(es) may frequently be postulated 
by comparison of the conditional stability constants of MeHg(II) with the 
various ligands. The conditional stability constant, Kcond , is defined . 
generally by 
/MeH gLall complexed species 
cond 1MeHg(II1 
'not bound to Ll[D-not bound to MeHg(II)) 
Even if the ligand is not involved in protolytic equilibria, since MeHg(II) 
is hydrolysable, Kcond is pH dependent. Figure 3.3 shows values of Kcond 
for MeHg(II) with a few of the ligands shown in Table 3.2. The condi- 
tional formation constant curves were calculated with COMIX for 10 -3 M 
solutions of MeHg(II) and ligand. It can be seen that thiolate complexes 
predominate, except at either extreme of the pH scale. At low pH, protons 
compete more effectively than MeHg(II) for ligand, whereas at high pH, 
hydroxide competes more effectively than ligand for MeHg(II). The 
extremely stable MeHg(II) thiolate complexes require special techniques 
for determination of their formation constants since protons cannot 
compete effectively with MeHg(II) for thiolate (page320). It is 
generally a simple matter to evaluate the dominant MeHg(II) species in a 
mixture of ligands, by comparison of the products, Kcond [L]. 
If thiolates are involved in the equilibria and are present at more 
than trace amounts, they will usually dominate the MeHg(II) species 
distribution, but in one important biological situation this is not the 
case. If MeHg(II) is ingested orally, comparisons of K cond indicate that 
significant concentrations of lipid-soluble MeHgC1 occur at the low pH and 
chloride concentration of the stomach, facilitating absorption into the 
354 
bloodstream. In this work, use has been made of competitive equilibria 
between thiolate ligands and iodide, or between two thiolate ligands, to 
t
Programs COMIX, COMIXH and TITRAT are described in Chapter 6. A listing 
of COMIXH is given as Appendix 2. 
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3 5 7 11 pH 
Figure 3.3: Conditional stability constants, log K cond , as a 
function of pH for MeHg(II) with several ligands. The donor atom is 
indicated. 
a hydroxide (0), b chloride (Cl), c iodide (I), d acetic acid (0), 
e methylamine (N), f mercaptoethanol (S). 
Calculated by COMIX for 0.001M MeHg(II) and 0.001M ligand. 
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obtain the stability constants for MeHg(II)-thiolate formation. 
3.2.2 NMR investigations of MeHg(II) interactions in solution  
Nuclear Magnetic Resonance techniques have produced much of the 
currently available information regarding MeHg(II) coordination in 
solution. The 1 H nmr spectrum of the methyl group of MeHg(II) consists 
of a singlet accompanied by two less intense satellites due to protons 
of the methyl group bonded to the isotope 
199 
 Hg (I=k, 16.9% abundance), 
e.g. see Figure 3.34 page 168. The coupling is due to a Fermi contact 
mechanism and the magnitude of the coupling constant 
2
J(
1
H-
199
Hg) is 
determined by the degree of s character of the Hg-C bond, and the s 
electron density at the nuclei of the coupled atoms.
322,355 
 Differences 
in the perturbation of the Hg 6s orbital electron density caused by 
bonding to donor atoms of different Lewis basicity, often allows the 
ligating atom to be identified in ambidentate ligands, by consideration 
of the magnitude of 
2
J(
1
H-
199
Hg), e.g. selenite, Se0 3 2- , has been shown 
to be bonded to MeHg(II) through oxygen 323 but sulfite, through su1furq 23 
Coordination of selenite through oxygen has been confirmed by Raman 
spectroscopy. 323 Since the donor Lewis basicity is often reflected in 
the BrOnsted basicity, 1
2
J(
1
H-
199
Hg)1 decreases linearly as pK a of the 
ligand donor increases, in series of structurally related compounds. 
Thus, linear correlations between 1
2
J(
1
H-
199
Hg)1 and ligand pKa  have been 
found for MeHg(II) complexes of unidentate pyridines, and N-substituted 
pyrazoles and imidazoles. 304 
Despite the high thermodynamic stability of MeHg(II)-thiolates, the 
Hg-S bond is extremely kinetically labile. 356-8 Thus, thiolate exchange 
in MeHgSR/SR' systems250 is usually fast on the nmr time scale, taking 
place by an associative nucleophilic mechanism via intermediates of the 
type 
76 
SR 
MeHg,, 
'SR' 
In the biological situation, the rapid exchange of glutathione, GSH, 
is of particular importance with regard to MeHg(II) transport. 359 
The rate constant, k
l' 
for the attack of sulfhydryl deprotonated 
glutathione on the MeHgGSH complex is high, 6 x 10 8  M-1 s-1.360 
MeHgSG + G*S
_ kl 
MeHgS*G + GS 
Although glutathione will be predominantly in the protonated form at 
physiological pH, 1( 1 is sufficiently high that this pathway dominates 
the methylmercury exchange mechanism 59 The analogous reaction, 
involving sulfhydryl-protonated glutathione, is slow (k 1 < 0.1M-1 
s
-1
).
360 
Direct exchange between MeHgX/MeHgY species is also rapid on the 
nmr timescale, except for the case where one of the complexes is 
MeHgCN.
356 
The exchange mechanism proceeds via a four centre bridged 
intermediate of the type 
MeHg, 110e 
The relative rates of bimolecular ligand exchange are proportional to 
the ligand bridging ability.
250 	Thus, the reaction is fast for thiols, 
'e.g. exchange between the MeHg(II) complexes of glutathione and cysteine 
-1 -1 360 
has k
2 
< 0.1M s . 
MeHgSG + MeHg*SCys MeHg*SG + MeHgSCys 
tRecent work by Bach et al. indicates that this may not be true for 
the interaction of MeHgSCH 2CO 2H with the Fe 2S 2 (SCys) 4 cluster of 
adrenodoxin.361 
77 
The bimolecular exchange between Bu tHgSCH and Bu tHgSCH(CH 3 )C6H 5 has 
k
2 
3 x 10
7 
M
-1 
s
-1 
in HCF2C1:HCFC1 2 
at 25 0 ,
250 
which would be four 
orders of magnitude faster than diffusion controlled processes if the 
exchange mechanism was dependent on uncomplexed thiolate or organo- 
250 
mercurial. 
When exchange is rapid on the nmr timescale, an exchange-averaged 
value for the chemical shift of methyl protons of MeHg(II), CH 3 , is 
observed. The pH-dependence of 6CH 3 has been used to evaluate 
MeHg(II) formation constants with a range of inorganic anions,323 
carboxylic acids, 309 amines and aminocarboxylic acids,331 methionine,338 
and recently, of several monothiols. 302 
3.2.3 NMR evaluation of MeHg(II)-thiolate formation constants  
Reid and Rabenstein302 have measured the displacement constants, 
K
d 
in their terminology, for the exchange equilibria: 
[RS - ][MeHgSCH 2 CO2 - ] 
MeHgSR + -SCH 2CO2 -:F====MeHgSCH2CO2- + RS - Kd -  
[MeHgSR][-SCH 2CO2 - ] 
The monothiOls, RSH = merCaptoethanol, penicillamine, N-acetylpenicill-
aMine, cysteine, homocysteine and mercaptosuccinic acid, are among the 
several whose formation constants with MeHg(II) were evaluated in this 
study using the potentiometric titration method. 
By monitoring the chemical shift of the methylene protons of 
mercaptoacetate, (MA 21 , as the pH of the equilibrium mixture is 
altered, Kd can be determined because the relative affinities of RSH 
and MAH2 for MeHg(II) are pH-dependent. Since Kd is the quotient of 
the individual formation constants of the two thiols for MeHg(II): 
[MeHgSR] [MeHgSCHCO2 ] 
K
d 
-  
 
[MeHgl ][RS - ] [MeHe][ -SCH2 CO2 - ] 
= K
f
(MeHgSR) K (MeHgMA-) 
78 
knowledge of Kf (MeHgMA- ) and Kd gives Kf(MeHgSR). The value of Kd is 
near unity for the thiols studied, and can therefore be precisely 
evaluated, despite the extremely high individual MeHg(II)-thiolate 
formation constants (Table 3.8, pages 98-100). 
Pf 
Kd can be expressed in terms of the fraction,of MAH in the free, 
uncomplexed (MA21 form: 
I Pf I a1 a3  
ll-Pf 
a
2
a
4 
where a is the fraction of MAH 2 in the fully protonated (MAH ) form, 1 
a2 is the fraction of MeHgMA - , a3 is the fraction of thiol in the 
MeHgSR form and a4 is the fraction of RS - . All these fractions can 
be expressed in terms of only the relevant ligand or complex protonation 
constants, and measured pH (for mixed constants) or [e] (for concen-
tration constants). 
The fraction P
f 
was evaluated by Reid and Rabenstein from the 
exchange-averaged proton chemical shifts of the free and complexed 
MA
2- 
forms, 
since thiolate exchange is fast on the nmr timescale. Collected values 
of 6 as a function of pH were fitted by non-linear least-squares to 
yield values of K
d 
at 25° (0.3M ionic strength). 
The formation constant of the MeHgMA - complex was evaluated in 
an analogous manner, using mercaptoethanol (MEH) competition and the 
value Kf (MeHgME) reported by Schwarzenbach and Schellenberg.
305 
The reliability of Kf(MeHgME) is crucial to the reliability of the 
derived constants, Kf (MeHgMA- ) and hence Kf (MeHgSR). The value of 
79 
log Kf(MeHgME) found in this study (page 98) [16.135(4), 0.1M ionic 
strength, 25°] is in excellent agreement with that reported by 
Schwarzenbach and Schellenberg [16.12, 0.1M ionic strength, 201. 3°5 
Therefore, values of log Kf(MeHgSR) found by Reid and Rabenstein 
should be directly comparable to those found here, except for a minor 
correction due to logy H+ to convert mixed constants into concentration 
!constants. 
The formation constants log Kf(MeHgSR) and proton dissociation 
constants of the MeHgSR complexes, found by Reid and Rabenstein 
have been included in Table 3.8 with those found during this study 
and will be discussed later in this Chapter. 
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3.3 Methylmercury(II) Complexation with Thiolate Ligands  
3.3.1 Methylmercury(II) monothiolate equilibria  
The thermodynamic stability of complexes formed between MeHg(II) 
and monothiolate ligands has not been extensively studied. Until the 
commencement of this study, and the publication of the work by 
Reid and Rabenstein, 302 few reports had been published containing 
formation constants of MeHg(II)-thiolate complexes. Some of the earlier 
work, by Simpson,
324 
 with cysteine and glutathione and by Schwarzenbach 
and Schellenbere 5 with mercaptoethanol recorded formation constants for 
the equilibria: 
+ - 
MeHg + RS .7.,==== MeHgSR K - [MeHgSR]  
in the range 15.2 < log K < 16.2, indicating the high stability of these 
complexes. A series of substituted thiophenols has been studied by 
Schwarzenbac
h362 
indicating that the MeHg(II)-thiolate formation constants 
are linearly related to the thiophenolic acid dissociation constants, pK 
For 17 substituted thiophenols, the linear relationship is found to be 
log K = 0.798 pKa + 877 
(which also reproduces log K for cysteine, glutathione and mercaptoethanol 
within 0.5 log units). 
It was therefore of some concern that Hojo et ai. 363 have more 
recently reported equilibrium constants for the interaction of MeHg(II) 
with some previously unstudied monothiols which were several orders of 
magnitude lower than expedted by consideration of the aliphatic thiol 
acidity in the above correlation. Thus, pKa values in the range 8.0 to 
10.4 would indicate log K values in the range 15 to 17, but values of 
6.7 to 9.0 were recorded by these workers. In addition, reported values 
[MeHg 4 ][RS - ] 
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of log K for cysteine, glutathione and mercaptoethanol (7.19, 8.11, 
8.76 respectively) were 8 or 9 orders of magnitude lower than 
reported by Simpson324 and Schwarzenbach and Schellenbere 05 for these 
thiols (Table 3.2). 
Equilibrium constants given by Hojo et al. are, in their termin-
ology, of the form 
= [M] / [L][M] 
where [L] represents deprotonated ligand. Unfortunately, [M] was 
undefined by these workers but presumably represents [MeHgCl] since 
methylmercury(II) was obtained commercially as the chloride. The 
quoted K 1 is therefore assumed to correspond to the equilibrium 
constant for the exchange reaction 
MeHgC1 +RS - r.F.= MeHgSR + Cl - 
[MeHgSR][C1 - ]  
K - 1 
[MeHgCl][RS - ] 
Using a mean value for the formation constant of MeHgC1 log L e- 
m HgC1 = 
5.3, taken from several literature sources shown in Table 3.3, Hojo's 
values for log K 1 have been corrected to give the MeHg(II)-thiolate 
formation constants defined previously (page 80 ). 
log K medium ref. 
5.25 20 0 , 0.1 M KNO 3 305 
5.45 25°, rt,0 315 
4.90 20 0 , 0.1 M KNO3 314 
5.32(9) 25°, 1M NaC104 366 
5.64(1) 25°, 2.5 M NaNO 3 342 
5.22(1) 25°, 0.1 M KNO 3 this work 
Table 3.3: Equilibrium Constants for the equilibrium 
MeHg
+ 
+ Cl MeHgC1 
82 : 
RSH 
log K(MeHgSR) 
,b 	
medium ref. 
cysteine 15.7 '125°, (‘-'0 324 
7.19 
(125)C 
22°, 'LO 363 
glutathione 15.9 r\,25°, ft,0 324 
8.11 (13.4) c 22°, r\JO 363 
2-mercaptoethanol 16.2 20 0 , 0.1M KI 305 
8.76 (14.1) c 22°, rt0 363 
penicillamine 6.72 (12•0) c 22°, q0 363 
N-acetylpenicillamine 8.87 (14•2) c 22°, A,0 
363 
2-mercaptopropionic acid 9.03 (14•3) c 22°, q..0 363 
2-mercaptosuccinic acid 8.16 (13.5) c 22°, q,0 363 
thiophenol 14.67 20°, 0.1M KI 362 
in 1:1 Me0H/H 20 
2-Me° 15.60 
3-Me° 14.48 
4-Me0 14.94 
4-0H 14.88 11 
2,4-diMe 14.82 
2-Me 14.71 tt 
3-Me 14.62 
4-Me 14.69 
4-F 14.13 
2-C1 13.89 
3-C1 13.85 
4-C1 14.09 
2-Br 13.77 
3-Br 13.82 
4-Br 13.86 
3-I 13.70 
2-S03 - ,4-NO2 12.72 20°, 0.1 KNO 3 364' 
2,4-diNO2 10.48 11 364 
4-NO2 12.3 20°, 0.1 NaC104 365 
Table 3.4: Previously reported formation constants of methylmercury(II)- 
monothiolate complexes. 
+ - a
for the equilibrium MeHg + SR 17== MeHgSR 
bthe thiolate is considered to be completely deprotonated. 
ccorrected for MeHgC1 equilibria, using log K(MeHgC1) = 5.3. 
dnot including nmr studies by Reid and Rabenstein,
302 
discussed on page 77 and recorded in Table 32 (page 98 ). 
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Even with this correction, if appropriate, the data in Table 3.4 show 
that serious discrepancies remain in the accepted values for methylmercury-
thiolate formation constants. For this reason, the equilibrium constants 
for MeHg(II) complexation with 2-mercaptoethanol, mercaptoacetic acid and 
its 0-methylester, mercaptosuccinic acid, cysteine, homocysteine, penicill-
amine, N-acetylpenicillamine, glutathione, thiocholine and N-mercapto-
piperidine (shown in Figure 3.4) were investigated by the potentiometric 
method involving iodide competition, described in detail in Chapter 6 of 
this thesis. Formation constants of MeHg(II) with cationic thiolates 
such as thiocholine have not previously been reported. 
Perhaps surprisingly, the earliest reported MeHg(II)-thiolate 
stability constants, determined by Hughes, involved the most complex 
thiols studied to date. Equilibrium constants for MeNgI exchange with 
human and bovine serum albumin, bovine oxyhemoglobin and bovine carbonyl-
hemoglobin were determined by distribution of MeHgI between toluene and 
aqueous phases of the thiols.
367-8 
The equilibrium constant of MeHg(II) with the sulfhydryl protonated 
form of human mercaptoalbumin 
[MeHgSAlb][H+ ]  
MeHe + + H K - 
[MeHe][AlbSH] 
has been calculated by Simpson 324 to be 106 ' 9 using values of the distri-
bution constant for MeHgI between tolueneand water, D = 500 and for MeHgI 
formation, 10
8.7 
determined by him; and Hughes 
368
value for MeHgI/AlbSH 
exchange in toluene,  
Thus K - 
[MeHgSR][e][I - ]  [MeHgI(toluene)] •  [MeHgn  
• 
[MeHgI(toluene)][AlbSH] [MeHgI] [MeHg+][I-] 
- 10 
 
• 500 • io8.7 = 10
6.9 
HSCH 2  CH OH -  
HS CH CO H — 2 2- HSCH CO CH - 2 2 3 
84 
HOC 	CO H 
- 2 \CH CH / 2- / - 2 
HS 
NH -3 
HSCH 2  CH / \ 
CO 2H . 2- 
/
NH 
HSCH CH CH - 2 2 \ 
CO 2H 
CH 3 	NH 
HSC.CH 2 
- - ' NCO H 	
- 	2 x 
CH 3 	2- CH 3 	
F.".I. 
NH 
HO2 CCH 2 	• NHC CHCH 2 NH • C CH 2 CH 2 CH
/ -3 
	
II 	I - 	II 	I 	II 
	x 
CO H 	HO C 	SH 	NH 	CO H 0 	SH 	0 	2- - 3- 2- 
+ 
+ 
HS CH H2N(CH3)3a 
b  Figure 3.4: 	Fully protonated form ds' of monothiolate ligands used for 
complexation of MeHg(II) in this work. 
used as the perchlorate sal t. b all thiols were used as neutral ligands, except for 
thiochol i ne 
c this shorthand structure is used by Rabenstein, 369 and 
be used here for brevity. till 
dissociable protons are underlined. 
CH 
1 	/3 	NH(02  CCH ) 
HSC-CH I 
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An approximation for the average sulfhydryl dissociation constant K a 367-8 
%1010 for mercaptoalbumin gives the formation constant of MeHg(II) 
with deprotonated albumin 
- MeHg
+ 
+ AlbS. MeHgSAlb 
[MeHgSAlb]  
KMeHgSR 
[MeHg+][AlbS - ] 
_ [MeHgSAlb][e] [AlbS - ]  
since KMeHgSR 	
[MeHg 4 ][AlbSH] [AlbS -][e] 
= 10
6.9 	
10
10 	
= 10
16.9 
This constant is directly comparable with the MeHg(II)-thiolate formation 
constants determined in this work and will be recalled later (page 158). 
The value, i0 22 , recorded by Rabenstein 41 and Carty, 246  would seem 
to be too high. 
It can be seen from Figure 3.4 that the thiol ligands investigated, 
except for 2-mercaptoethanol and thiocholine, have functional groups 
other than sulfhydryl which can be involved in protolytic equilibria. 
As a result, attempts to determine the equilibrium constant for complex-
ation of MeHg(II) by fully deprotonated ligands must also consider the 
coexistence of MeHg-thiolate species which are protonated at sites other 
than sulfur. The residual Lewis acidity of the coordinated sulfhydryl 
group is so low that protonation at this site is usually considered to 
be negligible. (A possible exception to this condition, occurring at 
low pH, will be discussed on page 111). 
For two of the monothiolate ligands used in this work, mercapto-
succinic acid and glutathione, sulfhydryl complexation of MeHg(II) 
leaves two carboxylic acid groups of comparable acidity which will 
protonate simultaneously in the range 3 < pH < 5. Under these condi- 
tions microscopic equilibrium constants can be defined, e.g. for •the 
H 2OC C 0 2
H / 
‘CHCH // 2 
MeHgS 
2 / 2 
CH CH / 2 
- 0 C 	CO 
K 2 
2\ / 2 
‘CHCH / 2 
MeHgS MeHgS 
MeHg(II) mercaptosuccinic acid complex, shown in Figure 3.5. 
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0 2 C\ 
• CHCH 
MeHgS 
(1) (2) 
HO C CO H - 0 C 	
_ 
2 \ y 2 
2 \ ,CO2 
• CHCH 2
CHCH 2 
MeHgS
/ / 
/(21MeHgS 
k
2
\  
• 0
2
C
\ 
CO - 
CH CH 
/ 
MeHgS 
Figure 3.5: Microscopic proton dissociation scheme a for the 1:1 
MeHg(II) complex of mercaptosuccinic acid (page 
aThe equilibrium constant nomenclature is Rabenstein's. 369 
The last subscript digit denotes the group being 
deprotonated, in the equilibrium under consideration. 
The previous digit indicates an already deprotonated 
S ite. 
Unlike the nmr method in which non-labile protons near each carboxylate 
group can be monitored simultaneously, 369 the potentiometric titration 
method cannot give any information regarding these microscopic constants. 
Instead, macroscopic equilibrium constants, K 1 ,K 2 , referring to deproton-
ation of an 'average' carboxylate group, were determined: 
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It can be shown 
369
that the microscopic and macroscopic equilibrium 
constants are related by the equations 
k 12 k 21  
and K2 - 12 + k21 
Completely analogous microscopic equilibria have been described elsewhere 
for the MeHg-glutathione complex.369 
3.3.2 Potentiometric determination of formation constants of MeHg(II)  
thiolates  
By alkalimetric titration of equilibrium mixtures containing 1:1 
ratios of MeHg(II) and monothiolate in acid solution, and in the 
presence of 0.1 M KI to maintain constant ionic strength, the exchange 
equilibria 
MeHgI + HSR.r.F=2: MeHgSR + I - + 
were investigated. The pH-titration data from several such titrations 
were evaluated by MINIQUAD81 (page 326) for the thiol ligands shown in 
Figure 3.4. The titrations were performed in the following manner: 
After standardisation of the electrode assembly in the pH(S) 4.008, 
6.865 and 10.012 buffers (page305 ), a solution of weighed thiol in 
0.1 M KI was titrated with 0.1 M KOH, and the titration data treated to 
evaluate the ligand acid-dissociation constants, analytical thiol 
concentration, and electrode calibration constants pH cal and Kwc (page 
295) . An aliquot of MeHg(II)/
H+
/NO3- solution was added to the iodide/ 
thiolate solution in order to obtain nearly 1:1 MeHg(II)-thiolate 
stoichiometry and at such a rate to prevent local precipitation of 
MeHgI. If the resultant solution (usually at pH 3 to 4) was cloudy, 
KOH was immediately added with vigorous nitrogen purging and magnetic 
stirring to dissolve MeNgI. The dissolution of precipitated MeNgI is 
tthe preparation and standardisation of this solution is described on 
pages 92-6 
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often slow, taking several hours if the precipitate is allowed to 
coagulate. On the few occasions the solution remained cloudy above 
pH 5, they were discarded, and the process repeated with more dilute 
solutions of thiolate and MeHg(II), or additional KOH was added to the 
KOH-titrated thiolate, prior to addition of MeHg(II) so that the final 
pH was not less than 4 to 5. 
In the discussion below of the MINIQUAD81 treatment of MeHg(II)- 
thiolate formation constants, reference will be made to a 'sum-of-squares' 
value, U, generated by the program. Values of U < 10 -9 generally 
indicate that all titration points are, on average, fitted to better 
than 0.005 pH units. Values U < 10
-10 
 indicate fits to better than 
0.002 pH units. This degree of agreement is difficult to depict on 
figures showing calculated and experimental titration curves over the 
range 3 < pH < 10. For such figures the experimental data points are 
circled, with circle radii equivalent to 0.02 pH units for clarity. 
This does not represent the reliability of pH or volume measurements, 
which for individual tirations were considered to be 0.002 pH units and 
0,001 mL respectively. Typical agreement between calculated and experi- 
mental titrations is shown in Table 3.5 for the MeHg(II)-mercaptoacetate-
iodide system (page 103), calculated by COMIXH using values of equilibrium . 
constants used by MINIQUAD81. All MINIQUAD81 treatments were performed 
using fixed values of the equilibrium constants for MeHg(II) hydrolysis', 
e.g. log 10-1 = -4.607. The binuclear species (MeHg) 20H + , with log 
1320-1 = -2.234, needed only to be considered in acidic Solutions 
containing excess MeHg(II) in the absence of iodide. Inclusion of this 
species otherwise increased the program running time with no decrease in 
U or improvement in parameter standard deviations. Constants for ligand 
protonation were fixed at the weighted geometric means of values obtained 
from preliminary titrations (using TITRAT) and are shown in Table 3.6. 
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volume 
0.09947M 
KOH/mL 
pH 
measured calculated 
0.000 3.030 3.022 
0.070 3.068 ' 3.063 
0.130 3.104 3.100 
0.190 3.141 3.139 
0.250 3.180 3.179 
0.310 3.221 3.221 
0.370 3.264 3.265 
0.430 3.309 3.311 
0.480 3.348 3.350 
0.530 3.388 3.391 
0.580 3.429 3.433 
0.630 3.473 3.477 
0.680 3.518 3.522 
0.730 3.565 3.568 
0.780 3.613 3.616 
0.820 3.653 3.655 
0.860 3.693 3.696 
0.9-0 3.736 3.738 
0.940 3.779 3.781 
0.980 3.825 3.825 
1.020 3.871 3.871 
1.060 3.919 3.919 
1.100 3.969 3.968 
1.140 4.022 4.020 
1.180 4.076 4.074 
1.220 4.134 4.131 
1.260 4.195 4.191 
1.300 4.259 4.255 
1.340 4.328 4.324 
1.380 4.402 4.398 
1.420 4.482 4.479 
1.450 4.548 4.545 
1.480 4.620 4.617 
1.510 4.696 4.697 
1.540 4.783 4.785 
1.570 4.880 4.886 
1.600 4.990 5.002 
mean deviation 0.003 
Table 3.5: Calculateda and measured pH values for the 
Methylmercury(II)-Iodide-Mercaptoacetic acid and 
titration data treated by MINIQUAD81. b 
a
calculated by COMIXH (Appendix 2 ) using the equilibrium 
constants refined by MINIQUAD81 and shown in Tables 3.6 
and 3.8 and the experimental conditions shown on Figure 3.8. 
-10 
sum-of-squares, U = 5.1 x100.  
this work [0.1 KNO 3 or KI] previous valuesb Ref. 
1. Mercaptoacetic Acid 
2. O-Methylmercaptoacetate 
3. 2-Mercaptosuccinic Acid 
4. 2-Mercaptoethanol 
3.553(8) 
7.944(3) 
3.119(5) 
9.583(2) 
10.157(7) 
4.588(2) 10.386(3) 
3.35(1) 
3.58 
3.48 
3.60 
3.42 
7.95(2) 
3.64 
3.30 
3.06(1) 
9.47 
9.444 
9.72 
9.93(2) 
9.78 
9.92 
10.55 
10.20 
4.64 
4.94 
4.56(1) 
10.37 
10.64 
10.39(1) 
[0.3 KNO ] 
3 
[0.15 KNO
3
] 
[0.58 NaNO 3 ] 
[ %0 ] 
[0.1 KC1] 
0.1 KNO
3
] 
[0.3 NaC104 ] 
[ %0 ] 
[ rb0 ] 
302 
370 
371 
372 
373 
374 
375 
376 
377 
378 
379 
380 
Table 3.6: Proton dissociation constants a of monothiol ligands used for MeHg(II) solution studies. 
zMacroscopic concentration constants obtained with TITRAT. Recorded values are weighted geometric 
means with estimated standard deviations of the last digit in parentheses. 
'Literature values at 25 9 . Mixed constants have been 
318 
 converted to concentration constants by 
calculation of logyH+ according to the Davies equation. 
5. L-cysteine 1.98(1) 8.226(3) 10.367(6) 1 .896 (6) 8.178(2) 10.361(1) [0.1KC1] 381 
1.97(1) 8.20(1) 10.87(1) [0.1 KNO3 ] 382 
8.48 10.55 [0.15 KNO3 ] 370 
8.13 10.11 [0.1 KNO3 ] 
383 
6. DL-Homocysteine 2.54(2) 8.94(1) 10.48(4) 2.27(2) [0.3 KNO 3] 
302 
8.66 10.55 384 
7. DL-Penicillamine 2.43(8) 7.998(12) 10.591(15) 1.90(2) 7.932(4) 10.658(3) [0.1 KC1] 381 
2.44 7.97 10.46 [0.15 KNO3 ] 385 
1.94 7.93 10.39 386 
2.02(2) 7.92(1) 10.75(1) [0.1 KNO3 ] 382 
1.95(1) 7.99(1) 10.56(1) [0.1 KNO3 ] 387 
7.88 10.43 383 
8. N-Acetyl-DL- 3.303(8) 10.137(13) 3.18 10.04 388 
penicillamine 
3.69(5) 10.01(10) [0.1 NaC104 ] 232 
9. Glutathione 1.98(2) 3.488(5) 8.754(3) 9.691(9) 2.05 3.40 8.72 9.49 [0.2-0.5] 369 
8.74 9.62 [0.16 KNO3 ] 389 
3.59 8.75 9.65 [0.15 KNO 3 ] 390 
2.09(2) 3.48(1) 8.67(1) 9.54(1)[0.1 KNO3 ] 382 
10. Thiocholine 7.883(4) 7.80 ] 391 
7.7 392 
11. 4-Mercapto-N- 8.330(6) 10.345(8) not previously determined 
methylpiperidine 
Table 3.6: Proton dis sociation consthntsa  of monothiol ligands used for MeHg(II) solution studies. 
(cont.) 
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Each ligand was titrated with 0.1M KOH and the titration equivalence 
point treated as a TITRAT parameter together with ligand pK a 's and 
electrode calibration constants, pH cal and Kwc (page 295). The 'proton 
purity' of the ligands was thereby established for each titration by 
comparing the refined equivalence point with that calculated from the 
weighed amount of thiol. The value of Kv(1 : was always refined by 
MINIQUAD 81 in titrations involving data above pH 9. For example, 
titrations used to determine MeHg(II) hydrolysis constants (Figure 
3.1) gave Kv;:values in the range 13.79(2) - 13.96(13) in agreement with 
values found by TITRAT during evaluations of thiol dissociation constants. 
Two stock solutions containing MeHgNO 3 (01.02M) in dilute HNO 3 were 
prepared for potentiometric studies. Care was taken to minimise contam- 
ination by mercuric ion, often present in commercial MeHg(II) salts. 
Methylmercury iodide was prepared, free of inorganic mercury, by Erni's. 
m 319,339 ethod. Commercial MeHgI (10.0 g, 30 mole) was dissolved in 
400 mL 2.5M NaOH. The grey, slightly cloudy solution was filtered 
through slow paper (Whatman No. 5) and acidified with conc. HNO 3 to re- 
precipitate MeHgI. This precipitate was stirred with excess KI to 
convert inorganic mercury to soluble iodide complexes (some MeHgI will 
be converted to MeHg I2 - by this process). The purified MeHgI was 
refiltered on a sinter, washed with water and dried in vacuo over P 2 
(yield 9.5 g, 95%). 
A portion of this product (20 mmole) was converted to methylmercuric 
hydroxide by stirring overnight under nitrogen with freshly prepared 
silver oxide (%20 mmole) in 50 mL freshly boiled water: 
2MeHgI + Ag 20 + H 20 ---> 2MeHg0H + 2AgI 
The resultant brown mixture was filtered in a nitrogen-flushed glovebox 
through fast paper (Whatman No. 54) directly into a one litre volumetric 
93 
flask containing a slight excess of nitric acid (20 mnole). 
After dilution to 1000 mL with freshly deionised water, the MeHg 4-/ 
1-1 4-/NO3- solution was nominally 0.02M [MeHg +] and 0.005M [e]. When 
required, aliquots were withdrawn under nitrogen. This solution and 
another prepared similarly, were stored in the dark and the concentra-
tions of MeHg(II) and H + determined periodically by the methods described 
below. 
Analysis of Fri- content  
Unless the MeHg(II) content is known, alkimetric titrations of 
+ + - 
MeHg /H /NO 3 solutions cannot be used to determine the H
+ 
content 
because MeHg0H species are readily formed (page 63 ). The equivalence 
point, which corresponds to the composite MeHg+ + H 4- content, of a 
titration of 0.005M (MeHg +/e/NO3- ) with 0.1M KOH can be located potentio-
metrically with a glass/double junction calomel (1M KNO 3 , sat. KC1) 
electrode pair. Although the equivalence point is not very sharp (e.g. 
Figure 3.1) it can be reliably located with a precision of 1-2 parts-per-
thousand (ppt), by employing Gran Type-I 393 or Type-I1 394 calculation 
procedures. 
In mixtures of 0.005M MeHg(II) and 0.01M chloride (or iodide), 
MeHg(II) hydrolysis is suppressed to the extent that MeHg0H comprises 
less than 1% of the total MeHg(II) content below pH 7.0 (or 10.3) due 
to formation of MeHgC1 (or MeHgI). 
+ + - 
To determine only the H content of MeHg /H /NO 3 solutions, 
aliquots were titrated with standardised KOH in the presence of 0.1M 
KI. The resultant strong acid-strong base titrations were monitored 
potentiometrically and the sharp equivalence points located by Gran 
methods
395 
with a precision limited by the content of weakly acidic 
impurities in the titration vessel e.g. carbonate, silicates etc. 
For example, 0.1M KOH titration of 10 mL aliquots of MeHg+/0.005M 
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NO 3  diluted to 50 mL with freshly deionised water, gave Gran 
plots which were curved near the equivalence point.395 indicating the 
presence of 41.2 pmole of weakly acid impurities. This amount corres- 
ponds to a titre of <0.002 mL or <4 ppt of the equivalence point. 
Similar levels of weakly acidic impurities were found in subsequent 
titrations of MeHg(II)-thiolate systems in either 0.1M KI or KNO 3 media. 
These titrations have equivalence points rb0.002 mL higher than expected 
from consideration of analytical concentrations of the component solu- 
tions. The impurities presumably arise from the 50 mL water, 0.5-0.8 g 
KI or KNO3' tit ration-cell walls etc. (page 304). 
The H  of the 0.02M MeHg +/0.005M H -1-/NO 3- solution was 
monitored periodically by this method over a period of 16 months and 
showed an increase from 0.003M to 0.005M during this time 
Analysis for MeHg(II) content  
Various methods have been reported previously for the analysis of 
methylmercury(II) stock solutions. Libich and Rabenstein 309 ' 331 used 
an nmr titrimetric method, based on thiosulfate complexation of MeHg(II), 
to analyse 0.19M MeHg0H solutions. 
MeHg0H + S 20.  + OH - 
The endpoint of this reaction was determined by 
1
H nmr with a standard 
deviation of 4-5 ppt. These workers confirmed the accuracy of the nmr 
method by atomic absorption spectrophotometric analysis of mercury, but 
with somewhat lower precision (10 ppt). Jawaid 333,342 and co-workers 
have used an atomic absorption method396 for analysis of MeHg +/e/NO 3 
solutions. Instrumentation for atomic absorption and nmr methods was 
unavailable for this study. 
Rabenstein and co-workers have subsequently determined the methyl- 
MTK (yellow) 
SHgMe 
11, H + 
MeHgMTK+ (purple) 
+ 
Me 2 N..( C -NMe 2 
! 
SH 
MeHg+ 
-N
M
e
2 
Me N Me
2 
95 
mercury(II) content of stock MeHg0H.solutions by chloride titration at 
pH 2 in 80% Et0H, with potentiometric endpoint detection.
306,360 	
P
r
e- 
liminary results indicated that the potentiometric chloride method could 
not be used to analyse the dilute (0.02M) MeHe/e/NO 3- solutions used in 
this work due to a significant chloride leak from the calomel reference 
electrode. A double-junction reference electrode was unavailable at 
that time. Ingman
366
'
397 has used a spectrophotometric titration based 
on dithizone to determine MeHg(II) with a precision better than 10 ppt. 
Simpson and co-workers
324,398 
and Hughes 367-8 have used dithizone titri-
metric methods, with visual endpoints. 
The most convenient method was found to be that described by 
Ern1
319,339 
in which MeHg(II) is titrated with thiosulfate in 50% 
aqueous methanol, using Michler's thioketone* (MTK) as an indicator. 
Schwarzenbach and Schellenbere 5 have determined the formation 
constant, log K = 8.27, of the 1:1 MeHg(II) - MTK complex: 
H-MTK
+ 
(yellow) 
and report that protonation of MTK occurs with pK a r‘,2. At pH 4, in the 
presence of MeHg(II), all the indicator is in the MeHg-MTK
+ 
form. Titra- 
tion with thiosul fate displaces MeHg(II), giving a sharp colour change 
Michler's thioketone, bis[4-(dimethylamino)phenyl]methanethione, was 
obtained from ICN Pharmaceuticals Inc. as bis(dimethylamino)benzophenone 
and stored at -20°C. 
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from purple to yellow at the equivalence point due to the equilibrium: 
MeRgMTK+ + MeHg(S 203 ) - + MTK 
Ten mL aliquots of MeHg +/e/NO 3- solution were diluted with 10 mL 1M 
pH 4 acetate buffer and 20 mL methanol then titrated in triplicate with 
0.2M Na 2S 203 us i ng MTK indicator (3 drops 0.1% MTK in acetone). An 
alternative but less convenient procedure was also used to determine the 
MeHg(II) content of the MeHg +/e/NO3- solutions. The total MeHg(II) + 
H
+ 
content was evaluated by alkalimetric titration with Gran
393-5 
equiv-
alence point evaluation and corrected for H+ content which had been 
previously determined in the presence of iodide (page 93). 
A comparison of the results from both methods is found in Table 3.7. 
[MeHg(II)] 1 [MeHg(II)] 2 
8.1.80 0•015386(19) b 11.10.79 0.017330(25)b 
16.1.80 0:015381(21) b 12.10.79 0•017242(25) b 
27.2.80 '0.015364(20)b 8.5.80 0.017186(23) c 
8.5.80 0.015324 .(27) c 18.12.80 0.017201(26)b 
28.4.81 .0.015396(25) c 
Table 3.7: MeHg(II) contenta of two Meliiii-/e/NO3 - stock solutions. 
avalues in parentheses are standard deviations of triplicate 
determinations. 
 
+ + 
[MeHg(11)] determined alkalimetrically as [MeHg(II) +  
c [MeHg(II)] determined by thiosulfate titration with MTK 
indicator. Thiosulfate titrant (0.2M) was standardised 
against primary standard KI0 3 . 399 
It can be seen from the above table that the MeHg(II) content of 
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both solutions remained unchanged, within experimental uncertainty, over 
a period of 15 months. 
Formation constants of MeHg(II) with the monothiols are discussed 
below and are recorded in Table 3.8. 
(i) 2-Mercaptoethanol was fractionally distilled in vacuo, bp 63.3-63.5°/ 
18 mm (lit. 75 157-8° (dec.)/742 mm) and stored under nitrogen at -20 0 . 
Titrations with KOH indicated a proton purity of 99.9(2)%. Values for 
the proton dissociation constant of mercaptoethanol were identical in 
0.1M KNO 3 and 0.1M KI solutions, indicating no iodide-thiolate interaction. 
The proton dissociation constant is in good agreement with that determined 
elsewhere (Table 3.6). In the presence of MeHg(II) and 0.1M KI, four 
sets of titration data were fitted satisfactorily with MINIQUAD 81 by 
considering the complex MeHgSCH 2CH 2OH as the only MeHg(II)-thiolate 
species present. No evidence of ternary MeHg(II)-iodide-thiolate 
species was indicated. In the presence of 0.1M KI, species such as 
(MeHg) 2SCH 2CH 2OH can be neglected. 
The value found for log f3110  [16.135(4), Table 3.8], agrees with 
305 
that found by Schwarzenbach and Schellenberg (16.12) but is in dis- 
agreement with the value found by Hojo et ca.
363 
[MeHgSCH 2CH 2OH] 
MeHg+ + -SCH2CH2OH=F=hMeHgSCH2CH2OH 
13 110 = [MeHg+][ -SCH 2CH 2OH] 
Calculated and experimental titration curves are shown in Figure 3.6, 
and the species distribution in the presence of 0.1M KI, in Figure 3.7. 
Because Schwarzenbach and Schellenberg
305 
 have reported the exis-
tence of a complex MeHg(SCH 2CH 2OH) 2- , a titration of MeHg(II) and a ten-
fold excess of mercaptoethanol in the presence of iodide was performed. 
Treatment of these data by MINIQUAD 81, using fixed values of the equili-
brium constants for MeHg(II) hydrolysis, ligand protonation and 
Thiol 
ligand 
equilibrium 
constant 
1. Mercaptoacetic 
acid 
log filo 
lll 
2. 0-Methylmercapto- 
log fil0 
acetic acid 
3. 2-Mercaptosuccinic log 1l0 
acid 
3111 
fil2 
4. 2-Mercaptoethanol log filo 
5. L-cysteine log 
°110 
111 
0112 
0210 
13211 
212 
0310 
Equilibrium constants a" of MeHg(II) complexes 
this work 
Rabenstein et al. 
with iodide 
competition 
with no competing ligand 
16.932(12) ). 
20.689(11) 
14.98(2) 
17.142(7) 1 
21.983(5) 
25.110(1)
} 
16.135(4) 
16.464(14) 1 
25.476(9) 
rejected 
3.757(6)  
4.841(2) 
3.127(7) 
9.012(6) 
25.40(1) 
28.06(3) 
25.26(2) 
29.69(3) 
32.13(13) 
29.02(3) 
3.730(2), 
8.936(6) 
} 
11.60(2) 
8.800(7) = log K 2f 
13.221(13) 1 
15.67(12) d 
12.56(2) d = log K3f 
3.78(2) e 
2.66(2) 
4.42(2) 
2.45(10) 
16.92(1)gi 
20.57(2)1 
17.31(6), 1 
22.01(8) 
25.39(11) 
16.12
h 
g 16.67(1)} 
25.32(3) 	1 
27.61(11) 
3.65(1) 
4.70(2) 
3 . 38(3) 
8.65(2) 
2.29(8) 
Table 3.8: Methylmercury(II)-monothiolate equilibrium constants refined by MINIQUAD81. 
6. DL-Homocysteine 
7. DL-Penicillamine 
8. N-Acetyl-DL-
Penicillamine 
9. Glutathione  
	
16.45(1) 	8.97 ( 2 ) 
25.42(3) 	2.11(6) 
27.53(9) 
1 
16.596(15), 8.743(7) 	 16•94(2)g l 7.99(1) 
25.339(10) 24.93(3) } 2.18 ( 5 ) 
rejected 27.11(8) 
10 9 13110 16.505(6) 
111 19.80(4)  f3 
 
log 13110 
 15.994(15)
} 9.263(7) 
	 9.11(2) i 
13111 25.257(9) 1 3.42(2) 3.41(12) 
B112 28.68(2) 3.27(5) 
B113  rejected 
1  
10. Thiocholinef log 13110 14.603(12) 
11. 4-Mercapto-N-
methyl piperidine 
log 16.06(3) B10 
Pill 25.33(3) } 268(7) 
Table 3.8: Methylmercury(II)-monothiolate equilibrium constants refined by MINIQUAD81. 
(cont. 
athe : equiTibrta corresponding to the macroscopic constants are described in the text'. Constants Which have been derived 
(e.g, pKa 's)rather than measured, are italicised. 
b
val
ues in parentheses are estimated standard deviations of the last digit from the least-squares refinement. Standard 
deviations of constants derived from two overall constants were calculated using correlation coefficients from the 
,least-squares refinement (footnote, page 329). 
°obtained by TITRAT treatment of titration data from the solid MeNg(II) complex. 
d
these constants are highly correlated and should be regarded as tentative. 
enot studied because of low ligand purity. 
'as the.perchlorate. 
gref. 302 , 25° and 0.3M ionic strength. Mixed constants involving protons have been converted to concentration 
constants using -logye = 0.15 from the Davies equation. 
ref. 305 , 20° and 0.1M ionic strength. 
• ref. 309 , 25 and 0.3-0.4M ionic strength. 
initial mmole 
MeHg(II) I - ME 	H+ 
	
[KOH]N vol•/mL 
6 
pH 
101 
a 0.07703 6.490 0.1445 0.16115 0.10087 64.97 
b 0.07703 5.502 0.07229 0.08910 0.10087 59.98 
c 0.07703 5.488 0.07207 0.07385 0.10087 54.97 
d 0.07703 5.499 0.07168 0.08782 0.09947 54.97 
moles H Ambles ME 
0 
	
0.75 1.5 
Figure 3.6: Methylmercury(II)-Mercaptoethanol (MEH) titration data 
with iodide competition. 
The fitted curves were calculated by COMIXH, using log 6(MeHgI) = 8.500 
and the equilibrium constants in Tables 3.6 and 3.8. 
100% MeHg(11) 
MeHgI 110 MeHgSCH 2CH 2OH 
50 
MeHg0H,(MeHg) 20H 4, 
102 
7 9 11 pH 
Figure 3.7: Species distribution calculated by COMIX for 0.0014M 
MeHg(II) and 0.0014M 2-Mercaptoethanol in 0.1M KI, using the equilibrium 
constants in Tables 3.6 and 3.8. 
The heavy line indicates the pH-range of MINIQUAD81 data. 
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MeHgSCH 2CH 2OH formation, could not refine a formation constant for the 
1:2 complex. Similar 1:2 formation constants were not sought for the 
other thiol ligands described below. 
(ii) Mercaptoacetic acid was fractionally distilled under reduced 
nitrogen pressure following azeotropic removal of water with benzene,
400 
bp. 58.5-60.5°/0.5 mm (lit.4 01 95-6°/8 mm). The thiol was stored under 
nitrogen as a solid at -20°. Titrations with KOH indicated a proton 
purity of 98.0(5)%. 
Values for the proton dissociation constants of the ligand are 
shown in Table 3.6 and fall within the range of previously reported 
values. 
In the presence of 0.1M KI and MeHg(II), KOH titrations could be 
fitted satisfactorily by consideration of the species MeHgSCH 2CO 2- and 
MeHgSCH 2CO2H with coexist with MeHgI below pH 5. 
Olin + 
"" [MeHg ][-SCH 2CO2- ] 
NeHgSCH 2 CO2HJ 
+ efiL==, MeHgSCH 2CO2H 13111 
[MeHg4I-SCH 2CO2- ][e] 
The constant p, 110  agrees with that found by Reid and Rabenstein in 0.3M 
KNO3 . 302 Their value for the proton dissociation constant, pK al[3.65(1)] of the 
MeHg(II) complex is close to that found here as log- log 13110 13 111 
[3.76(1)]. 	In the absence of iodide, the solid complex (page 38 ) 
titrates as a monoprotic acid with pK; 3.74(1) in good agreement with 
the above values. Calculated and experimental titration curves are 
shown in Figure 3.8 and the species distribution in the presence of 
0.1M KI, in Figure 3.9. 
Mixed constants reported by these workers have been converted to 
concentration constants in 0.3M ionic strength, using logy + = 0.15 
from the Davies equation. 
MeHg + SCH 2CO 2 -w—m.MeHgSCH 2CO2- 
[MeHgSCH 2CO 2 - ] 
MeHg
+ 
+ 
-
SCH 
	  [KOH]im Vol./
MeHg(II) 	MA 2- 	H+ 
a 
b 
c 
0.07703 
0.1895 
0.2051 
0.08244 
0.1895 
0.2051 
0.17977 
0.1895 
0.4144 
5.482 0.09947 
0.09649 
0.09837 
54.97 
100.0 
102.0 
t.‘ 
mmoles H
+
/moles MA
2- 
initial mmoles 
6 
pH 
4 
104 • 
0) 
0, 
CA' 
:"411 
0 1.25 2.5 
Figure 3.8: Methylmercury(II)-Mercaptoacetic acid (MAH 2 ) titration 
data, a with iodide competition; b,c with no competing ligand. 
The fitted curves were calculated by COMIXH, using log 8(MeHgI) = 8.500 
and equilibrium constants in Tables 3.6 and 3.8. 
MeHg(II) 
MeNgI 110 MeHgSCH 2CO2, 
MeHgSCH C 
111 
MeHg0H,(MeHg) 20H+ 
104b 
1 0 0% 
50 
5 9 11 pH 
Figure 3.9: Species distribution calculated by COMIX for 0.0014M 
MeHg(II) and 0.0014M Mercaptoacetic acid in 0.1M KI, using the 
equilibrium constants in Tables 3.6 and 3.8. 
The heavy line indicates the pH-range of MINIQUAD81 data. 
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(iii) Mercaptoacetic acid, 0-methyl ester was prepared by acid catalysed 
0-alkylation of mercaptoacetic acid in refluxing methanol. Fractional 
vacuum distillation gave a colourless oil bp. 46-7.5°/4 mm (lit. 378 
42-3°/10 mm). Data from alkalimetric titrationt of this thiol could 
not be fitted adequately by TITRAT without assuming the presence of a 
moderately acidic impurity, presumably mercaptoacetic kid. Treatment 
by TITRAT of this ligand as a mixture of mercaptoacetic acid and the 
0-methyl ester gave the relatively imprecise value of acid dissociation 
constant for the ester, shown in Table 3.6. The concentrations of 
both compounds were treated as parameters with fixed values for mercapto, 
acetic acid dissociation constants, indicating (0.4% Of this impurity .  
An approximate value for the previously unreported MeHg(II) formation 
constant of the 0-methyl ester was obtained by titration of the (impure) 
ligand with MeHg(II) in 0..1M KI'and is shown in Table 3.8, The 
MeHg(II) complexes of the mercaptoacetic acid *purity were included 
in the MINIQUAD 81 treatment', using values for their formation constants , 
recorded previously (page (0) 
MeHg+ + MeÔ2CCH 
 
MeHgSCH 9CO9Me 
[MeHgSCHCO2Me] 
110 + [MeHg ][Me02CCH 2S 7 ] 
 
.(iv) Mercaptosuccinic acid was purified by extraction of an alkaline 
aqueous solution with ether, followed by acidification of the aqueous 
layer.40o The white crystalline thiol was dried over la 205 under 
40o nitrogen, mp. 147-50° (lit. 153740, 149-50° 75 ) 	TitratiOns with 
KOH gave a proton purity of 98.5(4)%. Values for the two carboxylate 
and thiol proton dissociation constants obtained by TITRAT are shown in ' 
Table 3.6, and are in agreement with previously published literature 
values. In the presence of MeHg(II) and 0.1M KI the titrations could 
be fitted satisfactorily with - the three equilibria shown below: 
H
+ 	_ 	[1:0111/m vol./ mL MeHg(II) 	MS 3- 	I 
a 	0.07703 0.07619 0.2440 5.523 0.09947 54.97 
0.07723 0.08523 0.00485 	0.09946 67.47 
initial mmoles 
6 
pH 
106 
mmoles H
+
/mmoles MS
3- 
  
   
0 1.5 3 
Figure 3.10: Methylmercury(II)-2-Mercaptosuccinic acid (MSH 3 ) titration 
data. a with iodide competition; b with no competing ligand. 
The fitted curves were calculated by COMIXH, using log 8(MeHgI) = 8.500 
and the equilibrium constants in Tables 3.6 and 3.8. 
50 
100% 
107 
3 5 7 9 11 pH 
Figure 3.11: Species distribution calculated by COMIX for 0.0014M 
MeHg(II) and 0.0014M 2-Mercaptosuccinic acid in 0.1M KI, using the 
equilibrium constants shown in Tables 3.6 and 3.8. 
The heavy line indicates the pH-range of MINIQUAD81 data. 
MeHg+ + 
• 
-SCH(CO21CH 2 CO2 	+ 2H+=.4b MeHgSCH(CO 2H)CH 2 CO 2H 
[MeHgLH 2 ] a  112 - 	+ 	3- 	+ [MeHg ][L ][H ] 
108 
MeHg + + - SCH(CO 21CH 
(L3-  ) 
MeHgSCH(CO 2- )CH 2CO 2- 	8, 110 
[MeHgL2- ] 
[MeHgi ][L3- ] . 
MeHg+ + -SCH(CO21CH 2 CO 2 7 + erorMeHgSCH(CO )CH CO H 
[MeHgLEI - ] 
aill =+ 	3- 	+ [MeHg ][L ][H ] 
Calculated and experimental titration curves are shown in Figure 
3.10 and the species distribution in Figure 3.11. 	Values of f3 110' 12111 
and 8 112 were highly correlated (page 328). 	The overall constants 
yielded values of the proton dissociation constants pWal [3.13(2)] and 
pK; 2 [4.84(1)] for the carboxylate groups of the MeHg(II)-thiolate 
complex which are close to those found by Reid and Rabenstein in 0.3M 
KNO 3 , prai [3.38(3)] and piCa2 [4.70(2)]. 302 
MeHgLH Alo=bMeHgLH - + 
MeHgLH -.e=== MeHgL 27 + H i- 
[MeHgLH - ][e] 	B -112 
a 	 8 111 [MeHgLH 2 ] 
[MeHgL 2-][e] _ E 111' 
K2 	[MeHgLH-] 
(v) L-cysteine was used as received and stored over P 205 under nitrogen, 
mp. 205 (dec.) [lit. 402 220 (dec)]. 	Titrations with KOH, after addition 
of HNO 3 to fully protonate the zwitterion, gave a proton purity of 
99.0(6)%. 	Macroscopic acid dissociation constants are shown in Table 
3.6, and are in agreement with previously-published values. 	In the 
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presence of MeHg(II) and 0.1M KI, the titration curve, a, shown in 
Figure 12, was fitted satisfactorily (U = 8 x 10-10) by assuming the 
presence of the complex species shown below. The pq value of the 
mono-protonated species [9.01(1)] was obtained from the appropriate 
overall formation constants. The constant, a112' could not be 
refined precisely from thesedata, and could be evaluated more readily 
from data in the absence of iodide, described later. 
iNH2 
MeHg+ + SCH2C _ 
CO2 
 
/11H 
MeHgSCH Cif\ ' 
CO
2
- 
[MeHgL- ]  
110 + 2- 
[MeHTHL ] 
 
+ 
AH ./NH 1 
MeHg+ -SCH20-1\ 9 `_ MeHgSCH 2CH\ '_ f3111 - 
 
CO2 CO2 
+ 
/ 3 NH, NH [MeHgLH2 ] 
MeHg 
+ 
+ 
-
SCH e " +2H+-'-,=--- -'MeHgSCH2CH\ a112 
- [MeHg][L2 
2 t-][H+]2 
\CO - CO2H 
The equilibrium constants are recorded in Table 3.8. 
Expected sulfhydryl binding is supported by the crystal structure 
of the 1:1 complex (page 34 ).
236 
Reid and Rabenstein "2 report 
microscopic constants in 0.3M KNO3 for the equilibrium with deprotonated 
ligand (log Kf = 16.69 in their terminology, in close agreement with 
(3110 above), and with amino-protonated ligand: 
NH / NH 1 
--. 2 MeHg+ -
SCH CH/ 3 MeHgSCH2 H, log Ki = 15.38 
'CO2 - 
CO
2 
Addition of cationic MeHg to the sulfhydryl group of the amino-
protonated ligand is seen to be less favorable than to the deprotonated 
form. Microscopic proton dissociation constants of the ligand show a 
similar trend for addition of a proton instead of MeNg +) to the sulfhydryl 
site. 
[MeHgLH]  
MeHg+1[L2 ][H-1-] 
initial mmoles 
MeHg(II) Cys2- 	H+ I- pCOH]/m ° vol./mL 
110 
2 
a 	0:07703 
b 	0.15358 
. c,c'0.00703 
0.07721 
0.10996 
0.03684. 
0.17216 
0.01309 
0.09671 
5.500 0.17216 
-0.09946 
0.10087 
54.97 
63.66 
54.97 
moles H/moles Cys 
• ' 
-1 
Figure 3.12: Methylmercury(II)-L-cysteine (CysH 2 ) titration data. 
The fitted curves a,b,c were calculated by COMIXH using log 6(MeHgI) = 
8.500 and the equilibrium constants in Tables 3.6 and 3.8. The 310 
species was neglected. •Curve c includes the 310 species. 
1 0 
pH 
111 
Rabenstein and Fairhurst have nmr evidence that the MeHg(II) - 
complexed sulfhydryl group of the 1:1 glutathione and penicillamine 
complexes, may be protonated below pH2. 36° This study did not involve 
such acidic conditions and this type of species was therefore not 
considered for cysteine of the other mercaptoamino acids described 
subsequently. 
The equilibrium distribution diagram for the 1:1 system in the 
presence of iodide is shown in Figure 3.13a. 
In addition to the 1:1 MeHg(IF)-cysteine complex, a 2:1 complex 
of closely related DL-penicillamine has been isolated by Carty et al. 
which has been shown to have deprotonated-amino-bound MeHg(II) as 
well as the expected MeHg(U ).248 )-sulfhydryl binding (page 36 The 
2:1 MeHg(II).cysteine system has been investigated here by the titration 
of cysteine solutions containing more than one equivalent of MeHg(II) 
in the absence of iodide. Under these conditions, the sultydryl 
group is always coordinated therefore the equilibria were treated 
by MINIQUAD81 assuming a 'ligand' of the form MeHgSCH 2CH(NH 2 )CO2- , 
which may form complexes with MeHg(II) as follows: 
11119 NH2 HgMe 
MeHg+ + MeHgSCH CH\ ' q===' / MeNgSCH2CH 
CO2 CO2- 
(L' - )  
,NH 2 
(MeHg) 2 'SCH CH\ _ ÷÷ 
C° 2 . 
,NH 2 
MeHgSCH CFI\ 
CO2HgMe 
[MeHgC] 
2f 
[MeHe][L'-] 
The second stepwise constant, log K2f , for formation of the 2:1 complex 
was found to be 8.81(2). This is similar to that for amine complexes 
MeHg(II) 
/
NH
2 
MeHgI 111 112 MeHgSCH2CH\ _ 
CO2 
Me SCH CH/
NH 3 
MeHg0H, NCO
2
H 
112 (MeHg) 20 
112 
100° 
50 
3 5 7 9 11 pH 
Figure 3.13a: Species distribution calculated by COMIX for 0.0014M 
MeHg(II) and 0.0014M L-cysteine in 0.1M KI, using the equilibrium 
constants in Tables 3.6 and 3.8. 
The heavy line indicates the pH-range of MINIQUAD81 data. 
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but much higher than that for carboxylate and thioether complexes shown 
in Table 3.2, and is consistent with amino coordination such as that 
found in the 2:1 solid-state complex of penicillamine. 248 
Successive protonation of the 2:1 complex could occur at either 
the uncomplexed carboxylate group (A), or at the MeHg-complexes amino 
group with a concomitant shift of MeHg(II) . to the carbOXylate group .(B). 
,NH 2HgMe 
MeHgSCH2C1c 
/MH2HgMe H+ 
MeHgSCH CH\ 
CO2- 
(alkaline solution) 
CO ,H 2 
A. 
,NH3 
MeHgSCH 2CH\ 
CO2HgMe 
B. 
NH / 3 
(MeHg)2SCH H\ 
CO H 2 
D. 
/NH 2HgMe 
MeHgSCH 2CH\ 
1 CO H 2 
• 
,/N14 
Me0g)2SCH CH\ 
CO27 
C. 
•wall■ 
A second MeHg(II) group has been shown to bind to the MeHg-complexed 
group of glutathione in the range 0 < pH .< 4, but to the amino group at 
higher pH, 38° so conceivably, a third species (c) is also possible. 
Binding of two MeHg(II) groups in solution to the sulfhydryl site of 
N-acetyl-L-cysteile has also been described, 403 whereas a crystal structure 
of the 2:1 penicillamine complex isolated from alkaline solution, shows 
coordination to both amino and sulfhydryl sites.
248 	
By analogy, the 
species A (with carboxylate pKa equal to log 8 -211 - log 8 210 [4.42(2)]) 
is probably formed with cysteine. 
The experimental data obtained in the absence of iodide are shown in 
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Figure 3.12. The fitted curves shown in Figure 3.12 were calculated 
using fixed values of the formation constants for unprotonated and mono-
protonated 1:1 species (page 109) and 2:1 species, together with refined 
values shown in Table 3.8 for the diprotonated 1:1 and 2:1 (D or E) 
species. The distribution diagram for 0.002M MeHg(II) and 0.001M 
L-cysteine is shown in Figure 3.13b. 
The titration curves obtained in absence of iodide cannot be 
fitted well (U = 7 x 10  the two sets of data) in the range 
4 < pH < 5, using the abovementioned set of constants. The MeHg(II): 
cysteine ratios used in these titrations were 1.04 and 2.10. Refine- 
ment of the formation constant of 3:1 species significantly improved 
the fit to these data, which was most marked (U = 5.5 x 10 -9+4 x 10-11 ) 
for the titration with MeHg(II) = cysteine > 2. 
NH 2 
2MeHg
+ 
+ MeHgSCH CH ---*" 2 \ 
CO2 
+ + 
,NH 2HgMe + ,NH 2HgMe 
MeHgSCH 2CH, 4--+ (MeHg) 2 SCH 
\ 'CO2HgMe CO20 
F. G. 
  
K - 
3 2 - 
[MeHg
+ 
 ] [L' ] 
However, the 3:1 formation constant shown in Table 3.8 was very highly 
correlated with that for the twice protonated 2:1 species and both of 
these constants should be regarded as tentative. The magnitude of the 
third stepwise constant for addition of MeHe [3.76(1)] may be consistent 
with weak carboxylate binding near to the cationic complexed-amino group 
(F) or to a thioether type of binding (G), similar to that found with 
methionine (Table 3.2) and glutathione at low pH. 360 Under these '\,2:1 
UMeHg) 2L' + ] 
50 
25 
115 
3 7 9 11 
Figure 3.13b: Species distribution calculated by COMIX for 0.002M 
MeHg(II) and 0.001M L-cysteine, using the equilibrium constants in 
Tables 3.6 and 3.8. 
The heavy line indicates the pH range of MINIQUAD 81 data. 
 
The 1:1 species (red) are depicted on Figure 3.12. Note that MeHg0H 
(blue) and free MeHg+ (black) account for significant proportions of 
MeHg(II). 
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conditions, only a small proportion of the 310 species is formed in the 
range 4 < pH < 6, at the expense of the 212 species. 
In their nmr study of MeHg(II) complexation with N-Acetyl-L-
homocysteine, Simpson et 421. 403 do not preclude the formation of 
2+ 
(MeHg) 3SCH 2CH 2CH(NH0 2CMe)CO 2H at high MeHg(II): thiol ratios. Such 
a species is unlikely because of the high positive charge on the sulfur 
donor. In that study, the nmr solutions would have been appreciably 
acidic (pH < 4) due to the release of the sulfhydryl proton upon MeNg(II) 
coordination: 
MeHgC1 + HSCH 2CH 2CH(NHCO2Me)CO2H MeHgSCH 2CH 2CH(NHCO2Me)CO 2H + H+ + C1 
Formation of a 2:1 species with protonated carboxylate is likely to be 
favored over that of the 3:1 species under these conditions. In this 
work however, the amino group of cysteine is available for coordination 
to form the 3:1 species, F and G above, in which the doubly-positive 
charge is delocalised by analogy with the 2:1 protonated species, D and 
E. 
The refinement problems associated with 2:1 and 3:1 species 
(high correlation, large numbers of refinable constants, etc.) were 
avoided with the thiols described below by the use of MeHg(II) : RSH 
ratios close to unity. 
(vi) DL-homocysteine was used as received but stored over P 20 5 under 
nitrogen, mp. 225 (dec.) (lit. 400 232-3°). Titrations with KOH, after 
addition of HNO 3 to fully protonate the zwitterion, were evaluated with 
S - S 
NH2 
_ > 
02C 
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TITRAT to give the acid dissociation constants shown in Table 3.6. The 
relatively imprecise values of these constants reflect the proton purity, 
85.5(1.4)%, of the thiol. 
Titration data obtained in the presence of MeHg(II) and 0.1M KI, 
could not be fitted using MINIQUAD 81. This was ascribed to further 
decomposition of the already impure ligand, which may have been catalysed 
by MeHg(II). The likely decomposition products homocysteine thiolactone 
or deprotonated homocystine shown below may also complex MeHg(II) to some 
extent, e.g. via the amino groups. 
The formation constant shown in Table 3.8 is that obtained by 
Rabenstein and Reid who added small amounts (2 x 10-5M) of Na2H 2EDTA to 
their homocysteine solutions to minimise metal-catalysed decomposition.
302 
(vii) DL-Penicillamine was used as received, but stored over P 205 under 
nitrogen, mp. 190° (dec.) [lit.75 201° (dec.)]. Titrations with KOH, 
after addition of HNO 3 to fully protonate the zwitterion, were evaluated 
with TITRAT to give the acid dissociation constants shown in Table 3.6 in 
good agreement with previously published values, and proton purity of 
101.1(1)%. Titration data obtained in the presence of one equivalent of 
MeHg(II) and 0.1M KI were fitted with MINIQUAD 81 by simultaneously 
refining the overall formation constants f3. 110 and 3111  in a fashion 
identical to the cysteine system. 
NH < 
11 
NH
2 [MeHgL]  MeHg + + - SC(Me) 2CH‹ 2 _...1===MeHgSC(Me) 2 CH 13 0 CO 2 CO2 - 	[MeHg-I][L2-][H+] 
0 3.0 
118 
6 
2 
Figure 3.14: Methylmercury(II)-DL-Penicillamine(PenH 2 ) titration data 
with iodide competition. 
The fitted curve was calculated by COMIXH, using log (MeHgI) = 8.500 
and the equilibrium constants in Tables 3.6 and 3.8. 
10 
pH initial mmoles 
MeHg(II) Pen2- 	+ 
0.07703 0.07707 0.17368 5.498 0.10087 54.97 
[KOH]im vol./ 
moles H /mmoles Pen
2- 
5 7 3 
100A MeHg(II) 
NH 2 
MeHgSC(Me) 2C‹ 
110 
CO2 
50 
MeHg0H, 
(MeHg) 20H\ 
1  
11 pH 
119 
Figure 3.15: Species distribution calculated by COMIX for 0.0014M 
MeHg(II) and 0.0014M DL-penicillamine in 0.1M KI, using the equilibrium 
constants in Tables 3.6 and 3.8. 
The heavy line indicates the pH-range of MINIQUAD81 data. 
(*13112 estimated from the L-cysteine system). 
120 
NH NH3+ - [MeHgL]  MeHg + SC(Me) C 
O 
 + tw=t-MeHgSC(Me) CH‹CO 
 
B 
2 
- 111 + - 
[MeHg ]LL ] C 
These are recorded in Table 3.8 and are in good agreement with the 
microscopic constants found by Reid and Rabenstein for complexation with 
amino deprotonated ligand. 302 Expected sulfhydryl binding is supported 
by the crystal structure of the 1:1 complex. 247 Addition of more than 
one equivalent of MeHg(II) to penicillamine was expected to produce an 
equilibrium mixture of protonated and deprotonated 2:1 complexes with 
pH-dependent MeHg(II) binding sites similar to cysteine (page 111) and 
was therefore not studied here. A 2:1 complex with sulfhydryl-bound 
and amino-bound MeHg(II) groups has been isolated from alkaline solution. 248 
Calculated and experimental titration curves are shown in Figure 3.14 
and the 1:1 distribution diagram in presence of 0.1M•KI, in Figure 3.15. 
The pK; of the doubly protonated complex could not be evaluated in the 
pH range used here (pH > 4) but was estimated to be fL3, similar to that 
for the 1:1 cysteine complex. 
(viii) N-Acetyl-DL-Penicillamine was used as received but stored over 
P
2
0
5 under nitrogen, mp. 180-1
0  (lit. 75 183°). Titration with KOH 
and treatment of the data with TITRAT gave the acid dissociation constants 
recorded in Table 3.6, in good agreement with previously recorded values, 
and indicated a proton purity of 94.4(1)%. Since the amide group is not 
protonated in aqueous solution the 1:1 equilibrium system with MeHg(II) 
in the presence of 0.1M KI was treated by MINIQUAD 81 by considering. 
Only the two equilibria shown: 
+ 
NH(0
2 
 CMe) . NH(.0 9CMe) 
- 
MeHg +; SC(Me) 2CH‹ ;----i-MeHgSC(Me) 2  CH‹ ` 
2 CO2 CO - , 2 
(L) 
- 
[MeHgL-J  
6  110
][L 2 ] 
41 
initial mmoles  
2- + 
[KOH]/m vol./ 
MeHg(II) NAP H 
0.07703 0.07460 0.17142 5.497 0.10087 54.97 
mmoles H
+
/mmoles NAP
2- 
I 
121 
0.5 1.0 
Figure 3.16: Methylmercury(II)-N-Acetyl-DL-penicillamine (NAPH 2 ) 
titration data with iodide competition. 
0 
The fitted curve was calculated by COMIXH using log 13(MeHgI) = 8.500 
and the equilibrium constants in Tables 3.6 and 3.8. 
8 
pH 
9 11 pH. 
Figure 3.17: Species distribution calculated by COMIX for 0.0014M 
MeHg(II) and 0.0014M N-Acetyl-DL-Penicillamine in 0.1M KI, using the 
equilibrium constants in Tables 3.6 and 3.8. 
The heavy line indicates the pH-range of MINIQUAD81 data. 
(*111 estimated from the L-cysteine system). 
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111 
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The 1:1 formation constants are recorded in Table 3.8. The value of 
6110 is in good agreement with that found by Reid and Rabenstein in 
0.3M KNO 3 . 302 The protonated complex is not very soluble below pH 5 
and so the value of 6 111  is not precise, being calculated from few data . 
points. The proton dissociation constant, OK; [3.29(5)], of the complex 
is close to that found . by the abovementioned workers [2.95(7)]. 
Calculated and experimental titration curvet are shown in Figure 
3.16, and the species distribution with 0.1M KI, in Figure 3.17. The 
2:1 system was not studied. 
(ix) Glutathione was used as received but stored over P 205 under 
nitrogen, mp. 190 (dec.) (lit.
75 
 195°). Protonation constants of 
the tripeptide were obtained by KOH titration of acidified solutions. 
Treatment of the data with TITRAT gave the results shown in Table 3.6, 
in good agreement with those previously reported. The proton purity 
was found to be 104.0(2)%. 
In the presence of one equivalent of MeHg(II) and 0.1M KI, titra-
tion data over the range 4 < pH < 10 were evaluated with MINIQUAD 81 
for the equilibria below: 
1 	 MeHg+ I +ll-0 C S - NH CO - 
 
2 2 
(L3- ) 
 
I I 	I
- 
[MeHgL2-1  
C SHgMe H CO2- 6110 	[MeHg4 ][L 7 ] 
 
MeHg
+ 
+ S NH 2 CO 2 	-0 2  C SHgMe NH 3  CO - 
I_I I_ 
2 
[MeHgLH - ]  
111 - [MeHg4 ][L 3- ][e] 
0 2 4 
1 0 
pH 
initial mmoles 
MeHg(II) Glut 3 	H+- 
0.07703 0.08232 0.25949 
124 
Figure 3.18: Methylmercury(II)-Glutathone (GlutH3 ) titration data 
with iodide competition. 
The fitted curve was calculated by COMIXH using log 13(MeHgI) = 8.500 
and the equilibrium constants in Tables 3.6 and 3.8. 
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Figure 3.19: Species distribution calculated by COMIX for 0.0014M 
MeHg(II) and 0.0014M Glutathione in 0.1M KI, using the equilibrium 
constants in Tables 3.6 and 3.8. 
The heavy lines indicates the pH-range of MINIQUAD81 data. 
(*f3 1 .13 estimated from the microscopic constants in ref. 309) 
MeHg+ + 
+ 1 	I 	+ 2H -7.==== 1I 	1 
NH CO2 HO C SHgMe NH CO 2 1. 3 2 
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fi112 	. 
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+
][1.
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][H
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The formation constants are recorded in Table 3.8. Inclusion of a 
thrice protonated complex Din) did not improve the fit to the data. 
The valueof 1l0  agrees with the previously reported values of 
Schwarzenbach and Schellenberg 305 and Simpson 324 Reid and Rabenstein 
have not published a value of this constant. Proton dissociation 
constants of the 1:1 complex, corresponding to log B 
. 112 - 
log 
 fill 
9.26(1)] are in .42(1)] and log fi ll a B ro EP Ki al = 3 - lo K 2 = - - 110 -. ; 
agreement with the macroscopic constants calculated from microscopic 
constants reported by Rabenstein 309 [3.31(12) and 9.11(2) respectively]. 
The calculated and experimental titration curves for the 1:1 MeHg(II)- 
glutathione system are shown in Figure 3.18. The species distribution 
over the range 2 < pH < 12 is shown in Figure 3.19, using values plio , 
fill' 112 evaluated in this work, and an estimate of log 113*
5 fr°111  
the microscopic constants reported by Rabenstein.
309 
 The 2:1 system 
has been previously studied
360 
 and was not considered here. 
(x) Thiocholine perchlorate was kindly provided by Philip Guerney 
(University of New South Wales), and stored at - 20 0  under nitrogen, 
mp. 137-9° 
Although the MeHg(II) complex of cysteamine has been isolated, 405 
the formation constants of MeHg(II) with cationic thiolates such as 
thiocholine have not been reported. Titration of the perchlorate salt 
of the ligand with KOH, and treatment of the data with TITRAT, gave 
the acid dissociation constant in agreement with the previously 
reported value, shown in Table 3.6 and proton purity 96.1(2)%. 
0.5 -0.5 
initial mmoles 
MeHg(II) 	Tc 	H+ 
0.07703 0.07068 0.09095 5.500 0.10025 
127 
11 
pH 
Figure 3.20: Methylmercury(II)-Thiocholine perchlorate IcH + ) 
titration data with iodide competition. 
The fitted curve was calculated by COMIXH using log 13(MeHgI) = 8.500 
and the equilibrium constants in Tables 3.6 and 3.8. 
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MeHg(II) 
MeHgI 110 MeHgSCH 2CH 2 NMe 3 
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Figure 3.21: Species distribution calculated by COMIX for 0.0014M 
MeHg(II) and 0.0014M Thiocholine perchlorate in 0.1M KI, using the 
equilibrium constants in Tables 3.6 and 3.8. 
The heavy line indicates the pH-range of MINIQUAD81 data. 
(3. 111 -  [MeHig4 ][L - ][H+ ] 
IMeHgLe] 
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Titration of the solid 1:1 MeHg(II) complex with KOH in the presence 
of 0.1M KI yielded the value of (3 110 (Table 3.8), using MINIQUAD 81 
on data in the range 4 < pH < 10. 
+ - • 
MeHg + SCH 2CH 2N(Me) 3  c MeHgSCH,,CH 2  N(Me) 
[MeHgSCH 2CH 2N(Me)3] al 10 = + 
[MeHg+][ -SCH 2CH 2N(Me) ] 
This constant is the smallest stability constant of MeHg(II) with the 
thiols studied here, reflecting the relatively high acidity of the 
thiocholine sulfhydryl group. Calculated and experimental titration 
curves are shown in Figure 3.20 and the distribution diagram in the 
presence of 0.1M KI, in Figure 3.21. 
(xi) 4-Mercapto-N-methylpiperidine was prepared by the method of Barrera 
and Lyle
406 
 from N-methylpiperidine via 4,4'-dimercapto -N-methylpiperidine 
hydrate (page 344) to give a colourless oil, which was fractionally 
l 
distilled under reduced nitrogen pressure, bp. 31-2°/1 
mm (1it o6 62 ,/ 
 
0.8 mm) and stored under nitrogen at -20°, mp. 7-9 0 • Titration of the 
thiol with KOH after protonation with HNO 3 , and treatment of the data 
with TITRAT, gave acid dissociation constants shown in Table 3.6, and 
proton purity 92.9(2)%. Titration of the solid 1:1 MeHg(II) complex 
(page 38 ) with KOH in the presence of 0.1M KI, yielded the values 
a 110 and f3 111  (Table 3.8) by treatment with MINIQUAD 81. 
\ [MeHgL]  
MeHg
+ 
+ N-Me MeHgS N-Me (3110 - 
 / [MeHg4-][L - ] 
(L - ) 
MeHg + S N-Me + H .-E===MeHgS +N 
+ - < \ 
/ 
+ VI 
Ligand hydrolysis and complexation with MeHg(II) have not previously been 
reported. Calculated and experimental titration curves are shown in 
/'Me 
0.5 1 -0.5 1.5 0 
11 
pH 
7 
H+ 
	 [KOH]im vo1.411, 
MeHg(II) MMP 
0.07703 0.08329 0.10179 4.999 0.10025 54.97 
initial mmoles 
130 
3 
Figure 3.22: Methylmercury(II)-4-Mercapto-N-methylpiperidine (MMP) 
titration data with iodide competition. 
The fitted curve was calculated by COMIXH using log (MeHgI) . = 8.500 
and the equilibrium constants in Tables 3.6 and 3.8. 
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Figure 3.23: Species distribution calculated by COMIX for 0.0014M 
MeHg(II) and 0.0014M 4-mercapto-N-methylpiperidine in 0.1M KI, using 
the equilibrium constants in Tables 3.6 and 3.8. 
The heavy line indicates the pH-range of MINIQUAD81 data. 
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Figure 3.22 and the species distribution in the presence of 0.1M KI, 
in Figure 3.23. 
The equilibrium constants for MeHg(II)-monothiolate interaction 
found in this study, and elsewhere, lie in the range 14.64 to 17.60 
and are highly correlated with the BrOnsted basicity of the sulfhydryl 
donor groups. This can clearly be seen from the plot of log 
versus pKa (SH) in Figure 3.24 which includes values for all monothiols 
studied in this work and by Reid and Rabenstein. 3021he values found by 
363 	. 
Hojo et al. are in disagreement. 
The intrinsic BrOnsted basicity of the sulfhydryl group in the 
u-mercaptoamine ligands studied here, cannot adequately be represented 
by macroscopic proton dissociation constants because the amine and 
thiolate groups protonate simultaneously. Microscopic sulfhydryl 
protonation constants for these ligands were estimated by assuming the 
same relationships between macroscopic and microscopic constants as were 
found in glutathione by Rabenstein. 369 For glutathione, the following 
microscopic constants were determined 369 
--NH 2 
---002- 
The amino group is apparently 0.2 log units more basic than the thiolate 
group, independent of whether these groups are protonated or deprotonated. 
17 
16 
15 
14 
133 
8 9 10 	pKa (SH) 
Figure 3.24: Correlation between the MeHg(II)-thiolate formation 
constant, log 13110'  and BrOnsted basicity of the sulfhydryl donor, 
pKa (SH). The monothiol ligand numbering follows that of Tables 3.6 
and 3.8. 
Log elm from this work4), using estimates of microscopic pK a (SH) for 
mercaptoamines (page 134) and microscopic constants reported by Reid and 
Rabenstein
302 
for ligands in which the amino group is protonated,(:), 
and unprotonated,(E). 
1 34 
Similar relationships have been found for the microscopic constants of 
cysteine:4" 
Macroscopic constants for composite SH + NH 3+ deprotonation, Ka/ 
and Ka2  are related to the microscopic constants by the relationships ' 
K
al 
= K123  + k123 
Ka2 - k
1234 
+ k
1243 
Use of the approximations plc 1234 = Pk1243 + 0.2 and pk124 = 
Pk123 0 ' 2 
enables the microscopic protonation constants of the sulfhydryl (k 1243 ) 
amine (k1234 ) groups of the mercaptoamines to be separately evaluated 
from the macroscopic constants and these are recorded in Table '3.9. 
pka (NH 3+ ) pka  (SH) 
L-cysteine 10.15 9.95 
(10.09) 
(9.74)302 
DL-penicillamine 10.38 10.18 
(10.29) 
(9.70)302 
glutathione 9.53 9.33 
(9.20)4°7 
-mercapto-N-methylpiperidine 10.13 9.93 
Table 3.9: Estimateda microscopic proton dissociation constants of 
amine and sulfhydryl groups of fully depronated a-
mercaptoamines. 
a
Using the approximation pk a (NH 3+ ) = pk a (SH) + 0.2 
described in the text and using macroscopic constants 
recorded in Table 3.6. 
k
1234 
• k
1243  
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The relationship between 8 110 for log KmeH gsR and pKa(SH) from this 
combined data is found to be 
log
KMeHgSR = 0.893 pK a  (SH) + 7.77 
The relevance of these formation constants to the interaction of 
antidotal thiols in vivo will be discussed in the next Section, after 
the formation constants with some vicinal dithiols have been established. 
136 
3.3.3 Methylmercury(II) Formation Constants with Vicinal Dithiols  
The only formation constants in the literature of methylmercury(II) 
with a dithiolate ligand seem to be those reported by Hojo et al. for 
the interaction with BALH 2' 
363 
 Some serious discrepancies with values 
obtained by these workers for the formation constants of MeHg(II)- 
monothiolate complexes have previously been discussed (page 80 ). 
As several important antidotes for methylmercury(II) toxicity are 
vicinal dithiols (BALH 2 , Unithiol and DMSH 4 ) it was of interest to 
determine the equilibrium constants for the formation of MeHg(II) 
complexes with these ligands. 
To completely describe the solution chemistry of MeHg(II) complexes 
with dithiols, both 1:1 and 2:1 species (protonated and unprotonated) 
need to be considered, which renders evaluation of individual equilibrium 
constants much more difficult than for monothiols. 
Attempts to purify the non-vicinal dithiol, 1,3-dimercapto-2- 
propanol, DMPH 2 , by fractional distillation under reduced nitrogen 
pressure, bp. 61.5-3.5°/0.2 mm (lit.400 82°/1.5 mm) apparently caused 
decomposition, indicated by low proton-purity of the product (<85% by 
alkalimetric titration). Consequently, comparison of MeHg(II) stability 
constants with 0MPH 2 and its vicinal dithiol analog, BALH 2 , was not 
possible. 
2,3-dimercapto-l-propanol, BALH2 , was fractionally distilled under 
reduced nitrogen pressure, bp. 74-570.5 mm (lit. 408 74-671 mm), and 
stored under nitrogen at -20°. Titration of the dithiol with KOH, and 
treatment of the data with TITRAT, gave the two macroscopic proton 
dissociation constants recorded in Table 3.10, and indicated a proton 
purity of 97.5(6)%. It should be noted that, since the two sulfhydryl 
groups are of comparable basicity, they are simultaneously protonated 
this work [25°, 0.1 KNO3 or K1] previous values
b ref. 
2,3-dimercapto-1-propanol, BALH 2 
meso-2,3-dimercaptosuccinic acid, 
DMSH4 
2,3-dimercapto-1-propanesulfonate 
(sodium salt), Unithiol 
2.24(1) 
8.654(2) 
3.429(3) 
8.691(1) 
10.620(4) 
9.648(3) 11.50(2) 
11.379(16) 
8.69 10.79 [25°, 0.1 NaCl] 
8.618 10.567 [25 , fq) ] 
2.71 3.48 8.89 10.79 [25°, 0.1 KNO3] 
2.31 3.69 9.68 11.14 [20°, 0.1 KG]] 
2.40 3.46 9.44 11.82 [20°, 0.1 KG]] 
8.84 11.20 
8.65(2) 11.91(4) [25°, 0.1 KC1] 
8.74(10) 11.17(1) 
409 
379 
375 
410 
411 
412 
413 
414 
Table 3.10: Proton dissociation constantsa of dithiol ligands used for MeHg(II) solution studies. 
a 
Macroscopic concentration constants obtained with TITRAT. Recorded values are weighted geometric means 
with estimated standard deviations of the last digit, in parentheses. bMixed constants 44te been converted to concentration constants by calculation of logyH+ according to the 
Davies equation. 
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above pH 9 in a similar fashion to the a-mercaptoamines described 
previously. Microscopic proton dissociation constants of vicinal 
dithiols do not seem to have been previously recorded. 
Addition of one equivalent of MeHg(II) to BALH 2 is expected to 
establish the following equilibria: t 
HC--CH-CH 2OH 
MeHg
+ 
+ c 
S S 
(BAL2- ) 
 
HzC7-CtCH 2OH 
110 
[MeHgBAL2-]  
g S , [MeHg4][BAL2-] 
ileH‘ 
 
HC--CH-CH 0 H 9C--CH-CH 2  OH + 7 	\ _  [MeHgBALH]  MeHg+. + 7 	\ 	H 
- 
- S S - MeHgS SH 
111 
[MeHg+][BAL2-][H] 
Proton and MeHg(II) exchange in the 111 species is likely to be rapid. 
An order-of-magnitude estimate for the equilibrium constant for the 
addition of one MeHg(II) group to the deprotonated dithiol ligand was 
made using the correlation between sulfhydryl basicity, pK a (SH), and 
log KMeHgSR for monothiolates (page135 ). If the microscopic pKa 's of 
the sulfhydryl donors are assumed to be between the macroscopic proton 
dissociation constants, log plio should be in the range 15 to 17, and 
therefore be amenable to evaluation by iodide competition. However, 
when equivalent quantities of MeHg(II) and BALH 2 were titrated with KOH 
in the presence of 0.1M KI, it became apparent that.MbHg(II) was not 
dissociated from sulfur in the range 4 < pH <-10, indicating log 13110 
>17 to 18. Only the proton dissociation constant (Wa = 
(310110) of 
the 1:1 protonated species could be obtained from these data. More 
tDotted lines indicate that MeHg may be bound to either donor, possibly 
to both, and the curved arrow indicates rapid exchange in subsequent 
diagrams in this chapter. 
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efficient competition for MeHg(II) was achieved by using mercapto-
ethanol instead of iodide. A similar approach was coincidentally 
taken by Reid and Rabenstein in their nmr studies of monothiolates, 
using mercaptoacetate competition. 
309
This monothiol has only a 
single proton nmr resonance but mercaptoethanol has the advantage in 
this work of contributing only two extra equilibria to the overall 
equilibrium scheme, i.e. ligand hydrolysis and MeHg(II) complexation. 
Titration of a solution containing equivalent quantities of 
mercaptoethanol, BALH 2 , and MeHg(II) over the range 5 < pH < 10, 
yielded data which were treated with MINIQUAD81 to give log 
19.56(10) for the 1:1 MeHg(II) complexation of BALH 2 and pq = 7.60(1) 
for the protonation of the 1:1 complex (Table 3.11). The calculated 
and experimental titration curve for this titration is shown in Figure 
3.25 and the distribution diagram for the 1:1:1 system is shown in 
Figure 3.26A. 
The magnitude of 13110  is approximately 100 times higher than 
expected for a simple monothiolate interaction, even considering the 
availability of two sulfhydryl groups, which is expected to statistically 
advantage MeHg(II)-sulfhydryl coordination. 
In contrast to the very high stability of the 1:1 complex, addition 
of a second MeHg(II) group is less favorable. Addition of a second 
equivalent of MeHg(II) to the 1:1 system, in the presence of mercapto-
ethanol gave titration data which could be fitted adequately assuming 
only the 1:1 complex and MeHgSCH2CH 2OH. Similarly, with 0.1M iodide 
competition, suitable for MeHg(II)-thiolate interactions with log 8 in 
in the range 13 to 17, the second MeHg(II) group preferentially formed 
insoluble MeNgI. Thus both mercaptoethanol and iodide compete more 
effectively for the second MeHg(II) group, than does the remaining 
sulfhydryl donor of the 1:1 complex. 
Dithiol Equilibrium constantsa of MeHg(II) complexes 
ligand 
with competition with no competing ligand 
2,3-dimercapto-l-propanol 
(BALH 2 ) 
2,3-dimercapto-l-propanesulfonate, 
sodium salt (Na[UTH 2 ]) 
meso-2,3-dimercaptosuccinic acid 
(DMSH4 ) 
log 
log 
log 
110 
111 
112 
110 
111 
112 
210 
211 
110 
111 
112 
113 
210 
211 
212 
21.155(6) } 
21.01(8) b l 
28.57(8) 
30.82(8) 
17.11(3) C 1 
25.61(16) 
30.42(18); 
34.2 
-,,- x 7.00) 
7.559(4) 
2.250(7) d 
8.50(15) 
4.81.(8) 
3.8(3). 
30.02(11) 
3.1.1 
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39.6 
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10.26(8) 
,1,14e 
=log K2f 
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Figure 3.11: Methylmercury(II)-dithiolate equilibrium constants refined by MINIQUAD81 
avalues in parentheses are estimated standard deviations of the last digit, from the least-squares refinement. 
Standard deviations of derived constants (italicised) were calculated using correlation coefficients from 
the least-squares refinement (footnote, page 329). . 
bmercaptoethanol competition. cibdide competition. dassuming pKa (SO3H)=2.0. eestimated from behaviour 
of several titrations.' Complete MINIQUAD81 refinement non-...convergent ftitration of OeHgY2DMSH2, no competition. 
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Figure 3.25: Methylmercury(II)-BALI 2 titration data. 
a with mercaptoethanol (MEW competition; b -d with no competing ligand. 
The fitted curves were calculated by COMIXH, using the equilibrium 
constants in Tables 3.6, 3.8, 3.10 and 3.11. 
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Figure 3.26A: Species distribution calculated by COMIX for 0.0014M 
MeHg(II), 0.0014M BALH 2 and 0.0014M Mercaptoethanol, using the 
equilibrium constants in Tables 3.6, 3.8, 3.10 and 3.11. 
The heavy line indicates the pH-range of MINIQUAD81 data. 
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Figure 3.26B: Species distribution calculated by COMIX for 0.002M 
MeHg(II) and 0.001M BALH 2 , using the equilibrium constants in Tables 
3.10 and 3.11. 
The heavy line indicates the pH-range of MINIQUAD81 data. 
The 1:1 species are depicted on Figure 3.26A. 
K =   
2f + - 
[MeHg ][MeHgBAL ] 
[(MeHg) 2BAL] 
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By titration of the 2:1 system in the absence of competing ligands 
(as for the 2:1 cysteine and penicillamine systems) MINIQUAD81 was 
able to treat titration data over the range 5 < pH < 10 by assuming 
that the 1:1 complex, MeHgBAL - , is never dissociated and treating it as 
a ligand'. Calculated and experimental 2:1 titration curves are also 
shown in Figure 3.25. Equilibrium constants for the following reactions 
were determined under these conditions and are also recorded in Table 
3.11. 
MeHg
+ 
+ H2C--CH-CH OH H C--CH-CH 2  OH 
 
( \ 
S S- MeHgS 1-1gMe 
‘MeHg' 
H C--C-CH OH H C--CH-CH OH 
H + \ 2 2/\ 2 
MeHgS H 
'MeHg/ 
- 
[MeHgBALH]  
[MeHgBAL -][e] 
The 2:1 species distribution for 0.002M MeHg(II) and 0.001M BALH 2 in 
the absence of competing ligand is shown in Figure 3.26B. 
(ii) 2,3-dimercapto..-propanesulfonate (sodium sal -t), Unithiol, was used 
as received and stored under nitrogen at -20°C. The compound is a 
monohydrate of the sodium salt? imp.210 0 (dec.)E1it. 402 229(dec.)j, and is 
dehydrated by storage over P 205 . 90 However, it was more convenient to 
weigh the hydrate, as the anhydrous salt was found to be quite hygroscopic. 
Titration of the hydrate with KOH, and treatment of the data with TITRAT, 
gave values for the acid dissociation constants shown in Table 3.10, and 
proton purity of 97.0(7)7. No evidence was found for protonation of 
the sulfonate group above pH 2. Consequently, MeHg(II) species with 
protonated or complexed sulfonate were not considered in MINIQUAD81 
treatments. 
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Titration of equivalent quantities of Unithiol and MeHg(II) in 
the presence of iodide indicated that iodide competition is inapprop-
riate as a method of evaluating log 13110'  as was the case for BALH 2 . 
Titration of equivalent quantities of mercaptoethanol, Unithiol and 
MeHg(II) over the range 4 < pH < 11 and treatment with MINIQUAD81, 
gave values of the constants, log110 [21.01(8)] and pq [7.56(1)] 
13  
for the species in the equilibria below: 
+ 
H C--CH-CH 2  SO 3 H C--CH-CH 2  SO3 - _  [MeHgUT2- 4  
 
MeHg + 3 	_ 	2/ \ 
S S S S 
110 
[MeHg+HUTJ7 ] 1 	/ 
(UT3- ) 
H 9p,-CH-CH 9S 
MeHg' + 7 	\ 	- 
	
-s 	s- 
H C--CH-CH SO 2/ \ 3 _ 	[MeHgUTH 7 ]  
' + + 
MeHgS SH 
111 
[MeHg HUT
3- 
 ][H ] 
The calculated and experimental 1:1:1 titration curve is shown in 
Figure 3.27 and the species distribution in Figure 3.28A. 
Formation of the 2:1 MeHg(II)-Unithiol complex was evaluated in the 
absence of competing thiol or iodide, in an identical fashion to that for 
BALH 2' to give the constants (Table 3.11) corresponding to the equilibria: 
. 
/ 
' 
H 2  C--CH-CH 3 2 Hf-- \ CH-CH-eS0 3 v . . [(MeHg)2UT-] 
MeHig 2f + 2- 
MeHgS SHgMe [MeHg ][MeHgUT ] 
MeH4 
H,C--CH-CH,S0, 7 H oc—CH-CH 2SO3 
H+ + y 	L 	7, \ -s 	S 7 MeHgS SH 
'MeH6 
K" - 
[MeHgr]i.  
a [MeHgUT 7][H ] 
The calculated and experimental titration curve for the 2:1 system is 
also shown in Figure 3.27, and the distribution diagram for 0.002M 
MeHg(II) with 0.001M Unithiol, in the absence of competing ligand, in 
MeHg(II) UT 2- ME 
[KOH]im vol/mL initial mmoles 
a 0.07703 0.7368 0.2468 0.07654 0.10025 64.97 
b 0.15368 0.07494 0.18998 - 0.09947 59.96 
a 
moles H /mmoles UT
2- 
146 
-0.2 0.6 1.4 2.2 3.0 
Figure 3.27: Methylmercury(II)-Unithiol (Na[UTH 2 ]) titration data. 
a with Mercaptoethanol (MEH) competition; b with no competing ligand. 
The fitted curves were calculated by COMIX, using the equilibrium 
constants in Tables 3.6, 3.8, 3.10 and 3.11. 
100% 
50 
147 
3 5 7 9 11 pH 
Figure 3.28A: Species distribution calculated by COMIX for 0.0014M 
MeHg(II), 0.0014M Uhithiol and 0.0014M Mercaptoethanol, using the 
equilibrium constants in Tables 3.6, 3.8, 3.10 and 3.11. 
The heavy line indicates the pH-range of MINIQUAD81 data. 
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Figure 3.28B: Species distribution calculated by COMIX for 0.002M 
MeHg(II) and 0.001M Unithiol, using the equilibrium constants in 
Tables 3.10 and 3.11. 
The heavy line indicates the pH-range of MINIQUAD81 data. 
The 1:1 species are depicted on Figure 3.28A. 
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Figure 3.28B. 
(iii) meso-2,3-dimercaptosuccinic acid was used as received but stored 
415 
over P
2
0
5 
under nitrogen, nip. 185° (dec.) [lit. l82_50 15  
(dec.) ]. Titration with 0.1M KOH, after addition of HNO
3 to pH 2.8 
to 3.0, and treatment of the data with TITRAT provided values of the 
two carboxylic acid and two thiol proton dissociation constants recorded 
in Table 3.10 and proton purity 97.6(3)%. The value for pKa4 is in 
least agreement with previously recorded values. The determination of 
pKa 's > 10.5 has been found in this study to be extremely sensitive to 
the value used for K. K% was treated as a parameter by TITRAT and 
hence contributes to some of the imprecision of pK a4 . The refined 
values of Kvci for DMSH4 titrations are entirely consistent with those 
values found during refinement of acidity constants for all the other 
thiols used in this study, whereas the value for K  often not 
recorded by other workers or has been taken from previously reported 
literature values. It is particularly noticeable (Tables 3.8 and 
3.10) that large disparities exist in previously recorded pK a 's above 
1 0. 
In an equilibrium mixture of DMSH and one equivalent of MeHg(II), 
the following equilibria involving 1:1 MeHg(II)-DMSH4 complexes are 
expected: 
S7 
- [MeHgDMS.
3-
]  
6   
HgMe 
110 
[MeHg
+
][DMS
4-
] 
+,MbHg+ 
 
0 SH 
 
- 
[MeHgDMSH
2-
]  
111 
[MeHg
+
][DMS
4-
1[ 
+
] 
    
+ MeHg
+ 
+ H 
   
   
 
-0
2 
SHgMe 
C 	S - 
+ 2MeHg
+ 
• 
[(MeHg) 2DMS 2- ] 
12.210 - +.) 4- 
[MeHg ] [DMS ] 
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7,0 C 
[MeHgDMSH
2  
H ) [MeHg+][DMS4- ][e] 2 
+ + i , -] 
+ MeHg + 2H =z-F= 1 13.112 - 
\02C SHgMe 
HO 2C 
+ MeHg+ + 3H+ --- 
HO2C 
SH) 
SHgMe 
[MeHgDMSH 3 ] 
[meHg+][Dms4- ]oi+j 3 
Unlike the 1:1 systems of MeHg(II)-BALH 2 and MeHg(II)-Unithiol, 
titration of MeHg(II) and DMSH 4 in the presence of mercaptoethanol gave 
a formation constant for the 1:1 complex' 
' 
of approximately 10 16 , 3110 
accompanied by three successive protonation equilibria as shown. And 
in contrast to the BALH 2 and Unithiol 1:1 systems, in order to satis-
factorily fit the titration data with MINIQUAD81, a series of 2:1 
species needed to be simultaneously included. Unsatisfactory results 
were obtained by simultaneous refinement of all 1:1 and 2:1 constants, 
since these were highly correlated, but the 2:1 constant 13 210 was 
indicated to be in the range 10
14
-10
16
. Iodide competition was 
therefore necessary to obtain the 2:1 formation constants for the 
equilibria shown: 
O C SHgMe 
+ 2MeHg
+ 
+ H+ 
H ‘ 
02 C SHgMe 
[(MeHg),DMSH - ] 
13211 -  + 2 4- + 
[MeHg ] [DMS ][H ] 
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HO
2
C SHgMe 
[(MeHg) 2DMSH 2 ] 
212 
_  
[MeHg+] 2[DMS4- ][H+ ] 2 
+ 2MeHg
+ 
+ 2H+ 
 
 
 
HO
2
C SHgMe 
 
Titrations of DMSH 4 solutions containing more than two equivalents 
of MeHg(II) in the presence of iodide where the 1:1 species can be 
neglected, gave values for the overall formation constant for the 2:1 
mono-protonated complex B ' 211 but not for the diprotonated complex, 
13
212 
The twice protonated 2:1 complex has been isolated and character- 
ised in the solid state (page 38 ). The formation constant of the 
unprotonated 2:1 complex B 
' - 210' 
system is highly correlated, however MINIQUAD81 consistently indicated , 
a value log B 
-210 
,L14. The value for 13 210 of 10
14 
was fixed in a 
subsequent MINIQUAD81 refinement of the formation constants corresponding 
to the unprotonated, once and twice protonated 1 .:1 species and once 
protonated 2:1 species over.the range 4 < pH < 10 in the presence of 
.0.1M KI, to give the refined values shown in Table 3.11. The calculated 
and experimental titration curves are shown in Figure 3.29. 
Using the formation constants for the 2:1 and 1:1 complexes shown 
in Table 3.11, the distribution diagram was calculated for a 1:1 ratio 
of MeHg(II):DMSH 4 in the presence of 0.1M iodide. Figure 3.30 indicates 
the complexity of the system, which involves six MeHg(II) species at 
significant concentrations in the range 2 < pH < 12. 
A comparison of the 1:1 and stepwise 2:1 formation constants for 
MeHg(II) complexation with Unithiol, BALH 2 and DMSH4 is of interest 
(Table 3.12). It can be seen that Unithiol and BALH 2 form 1:1 species 
with enhanced stability compared to DMSH 4 and monothiolates. The high 
stability of these 1:1 complexes is not solely due to high sulfhydryl 
basicity, since the sulfhydryl groups of DMSH 4 are more basic than those 
could not be refined precisely since the 
0 
0 
0 
• 0 
11 
pH 
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initial mmoles 
[KOH]m 
MeHg(II) UT3- H 
a 0.07703 0.09267 0.10611 0.07603 -0.09840 68.61 
b 0.07703 0.09267 0.46942 0.07603 0.10025 64.97 
c 0.15358 0.14993 0.63577 5.9984 0.09943 
mmoles eimmoles UT 3- 
3 
0 1.5 
Figure 3.29: Methylmercury-Unithiol (Na[UTH 2]) titration data. 
a,b with mercaptoethanol (L=ME - ) competition 
c with iodide competition (L=I - ) 
The fitted curves were calculated by COMIXH using the equilibrium 
constants in Tables 3.6, 3.8, 3.10 and 3.11 with log (3(MeHgI) = 8.500. 
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Figure 3.30: Species distribution calculated by COMIX for 0.0014M 
MeHg(II) and 0.0014M DMSH 4 in 0.1 KI, using the equilibrium constants 
in Tables 3.10 and 3.11. 
Note the existence of a 2:1 species (green) at these concentrations. 
The heavy line indicates the pH-range of MINIQUAD81 data. 
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of BALH 2 and Unithiol. The carboxylate groups of DMSH 2
2- 
do not 
appear to reduce the BrOnsted basicity of the sulfhydryl donors and 
it is unlikely that an electronic effect could produce the marked 
reduction in MeHg(II) affinity. 
a 	b 
ligand log 110 
log 
13 
B . 210-1°m P110 al (SH) pK2 (SH) 
Unithiol 21.01(8) 10.26(7) 11.38(2) 8.69(1) 
BALH
2 ' 
19.56(9) 10.47(10) 10.62(1) 8.65(1) 
DMSH4 17.11(3) 
mercaptoacetic 
acid° 17.10(1) 
'114 11.50(1) 
10.16(1) 
9.65(1) 
Table 3.12: Methylmercury(II)-sulfhydryl association constants for 
the dithiolate antidotes. 
aindicates the magnitude of binding of one MeHg(II) group 
to the dithiolate. 
bindicates the magnitude of binding of MeHg(II) to the 
remaining sulfhydryl group of the 1:1 complex. 
°typical monothiol included for comparison. Data taken 
from Tables 3.6 and 3.8. 
The enhanced stability is attributad to a chelate effect due to 
bridging MeHg(II) in the 1:1 complexes of Unithiol and BALH 2 as 
shown 
H 2 1 
C--CH-CH 2OH 1 S S 
\ 
Hg 
Me 
and 
H C--CH-CH
2
SO
3
7 I 	I s s 
/ 
Hg 
Me 
155 
The absence of such bridging in the 1:1 MeHg(II)-DMSH 4 complex may be 
due •to an unfavorable conformation of the meso-dicarboxylic acid, 
possibly caused by steric or electrostatic effects of the two bulky 
negatively charged carboxylate groups. The 2:1 complexes for the 
three vicinal dithiols all have overall formation constants in the 
range 10
30 
 to 10
31 
Thus it would appear that the structures of the 
2:1 complexes may be similar, and may all involve either simple mono-
dentate MeHg-S bonding, or chelated structures similar to that found 
by Moore et al. for the 2:1 MeHg(II) complex of trans-1,2-cyclohexane- 
dithio1 230 (Figure 2.4, page 42). Such chelating behaviour may also 
be present in solution in the 1:1 complexes of Unithiol and BALH 2 . 
There does not appear to be definitive vibrational spectroscopic 
evidence for MeHg(II) chelation in the solid-state of these 2:1 anti-
dotal dithiol complexes (Chapter 2). 
3.4 Interactions of antidotal thiols with MeHg(II) in vivo  
The mechanisms of MeHg(II) toxicity will not be discussed here but 
it is assumed that interactions with endogenous sulfhydryl groups are 
of primary importance (Chapter 1). The modes of action of several mono- 
thiols and vicinal dithiols for which stability constant data have been 
obtained in this study, will be discussed in terms of their competition 
with biological sulfhydryl groups for MeHg(II). It is further assumed 
that the antidotal thiols (RSH) which will be protonated at physiological 
pH act by removing MeHg(II) from binding sites of a model protein, 
mercaptalbumin, AlbSH, according to the rapidly established equilibrium: 
156 
MeHgSAlb + RSH---- MeHgSR + AlbSH 
The physicochemical properties of the complex MeHgSR are assumed to be 
primarily responsible for the subsequent pattern of methylmercury 
redistribution and hopefully, excretion. Polar and/or charged 
complexes are expected to be amenable to rapid renal clearance. In 
contrast, relatively non-polar, uncharged species are expected to have 
enhanced lipid solubility, thus facilitating possible redistribution 
through lipid membranes, in particular, the blood-brain barrier. 
3.4.1 Physiological pH  
In order to predict the metal-ligand species distribution in a 
simple biological model, some estimate must be made of the 'pH'at or 
near the site of metal interaction, e.g. in blood plasma, inside 
erythrocytes or at the surface of cell membranes, etc. The pH of 
many biological environments has been measured by both intrusive methods, 
417 
e.g. micro pH-electrodes or indirect methods, e.g. monitoring phosphate 
equilibria in vivo by 31 P nmr.418 
In this study, no attempt has been made to examine actual sites of 
MeHg(II) binding in vivo. 	In discussing the possible existence of 
methylmercury(II) thiolate species in extremely simplistic models of 
biological systems, it has been assumed that the pH of the interactive 
site is near 7.4. t Since no effort has been made to propose a complex 
system of competing ligands, e.g. a plasma model such as that used for 
2+ 2+ 2+ 3+ 2+ 2+ 2+ 419 
Ca , Mg , Mn , Fe , Cu , Zn , Pb speciation, it was felt 
that this pH represents a reasonable value for the sake of chemical 
rather than toxicological discussion. Further, it will be seen that 
tpH 7.40 is the generally accepted value for plasma pH under conditions 
• of pC0 9 = 5.33gp and constant saturation - fraction'of 02 in arterial 
blood at 370: 
157 
in most cases discussed here, variations in pH in the range 6.0 to 
8.0 have little effect on conclusions drawn at pH 7.4. In addition, 
it should be realised that the site of interaction may not even be in 
an environment of constant pH, since many of the multitudinous reactions 
in cell metabolism involve protolytic equilibria and which may be 
dependent on the partial pressures of oxygen and CO 2 .
417 
3.4.2 Competition of antidotal thiols with endogenous ligands in vivo  
For an antidotal thiol to remove intracellularly bound MeHg(II) 
from protein binding sites, it must firstly be capable of reaching the 
target cell without undergoing appreciable metabolic breakdown. 
Cysteine and glutathione are unsuitable as antidotes since they are 
readily incorporated into normal metabolic pathways,
354 
and in fact, 
glutathione has been shown to increase the MeHg(II) content of the 
82 
brain after administration to mice. The metabolic product of some 
antidotes may be more active than the administered form, e.g. the 
substituted steroid thiomestrone (below) has some antidotal activity 
towards HgC1 2 and MeHgC1 which may be due to the deacetylated (sulfhydryl 
form). 120 
Me
OH 
'SAc 
Once transported to the MeHg(II) binding area, the thiolate must be 
suited to passage through the cell membrane to the presumed intra-
cellular binding site. Here it must compete effectively with endogenous 
ligands to form a MeHg(II) complex having the required properties to pass 
out of the cell, and which may be sufficiently water soluble to be renally 
excreted. Lipophilic MeHg(II) complexes may be excreted with the 
AcS 
Me 
--Me 
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bile into the gut, where they may be localised by thiol-containing 
polymers (page 18). 
Both methods of treatment require that the antidote compete 
effectively for MeHg(II) in comparison With endogenous ligands. 
Since many of these ligands Will contain sulfhydryl groups, thiol 
antidotes are generally used (Chapter 1). Effective competition need 
not imply that the MeHg(II)-antidote complex predominate at the site of 
interaction. If the antidotal thiol-complex is highly mobile, even a 
relatively low concentration of the complex may serve to remove MeHg(II) 
from protein bound sites. For this reason low molecular weight, 
highly polar thiols are usually effective at Mobilising MeHg(II). 
A high negative correlation between molecular weight and the ability 
of thiol to mobilise inorganic mercury from bovine hemoglobin in vitro 
has been demonstrated. 421 The distribution of the antidotal-thiol 
complex between lipid and aqueous phases is crucial in determining the 
redistribution of MeHg(II). In this context, BALH 2 is a poor antidote 
for .MeHg(II) intoxication, since it is found to redistribute the metal 
into the brain. 66-7 
In discussing postulated equilibria involving MeHg(II), antidotal 
. thiols and endogenous ligands in vivo, it will be assumed that MeHg(II) 
is initially complexed to protein with a stability constant of 10
17 
 
similar to that calculated by Simpson 324 from Hughes' data for human 
mercaptalbumin
368 
 (page 85 ). Further, it has been assumed that the 
effective 'concentration' of protein sulfhydryl groups is 10 mM at the 
binding site, which is the total sulfhydryl content of human erythrocyte 
proteins.354 A 5,000-fold excess of sulfhydryl groups over MeHg(II) 359 
-7 
(2 x 10 M) has been considered. This is typical at the MeHg(II) 
levels at which toxic symptoms first appear.
422 
Although MeHg(II) has been found to be predominantly in the form 
159 
of a hemoglobin complex in erythrocytes, formation constants with 
hemoglobin are unknown. 
It is more difficult to estimate the antidote concentration at 
the active . site. Under conditions used for animal studies, typically, 
the antidote is given at a level more than lop times greater than the 
MeHg(II) burden. If 1 g of antidotal monothiol with M.Wt. 200 was 
equally dispersed throughout 5 L of body fluids, its concentration 
would be 1 mM. As a comparison, the cellular glutathione cOncen- 
tration is 0.1-10Nm.
423 
 A preliminary in vitro distribution of 
MeHg(II)-DMSH4 species using this antidote:metal ratio was presented 
at a conference in 1981 and is included as Appendix 1 of this thesis. 
Figure 3.31 shows conditional stability constants calculated under the 
above conditions for the antidotal thiols penicillamine and N-acetYl-
penicillamine, and the dithiols BALH 2 , DMISH4 and Unithiol obtained in 
this work. Human mercaptalbumin, described above, is included for 
comparison. The MeHg(II) species distribution diagrams for each of 
these antidotal thiols in the presence of human mercaptalbumin, are 
shown in Figure 3.32. Although a chloride concentration of 0.1M was 
included in the COMIX calculation to simulate the plasma chloride 
content,424 MeHgC1 is negligible on the scale shown. 
The relative proportions of protein-bound and antidote-bound 
MeHg(II) species will vary considerably due to errors in the postulated 
concentrations of MeHg(II), antidotal, and protein thiols, but the 
pH-dependence of the species distribution will not. Therefore to 
assess antidotal activity, we may consider the nature of the major 
predicted antidotal - thiol MeHg(II) species at pH 7.4, irrespective of 
whether it predominates over protein-bound MeHg(II). 
For the antidotal thiols shown, except BALH 2 , it can be seen that 
all the major MeHg(II) thiolate species are anionic at pH 7.4. It is 
160 
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Figure 3.31: Conditional stability constants of antidotal thiols and 
dithiols with MeHg(II). 
Calculated using the equilibrium constants in Tables 3.6, 3.8, 3.10 and 
3.11 for 2 x 10 -7M MeHg(II) and 0.1M chloride with 0.001M thiols: 
a DL-penicillamine, b N-acetyl-DL-penicillamine, c BALH 2 , 
d Unithiol and e DMSH4. 
f mercaptalbumin (0.010M) is included for comparison. 
7 7 7 7 7 
Figure 3.32: Species distribution in the range 6 < pH < 8 calculated by COMIX'fdr .2 x .1.07 7,M Mel-19( 1 0 -, 0.10M Chloride, 
_ 
10 x 10
-3
M Mercaptoalbumin (AlbSH) and 1 x 10 3M antidotal thiols: a) DL-Penicillamine, b) N-Acetyl-DL-Penicillamine, 
c) Unithiol, d) BALH 2 and e) DMSH4 . Equilibrium constants are taken from Tables 3.6, 3.8, 3.10 and 3.11. 
MeHg(II)-antidote species are shown in red, MeHgSAlb in green. Note the different scale for DMSH4. 
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expected that these species would have high aqueous and relatively 
low lipid solubility. All are 1:1 species, consistent with the low 
MeHg:thiolate ratio at the active site. 
The situation with BALH 2 is unique in this series of thiols in 
that a large proportion of the MeHg(II)-BAL complex is uncharged at 
pH 7.4 and probably relatively lipophilic. This presumably is 
responsible for the ready passage of BAL-complexed MeHg(II) through 
the blood/brain barrier. The species (MeHg) 2BAL is present at a 
concentration of 10
-17
M under these conditions, too low to affect 
MeHg(II) redistribution. The low formation constants of DMISH 4 result 
in a very small fraction of antidote-bound MeHg(II) compared with the 
other thiols shown. This antidote has been shown to effectively 
increase urinary MeHg(II) excretion however (page 15 ),supporting the 
hypothesis that only small concentrations of mobile low molecular 
weight species are necessary for efficient MeHg(II) transport. 
3.5 Methylmercury(II) interactions with selenium donors in aqueous  
solution  
3.5.1 MeHg(II)-selenolate equilibria  
There is indirect evidence from I H nmr studies that selenium in 
selenoamino acids 4°4 and selenocyanate 323 has a higher affinity for 
MeHg(II) than sulfur in corresponding mercaptoamino acids and thio-
cyanate. The pH-dependence of chemical shift data for MeHgSeCN has 
been used to show that the formation constant of this complex (Table 
3.2) is 0.72 log units higher than for MeHgSCN. 323 For several 
selenoamino acids, the evidence relies on the observation that 
2 1  
J( H-
199  Hg)I is smaller than for analogous mercaptoamino acids. 
Similarly
2
J(
1
H
)99
Hg)I is smaller for selenocyanate than for 
thiocyanate 323 andselenide than for sulfide.323 
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Formation constants for MeHg(II) with selenohydryl-containing 
ligands are of some interest, considering the presence of reduced 
selenol groups in glutathione peroxidase
176 
and glycine reductase,
179 
and the uncertain method by which selenium reduces the toxicity of 
MeHg(II) (page 27 ). Furthermore, selenols are stronger BrOnsted 
425 
acids than are thiols, e.g. selenocholine has a selenohydryl pK
a = 4.68(5), 
while thiocholine has pK a = 7.883(4) (Table 3.6), yet I H nmr evidence 
indicates the possibility of higher MeHg(II) stability constants with 
selenols than for thiols. Because no MeHg(II)-selenohydryl formation 
constants have been reported to date, some consideration was given in 
this work to the potentiometric study of these systems. 
Most of the monothiols investigated in this work have previously 
reported selenium analogs. The ease of oxidation of the selenohydryl 
group renders these ligands difficult to prepare and maintain in a 
pure state, e.g. Zdansky doubts whether selenocysteine and seleno- 
homocysteine have been obtained in pure for
m
s.
426 	
The fairly lengthy 
published synthetic routes to selenocysteine4! 27-8selenopenicillamine429 
and selenocholine425 were not attempted. 2-Selenoethanol was prepared 
in low yield by reduction of the diselenide, 43° but the oily compound 
was difficult to handle and decomposed when stored over molecular 
sieves (page 360). Selenoglutathione does not seem to have been 
isolated in an unprotected form (Table 5.1).
431 
2-Selenosuccinic acid 
is unknown (but see page 241 for a possible synthesis). 
Because the complex MeHgSeCH 2CO2H had been prepared for solid-
state characterisation of MeHg(II)-selenolates (page 220, attempts 
were made to study the MeHg-selenoacetate system in solution. The 
proton nmr spectrum of this complex (Figure 3.33) has 1 2 J( 1 H- 199Hg)I 
166.5 Hz, - which is smaller than that for the analogous thiolato complex 
(170.0 Hz, page 359 ),but the difference is less than that for the seleno-
amino acids reported by Sugiura4" 
7 6 8 
1 2JI = 166.5 HZ 
fifaiialv411)1444 
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Figure 3.33: Proton nmr spectrum of MeHgSeCH 2CO2H in D20 
(pD = 5.4) showing 
1
H-
199
Hg coupling. The methylene proton reson-
ance (6 = 7.06) is measured relative to dioxane (8=10.00) internal 
165 
and'shown . in Table 3.13. In order to determine the MeHg-selenoacetate 
formation ,constant, the proton dissociation constant of the free ligand 
is required. 
Attempts to isolate the ligand by borohydride reduction of diseleno-
diacetic acid were unsuccessful. Since the MeHg(II)-selenoacetate 
formation constant will be very sensitive to the dissociation constant 
used for selenohydryl dissociation, any preparative procedure for the 
ligand must ensure the absence of acidic or basic impurities. This 
situation is difficult to achieve using commonly used veductants sodium 
borohydride, hypophosphorus acid, etc. Although electrochemical 
reduction of various diselenides has been reportedNhis technique does 
not seem to have been used for the preparation of selenols for proton 
dissociation studies, but may be suitable in this regard. 
Microscopic hydrolysis constants of selenoacetic acid have been 
previously determined spectrophotometricallyr 4 The selenol was prepared 
by borohydride reduction of the diselenide and extraction into chloro-
form. From the small difference in 1
2
J(
1
H-
199
Hg)I between selenolate- 
and thiolate-complexes, it was expected that selenohydryl binding to 
MeHg(II) would probably be less than one log unit (at most) stronger 
than thiol binding. It was considered that the use of macroscopic 
ligand hydrolysis constants derived from the microscopic constants 
determined elsewhere, under different conditions, may have produced a 
misleading comparison between selenoacetate and mercaptoacetate binding. 
A valid comparison between MeHg(II) selenolate- and thiolate-
formation constants awaits future accurate determination of selenohydryl 
dissociation constants. The MeHg(II) complex of Bu
tSH has the lowest 
mercury-sulfur coupling constant of MeHg(II)-thiolates studied to date.250 
In fact, only the complexes with sulfide and the carbanions CH 3- and 
C6H 5- (Table 3.2) have lower values of 
2
J, reflecting the high basicity 
166 
1 2J( 1 H_199Ho1 a 
complex X=S ref. X=Se ref. 
+ 166.5 (pH=4) 433 
MeHgXCH 2CH(CO 2- )NH3 174.0 360,433 
164.3 404 
+ _ 
MeHg[XCH 2CH(CO 2 )NH 3 ] 2 185.4 404 
+ 
MeHgXCH 2CH 2NH3 185.7 404-5 162.0 404-5 
+ 
MeHg[XCH 2CH 2NH 3 ] 2 216.6 404 187.0 404 
+ 
MeHgXCH2 CH 2NH3 159b 404 
+ 
MeHg[CH3XCH 2 CH2 CH(CO2 )NH3 ] 217.4 (p0=0.8) 404 217.0 (p14=0.5) 404 
214:6,216.0c (pH=1) 433 
MeHg[NH 2CH(CO2 - )CH 2CH XCH 3 ] 209.2 (p0=10.8) 404 210.5 (p0=10.5) 404 
223 (pH=7) 338 
215.2,225.8c (p14=7) 433 
[MeHgXC(NH 2 ) 2 ] 1- 199.6±0.4d 434 191.0±0.4d 434 
[MeHgXC(NH 2 )(NMe )]/- 191.2e 434 
MeHgX- 146.2 323 143.1 323 
MeHgXHgMe 156.6f 250 146g 435 
MeHgXCN 203.0
h 323 200.4 323 
MeHgXMe 157.1,f 250 155 . 3 , i 158 . 7j, 0 433 
158.2i 433 
150.2f 250 
MeH gXBut 
. 
 
1501
k
this 
work 
1 46.8k this 
work 
MeHgXCH 2CO2 - 170.5 this 166.5 (pH=5.8) this 
(pH=5.6) work work 
MeHgXC6H 161.5f 250 154.0,j' k 1 433 
168.4i 433 164.8 j' c' k 
MeHg[C6H 5XXC6H 5 ] 193.9i 433 
Table 3.13: Mercury-Proton coupling constants of Methylmercury(II) Complexes 
with selenium-containing ligands and their sulfur analogs. 
a) measured from 1 14 spectra in aqueous solution unless otherwise 
stated. b) taken from Figure 2, ref. 404 0) from 199Hg 
spectra. d) as Br- , Cl - , NO3- or C104- salts. e) as Br- salt 
A in CH 2C1 2 . g) in CS2 . h) see also Table 3.2 for additional 
values of 2J. i) in DMF. j) in DMSO. k) in CDC13. 
167 
of the tert-butyl group. Since Bu tSeH had been prepared in order 
to synthesise the new bis mercury(II) selenolate Hg(SeBu t ) 2 
(page186 ) it was of interest to prepare MeHgSeBu t and compare 
I 2J( 1 H- 199Hig)1 for this complex with that of the sulfur analog. 
Addition of an ethereal solution of Bu
t
SeH (prepared by the 
Grignard route, page 349) to an ice-cold solution of MeHg0H 
(3.3 mole) in 1:2 aqueous methanol (50 ml) and careful evaporation 
of the combined hexane extracts (5 x 25 ml) at 0°C under low 
vacuum (25 mm Hg), produced crude MeHgSeBu t . The white solid was 
purified by sublimation (50-60°/15 mm), mp. 57-8.5°, and analysed 
satisfactorily for carbon, hydrogen and mercury (page 351). The 
analogous thiolate was prepared similarly using Bu tSH. The proton 
nmr spectrum of MeHgSeBu t in CDC1 3 is shown in Figure 3.34. The 
mercury-proton coupling constant (measured from an expanded spectrum) 
was found to be 146.8 Hz, lower than that for the sulfur analog under 
1 
the same conditions. The H nmr resonances of the methyl and 
tert-butyl protons are shifted downfield in MeHgSeBu t (cS = 0.85, 
1.65 relative to TMS) compared with those in MeH
g
SBu
t (S = 0.78, 
1.51). Similar small downfield shifts have been found in several 
selenium-substituted dicarboxylic acids discussed in Chapter 5. 
Due to the correlation between 
2
J and donor basicity, 
MeHgSeBu
t presumably has the highest MeHg(II)-selenohydryl formation 
constant of the selenols in Table 3.13. 
168 
C(CH) 
HgCH3 
IFJ] = . 146ji Hz 
Figure 3.34: Proton nmr spectrum of MeHgSeBut in CDC1 3 showing 
1 14- 199Hg coupling. Spinning sidebands are indicated by asterisks. 
(Dioxane = 10.06). 
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3.5.2 MeHg(II)-Diselenide interactions  
Sugiura et a/. have reported that values of 1 2J( 1 H- 199Hg)I in 
mixtures of MeHg(II) and the diselenides, selenocystamine and seleno-
cystine (Table 3.13), are similar to those with sulfhydryl donors, 
implying that these diselenides have an affinity for MeHg(II) comparable 
to that of thiols.
404 
As the 'interactions of MeHg(II) with disulfides 
are weak, the possibility of strong interaction in solution between 
MeHg(II) and diselenodiacetic acid was investigated potentiometrically. 
Attempts to obtain solid complexes from mixture of diselenodiacetic 
acid and MeHgNO 3 in acetone were unsuccessful, always resulting in 
recovery of diselenide. A similar situation resulted with dibenzyl- 
diselenide which was unsuited to potentiometric studies here since it 
is aprotic and insoluble in water. Elsewhere, attempts to prepare a 
MeHg(II) complex with selenocystamine dihydrochloride have failed, and 
no cleavage product was obtained. 433 
Titrations of MeHg(II) and diselenodiacetic acid in the presence 
of competing ligand in the range 2.7 < pH < 10.4, show that MeHg(II) 
hydrolysis is suppressed, indicating complexation. These titrations, 
shown in Figure 3.34, were treated with MINIQUAD81 but only poor fits 
(U > 10-8 ) were obtained above pH 5.- Below this pH, the data can be 
fitted as a simple diprotic acid with PKal = 3.04(3) and pK 82 = 4.00(4) 
which are similar to values for the diselenide ligand, pKa 1  = 3.196(1), 
pKa 2 = 4.058(2). This is consistent with very weak interaction (if 
any) with the carboxylate groups. It appears that the MeHg(II)- 
diselenide complex is stable, with log 12. 10, since the titrations 
can be fitted reasonably by assuming that MeHg(II) is never dissociated 
from the complex below pH 5. 
In the presence of 0.1M KI, insoluble MeHgI is formed below pH 10.5 
with [MeHg(II)] = 1.5 x 10 -3M and [RSeSeR] = 3 x 10 -3 . The same MeHg(II) 
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concentration was used in the monothiolate systems described previously, 
but MeHgI was absent above pH 4, thus it appears that the diselenide 
is not as efficient at competing with iodide for MeHg(II) as the mono- 
thiols described previously. Therefore the MeHg(II)-diselenide forma- 
tion constant is probably less than 10 16 With more dilute solutions, 
(0.05M I - , 0.7 x 10-3M MeHg(II), 1.5 x 10 -3M RSeSeR), no precipitation 
of MeHgI was observed in the range 3 < pH < 11. This titration was 
treated with MINIQUAD81, using several hypothetical systems of equilibria 
involving 1:1 and 1:2 MeHg(II)-RSeSeR complexes and their protonated 
analogs but the data could not be fitted adequately (U > 10 -8 ) over this 
pH-range with any combination of these species. 
Conclusions  
Equilibrium constants which describe the aqueous solution 
behaviour of equivalent quantities of MeHg(II) and various monothiols 
over the pH-range 3 < pH < 10, have been determined potentiometrically 
using iodide competition. The values obtained here agree well with 
those found elsewhere by an nmr method 
302
for the monothiol ligands 
2-mercaptoehtanol, mercaptoacetic acid, mercaptosuccinic acid, 
L-cysteine, DL-penicillamine, N-acetyl-DL-penicillamine and 
glutathione. In addition, new formation constants are reported for 
the thiocholine cation and 4-mercapto-N-methylpiperidine. Monothiolate- 
MeHg(II) formation constants are now firmly established and may be 
estimated from the correlation with pK a of the sulfhydryl donor: 
log K (MeRgSR) = 0.893 pK (SH) + 7.77 
Previously unreported equilibrium constants with the vicinal 
dithiol antidotes BALH 2 and Unithiol indicate that significantly more 
stable 1:1 complexation occurs for BALH 2 and Unithiol than is 
expected from estimates of the basicity of the sulfhydryl donors 
in these ligands. Chelation of MeHg(II) by the vicinal 6-donor atoms 
is suggested as an explanation for this phenomenon. In contrast, 
DMSH4  behaves like a monothiol inthe 1:1 interaction. 
Equilibrium constants for the competition of human mercaptalbumin 
with the antidotal thiols DL-penicillamine, N-Acetyl-DL-penicillamine, 
Unithiol and DMSH4 for MeHg(II), indicate that polar, electrically 
charged MeHg(II)-antidote species are formed at physiological pH. 
In contrast, a large proportion of the complex formed withBALH 2 is 
neutral and non-polar, which may explain the observed redistribution 
of MeHg(II) into the brain upon administration of BALH2.66'67 
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CHAPTER FOUR  
SYNTHESIS, VIBRATIONAL SPECTROSCOPY AND STRUCTURE OF 
MERCURY(II) SELENOLATES  
Direct chemical interactions between mercury and selenium have been 
recognised for many years. The first characterised organoselenium 
compound, 'selenomercaptan', EtSeH, produced the first example of 
Hg-Se bonding in 1847 as yellow crystalline Hg(SeEt) 2436 Despite  
the preparation of many such iselenomercaptides' as derivatives for 
the qualitative identification of selenols, the structural chemistry 
of these bis(Selenolato)mercury(II) compounds has not been studied. 
It has already been shown (Chapter 1) that interactions between 
selenium and mercury(II) may be of some importance in the mechanisms 
of the protective effect of Se against inorganic (and perhaps organic 
mercury(II) toxicity. In this light, it is therefore somewhat 
surprising that no complexes, formed between mercUry(II) and selenohydryl-
containing ligands, have been investigated although Ganther 224 has 
reported that the important selenite metabolite, selenodiglutathione 
(Figure 1.1, page 20) interacts with Hg 2+ in vitro. 
In this study, several complexes of the type Hg(SeR) 2 formed 
between Hg2+ and simple monoselenols RSeH (R=Me,Et,Bu t ,CH 2Ph) and 
CH 2  CO2  H) have been prepared and structurally characterised in the solid 
state by X-ray diffraction and vibrational spectroscopic methods. 
It will be demonstrated that several of these complexes are not 
isostructural with their sulfur analogs. In addition, 1:1 complexes 
of the type RSeHgX have been prepared and characterised either 
directly (HgX=Me,0 2CMe) or as pyridine adducts (R,X=Et,C1; But,C1) 
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by crystallography. 
It is hoped that some of these simple model compounds may be of use 
for future characterisation of Hg-Se complexes of biological significance. 
4.1 Preparation of mercury(II) selenolates  
4.1.1 Preparation of Hg(SeR) 2 complexes  
Several complexes Hg(SeR) 2 have previously been prepared as 
derivatives for selenol identification, generally by two methods: 
(i) reaction of the selenol with a mercuric salt or oxide following 
the analogous mercaptide procedure of Wertheim437 or Claesson438 
2 RSeH + HgX 2 Hg(SeR) 2 + 2HX R,X = Me, CN439 Et, C1 440 
2 RSeH + Hg0 -± Hg(SeR) 2 + H 20 R = t
441 
and (ii) reductive cleavage of diselenides by metallic mercury. 
RSeSeR + Hg Hg(SeR) 2 
(R = CH3443; CH
2-- 
CO
2 H
444 (and other alkyl carboxylic acids
)440; 
--  
c05445-6 tru 	ru Iru 	ru 	, C6H5CH2CH 2 ; CF ; kw13/2kAl, 	 442 3447-8, c3F7, 
C6 F5449-50 , and the mixed complex C6 F5SHgSeC6F5450 ). 
Trifluoromethylselenyl chloride, CF 3SeC1, reacts with metallic 
mercury to form Hg(SeCF3 )
2447 . Bis(n-butylselenolato)mercury(II) has 
been prepared by the reaction of diethylmercury with n-butylseleno1. 451 
The compounds Hg(SeR) 2 , R=Me, Et, CH2CO2H have been obtained in this 
work by the reductive cleavage of the appropriate diselenide with excess 
metallic mercury. The compounds with R=Bu t and CH 2Ph were obtained from 
the appropriate selenols and mercuric cyanide. All complexes have been 
isolated in analytical purity (Table 4.1). 
The complexes, except for the selenoacetate complex, are very poorly 
soluble in common solvents. 
calc % found % mpt. 
Hg(SeR) 2 
      
     
Method of preparation 
C H Hg C H Hg this work Hg(SR) 2 
R = Me 6.2 1.6 51.6 6.3 1.5 51.8 119(dec) 175  + Hgi---2P-2-3.Hg(SeMe) 2 
Et 11.5 2.4 48.2 11.2 2.3 47.7 72(dec) 76
437 
EtSeSeEt + Hg 
CHC13  
Hg(SeEt) 2 
Bu
t 20.3 3.8 42.2 20.3 3.9 42.7 145(dec )b 	159-60452 2ButSeH + Hg(CN)2  Et20  Hg(SeBut)2 
CH Ph 
CH 2CO2H 
 
31 .L 2.6 37.1 30.9 2,6 36.9 111(dec) 117-8d 2PhCH 2  SeH + Hg(CN) 2 
MOH 
.  
10.1 1.3 42.1 10.3 1.4 42.1 80(dec) c >190(dec) d (HO CCH 2Se) 2 + Hg 2.H SO 
1.NaHCO/ 
>Hg(SeCH CO H) 2 
24 
Table 4:1: Methods of preparation and analytical data for bis(alkylselenolato)mercury(II) complexes. 
a
all compounds blacken without melting. bsublimes 165°/0.1 mm. °this compound is photosensitive. 
dthis work. 
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The complex Hg(SeMe) 2 can be crystallised as yellow diamond-shaped 
plates from a large volume of hot pyridine. These were sufficiently 
well-formed to permit single crystal X-ray diffraction studies on the 
complex - the first mercury(II) selenolate structure reported. 
• The complex Hg(SeEt) 2 was obtained as a yellow crystalline product 
by very slow evaporation (several months) of a pyridine solution. 
However, the crystals were not of sufficient quality for X-ray structure 
determination and give a very poor quality X-ray powder diffraction pattern 
- perhaps indicating a highly polymeric structure. 
The complex Hg(SeBu t ) 2 seems to be previously unreported and could 
be recrystallised from benzene or chloroform as fine, hairlike, colourless 
needles, very similar to the sulfur analog, but were unsuitable for X-ray 
analysis. The reported single crystal X-ray structure of Hg(SBu t ) 2 used 
crystals obtained by vacuum sublimation of the complex. The selenium 
analog could be sublimed but the resulting crystals were extensively 
twinned and unsuitable for single crystal analysis. 
The complex Hg(SeCH 2Ph) 2 , previously reported by Antweiler1 49bwas 
crystallised from benzene or chloroform as a yellow microcrystalline 
product unsuitable for single crystal analysis. The sulfur analog was 
obtained similarly as a white product. 
The complex Hg(SeCH 2CO2H) 2 was obtained as a fine yellow powder on 
acidification of an aqueous alkaline (bicarbonate) solution. It can be 
recrystallised from methanol, but this does not produce high quality 
crystals. Fredga has reported that this compound gives large crystals 
(1 cm) when crystallised in large quantity from water, 44° but insufficient 
material was obtained here for this approach. The sulfur analog was 
obtained as small, shining, colourless plates by the reaction of two 
equivalents of mercaptoacetic acid with mercuric cyanide in ethanol. 
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Although most of these Hg(SeR) 2 compounds have been reported 
previously, they have not previously been structurally, characterised 
in any way. The complexes prepared here are generally yellow (except 
for Hg(SeBu t ) 2 , which is colourless) and light sensitive, particularly 
water-soluble Hg(SeCH 2CO2H) 2 . An abstract of Fredga's early work with 
this compound, records it as grey,
444 which may have been due to contamination 
by metallic mercury in his preparation. All of the compounds appear to 
be stable when refrigerated in amber glass at -20 0 . 
4.1.2 Prepartion of RSeHgX complexes  
Thiolatomercury(II) complexes, RSHgX can be prepared by the reaction 
of equimolar amounts of Hg(SR) 2 with mercuric salts,HgX 2 : 
Hg(SR) + HgX2 2RSHgX 
This reaction is an equilibrium (in Me0H) for CF 3SHgX (X = Cl,Br,I), 
with equilibirium constants K = 2.3±0.3 for CF 3SHgBr and 20±10 for CF 3SHgC1 
formation 290 
Alternatively, reaction of HgX 2 with RSH also produces RSHgX 
products: 
HgX 2 + RSH RSHgX + HX 
Many of these compounds form adducts with pyridine bases, some of which 
have been crystallographically studied (Chapter 2, page 55 ). 
The only analogous selenolatomercury(II) derivatives reported to 
date have been CF 3SeHgX (X = Cl,Br,I,CN,SCN,02CMe).4
48 	[Dr. A.J. 
 
Carty (University of Waterloo) has kindly described the formation of 
PhSeHgC1 from Hg(SePh) 2 and HgC1 2 ,433 but this work has not yet been 
published.] 
Of particular interest inthis study was the preparation of MeSeHg0 CMe, 
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whose sulfur analog has been shown by Raman spectroscopy to be dimeric in 
aqueous solution at pH 6.
292 
 Yellow, otherwise insoluble Hg(SeMe) 2 
dissolves in an aqueous ethanolic solution of Hg(02CMe) 2 to precipitate 
white, crystalline MeSeHg02CMe1' which has been shown by X-ray powder 
diffraction (page 190) to be isomorphous with MeSHg02CMe. Unfortunately, 
the selenium analog is not sufficiently water-soluble to allow Raman 
spectroscopic investigation of its structure in solution. Preliminary 
experiments with other Hg(SeR) 2 complexes suggest that preparation of 
RSeHg0 2CMe complexes with Hg(0 2CMe) 2 may be a general phenomenon. 
In contrast to the water-soluble MeSHg0 2CMe, monothiolatomercury(II) 
halides are insoluble (Chapter 2, page 55 ) and so no new RSeHgX (X = 
halide) complexes were characterised here, although preliminary experiments 
showed that they are readily formed, as expected. HOwever, reaction of 
Hg(SeR) 2 (R = Et,Bu t) with HgC1 2 in pyridine produced colourless crystalline 
adducts which were recrystallised from ethanolic pyridine to produce 
relatively large good-quality crystals. The single-crystal X-ray diffraction 
structures of [EtSeHgC1(py)]4 and [Bu SeHgCl(py) 0.5 ] 4 will be described 
later in this Chapter. 
• MeSeHg02CMe (C3H602SeHg) requires: C 10.2, H 1.71, Hg 56.7%; found: 
C 10.2, H 1.75, Hg 56.5%. 
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4.2 X-ray Diffraction Characterisation of Mercury(II)-Selenolates  
4.2.1 Hg(SeR) 2 
As a preliminary investigation into the structure of the complexes 
Hg(SeR) 2 (R=Me, Et, Bu t , CH2Ph, CH 2CO2H), X-ray powder diffraction 
patterns were obtained and compared with those of the sulfur analogs. 
The complexes Hg(SR) 2 (R=Me,Et,Bu t 231 ' 453 , CH2Ph, CH 2CO2H) were obtained 
as white crystalline products. The methanethiolato complex can occur 
in two crystalline modifications. 291 The X-ray powder diffraction pattern 
of Hg(SMe) 2 prepared by Wertheim's method 437 in this laboratory and re-
crystallised from ethanol can be indexed with unit-cell dimensions reported 
by Bradley and Kunchur. 271 Samples prepared by addition of imidazole to 
aqueous solutions of MeHgS02CMe
291 
gave a different powder diffraction 
pattern. In historical context, these will be referred to as the 'old' 
and 'new' forms respectively. Infrared spectra of the two forms are 
similar, indicating linear S-Hg-S geometry in the new form. The structures 
271 	274 	t273 
of the compounds with R=Me, (old form), Et, Bu have been determined 
by single crystal X-ray diffraction (Section 2.3, page 43 ). 
Because the compounds Hg(SeMe) 2 ,Hg(SeEt) 2 , and Hg(SeBu t ) 2 have 
unpleasant odours, Debye-Scherrer powder diffraction patterns were 
recorded photographically from ground samples contained in sealed Lindemann 
glass capillaries. t The analogous sulfur compounds were treated identi- 
cally (though they are odourless) facilitating comparison of the patterns. 
The seleno- and mercaptoacetate complexes are odourless and although 
photographic powder patterns were obtained from samples in Lindemann 
capillaries, better results were obtained from automatic chart-recordings 
using larger (planar) specimens in a powder diffractometer. 
For the qualitative comparison of the powder diffraction-patterns 
tThe assistance of Mr. R. Ford (Geology Department) in this task is 
gratefully acknowledged. 
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of analogous sulfur- and selenium compounds, due care must be taken of 
the different scattering powers of S and Se. Differences in atomic 
radii of sulfur and selenium were expected to produce relatively small 
changes in unit-cell parameters for isomorphous compounds. In 
compounds containing large quantities of both selenium and mercury, 
the intensity of the diffracted X-rays might be expected to differ 
considerably from the sulfur analog, where the Hg-atom scattering 
dominates more than for selenolates. 
If the powder diffraction patterns of a known isomorphous pair of 
Hg-S and Hg-Se compounds could be obtained, the magnitude of this sulfur 
versus selenium 'phase' problem could be assessed qualitatively. Such 
a pair of compounds was unavailable prior to this work. 
It will be shown subsequently (see Figure 4.5), that the compounds 
[ButSeHgCl(py) 0. 04 and [Bu tSHgC1(4-Mepy) 0.5]4 are isomorphous and that 
the powder diffraction intensities and positions of both compounds are 
very similar, and are particularly characteristic at low (2e<20 0 ) 
scattering angles. Powder diffraction patterns of pairs of compounds 
Hg(XR) 2 (X=S,Se) (R=Me, Et, Bu t , CH 2CO2H, CH 2Ph) were examined quali-
tatively in view of this finding. 
Hg(XMe) 2  (X=S,Se) 
X-ray powder pattern data obtained for bis(methaneselenolato) 
mercury(Inweremeasured from a photographic recording and are shown 
in Table 4.2, together with powder diffraction data for both forms of 
the sulfur analog. 
The complex Hg(SeMe) 2 does not seem to be isomorphous with either 
crystalline modification of its sulfur analog. Fortunately, crystals 
of the selenolate grown from pyridine were available and a single-crystal 
X-ray diffraction study was undertaken by Drs. A.H. White and B.W. Skelton 
9.86s 10.05, 9.61, s db 
8.91, 8.41, s,db 
5.90 m 
4.28w 
4.09 w 
3.80 m,br 
3.57 w 
3.50 w 
3.25 w 
8.3 s,br 
6.63 vw 
5.61 w 
4.16m 
3.90 w 
3.63 m 
3.31 w 
3.17 vw 
3.07 m 
3.005 w 
2.457 m 
1.966 w 
1.903 vw 
1.602 vw 
3.02, 2.99 w,db 2.90 w 
2.87 w 
2.70w 
2.66 w 2.66 w 
2.59 w 2.56 m 
2.45 w 2.46 w 
2.37 w 2.42 vw 
2.23 w 2.27 m 
2.22 vw 
2.08, 2.05, w,db 2.05 w  
1.99w 1.96 vw 
1.96w 1.91 m 
1.87w 
1.78 vw 
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0 
Hg(SMe dmeas/A Hg(SeMe) 2d dmeas/A 
'old' ford° 'new' forma 
Table 4.2: X-ray powder diffraction data for Hg(XMe) 2 (X=S,Se) a 
athe finely ground samples were contained in 0.3 mm 
diameter Lindemann capillaries. 
b
prepared by Wertheims method in ref. 291 
aNi-filtered CuKa (12 hrs). 
d
Mn-filtered FeK (6.5 hrs.) 
a 
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(University of Western Australia). The powder diffraction pattern 
could be satisfactorily indexed using cell dimensions obtained from 
the single crystal used for data collection. 
Crystal and molecular structure of Hg(SeMe) 2 
A crystal of this complex was mounted in Tasmania and preliminary 
Weissenberg and oscillation photographs taken to ensure its suitability 
for single crystal structure refinement. Subsequently, a yellow 
prismatic crystal 0.10 x 0.16 x 0.16 mm was used for the crystallo- 
graphic work at the University of Western Australia. A unique data 
set was gathered at 295 K using a Syntex P2 1 four-circle diffractometer 
in the conventional 20/0 mode, within the limits 20<50°. 1058 reflec- 
tions were obtained, 818 of these with I>30 - (I) were considered 'observed' 
and used in the least-squares refinement after absorption correction. 
The crystal did not deteriorate appreciably during data collection. 
Crystal data for Hg(SeMe) 2 
C2H6HgSe 2 , M=388.6, Monoclinic, space group P21/c (Ch,  No. 14). 
a = 8.440(4), b = 10,732(3), c = 6.681(3) A 
= 96.14(4)° 
U = 601.7(4) A3 , Dc (Z=4) = 4.29 g cm -3 
F(000) = 664 
0 -1 
Monochromatic Mo Ka radiation, X = 0.71069 A, p = 339 cm . 
The structure was solved by the heavy atom method and refined by 
full matrix least squares with anisotropic thermal parameters for the 
non-hydrogen atoms. Hydrogen atoms were included with (x, y, z, U) 
as invariant estimates. Neutral atom scattering factors were used, 
those for non-hydrogen atoms being corrected for anomalous dispersion 
454-6 
f"). All computations were performed using the X-RAY 
76 system 457 implemented by S.R. Hall on a Perkin-Elmer 32/40 computer 
182 
(University of Western Australia). 
The structure was refined to residuals R, R' = 0.044, 0.057, with 
reflection weights (a 2 (F0 )+0.0005(F0 ) 2 ) -1 . 
The complex Hg(SeMe) 2 is polymeric, with infinite one-dimensional 
chains along b. The mercury atoms are pseudo-tetrahedrally coordinated 
to pairs of bridging methane-selenolato ligands. The chain is generated 
by a succession of inversion centres and twofold (screw) rotations. 
The pseudo-tetrahedral mercury geometry is similar to that in Hg(SBu t ) 2 
although the thiolate has an inversion centre between each mercury atom. 
An ORTEP diagram of the unit-cell contents, projected down c, is shown 
in Figure 4.1. 
The spacings between successive mercury atoms are different and 
0 
alternating, being 3.538(1) A for a pair of mercury atoms bridged by a 
0 
pair of Se(2) ligands (related by an inversion centre), and 4.070(2) A 
for a pair separated by two Se(1) ligands (related by a 2-fold axis). 
0 
Mercury-selenium(1) distances are similar, 2.625(2), 2.659(2) A, and 
0 
are comparable to one of the Hg-Se(2) distances, 2.614(2) A. The other 
0 
Hg-Se(2) distance is appreciably longer, 2.764(2) A, reflecting the 
distorted mercury geometry. Moreover, whereas the three angles, about 
Se(1), are nearly equal, 98.6(7)-100.77(7)°, those about Se(2) are more 
irregular, 82.61(6)-100.7(6)°. The smallest angle, 82.61(6)°, is 
contained between two mercury atoms and Se(2). This geometrical 
distortion about se(2) may be a consequence of methyl-methyl interactions 
within the chain about its twofold (screw) axis. 
0 0 
The distances C(2)-C(2) and C(1)-C(1) are 4.21(3) A and 3.80(4) A 
respectively. 
b
> 
Figure 4.1: Unit-cell contents of Hg(SeMe) 2 projected down c. 
184 
Atoms Parameters 
0* 
Distances/A 
Hg-Se(1) 2.625(2) 
Hg-Se(2) 2.614(2) 
Hg-Se(2 i ) 2.764(2) 
Hg-Se(1 i1 ) 2.659(2) 
Se(1)-C(1) 1.96(2) 
Se(2)-C(2) 1.97(3) 
Angles/deg. 
Se(1)-Hg-Se(2) 124.63(8) 
Se(1)-Hg-Se(2 1 ) 111.01(6) 
Se(1)-Hg-Se(1 i1 ) 103.70(7) 
Se(2)-Hg-Se(2 i ) 97.79(7) 
Se(2)-Hg-Se(1
11
) 115.02(7) 
102.64(6) 
Hg-Se(1)-C(1) 98.6(7) 
Hg-Se(1)-Hgiii 100.77(7) 
C(1)-Se(1)-Hg' 99.3(8) 
Hg-Se(2)-C(2) 100.7(6) 
Hg-Se(2)-Hg 1 82.21(6) 
C(2)-Se(2)-Hg 1 99.3(7) 
Atom transformations: i (1-x,,i) 
 
ii (x,1/2-y,4z) 
iii (x,3/4-y,z-k) 
*Hg...Hg i , 3.538(1) A, Hg...Hgi i , 4.070(2) A 
Table 4.3: Interatomic bonding distances and angles (non-hydrogen atoms) 
for Hg(SeMe) 2 . 
Least-squares estimated standard deviations of the last digit 
are given in parentheses. 
Atom U11 	U22 	U33 	U12 	U13 	U23 
Hg 0.45780(9) 0.14166(7) 0.11886(12) 38.2(5) 31.7(5) 41.6(6) 1.2(4) 13.3(3) -3.3(3) 
Se(1) 0.3715(2) 0.3651(2) -0.0100(3) 36.7(11) 28.5(10) 32.2(10) -4.6(8) 7.3(8) -2.0(8) 
C(1) 0.143(3) 0.335(2) -0.072(4) 38(12) 59(15) 71(16) 6(11) 21(11) 5(13) 
H(1A) 0.120(-) 0.272(-) -0.176(-) 84(-) 
H(1B) 0.092(-) 0.310(-) 0.042(-) 84 (-) 
H(1C) 0.110(-) 0.414(-) -0.121(-) 84(-) 
Se(2) 0.7335(2) 0.0392(2) 0.0774(3) 26.1(10) 31.1(10) 44.0(11) -5(8) 2.8(8) -3.3(9) 
C(2) 0.794(3) 0.131(2) -0.158(4) 44(13) 30(11) 81(17) -14(9) 19(12) 4(11) 
H(2A) 0.721(-) 0.118(-) -0.276(-) 78(-) 
H(28) 0.805(-) 0.218(-) -0.135(-) 78(-) 
H(2C) 0.895(-) 0.094(-) -0.176(-) 78(-) 
° 
Table 4.4: Atomic coordinates (X,y,z), and anisotropic thermal parameters (10
3 
 A2 ) for Hg(SeMe) 2 . 
Least-squares estimated standard deviations of the last digit are given in parentheses. 
Anisotropic thermal parameters-are of the form: exp(-2n
2
(U11h
2
a
*2
+...2U23k1b*c*)). 
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Hg(XE0 2 , (X=S,Se)  
The complex Hg(SeEt) 2 , contained in a 0.3 mm diameter Lindemann 
capillary, gave a very diffuse X-ray powder pattern on exposure to 
Ni-filtered CuKa (6 hours) or Fe-filtered CoKa (22 hours) radiation. 
The sulfur analog, in contrast, diffracts well under the same conditions. 
The selenolate is hard and brittle and may be a glass. 
Hg(XBu t ) 2 , (X=S,Se)  
The complex Hg(SBu
t
) 2 is of interest as it is the only simple 1:2 
complex to show pseudo-tetrahedral 'HgS 4 ' geometr
y
.
273 
It is therefore 
the model compound for vibrational spectroscopic characterisation of 
thiolate-mercury(II) compounds with tetrahedral coordination. 231 
Bis(tert-butaneselenolato)mercury(II) was isolated as fine, long, 
colorless hairlike needles, identical in nature to the thiol analog.. 
These crystals were unsuitable for single crystal X-ray studies. 
The powder diffraction data for Hg(XBu t ) 2 (X=S,Se) were obtained 
photographically and are recorded in Table 4.5, and are very similar to 
that obtained for the sulfur analog under identical conditions. The 
selenolate data can be indexed satisfactorily using the published 273 
orthorhombic unit-cell parameters of the sulfur analog. 
The compounds Hg(XBu t ) 2 (X=S,Se) are therefore considered to be 
isomorphous. The vibrational spectra are discussed in Section 4.3.1 
in terms of tetrahedral ''HgSe 4 1 geometry. 
Hg(XCH 2CO2H) 2  (X=S,Se) 
The complex Hg(SCH 2CO2H) 2 can be dissolved in aqueous solution by 
deprotonation, and vibrational studies in both, solid state and in 
solution indicate that it has the expected linear 'HgS 2 ' coordination 
187 
Hg(SBu t ) 26 Hg(SeBu t ) 2C 
d
calc 
(hkl)
d 
d
meas 
d
meas 
9.0 s,br 
6.58 m,br 
4.54 m 
4.15 m 
3.97 m 
3.03 m 
2.71 w 
2.32 w 
9.3 vs,br 
6.45 m,br 
4.58 w 
4.10 m 
3.89 w 
3.06 w 
2.74 m 
2.30 w 
9.18(200) 
6•49(210) 6 
4.59(020,400) 
4.11(220), 4.22(311) 
3.92(021,401) 
3.03(312) 
2.74(330) 
2.30(040) 
Table 4.5: X-ray powder diffraction data a for Hg(XBu t) 2 (X=S,Se) 
a
The finely ground samples were contained in 0.3 mm 
diameter Lindemann capillaries. bMn-filtered FeKa , 24 
hrs. Nn-filtered FeKa , 16 hrs. dUsing h,k,1<4 and 
orthorhombic unit cell parameters for Hg(SBu t ) 2 .273 eHowever, the (210) reflection is not allowed for space 
group C222. 
geometry (Section 2.3). The analogous selenolate was obtained as 
small shiny plates, similar to the sulfur compound, and is similarly 
soluble in aqueous alkaline solution. As this compound is odourless, 
powder diffraction patterns could be obtained from a large powdered 
sample using a Philips diffractometer, -although significant darkening 
was evident after 3 hours exposure to 40 kV CuK a radiation. 
The powder diffraction patterns of the selenolate and analogous 
thiolate are shown in Figure 4.2. Peak splitting at low angle, in the 
selenolate case, results from presence of an inadequate amount of sample 
in the sample holder. Photographically recorded Lindemann capillary 
samples do not show this splitting. 
The two compounds are apparently not isomorphous, although it will 
188 
cc L 
89 .471 
2C -17Z 
9E'SZ 
50'9Z 
Z6'9Z 
068Z 
Og'6Z 
080C 
SUCE 
086E 
- S0'9E 
S8'9C 
5.47'6C 
ST'0 17 
co 
00'CV 
g8 .17 17 
ogg'L=OZ 
6076 
gO'ST 
ET'ST 
91'61 
9L61 
80 .17Z 
9Z'LZ 	 
09'LZ 
11 . 6Z 
990C ---- 
Cr9C 
6 47'8C 
86'6C 
08 —P7 
175-47 17 
8T *9=0Z____ 
ST*8 ---- 
 - 
89'8 
  
9£'91 
9C91 
L0'8T 
89 . 81 
WOZ . 
LS'EZ 
CitZ 
S9"7Z 
SZ'9Z 
8I'LZ 
OT . 8Z 
09 . 6Z 
L8 . 0£ 
EVIC 
189 
              
 
6 17'S 
           
              
 
8Z . 9 
689 
SU.L 
           
            
            
            
            
  
    
 
c6 01 
OUTT 
00'ET 
Oc'ET 
S9' 47T 
 
  
  
  
  
              
_c 
V) 
-cr 
• 
_c 
C \ 
Cr) 
4- 
0 
In 
4-3 
co 
0 
•r- 
4- 
•r- 
• -0 
S-
Q./ 
"0 
0 	• 
0- 
X 
= 
190 
be shown from vibrational spectral studies (Section 4,3) that 
Hg(SeCH 2CO 2H) 2 has linear 'HgSe 2 ' in the solid state. 
Hg(XCH 2Ph) 2  (X=S,Se) 
X-ray powder diffraction patterns obtained from these compounds, 
as flat specimens in a diffractometer, show significant differences 
in the low-angle scattering region (Figure 4.3). Subsequent vibra- 
tional studies (page 220) have shown that, like Hg(XMe) 2 , the sulfur 
compound has linear 'HgS 2 1 , but the selenium compound has tetrahedral 
'HgSe4 1 geometry. 
4.2.2 X-ray diffraction studies of RSeHgX  
In a similar manner to Hg(SeR) 2 compounds, X-ray powder diffraction 
patterns were obtained from analogous pairs of compounds MeXHg02CMe 
(X=S,Se) and the pyridine adducts of Bu tXHgC1 (X=S,Se). 
MeXHg02CMe (X=S,Se)  
The sulfur compound of the analogous pair has previously been 
characterised by single crystal X-ray diffraction. 293 The X-ray 
powder diffraction pattern of MeSeHg0 2CMe, obtained photographically, 
is identical to that obtained from MeSHg0 2CMe under similar conditions 
(Table 4.6). The pattern can be adequately indexed using monoclinic 
unit cell parameters obtained from the single-crystal study of 
MeSHg0 2CMe.
293 
The selenium compound was therefore considered to be isomorphous 
with MeSHg0 2CMe, and thus has a polymeric structure of (-Hg-SeMe-) n 
chains linked into sheets by bridging acetate groups (Figure 4.4). 
The small amount of MeSeHg0 2CMe available could not be crystallised 
sufficiently well for a single crystal X-ray diffraction confirmation 
of its isomorphism with MeSHg02CMe. 
191 
Figure 4.4: . 	The structure of MeSeHg0 CMe projected along 
192 
MeSHg02CMe MeSeHg0 2CMe 
d
meas 
d
meas dcalc 
(hkl)a 
8.2 s,br 8.15 br 8.0(020) 
4.98 m 4.86 w 5.02(110) 
4.02 w 3.99 w 3.98(040) 4.00(111) 
3.73 m 3.73(130) 
3.23 x 3.21 m 3.23(022) 
[
3.26(131) 
3.18(140) 
2,64 w 2.65 m,br 2.64(042,200) 
Table 4.6: X-ray powder diffraction data for MeXHg0 2CMe (X=S,Se) a 
using h, k, 1 < 4 and monoclinic unit cell parameters 
for MeSHg0 2CMe. 293 
u
tX11C1(PY) 0. 04  and [Bu tXHgC1(4-Mepy) 0.5] 4  (X=S,Se)  
The complexes [Bu tSHgCl(py) 0. 04 293 and [Bu tSHgC1(4-Mepy) 0. 04 295 
have been examined by single-crystal X-ray diffraction and have been 
found to be - isostructural but notisomorphous. The eight-membered 
ring structures, (-Hg-SBu t ) 4 , have been described in Chapter 2. 
Insufficient of the 4-Mepy adduct was available for powder diffraction 
studies, but the low angle X-ray powder diffraction pattern of the 
pyridine adduct is shown in Figure 4.5 and should be compared with those 
obtained from the sulfur compounds described above. Close coincidence 
of peaks can be seen for [BultSeHgCl(py) 0. 04 and with [Bu tSH9C1(4-Mepy) 0. 04 
' but not with [ButSHgC1(py) 0. 04 (Figure 4.6), suggesting that the former 
two compounds are isomorphous. 
Crystals of [Bu tSeHgCl(py) 0. 04 grown from ethanolic pyridine were 
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Figure 4.5b: CuK X-ray powder diffraction pattern of [ButSHgCl(py) ]. (cf. Fig. 4.5a) _ 0.5 Li 
195 
examined in Tasmania for single-crystal diffraction suitability. 
Preliminary oscillation and Weissenberg photographs of one such crystal 
mounted about the c-axis gave estimates of unit cell parameters c = 
0 0 
9.95 A and C(a) = 0.127, (b) = 0.09121 (giving a = 12.14 A, b = 
0 
16.91 A assuming a = = y sk, 90'). The 0-level Weissenberg photograph 
required reflections Ok0, k=2n, consistent with species group P2 1 /c, 
and also appeared to have all reflections h10 absent. 
A single crystal X-ray diffraction study of this crystal was 
undertaken by Drs. A.H. White and B.W. Skelton (University of Western 
Australia). 
Crystal and Molecular structure of [Bu tSeHgCl(py) 0. 04 
A unique data set was gathered at 295 K from a crystal 0.26 x 
0.1 x0.55 mm mounted in a capillary containing some pyridine, using 
a Syntex P/2 1 four-cycle diffractometer in the conventional 20/0 mode 
within the limits of 20<50°. 3209 reflections were obtained, 2016 
with 1>30. (I) were considered to be 'observed'. The crystal blackened 
badly during data collection, necessitating appropriate scaling of the 
reflection intensities. 
Crystal data for [Bu tSeHgCl(py) 0. 04 
C8 H 50  Cl 4  Hg 2 N2 Se4'  M = 836.4, Monoclinic, space group P2 1  /c. 
a = 12.151(5), b = 16.738(7), c = 10.138(6) A, = 90.93(4)° 
U =2062(2) A3 , Dc (Z=2) = 2.69 g cm-3 
F(000) = 1512 
Monochromatic MoK radiation, A = 0.71069 A, u mo = 180 cm-1 a 
The structure was refined in an identical manner to that for Hg(SeMe) 2 
(page 181) to residuals R, R' = 0.058, 0.066. 
The tetranuclear complex [Bu
t
SeHgCl(py) (0.0 4 is isomorphous with 
the 4-methylpyridine complex [Bu SHgC1(4-Mepy) 0.04 (a = 12.334(7), 
196 
5 
Unit-cell contents of Du (" ) 05 SeHgC1 	4 projected down c. .  Figure 4.6: 
Atom Distance Atoms Angle Atoms Angle 
Mercury a 
Hg(a)-C1(a) 2.478(9) Cl(a)-Hg(a)-Se(a) 112.9(2) Se(a)-Hg(a)-Se(b 1 ) 133.7(1) 
Hg(a)-Se(a) 2.579(3) Cl(a)-Hg(a)-N . 95.6(5) N-Hg(a)-Se(b 1 ) . 99.1(5) 
Hg(a)-N . 2.49(2) Cl(a)-Hg(a)-Se(b 1 ) 110.6(2) Hg(b)...Hg(a)...Hg(b i ) 
Hg(a)-Se(b 1 ) 2.589(3) Se(a)-Hg(a)-N 91.7(5) 
Mercury b 
Hg(b)-C1(b) 2.723(6) Cl(b)-Hg(b)-Se(b) 89.4(1) Hg(a)...Hg(b)...Hg(a i ) 123.85(3) 
Hg(b)-Se(b) 2.501(3) Cl(b)-Hg(b)-Se(a) 107.1(1) Hg(b i )...Hg(b)...Hg(a i ) 62.10(2) 
Hg(b)-Se(a) 2.503(3) C1(b)-Hg(b)-C1(b 1 ) 95.2(2) 
Hg(b)-C1(b 1 ) 2.720(6) Se(b)-Hg(b)-Se(a) 155.0(1) 
Hg(b)...Hg(a) 3.905(2) Se(b)-Hg(b)-C1(b 1 ) 108.2(1) 
Hg(b)...Hg(b 1 ) 3.670(2) Se(a)-Hg(b)-C1(b 1 ) . 89.3(1) 
Hg(b)...Hg(a 1 ) 3.892(2) Hg(a)...Hg(b)...Hg(b 1 ) 
. Chlorine b 
Hg(b)-C1(b)-Hg(b 1 ) 84.8(2) 
Selenol a 
Se(a)-C(1a) 2.03(2) Hg(b)-Se(a)-Hg(a) 100.4(1) Se(a)-C(1a)-C(4a) 111(17) 
C(1a)-C(2a) 1.51(3) Hg(b)-Se(a)-C(1a) 102.0(6) C(2a)-C(1a)-C(3a) 111(2) 
C(1a)-C(3a) 1.56(3) Hg(a)-Se(a)-C(1a) 105.3(7) C(2a)-C(1a)-C(4a) 114(2) 
0 cont... 
Table 4.7: Interatomic distances (A) and angles (degrees) for [Bu tSeHgCl(py) 0.5]4 . 
Transformation of the asymmetric unit: i (1-x, 1-z) 
Least-squares estimated standard deviations of the last digit are given in parentheses 
C(1 a)-C(4a) 1.42(4) Se(a) 7C(1a)-C(2a) 105(2) C(3 )-C(1a)-C(4a) 113(2) 
Se(a)-.C(la)-C(3a) 102(2) 
Selenol b 
Se(b)-C(1b) 2.02(3) .Hg(b) , -Se(b)-C(1b) 102.3(7) Se(b)-C(1b)-C(4b) 111(2) 
C(1b)-C(2b) 1.50(4) H4(a 1 )-Se(b)-C(1b) 106.3(8) C(2b)-C(1b)-C(2b) 106(2) 
C(1b)-C(3b) 1.54(4) Hg(b) 7Se(b)-Hg(a 1 ) 99.7(1) C(2b)-C(1b)-C(4b) 115(3) 
C(1b)-C(4b) 1.44(4) Se(b)-C(1b)-C(2b) 106(3) C(3b)-C(1b)-C(4b) 113(3) 
Se(0)-C(1b)-C(3b) 106(2) 
Pyridine 
N-C(2) 1.37(3) Hg(a)-N-C(2) 120(2) C(4)-C(5)-C(6) 117(3) 
N-C(6) 1.27(5) Hg(a)-N-C(6) 126(2) C(5)-C(6)-N 129(3) 
C(2)-C(3) 1.33(5) C(2)-N-C(6) 113(3) 
C(3)-C(4) 1.38(6) N-C(2)-C(3) 124(3) 
C(4)-C(5) 1.35(6) C(2)-C(3)-C(4) 118(3) 
C(5)-C(6) 1.33(5) C(3)-C(4)-C(5) 118(3) 
Table 4.7: 
 Interatomic distances (A) and angles (degrees) for [Bu tSeHgCl(py) 0.0 4 
(cont.) 	Transformation of the asymmetric unit: i (1-x, je, 1-z) 
Least-squares estimated standard deviations of the last digit are given in parentheses. 
Atom 
Section a Section b 
Hg 0.73230(8) 0.02706(7) 0.31574(9) - 0.41321(8) 0.01682(6) 0.35281(9) 
Cl 0.8800(6) 0.1126(6) 0.2266(8) 0.4758(5) 0.1137(4) 0.5563(6) 
Selenol 
Se 0.5531(2) 0.0326(1) 0.1762(2) 0.2228(2) 0.0129(2) 0.4426(2) 
C(1) 0.534(2) 0.149(1) 0.126(2) 0.159(2) -0.085(2) 0.355(2) 
C(2) 0.417(2) 0.156(2) 0.075(3) 0.154(3) -0.067(3) 0.210(3) 
C(3) 0.618(2) 0.158(2) 0.011(2) 0.039(2) -0.090(2) '0.399(3) 
C(4) 0.560(3) 0.200(2) 0.235(3) 0.222(2) -0.155(2) 0.390(4) 
Pyridine 
N 0.792(2) -0.097(1) 0.204(2) 
C(2) 0.861(2) -0.094(2) 0.099(3) 
C(3) 0.905(3) -0.157(3) 0.041(3) 
C(4) 
0.872(4) -0.232(2) 0.083(4) 
C(5) 0.807(3) -0.237(2) 0.189(4) 
C(6) 0.770(2) -0.168(2) 0.238(3) 
Table 4,8: 
 
'Non-hydrogen atom atomic coordinates of [Bu SeHgCl(py) 
04' 
Least-squares , estimated standard deviations of the Tas digit are given in parentheses. 
200 
Atom U 11 U22 U33 U12 U13 U23 
Section a 
Hg 29.8(6) 47.6(7) 48.6(6) -1.0(5) -0.1(4) 5.3(5) 
Cl 42(5) 94(7) 91(6) -19(5) 6(4) 32(5) 
Selenol a 
Se 32(1) 28(1) 37(1) -1(1) -2(1) 0(1) 
C(1) 53(17) 15(12) 31(12) -2(11) 11(10) -1(10) 
C(2) 34(17) 46(17) 72(18) 13(13) 5(13) 16(15) 
C(3) 54(18) 59(19) 39(14) -21(15) 1(12) 2(13) 
C(4) 96(26) 51(20) 56(18) 4(18) -17(16) 17(15) 
Pyridine 
45(15) 47(15) 45(12) 11(12) -6(10) -1(11) 
C(2) 56(20) 60(21) 54(17) 11(16) -1(13) -15(15) 
C(3) 63(24) 137(41) 64(21) 0(26) 12(16) -21(24) 
C(4) 103(31) 55(24) 104(29) -3(23) 9(22) -32(22) 
C(5) 111(33) 46(21) 106(28) 7(21) 45(24) -8(21) 
C(6) 57(21) 86(28) 58(18) -1(20) 23(14) -19(19) 
Section b 
Hg 27.4(6) 40.2(6) 43.9(5) -5.1(5) 1.5(4) 2.8(5) 
Cl 45(4) 25(3) 50(3) -1(3) -1(3) -5(3) 
Selenol b 
Se 26(1) 47(2) 42(1) 2(1)' 1(9) 0.(1) 
C(1) 22(15) 94(26) 55(16) -20(16) 7(11) -29(16) 
C(2) 77(27) 227(59) 73(24) -62(33) 6(18) -24(29) . 
C(3) 23(16) 89(25)• 76(19) -11(16) 	- 14(12) -23(13) 
C(4) 31(21) 71(25). 222(44) -13(18) -35(23) -86(28) 
Table 4.9: Anisotropic thermal parameters for [Bu tSeHgCl(py) 0.04 . 
Form: exp(-2n2(U11h2a*2+...+2U23k1b*c*)) 
Atom 103 U A2 r 	A C-H 
Selenol a 
H(2a) 0.404(-) 	0.123(-) 	-0.002(-) 	78(-) 0.96(-) 111(-) 109(-) 
H(2b) 0.365(-) 	0.142(-) 	0.140(-) 	78(-) 0.95(-) 113(-) 110(-) 
H(2c) 0.407(-) 	0.211(-) 	0.050(-) 	78(-) 0.96(-) 106(-) 108(-) 
H(3a) 0.691(-) 	0.147(-) 	0.036(-) 72(-) 0.94(_) 114(-) 109(-) 
H(3b) 0.598(-) 	0.124(-) 	-0.063(-) 	72(-) 0.96(-) 112(-) 109(-) 
H(3c) 0.610(-) 	0.213(-) 	-0.015(-) 	72(-) 0.97(-) 103(-) 110(-) 
H(4a) 0.514(-) 	0.189(-) 	0.307(-) 93(-) 0.95(-) 112(-) 108(-) 
H(4b) 0.636(-) 	0.192(-) 	0.264(-) 	93(-) 0.98(-) 111(-) 105(-) 
H(4c) 0.553(-) 	0.256(-) 	0.213(-) 	93(-) 0.97(-) 113(-) 106( - ) 
Selenol b 
H(2a) 0.105(-) 	-0.021(-) 	0.191(-) 	160(-) 1.00(-) 111(-) 106(-) 
H(2b) 0.223(-) 	-0.055(-) 	0.173(-) 	160(-) 0.94(-) 115 ( - ) 110(-) 
H(2c) 0.122(-) 	-0.122(-) 	0.164(-) 	160(-) 0.96(-) 109(-) 106(-) 
H(3a) 0.034(-) 	-0.095(-) 	0.490(-) 	81(-) 0.93(-) 112(-) 110(-) 
H(3b) -0.002(-) 	-0.044(-) 	0.370(-) 	81(-) 0.96(-) 111(-) 108(-) 
H(3c) 0.007(-) 	-0.136(-) 	0.356(-) 	81(-) 0.97(-) 106(-) 110(-) 
H(4a) 0.296(-) 	-0.151(-) 	0.368(-) 	133(-) 0.92(-) 113(-) 108(-) 
H(4b) 0.218(-) 	-0.163(-) 	0.486(-) 	133( - ) 0.99(-) 108(-) 105(-) 
H(4c) 0.191(-) 	-0.203(-) 	0.352(-) 	133(-) 0.96(-) 112(-) 110(-) 
r.) c) _., 
Table 4.10: Methyl hydrogen atom parameters for [Bu SeHgCl(py) 0.04 . 
C-C-H , 	= H(n)-C-H(n+1), n = a,b,c. 
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0 
b = 17.468(9), c = 9.999(5) A, a= 91.18(4)° ., space group P2 1 /c) but 
not with the analogous pyridinate [Bu tSHgC1(py) 0. 04 (a = . 14.399(6), 
b = 9.893(6), c = 9.597(5) A, a = 121.82(1), = 102.52(4), y = 
102.94(4) , space group P1). These findings are consistent with X-ray 
powder diffraction patterns. Consistent With the presence of pyridine 
rather than 4-Mepy, the complex has an asymmetric unit Volume of 
515.5(5) A3 ,' very similar to 517.8(4) A3 for [Bu tSH9C1(py) 0 .:04 , but 
not the 4 .-Mepy analog, 538.5(5) A3 . 
Finally, no peaks in the Fourier difference map could be attributed 
to presence of a methyl carbon' of 4-Mepy, indicating that a mistake in 
sample labelling or preparation had not occurred. In addition, a 
- freshly prepared sample of [BU tSH9C1(py) .05]4  had all unit cell parameters 
in agreement with those previously published. Molecules of tetrameric 
[BU
t
SeHgCl(py) (L 0 4 are based on an eight-membered ring of alternating 
mercury and selenium atoms (-Hg-SeBu )4. The rings have a centre of 
symmetry and two mercury environments, Hg(1140 2 (i.17C1)2 and 'Hg(11-Se) 2C1(py)' 
with a dichlOro bridge linking the former mercury atoms (Figure 4.6). 
The close relationships between the eight Membered ring structures for 
[Bu tSeHgCl(py) 0. 04 and the sulfur analogs [Bu tSHgC1(4-Mepy) 0 ..04 
(isomorphous) and [ButSHgC1(py) 0. 04 can be clearly seen as projections . 
of these structures normal to planes containing the four Se or S atoms 
(figure 4.7). All of these compounds have distorted tetrahedral 
geometry for mercury, with the largest angles formed by dominant 
Se-Hg-Se and S-Hg-S moieties. 
[EtSeHgC1(py)] 4 
Reaction of equimolar quantities of Hg(SeEt) 2 and HgC1 2 in pyridine 
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produces a colorless crystalline complex which does not readily lose 
pyridine and analyses as EtSeHgCl(py). The analogous sulfur compound 
is unknown. High quality prismatic crystals were deposited when the 
complex was dissolved in pyridine, and ethanol added, to produce a 1:1 
Et0H/pyridine ratio. 
A single crystal X-ray diffraction study was performed by Drs. 
A.H. White and B.W. Skelton (University of Western Australia) on a 
crystal of this complex. 
Crystal and molecular structure Of [EtSeHgCl(py) . 14 
A unique data set was gathered at 295 K from a crystal 0.11 x 
0.07 x 0.06 mm mounted in a sealed capillary to minimise pyridine loss. 
A Syntex P2 1 four-circle diffractomer was used in the conventional 26/6 
mode with 20<60° to give 3794 reflections, 1678 with I>3a(I) were 
considered to be 'observed'. The crystal blackened during data 
collection, but no data scaling was necessary. 
Crystal data for [EtSeHgCl(py)] 4  
C 040C1 4Hg4N4Se4 , M = 1692.7 Monoclinic, space group P2 1 /c 
0 
a = 8.044(5), b = 17,387(14), c = 15.585(21) A, a= 101.75(2)° 
U = 2134(3) A3 , Dc (2.2) = 2.63 g cm-3 
F(000) = 1520 
0 
Monochromatic MoK radiation, A = 0.71069 A, 1.1 174 cm-1 
a Mo 
The structure was refined in an identical manner to Hg(SeMe) 2 (page 181) 
to residuals R,R = 0.046, 0.049. 
Molecules of tetrameric [EtSeHgC1(py)]4 are based on the same eight-
membered ring found in tert-butylthiolato and tert-butylselenolato hemi-
base adducts described previously. The ( - Hg- SeEt- ) 4 rings contain 
mercury atoms bridged by ethaneselenolate groups, but contain only one 
mercury environment 'Hg(p-SeEt) 2C1(py).' in contrast to the t-butyl 
Single molecules of a [EtSeHgCl(py)] 4 , b [ButSeHgC1(py) 0.5 ]4 , c [ButSeHgCl(py) 0.5 ]4 
and d
t
SHgC1(4-Mepy) 0.5 1 4 projected normal to the plane of the four chalcogen atoms. 
Tjaire 4.7: 
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Atoms Parameters 
0 
Distances/A 
HgC1 2.543(7), 2.546(6) 
Hg-N 2.42(2), 2.48(2) 
Hg-Se(A) 2.542(3), 2.541(4) 
Hg-Se(B) 2.543(3), 2.551(3) 
Angles/degrees 
Cl-Hg-N 92.8(5), 95.0(5) 
Cl-Hg-Se(A) 111.9(2), 113.6(2) 
Cl-Hg-Se(B) 103.7(2), 106.7(2) 
N-Hg-Se(A) 99.3(5), 101.3(6) 
N-Hg-Se(B) 106.5(5), 99.7(5) 
Se(A)-Hg-Se(B) 134.7(1), 132.2(1) 
Hg-Se-C(11) 103.6(8), 101.3(8) 
Also: Hg(A), C(1B)-S (13)-Hg(A)(R,1-y,l-z), 99.20(8), 100.7(9)°. 
Table 4.11  : Mercury/selenium geometries for [EtSeHgCl(py)] 4 . 
The two entries in each column are for Hg, Se, A,B 
respectively. Italicized entries involve Se(B) 
(R,1-y,l-z). 
Least-squares estimated standard deviations of the last 
digit are given in parentheses. 
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Ligand a 	Ligand b 
(a) ethaneselenolate ligand 0 Distances/A 
Se-C(11) 
C(11)-C(10) 
1.92(3) 
1.35(5) 
1.99(3) 
1.47(5) 
Angles/degrees 
(b) 
Se-C(11)-C(12) 
pyridine rings 
120(3) 113(2) 
0 Distances/A 
N(1)-C(2) 1.33(4) 
1.31(3) 
1.36(4)
•N(1)-C(6) 1.32(4) 
C(2)-C(3) 1.36(5) 1.38(4) 
C(3)-C(4) 1.34(5) 1.40(4) 
C(4)-C(5) 1.33(4) 1.37(5) 
C(5)-C(6) 1.34(4) 1.36(5) 
Angles/degrees 
C(2)-N(1)-C(6) 118(2) 120(2) 
N(1)-C(2)-C(3) 120(3) 120(2) 
C(2)-C(3)-C(4) 121(3) 120(3) 
C(3)-C(4)-C(5) 118(3) 118(3) 
C(4)-C(5)-C(6) 119(3) 121(3) 
C(5)-C(6)-N(1) 123(2) 122(3) 
Hg-N(1)-C(2) 120(2) 114(2) 
Hg-N(1)-C(6) 122(2) 125(2) 
Table 4.12: 	Ligand geometries for [EtSeHgCl(py)] 4 . 
Least-squares estimated standard deviations of the last digit are given in parentheses. 
Atom 
Section a Section b 
Hg 0.00980(13) 0.47808(6) 0.29104(7) 0.21525(13) 0.43468(6) 0.53369(6) 
Cl -0.0344(9) 0.3927(4) 0.1559(4) -0.0868(8) 0.3846(4) 0.5182(4) 
Se 0.3016(3) 0.4589(1) 0.3880(2) 0.2883(3) 0.5038(1) 0.6809(2) 
C(11) 0.373(4) 0.361(2) 0.351(2) 0.370(4) 0.417(2) 0.762(2) 
C(12) 0.266(6) 0.301(2) 0.342(2) 0.421(5) 0.440(3) 0.854(3) 
N(1) 0.068(3) 0.590(1) 0.290(1) 0.353(3) 0.309(1) 0.576(1) 
C(2) 0.109(3) 0.657(2) 0.252(2) 0.519(4) 0.306(1) 0.571(2) 
C(3) 0.153(4) 0.718(2) 0.207(2) 0.605(3) 0.237(2) 0.581(2) 
C(4) 0.155(4) 0.713(2) 0.121(2) 0.518(4) 0.169(2) 0.592(2) 
C(5) 0.115(4) 0.647(2) 0.081(2) 0.349(4) 0.175(2) 0.595(2) 
C(6) 0.077(4) 0.586(1) 0.127(1) 0.270(4) 0.244(2) 0.585(2) 
Table 4.13: Non-hydrogen atom coordinates for [EtSeHgC1(py)] 4 . 
Least-squares estimated standard deviations of the last digit are given in parentheses. 
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Atom U11 U33 P12 - u13 - U23 
Section a 
Hg 50.4(6) 56.6(7) 53.2(6) -4.4(6) 19.9(5) -4.2(6) 
Cl 77(5) 76(5) 68(5) - 4(4) 20(4) -26(4) 
Se 50(1) 63(2) 63(2) 7(1) 28(1) 4(1) 
C(11) 134(29) 61(21) 62(19) 58(21) 19(19) - 8(17) 
C(12) 293(56) 32(18) 107(30) -26(28) -13(32) -35(20) 
N(1) 71(14) 67(16) 37(12) 1(12) 21(11) - 	8(11) 
C(2) 68(19) 81(22) 53(18) - 9(17) 21(15) 16(17) 
C(3) 126(29) 103(28) 54(20) -27(22) 15(20) - 6(20) 
C(4) 133(28) 40(18) 103(26) - 3(19) 49(23) 53(19) 
C(5) 1E4(33) 60(20) 27(15) 23(21) 51(18) 4(15) 
C(6) 135(27) 52(18) 48(17) -13(17) 37(18) 11(14) 
Section 
Hg 54.6(6) 58.6(7) •53.3(6) 9.4(6) 22.5(5) -0.6(6) 
Cl -'55(4) 61(4) 71(5) - 5(3) 27(4) - 5(4) 
Se 47(2) 64(2) 67(2) - 8(1) 20(1) -11(1) 
C(11) 113(26) 77(23) 64(19) 51(19) 0(18) 41(17) 
C(12) 171(41) 184(42) 101(30) 12(34) - 5(28) -44(31) 
N(1) 62(17) 69(18) 91(19) 30(14) 28(14) 1(14) 
C(2) 82(20) 32(14) 50(16) 10(15) 20(15) 1(12) 
C(3) 52(17) 102(25) 64(18) 40(18) 19(15) 23(18) 
C(4) 100(26) 51(20) 116(27) 25(18) 49(22) 13(18) 
C(5) 67(22) 70(23) 143(31) - 1(18) 44(21) - 2(21) 
C(6) 73(22) 86(25) 127(29) -14(21) 53(21) - 8(23) 
Table 4.14: 
	
3 	° 
 
Non-hydrogen atom thermal parameters, 10 - 	.A2  for ij 
[EtSeHgCl(py)] 4 . 
Anisotropic thermal parameters are of the form: 
exp(-27r2( Ull h2a*24. ...+2U 23klb*c*)) 
Least-squares estimated standard deviations of the last 
digit are given in parentheses. 
Atom 
3 °2 
10 U A 
0 
r A 4) 0 
Aromatic hydrogens 
Section a 
0,0 = N,C(n+1)-C(n)-H(n) 
H(2) 0.114(-) 0.661(-) 0.315(-) 81(-) 0.98(-) 120(-) 120(-) 
H(3) 0.180(-) 0.768(-) 0.238(-) 115(-) 1.00(-) 120(-) 119(-) 
H(4) 0.181(-) 0.758(-) 0.088(-) 97(-) 0.97(-) 122(-) 120(-) 
H(5) 0.117(-) 0.641(-) 0.021(-) 104(-) 0.95(-) 122(-) 119(-) 
H(6) 0.055(-) 0.536(-) 0.098(-) 97(-) 0.99(-) 120(-) 117(-) 
Section b 
H(2) 0.578(-) 0.354(-) 0.560(-) 63(-) 0.99(-) 120(-) 120(-) 
H(3) 0.728(-) 0.235(-) 0.582(-) 84(-) 0.99(-) 120(-) 120(-) 
H(4) 0.579(-) 0.120(-) 0.597(-) 92(-) 0.98(-) 120(-) 122(-) 
H(5) 0.287(-) 0.128(-) 0.607(-) 104(-) 1 .00(-) 119(-) 120(-) 
H(6) 0.148(-) 0.248(-) 0.583(-) 106(-) 0.97(1) 120(-) 118(-) 
Methyl hydrogens 0 = C-C-H, 0= H(n)-C-H(n+1), n = A,B,C 
Section a 
H(12A) 0.229(-) 0.294(-) 0.398(-) 165(-) 0.98(-) 108(-) 105(-) 
H(12B) 0.164(-) 0.317(-) 0.301(-) 165(-) 0.98(-) 106(-) 109(-) 
H(12C) 0.300(-) 0.254(-) 0.325(-) 165(-) 0.91(-) 120(-) 108(-) 
cont... 
• - Table 4.15: Hydrogen atom parameters for [(EtSeHgC1)py] 4 . 
Least-squares estimated standard deviations of the last digit are given in parentheses. 
Section b 
H(12A) 0.511(-) 	0.476(-) 0.860(-) 155(-) 0.94(-) 110(-) 110(-) 
H(128) 0.327(-) 	0.464(-) 0.873(-) 155(-) 0.96(-) 110(-) 107(-)  
H(12C) 0.458(-) 	0.397(-) 0.893(-) 155(-) 0.97(-) 113(-) 109(-) 
Methyl hydrogens 0,0 = Se, C-C-H, x = H-C-H 
Section a 
H(11A) 0.412(-) 	0.369(-) 0.297(-) 104(-) 0.97(-) 108(-) 109(-) 104(-) 
H(118) 0.478(-) 	0.347(-) 0.394(-) 104(-) 1.00(-) 107(-) 108(-)  
Section b 
H(11A) 0.277(-) 	0.377(-) 0.757(-) 98(-) 1.00(-) 109(-)  109(-) 104(-) 
H(11B) 0.461(-) 	0.389(-) 0.743(-) 98(-) 0.97(-) 111(-) 110(-) 
Table 4.15: 	Hydrogen atom parameters for [(EtSeHgC1)py4. 
(cont.) 
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[EtSeHgC1(py)]4 
Plane a (2) Plane b (2) 
[ButSeHgCl(py) 0. 04 
(3). 
104 p 9332 0351 7733 
104q -2750 1264 0103 
10
4
r 2315 9914 6340 
s -2.174 9.410 8.710 
a 0.01 0.01 0.02 
6N(1) -0.02 0.02 0.00 
dC(2) 0.00 -0.02 -0.01 
oC(3) 0.01 0.01 0.03 
6C(4) -0.01 0.00 -0.03 
6C(5) -0.01 0.00 0.02 
oC(6) 0.02 -0.01 0.00 
olig 0.13 -0.38 0.16 
Table 4.16: Pyridine ring planes for [EtSeHgCl(py)] and [Bu tSeHgCl(py) 0. 04 . 
Least-squares planes are given in the form pX + qY + rZ = s, 
0 
where the R.H. orthogonal A frame (X,Y,Z) is defined with X 
parallel to a, Z in the ac plane. a(defining atoms) and 
atom deviations, d, are in A. Planes are defined by the 
C5 N skeleton. 
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Figure 4.8: 	Unit-cell contents Of [EtSeHgC1(py)] 4 projected down a. 
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derivatives. A projection of the unit cell contents along c is 
shown in. figure 4.8. The molecule is centrosymmetric about a 
crystallographic symmetry element, and the two independent mercury 
atoms have very similar geometries with bond distances within 2a 
and bond angles within 3 0  .(except for angles N-Hg-Se(b) which differ 
by 6.8°). The structure lacks 6 dichloro bridge between Hg atoms• 
'found in the t,butyl substituted derivatives, but instead has an 
extra Pyridine molecule coordinated to these mercury atoms. 
A view of a single molecule of [EtSeHgC1(py)] 4, projected normal 
to the plane containing the four selenium atoms is shown in Figure 
4.7. In the t-butyl derivatives, steric hindrance permits 
coordination of only two pyridine base's per tetrameric.unit, in 
contrast to foUr for the ethyl derivative, with- concomitant dichloro 
bridging to maintain tetrahedral mercury'coOrdination, .The disposition 
.of t-butyl methyl groups in [ tBuSeHgCl(py) 0 04.i .s.consistent with this 
observation, being such as to allow coordination of pyridine bases to 
two of the centrosymmetrically related mercury atoms when the ring is' 
chlorine bridged, but not at the other pair. 
The pyridine rings in [EtSeHgCl(py)] and [Bu tSeHgCl(py) 0.5 .] 4 are 
planar as expected: The maximum deviation from least squares planes, 
0 
defined by the C 5N skeletons, being 70.03 A in the t-butyl derivative. 
Table 4.16 shows that mercury atoms coordinated to pyridine lie close 
to the pyridine plane.- 
4.2.3 Comparison of Hg-S and Hg-Se bonding distances  
This work has produced the first report of Mercury(II)-selenolate 
bond distances. It is of interest to compare Hg- S and Hg -Se bond 
distances in closely related complexes because it has been noted earlier 
214 
458 
0 
that Hg-Se bond lengths in [HgC1 2  (Ph 3  PSe)] 2 
(2.53 A) and the 
0 
selenourea complex of MeHg(II), [MeHgSeC(NH 2
)
2
]N0
3
434 
(2.477(3) A) 
are shorter than expected, even though for these complexes suitable 
sulfur analogs are not available for a direct comparison. 
0 
The covalent radii of sulfur and selenium differ by 0.13 A . 
242 
(Pauling), although recent - determinations:Of the structures of elemental 
sulfur and selenium, and of R2X2 (X=S,Se) result in distances 
0 
{1/21(Se-Se)(S-S)]l covering the range 0.13(2) - 0.182(4) A (Table 4.1 7 ). . 
Values Df Hg-S and Hg-Se bond distances in closely related 
complexes are given in Table 4.18 for 'Hg(p-SR) 4 1 ; the difference 
0 
between average values is 0.04 A. For [BU
t
SeHgCl(py) 0.5 14 which has 
bond angles at mercury Within 5 0  of those for the sulfur analogs, the 
0 
differences are 0.12 A for 'Hg(p-XBu t ) 2 (p-C1)2' and 0.08 A for 
'Hg(p-XBu
t
) 2C1N'. 
In general it can be concluded that Hg-Se bond distances are 
slightly shorter than expected from a consideration of sulfur and 
selenium covalent radii. In the MeHg(II)-selenourea complex, this 
has been considered to be a reflection of 'strong' Hg-Se bonding4.34 
Sugiura has suggested that this may be due to the enhanced ability of 
selenium to participate in metal-ligand backbonding.
404 
Cl C l 
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Structure 
0 
S-S/A 
monoclinic-X
8 
K
2
X
3 
H02C-K(7),CO2H 
2.046(4) 459 
2 . 083(1) 461  
2.076(5)
462 
2.069(15)
463 
2.068(8) 464 0 N-XX-4-7b 
2.030(5)
466 
2.023(1) 
467 
2.0394 68 
F F 
- XX 2.059(4) 466 
F F 
[(H 2N) 2C-XX-C(NH 2 ) 2]C1 2 2.017(2) 47° 2.380(6) ° 
 
X-X distances 1.009(1)-1.042(1) a 1.145(5)-1.190(3)b 
Table 4.17: Differences between covalent radii in isomorphous sulfur 
and selenium structures. 
a' b The X - X distances are in good agreement with the Pauling 
0 0 242 
covalent radii of 1.16 A (Se) and 1.02 A (S). 
0 0 
Se-Se/A kl(Se-Se)-(S-S)]/A 
2.334(6)450 0.144(5) 
2.383(2)461 0.150(2) 
2.40( 
462 
0.16(3) 
2.321(15) 463 0.126(15) 
2.346(1)
465 
 
2.290 (10 ) 466 
2 .333(15 ) 469 
2 . 319 (4 ) 466  
0.139(5) 
0.134(6) 
0.147 
0.130(4) 
0.182(4) 
 0 0 
Hg-S/A [(Hg-Se)-(Hg-S) ]/A 
f 2.38(1), 2.39(1) 293b 0.12 
295° 
I 2.379(8), 2.395(8) 
2.488(7), 2.509(9)
293b  295c 0.08 
2.501(8), 2.505(8) 
Hg-Se/A 
'Hg(p-XR) ( -C1) 2 1 2.501(3), 2.503(3) a 
'Hg(p4R) 2C1N 1 2.579(3), 2.589(3) a 
2.541(4)-2.511(3) d 
'Hg(p-XR) 4 1 2.624(2)-2.764(2) ° 
433 
'MeHgXCH 2CH(NH 3)(C0 ) 2.466(5) 
2731 
2.59, 2.68 0.04 
236 
2.352(12) 0;06 
Table 4.18: Comparisons of Hg-S and Hg-Se bond lengths in closely related structures 
a [ButSeHgCl(py) 0.04 , b [Bu tSHgCl(py c  [844t  SHgC1(4-Mepy) (m4, [EtSeHgCl(py)4, 
eHg(SeMe) 2,(SBut 
crl 
4.3 Vibrational spectroscopy of mercury(II) selenolates  
4.3.1 Bis(selenolato)mercury(II) complexes, Hg(SeR) 2 
No vibrational spectroscopy has been reported to date for 
bis(alkylseleno)mercury(II) compounds. During this work Dr. A.J. Carty 
(University of Waterloo) kindly informed us of work in his laboratory 433 
which involved structural and vibrational characterisation of mercury(II), 
CH3Hg(II) and CFpg(II) complexes with the selenoamino acids seleno-D,L-
methionine and seleno-D,L-cysteine, but is as yet unpublished. • Infrared 
and Raman spectroscopic data have been reported for the perfluoroaklyl-
seleno complex (CF3Se) 2Hg, which was ascribed an approximately linear 
structure
448 
 with v
s 
 (SeHgSe)233 and v (178vs cm polarised in Raman) 
a 
by comparison with the spectra of (CF3S) 2Hg.
490 
 Some infrared spectro-
scopic data is available from the dimeric complexes formed between 
mercuric halides and selenoethers.
471 
 Detailed vibrational studies 
have not been reported, but it is claimed that infrared absorptions at 
190,202 cm  attributed to Hg-Se stretching are consistent with the 
expected centrosymmetric dimeric structure containing bridging halides, 
by analogy with 1:1 mercuric halide complexes with tertiary phosphines 
and arsines. 458 
S e 	CI 	Cl 
Hg 	Hg 
Cl/ \Cl/ \ R Se 2 
Similarly, a centrosymmetric chlorine bridged structure has been 
determined for [HgC1 2 (Ph 3PSe)] 2458 by single crystal X-ray diffraction. 
Vibrational spectra of Hg(SR) 2 have mercury-sulfur stretching modes 
which show the expected472 decrease in frequency with increasing 
217 
]ms/ms Hg 112 vHgSe vHgS 
SelmSemHg 
0 . 7 'Has 
218 
coordination number, e.g. Hg(SMe) 2 which has linear 'HgS 2 ' geometry 271 
1 
(Figure 2.6, page 45) has v s (SHgS) 297 cm- and vas (SHgS) 337 cm -1 
whereas tetrahedra1 273 Hg(SBut) 2 (Figure 2.8, page 45) has v s (SHgS) 
• - 188 cm' and vas (SHgS) 172 cm-1•231 	Substitution of sulfur by 
• selenium in isostructuiva compounds would be expected 473 to lead to a 
decrease in the mercury-chalcogen stretching frequencies, according to•
the ratio of Hg-S and Hg-Se reduced-masses, as follows: 
This calculation can only be considered an approximation which assumes 
that vibrational force-constants remained unchanged on substitution of 
S by Se. Since there is some evidence that Hg-Se bonds may be somewhat 
stronger than Hg-S bonds (page 214), calculated values of vHgse will be, 
to a first approximation, too low. 
Linear 'HgSe' coordination is therefore expected to give rise to 
vas (SeHgSe) 1,235 cm-1 and vs (SeHgSe) n,210 cm  comparison with 
Hg(SMe) 2 . The perfluorinated complex Hg(SeCF 3 ) 2448 has vas 233 cm-1 
(solid mull), and v s 178 cm-1 (Me0H solution) which is in good agreement 
-1 -1 
with the calculated value v s 170 cm (from v s 243 cm for Hg(SCF3 ) 2 in 
290 • 435 
Me0H solution ). Similarly Se(HgMe) 2 has vas 231, v s 201 cm-1 , 
compared with v as 344, v s 300 cm-1 for the linear sulfur analog. 269 
Tetrahedral 'HgSe 4 ' coordination can similarly be expected to give 
both vas and v s near 140 cm by consideration of Hg(SBu t ) 2 which has 
-1  
vs 172 (IR) and v as 188 (Raman) cm 219 Tetrahedral [Ph4P]2[Hg(SePh) 
has v s 150 cm
-1
.
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• Vibrational spectra of the Hg(SeR) 2 complexes prepared in this work 
are recorded in Table 4.19 together with the spectra of their sulfur 
Hg(SMe) 2b Hg(SeMe) 2 Hg(SEt) 2 Hg(SeEt) 2 Hg(SBu t ) 2 Hg(SeBu t ) 2 Hg(SCH 2Ph) 2 
	Hg(SeCH 2Ph) 2i Hg(SCH 2CO2H)2 Hg(SCH 2C0-2 ) 2 Hg(SeCH 2CO2H) 2i'i 
578w,sh[576w,sh] 598s [605s] 
570w [572m] 570w,sh 573m [579m] 565m[566w] 
555m [550m] 549m [550w] 
514m [519s] 
472m[476vw] 464w,sh 446m 
449m [453w] 446s,b 431s[437w] 433w,sh 
[417w] 
381s[385vw,sh]' 379s[370w,sh]e 
352w[356vs]d 351w[347s] 1 355s[360mo]°  
405s,brc ' e 416vw[410m] 
[394 vs 397m 
377m [382vs] 
337vs[338w] ° 332w [335w] 
296m [297vs]
d 	
268sd' f 
[245vs] 
204m 198w [188vs]d 
[178m] [182vw,sh] 175vs,vb 172vs,b 
161vs,b[158m] 161m 
151vs,b [151s] 150vs,vb 
134vs,b[131vs] g 140m,sh 130vs[131vs]9' h 
110s,vb 103m[112w] 110vs,b 119m 
135vs[139vs,b]g' h 
[107vs] 
226s[225m] 
[177w] 
g,h 
158s,vb[149vs,b] 155m 
[142vw] 
321w[328vsf1 [313m] 
[284s] 
235w[241w] 2415g 
222m[224m] 
[192s]h 
[172m] 
336s [336m] 
322m [322vs] 325vw[327w,sh] 328vw[335vw] 
291w [298w] 292vs[293w] 296w[299m] 
270w[272w] 
246w [244s] 236w [237w] 
Table 4. g: Vibrational spectra (600-100 cm -1 ) for Hg(XR) 2 (X=S,Se).a 
°Raman values in parentheses [ ]. Abbreviations: v, very; s, strong; 
b 'old phase structure determined by X-ray crystallography. 271 
fvs (SHgS) may be 245 cm -1 . 231 gvas (SeHgSe). hvs (SeHgSe). i very weak 
excitation. jRaman spectrum obtained at 10 K. 	kregion not examined. 
[202s] (ref. 205) and is probably linear. 
m, medium; w, weak; b, broad; s, shoulder. 
avas (SH0). dv s (SENS). '-'vas (SHgS) may be 268 cm-1 .231 
Raman spectrum obtained with orange-red 
1Hg(SePh) 2  has been assigned 4"as (SeHgSe) 218s, ■?5 (SeHgSe) 
220 
analogs. The single-crystal X-ray structure of Hg(SeMe) 2 indicates 
polymeric 'HgSeil l geometry (Figure 4.1, page 183) and powder diffraction 
patterns confirm that Hg(SeBu t ) 2 is isomorphous with the tetrahedral 
sulfur analog. 
The spectra of Hg(SeM0 .2 and Hg(SeBu t ) 2: haye intense bands at 
-1 
130-140 cm which have been assigned as Hg-Se stretching modes by 
analogy with Hg(SBu t ) 2 . The features 158s,vb [149vt,b) in the 
spectrum of . Hg(SeCH 2Ph) 2 have also been assigned as Hg-Se modes due 
to the tetrahedral ligSe 4 1 moiety. . X-ray powder diffraction indicates 
that this complex is not isomorphous with its sulfur analog (Figure 4.3,. 
.page 189).. 
In contrast to these tetrahedral complexes, Hg(SeCH 2CO2H) 2 appears 
to be linear, although X-ray powder diffraction (Figure 4.2, page 188) 
indicates that. it is not isomorphous with its sulfur analog. 
The selenium. compound is phototensitive, 444 and very readily 
decomposes in the Raman laser-beam. By Using low energy (red) excitation 
and cooling thesample to 10K, a weak, but informative Raman spectrum was 
obtained which has - a strong band at 192 cm  in the infrared) 
which has been assigned v s (SeOgSe) i .and no significant bands in the range . 
,1 
170-100 cm. The strong infrared band at 241 cm is probably v as (SeHgSe). 
These values compare well with v s 178(Me0H) and vas 233 cm-1 for 
Hg(SeCF3 ) 2448 and vs201, vas231 cm71 for Se(HgMe) 2 435 . which are assumed 
to be linear. , 
The methylmercury(II) complex MeNgSeCH2CO 2H, which is almost 
certainly linear, is also,somewhat phOtosensitive, but a Raman spectrum 
was obtained from a solution which had been. used to measure the proton: 
nnIr spectrum (Figure 3.34, page 164). Although rather noisy, the Raman 
spectrum shown in Figure 4.9 has Moderate intensity bands which are 
,(0 
II 
x 103 cps 
221 
215 
	
i 	-1 600 	500 	400 	300 	200 	100 cm 
- Figure 4.9: 	Raman sPectruma of MeHgSeCH2CO 2H in D 20.( 0.2 , H=5.6) 
a 100 inW Ar (514.5nm) excitation at the sample. 
26 
22? 
coincident in the infrared: v(HgC) 526s[526s] and v(HgSe) 210s,b[215m]. 
The spectra of MeHgSeBu t confirm these assignments: v(HgC) 521m L526m] 
and v(HgSe) 194s [200s]. The unpublished spectra of a selenocysteine 
complex,433 MeHg[SeCH 2CH(NH3 )CO2].H 20, also has v(HgC) 536s [530s] and 
v(HgSe) 228m [220s] and is apparently isomorphous433 with the (linear) 
sulfur analog (Figure 2.1, page 34). 
4.3.2 Mercury(II) diSelenblates  
During the attempted preparation Of 1,3-diseleno-2-propanol. (the 
selenium analog of the non-vicinal isomer of BALH 2 , DMPH 2 ), an intractable 
pale-yellow mercury(II) complex was obtained by the addition of Hg(CN) .2 
to a solution containing the diselenOlate (Chapter 5, page274 ). The 
product has an analysis consistent with 1.:1 stoichiometry t and is the 
selenium analog of HgDMP, previously characterised in this laboratory. 38 
HgDMP has the interesting property that it can be obtained as a 
crystalline adduct, HgDMP.(py) 1.5 , from pyridine, and is dimeric in this 
solvent. 238 Unfortunately, HgSeDMP is insoluble (<100 mg/100 ml) in 
pyridine and appears to be insoluble in all common. solvents, like HgBAL., 
Like the dithiolates studied in this laboratory (Chapter2 , page53 ), 
HgSeDMP has very, broad, diffuse vibrational spectra, consistent with a 
polymeric structure. 
The far infrared spectrum of HgSeDMP shows only two weak, extremely 
broad features at 400-500 - cm-1 and 100-220 cm -.. 1 and is thus unusable. 
In contrast, the Raman spectrum shows an intense band at 167 cm 
the only feature below 600 cm-1 . This is probably v s (SeHgSe), due to 
tetrahedral 'HgSe4 1 centres in the polymer, and this distinguishes 
tHgDMP (HgC 3H 6OSe 2 ) requires C 8.65 H 1.45, Hg 48.2%; found C 8.88, 
H 1.56, Hg 48.2%. 
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HgSeDMP from its sulfur analog which has a linear, polymeric structure 
with v(HgS) 333m,b [325vs]. 238 
A similar attempted preparation of the vicinal diselenol analog of 
BALH 2 , 2,3-diseleno-l-propanol, failed, but a very small quantity of 
yellow powder was obtained by the addition of Hg(CN) 2 to the solution 
suspected to contain the diselenolate. Like HgSeDMP, this powder was 
insoluble in all common solvents. Some of this product was stored 
under pyridine for three months (in an attempt to induce some dissolution 
and/or crystallisation) but only an insignificant amount had dissolved 
in this time. 
The near infrared (3000-300 cm -1 ) spectrum of the pyridine-insoluble 
residue shows several bands which appear to be due to coordinated pyridine, 
e.g. 1607, 1590m, 615m, and 413, 406w (free pyridine has these bands at 
1518, 601 and 403 cm-1 475 ), despite prolonged (24 hrs/ 0.1 mm) high 
vacuum pumping and subsequent storage over concentrated H 2SO4 . The 
Raman spectrum of this product is superimposed on a high intensity 
background which gradually decays over several hours to reveal two sharp 
bands at 1036s, 1004m cm  to the totally symmetric ring mode of 
coordinated pyridine (free pyridine has 990 cm  and a strong band 
at 179 cm-1 (HgSeDMP has 168 cm -1 ) due to v(HgSe). Unfortunately, 
insufficient sample was available for microanalysis or far infrared 
spectrum, but it would appear that this product may also have a polymeric, 
tetrahedral structure like HgSeDMP, and unlike HgBAL, 231 consistent with 
the general tendency toward tetrahedral 'HgSe4 1 geometry in mercury(II) 
selenolates. 
4.4 Conclusions  
Evaluation of vibrational spectra for many complexes of the type 
Hg(SR) 2 shows a predominance of linear (S-Hg-S) geometry. In contrast, 
single-crystal X-ray diffraction studies of Hg(SeMe) 2 and vibrational 
studies of Hg(SeR) 2 suggest that polymeric structures with tetrahedral 
iNgSe4 1 geometry may be more common for Hg(II) selenolates. 
All 1:1 thiolates RSHgX examined crystallographically, are polymeric 
and form complexes with pyridine bases which are polymeric or tetrameric. 
Analogous 1:1 selenolates RSeHgX behave similarly, e.g. MeXHg0 2CMe (X= 
S,Se) are isomorphous, [Bu
tSeHgC1(py) 0. 04 is isomorphous, with 
[ButSHgC1(4-Mepy) 0. 04 , and [EtSeHgCl(py)]4 has a similar eight-membered 
(-Hg-SeR-) 4 structure, but lacks a dichloro bridge found in the tert-
butyl complexes. 
The intractable complexes HgSeBAL and HgSeDMP are probably polymeric 
with tetrahedral 'HgSee geometry, in contrast to the linear sulfur 
analogs HgBAL and HgDMP. 
224 
225 
CHAPTER FIVE  
SELENIUM ANALOGS OF ANTIDOTAL DITHIOLS  
5.1 Introduction  
Selenium analogs of dithiol antidotes have not been reported. 
Attempts to synthesise analogs for studies of their interactions with 
Hg(II) and MeHg(II) were commenced for several reasons. Of particular 
interest are structural differences between Hg(SR) 2 and Hg(SeR) 2 
favouring higher co-ordination numbers for mercury in the selenolates 
(Chapter 4), and solution results suggesting that some dithiols act as 
bidentate ligands toward MeHg(II) (Chapter 3). 
It was hoped that free diselenol ligands could be obtained so that 
MeHg-diselenol stability constants could be determined and compared with 
those for the analogous dithiols. In view of possible direct in vivo 
interactions between mercuric ion and selenium synthetic routes to 
analogs of antidotal dithiols BALH 2 and DMSH4 were investigated.* It 
was expected that a diselenol analog of Unithiol, III, would probably 
form intramolecular mixed S-Se species (e.g. organo-Bunte salts RSSe03 ), 477 
and its synthesis was not considered. 
H 21C- 	0 \  
HSe SeH 
HO C CO H H 2C-CH-CH 2S0 - Na+ 
. 2 \ /. 2 
/CH--CH\ H5d'SeH 
.HSe SeH 
I, SeBALH 2 II, SeDMSH4 
*For convenience, these will be abbreviated as SeBALH , I, and SeDMSH , II. 
226 
Two general strategies can be applied to the determination of viable 
synthetic routes to diselenols, namely (i) extensions of those methods 
used to prepare thiols, using selenium analogs of organosulfur reagents 
and (ii) methods using particular properties of organoselenium reagents. 
Additionally, consideration was given to the fact that the dithiols 
of interest contain vicina thiol groups. Few synthetic routes have been 
applied to the synthesis of vicinal dithiols and only two vicinal diselenols, 
ethane-1,2-diselenol, IV, 478 and 1,2,3-triselenopropane, V, 479 have been 
described. Another report claims that IV is inherently unstable and 
eliminates H 2Se and seleniumP° 
SeH 
i 
HSeCH CH SeH H C-CH-CH 2 2  
HSe SeH 
IV 
Several metal complexes of vicinal diselenols have been reported, 
but the diselenols have not been isolated, e.g. the novel unsaturated 
heterocycle bis(trifluoromethyl)-1,2-diseleneten, VI, reacts with Ni(C0) 4 
to produce crystalline cis-[1,2-di(trifluoromethyl)ethylene-1,2-diselenolato] 
nickel(II) complex, 481 VII, but the free diselenol ligand is unknown. 
Se Se-........CF
3 
"Ni '  
/ 
Se Se--CF
3 
VI 
	
VII 
It should also be noted that SeDMSH 4 , in addition to being a vicinal 
diselenol, would have carboxylic acid groups geminal to the selenohydryl 
groups. Only one example of such a-selenocarboxylic acids has previously 
been isolated. Selenoacetic acid, VIII, has been prepared in variable 
X 
1) alkaline 
reduction 
2)acidification SeH 
SeH 
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yield in aqueous alkaline solution by removal of mercury from 
Hg(SeCH 2CO2H) 2 with Na2S,482 or by electrolytic reduction of the 
diselenide, IX, under a hydrogen atmosphere in 50% yield. 432,482  
A spectrophotometric determination of the acidity constants of VIII 
was achieved by reduction of IX with sodium borohydride, careful acidi-
fication with deaerated HC1 and extraction into CHC1 3 . 374 
HSeCH 2  CO H HO2 
 CCH
2  SeSeCH 2 
 CO
2 
 H 
VIII IX 
The difficulties involved in obtaining compounds with geminal 
carboxylic acid and selenohydryl groups have been noted elsewhere. 483 
Fredga has attempted to produce the diselenol, X, by reduction of 
1,2-diselenane-3,6-dicarboxylic acid, x1,484  in alkaline solution. 
Acidification leads to rapid decomposition and formation of red selenium: 
CO 2H 2 
Se 
\r)e 
CO2H 
XI 
Similarly, in this work, it has not been possible to isolate 
SeBALH 2 and SeDMSH 4 despite several attempts using various synthetic 
routes, but the Hg(II) complex of SeBALH 2 and of the isomeric non-vicinal 
diselenol have been prepared. 
5.2 Possible routes for synthesis of dithiols and diselenols  
Free selenols are very easily oxidised e.g. by atmospheric oxygen 
to form diselenides. 	This is of paramount importance in all reported 
selenol syntheses described below. 
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5.2.1 Direct introduction of SeH  
Alkylation of NaHSe to form alkaneselenols has often been reported. 485-6 
NaSeH + RX•> RSeH + NaX 
Common alkylating agents used are alkyl halides and potassium alkyl 
sulfates. The sodium hydrogen selenide reagent can be prepared by 
dissolving gaseous H 2Se in NaOH, by dissolving Se in methanolic Na0Me 
or, more recently by reducing Se with sodium borohydride in aqueous 
or ethanolic solution. 487 Many thiols, including several non-vicinal 
• dithiols, have been prepared in this fashion, using H 2S, or metal 
sulphides etC. 488-9 Vicinal dithiols, e.g. BALH 2 , 490-1 Unithio1 9 re 
formed under these conditions but in lower yields. If both halide 
groups are secondary, extensive dehalogenation occurs to produce a 
trans-olefin. 492-5 
1 • R2 	
NaSH _ 
	
Br 
Br Br 
R 2 
Owen has commented that halide replacement, to produce dithiols,.is 
most favorable when both groups are primary and less favorable when 
one is secondary,496 e.g. 2,3-dimercapto-T-butanol and 2,3-dibromo 7 2- 
methyl-l-propanol could not be prepared by this method. 497 
Although :HSeCH 2CH 2SeH cannot be prepared in this way, 48° the non-
vicinal diselenols HSe-(CH 2 ) 3-SeH 480 and HSeCH 2CH(OH)CH 2SeH479 have been 
prepared using this method, but they are often contaminated with cyclic - 
diselenides formed by oxidation. 
Interestingly, the only reported triselenol, propane 7 1.,2,3-.- 
' triselenol,.V, the selenium analog of glycerine, was reputedly formed 479 
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from alkylation of an alkaline solution of sodium hydrogen selenide by 
1,2,3-tribromopropane. Although the preparation of the related 
compounds 1-seleno-2,3-propanediol and 1,3-diseleno-2-propanol has 
been reported by Baroni, 479 the compound of interest here, 2,3- 
diseleno-l-propanol, SeBALH 2 , was not prepared. It should be noted 
that the parent vicinal dibromide in this case contains one primary and 
one secondary bromide group. 
Considering the ease of oxidation of the selenohydryl group, it 
is more usual to introduce selenium as a protected selenoether during 
monoselenol syntheses, especially if subsequent modifications are to 
be made to other functional groups. The last stage in a multi-step 
synthesis of such compounds is cleavage of the Se- protecting group 
(deprotection). 
5.2.2 Use of protected Thiols and Selenols  
In the multi-step synthesis of complex molecules containing the 
-XH (X=S,Se) fUnction, it is generally necessary to introduce X as the 
 
• thio-or selenoether group in order to protect against oxidation. Much 
of the literature concerning sulfur and selenium protecting groups is 
concerned with the preparation of peptides containing cysteinyl- or 
selenocysteinyl residues. " The literature of thiol protecting groups 
has been well reviewed. 499-9 Protecting groups which have been used 
for selenoaminO.acid and selenopeptide syntheses are summarised in 
Table 5.1. 
About seventy thiO1 protecting groups have been,described. 499 Many 
have been used to protect an already existing -SH function so that 
subsequent reactions may be carried out elsewhere in the molecule. For 
the current purpose, these are therefore not useful. However, - if the 
protective reaction inVolves, generation of a thiol group in situ by 
reduction of a disulfide, it was considered for inclusion in this work. 
. 
selenocystelne
b 
 
C1CH 2CH(NH 3 )C02Me 
C1CH2CH(NH 2 )C02H 
0  
230 
K2Se2/KOH c,d ;242Tt > 4SeCH2CH(NH 2 )CO2Hh 	I 	z 1 >Bz1SeCH2CH(NH 2 )CO2H II 36 hrs, 25° 
_1111ja-__> 
Na/NH,f 
Bz1SeCH 2CH(NHR)CO2H -----=> I R = H (36%) 
[0] 
R = COPh (24%) PhSe- PhSeCH 2CH(NHR)C02
Hg 
1. Ba or Ca(SeH),› 
IC (11%) 
2. [0] 
1. C1CH2SeCH 2Ph> 
1. HI 
2. HC1 2. [0] 
Ref. 
500 
501-3e 
501 
504 
505-6 
431 
507 
428a 
,,CO2Me Bz1SeH 1. NaOH 1. Na/NH 3
f 
I 70% 
Na0Me 2. H
+ 
2. [0] 
Bz1Se - • HBr/HOAcf NaOH 
 > II TosOCH 2CH(NHZ)C0 2Bzh (60%) (99%) (50%) 
1. HSe - 
2. Na0H-,  [ SeCH 2CH(NHZ)CO2fizh] i ----> > I 
1. Na/NH3f 
 > RSeCH2CH(NH2)CO2H 
R 
 Me,' Pr, al lyl 
2. RI 
selenohomocysteine
b 
1. Bz1Se- 
BrCH 2CH2 / 	-13 ---------> Bz1SeCH
2CH (70%) 
HN, ,eNH x III 
0 
1. Na0H,155° 
 > Bz1SeCH2CH 2CH(NH 2 )CO2H 
2. H+ ,pH 5.5 
508 
 
IV (86%) 
 
H 2C=C\ 
NHC(0)Me 
II 
Na/NHlf 
fSeCH 2CH2CH(NH 2 )CO2H]2 
[0] 
Bz1Se- 
C1CH 2CH2CH(Naz)C02H  > IV 
(72%) 
+ Bz1Se - 
IV (79%) BrCH 2CH 2CH(NH 3 )COH  > 
 
Bz1Se - 1. Na0H/diox. NH AOH 
T0sOCH2CH 2CH(NHZ)C02Np  > Bz1SeCH 2CH 2CH(NHZ)C02Np >  ' > IV (38%) 
2. HBr/HOAc pH 5.5 
0 Bz1SeH HCN/N11 3> 1. HC1,H0Ac b 
R1 =R2=R3 =R4=H 
R R C=CR -C15   IV (50%) 1 2 3
R4 Cat. Me0H 2. OH ,pH5.8 
mono Me-substituted IV (25-52%) 
R1  =R2 =R3' =H. R4  =Me 
R
1  =R2 =R4' =H- R3  =Me 
R2  =R3 =R4' =H. R4  =Me 
Bz1SeH (NH4 ) 2  > CO3 1. Na0H,108°  > > IV (41%)m RI =R2=R3 =R4=H 
Cat. NaCN 2. H
+
,pH 5.8 
monomethyl derivatives above 
diMe IV = R1 =R3=Me; R2=R4=H 
triMe IV = RI =R2=R4=Me; R3=h 
509 
sloe 
Na/NH 3> 	512 
[0] 
513 
514-5 
516 
selenomethionine and selenoethionine l 
Na/NH,f 
RI 
IV or V "> RSeCH2CH2CH(NH 2)C02H VI = R=Me 
R=Me,Et 
including mono-Me derivatives (R=Me) 
509,512 
514-5e 
510e,517 
Table 5.1: Synthesis of selenoamino acids and selenopeptides. a 
RCH2C(Me) 2CH(OH)CONHCH 2CH 2CONHCH 2CH 2SeBz1 
Na,NH 3f 
[0] 
IRCH2C(Me)2CH(OH)CONHCH2CH2CONHCH2CH2Se32 531 
231 
1. ReSe- ,160° 
 > VI R=M0 
 
  
2. H
+
,pH 5.8 518 
    
RSe 
T0sOCH 2CH 2CH ( NH2)C02H VI R=Me,Et 5118 
selenolanthionine and selenocystathioninel'i  519-21 
"CO2Et 1. -SeCH 2CH(NH 2 )CO2H1 HO2CCH(NH 2 )CH2x  H 
1. HC1 
2C=C,‘ 
NHC(0)Me Cat. 2. OH- , pH 6 Se 
HO2CCH(NH 2)(CH 2 ) n/ 
 
n=1 VII (selenolanthionine) 522 
C1CH 2CH(NH 2 )C02H 
1. -5e(CH) nCH(NH2)CO2H1 
VII 505be 
n=2 VIII (selenocystathionine) 5238 
-SeCH2 CH(NHZ)C0 2Bzh1  
T0sOCH 2CH(NHZ)CO2Bzh > > VII 
Se(CH 2 ) 2CH(NHZ)C02Bzh
i 
TosOCH 2CH(NHZ)C02Np » VIII 511 8 
selenoglutathione (Glu-SeCys-Gly) b 
[ZNH-SeCys] 2 
2NH 2CH 2CO2Et OH - 
[0] 
Cys(SeBz1)-Gly 
a-Et-(NHZ)-G1u 
[Glu-SeCys-Gly} 2 
IX 
524 
   
[0] 
5078 
CH2  OH 
B0cNHCHCO.NHCH 2CO2Bz1 
 
1. TosCl/pyr 
2. Bz1Se - DCC 
Glu(ZNH 2OBz1) - Cys(SeBz1) - Gly(0Bz1) 431 
3 ' CF3CO2H 
CO BZ1 2 
ZNHCHCH 2CH 2OH 
  
selenooxytocins (and uncyclised nonapeptides)  
1-seleno: ZSeCys(Bz1)-Tyr-Ile-Gln-Asn---Cys(Bz1)-Pro-Leu-Gly-NH 2 X 525 
6-seleno: (Bz1)-Tyr-Ile-Gln-Asn-SeCys(Bz1)-Pro-Leu-Gly-NH 2 . XI 525 - 7 
1,6-diseleno: ZSeCys(Bz1)-Tyr-Ile-Gln-Asn-SeCys(Bz1)-Pro-Leu-Gly-NH 2 XII 528- 9 
deamino 
-1-seleno: (Bz1)-Tyr-Ile-Gln-Asn---Cys(Bz1)-Pro-Leu-Gly-NH 2 XIII 525 
deaminon' 
-6-seleno: (Bz1)-Tyr-Ile-Gln-Asn-SeCys(Bz1)-Pro-Leu-Gly-NH 2 XIV 
, 
525 - 7 
deamino  
*-1,6-diseleno: (Bz1)-Tyr-Ile-Gln-Asn-SeCys(Bz1)-Pro-Leu-Gly-NH 2 XIV 530 
l ' NaNH f 3  x 	 1-selenooxytocin 525 
2. [0], pH 6.8 
selenocoenzyme-A, and isoselenocoenzyme-A 
R = OH (selenopantethine),-OPO 3H 2 
Table 5.1: Synthesis of selenoamino acids and selenopeptides. 
(cont.) 
N \ 
N4? R cH20 f-01-0- 
0 6H 6H 
R'iR" = OH 2OH; cyclic PO4; 
R'0 OR" P03H 2 ,H (SeC0A) 2 XV 
H,P03H 2 iso(SeCoA) 2 XVI 
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532 
Na/NH 3  XV,XVI 
Me 2NCH 2XH 2SeC(0)Ph 
Se-benzoyl-CoA and iso-Se-benzoyl-CoA 
1 Bu3Nf 
SeCoA iso-SeCoA 
Table 5.1: Synthesis of selenoamino acids and selenopeptides. 
(cont.) 
a
or substituted derivatives, usually DL- or meso- as shown (except see e). 
The following abbreviations are used: Bzl = benzyl, BZ = benzoyl, Bzh = diphenylmethyl, Boc = tert-butyloxycarbonyl, 
Z = benzyloxycarbonyl, Tos = p-toluene sulfonyl, Mpr = 5-mercaptopropionyl, Np = p-nitrophenyl, DCC = N,N'- 
dicyclohexylcarbodiimide. 
b
the selenohydryl amino acid has not been isolated in a pure state. 
eno protective group was used. 
dFischer-Raske cystine synthesis. Inconsistent yield. 
eapplied to preparation of optically active products. 
'reagent for removal of the selenohydryl-protecting group. 
gthe protective group could not be removed without decomposition to PhSeSePh. 
h
Gabriel-SOrensen phthalimidomalonic ester synthesis. Low yields. 
i
selenolate not isolated but used in situ. 
jnaturally occurring selenoamino acid. 
k
Strecker synthesis. 
/
selenoethers. 
m
Bucherer-Bergs hydantoin synthesis. 
crystallographic data are available. 
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• In addition, many routes use organosulfur reagents for which the organo-
selenium derivatives are either unknown, or hypothetically would require' 
reagents which would be difficult to manipulate (H 2Se or CSe 2 ). 
The common protecting groups meeting these requirements are described 
below. In addition to the preparation of the protected selenol, the 
means of deprotection or cleavage of.the Protected group was considered 
' (e.g. methods which required anhydrous HF were rejected). 
The benzyl (Bzl) group is the earliest Widely used protective group 
for cysteinY1 residues, and remains the most widely used for Se-containing 
peptides, etc. (Table 5.1). The benzyl group could be introduced using 
either benzylselenol (a foul smelling Colourless oil, but readily handled 
. under non-oxidising conditions) or its sodium salt (formed in situ by 
-reduction of the diselenide under alkaline conditions, e.g. using sodium 
borohydride or Rongalite).. Benzylselenol can also be formed from the 
" diselenide by in situ reduction with hypophosphorus acid. RemOval of - 
• the benzyl group from benzyl protected selenium peptides for example, is 
usually accomplished by sodium reduction in liquid ammonia, followed by 
acidification of the ammonium salt of the selenol. Alternatively, 
benzyl-protected-thiols have been deprotected with strong acids e.g. 
HF/anisOle 498br CF 3S03H. 533 
Substituted benzyl groups,. notably 4-Me0Bz1 or.4NO 2-Bz1, generally 
offer Tittle advantage over the unsubstituted groups for thiol protection, 
except that milder deprotective , conditions have been used. The selenols5347 
and diselenides are known. 538-9 
The S-triphenylmethyl (tritY1) protecting group has been usedin 
several thiol-..peptide syntheses. The trityl group can be removed by 
formation of the mercury(II)-thio-peptide complex. Mercury is subsequ- 
ently removed as the sulfide 51 0- by electrolytic 'reduction at a mercury 
cathode: 542 Triphenylmethaneselen01 and 'diselenide do not seem to have 
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been prepared to date. 
The Bu
t
- protecting group is usually added to a pre-existing thiol 
group in thio-peptide syntheses, using Bu tOH. It has been cleaved by 
anhydrous HF, but a recent report indicates that it can be cleaved under 
milder conditions by conversion to the S-(2-nitrophenyl)sulfenyl deriva-
tive or by NaBH4 reduction.543 Since we have used Bu tSeH in the 
preparation of Hg(SeBu t ) 2 and MeHgSeBu t (see pages 350-1 ), the formation 
of Bu t-selenoethers was considered as a means of selenol protection, 
although this has not been previously reported. 
Several thiols have been used to convert the cysteinyl moiety into 
asymmetric disulfides 544-7 as a means of protection of RSH: 
cys-SH + RSH ---> cys-S-S-R 
It should be noted that under these conditions, it is an entire cys-S-
group which is the protecting group, i.e. the disulfide bond is cleaved 
on deprotection. , Although selenol and diselenidereagents (for genera-
tion of selenol in situ) are available for use as protecting groups in 
this way, this technique do6s nOt seem to.. have been used for selenol 
protection. 
The Acetami .domethyl group has apparently become preferred to the 
. Bzl group for thiol protection in peptide synthesis,548 but it does not 
appear to have been used as a seleniUm protecting group. The selenol 
and diselenide are unknown. 
Schotte549 has indicated that,despite several synthetic routes to ,  
nOnLvicinal dimercaptodicarboxylit acids, "Special methods" need to be 
applied in the case of dimercaptosuccinic acid (DMSH4). The only 
'reported preparations of DMSH 4 have utilised the mild hydrolysis of 
S-acetyl protecting groups of 2.,3-bis(aCetylthio)succinic . acid, XII.4)6550 
The bis(S-acetyl) compound was prepared by 'addition of thiolacetic acid, 
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XIII, to acetylenedicarboxylic acid. 
0  
HO CCECCO H + 2H C.0 
HO22H
/ 
2 2 3 
\SH H3COC.S S.COCH3 
. By careful control of reaction temperatures, a predominance of 
racemic- or meso-XII could be obtainec0 15-6 Removal of the acetyl 
groups can be accomplished in one minute using 3N NaOH at 40° 416 
The acetylthio group has been widely used by Owen in the synthesis of . 
vicinal dimercapto alcohols, e.g. CH 2SH• .CHSH(CHOH) rICH 2OH [n=0(BALH 2 );. 551 
1,4922p2-3”2], CH 2SH.CHSH(CH 2 ) nCH2OH [n=1; 53 2P ] And:propane- 
1,20-trithio1 5 .5 
Direct utilisation of this technique for SeDMSH 4 synthesis would . 
require the use of selenolacetic acid XIV.. This compound has been 
mentioned in the early organoselenium literature. Addition of the 
Grignard reagent HSeMgBr (from H 2Se with EtMgBr) to acetylchloride in 
ether is reported to form XIV, Which decomposed to eo selenium on
•Attempted - isolatiOn. 556 An earlier report showed that XIV Could not be 
obtained by acetylatiOn of NaSeH 7 More recently, attempts to 
prepare acetyl, propionyl and isobutyryl selenols by the reaction of 
the acyl chlorides with H 2Se in pyridine were unsuccessful 58 (A 
report of XIV as an oil, bp. 135°, from the reaction of diacetyl- 
yohimbine with Se at 300 05,59 is almost certainly incorrect given the 
extreme oxidation sensitivity of Acyl selena.fg),. 
SeH \`SeH 
XIV 	 xv 
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The use of acyl-protecting groups other than acetyl is minimal, 
benzoyl (Bz) being the only common alternative reported for selenopeptide 
synthesis (Table 5.1). Benzoyl-protected DMSH 4 has not been prepared. 
Dibenzoyldiselenide is a stable, odourless, crystalline material which 
can be reduced to form an oily selenol, XV, in situ.558 The 'Biz group 
is usually removed by mild hydrolysis or methanolysis: 488-9 Benzoyl 
selenol has been shown to exist primarily as the selenohydryl tautomer 
the OH form being negligible 58 
Se 
OH 
5.2.3 Introduction of protected Selenol groups  
The actual introduction of protected selenol groups into substrate 
molecules can be achieved in several ways: 
Alkylation of selenolates  
The most common method for the preparation of mono-selenoethers 
(protected selenols) involves alkylation of a selenolate nucleophile 
with an alkyl halide, sulfate etc. 
RX + R'Se - 	RS R•+ 
Numerous examples of this type have been reported, and have been reviewed 
elsewhere. 485-6,560 In a few instances, alkylation has been performed 
with non-vicinal dihalides, to produce non-vicinal bis(alkylseleno)ethers. 
X(CH 2 ) 2 X + 2RSe - ne(CH 2 ) 2S eR 	-X=Br, n=2, R=PhCH 561 
X=C1, n=2,3, R=Me 562 
X=Br, n=3, R=Ph 563 
X=Br, n=2,3, R=Et 441,564 
2MeSe(CH 2 ) 2C1 + -Se(CH 2 ) 3Se --* MeSe(CH2)2Se(CH2)3Se(CH2)2SeMe 480' 
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Vicinal bis(alkylthio)ethers can be prepared using this route e.g. n=1 
above, but usually only when the ‘halide groups are not both secondary, 
e.g. 1,4-diacetoxy-2,3-dibromobutane eliminates bromide when treated 
with thiolacetic acid/pyridine to form 1,4-diacetoxybut-2-ene 492 (but 
10,11-bis(acetylthio)hendecanoic acid is formed from the corresponding 
vicinal secondary dibromide under the same conditions 585 ). 
Attempts to alkylate selenolates, using reagents with vicinal
•leaving groups, do not seem to have been reported, perhaps because Of 
problems faced in the analogous dithiol syntheses (see page 228 for 
. preparations Of non vicinal diselenols, using NaSeH). 
(ii) Addition of Selenols to alkenes and alkynes  
The addition of thiols to activated alkenes and alkynet is well 
established and may proceed via either radical 568 or: base-catalysed 567 
pathways e.g. the base-catalysed reaction has been usedto prepare 
crystalline derivatives of olefins;68 and several new dithioethers 
which may be potential heavy-metal antidotes have similarly been 
prepared. fromacetylenedicarboxylic acid. 569 Analogous addition of 
selenols (mainly aryl) has also received much attention, almost solely 
from Russian workers. Reported addition reactions of selenols to 
alkenes and alkYnes have been summarised in Tables 5.2 and 5.3 respect- • 
ively. 
Lactone and epoxide ring opening  
The preparation of selenium-containing carboxylic acids is often 
carried out by lactone ring opening, And epOxides are similarly opened 
to produce alcohols. These reactions have been summarised in Table 5.4.. 
. Phenyl selenide has recently been reviewed as an effective reagent for. 
S2-type cleavages of lactones and esters. 585 To prepare protected 
SeDMSH 4 using this method, two selenoether groups would need to be 
introduced. A possible route is shown below: 
571 Bz1SCH ,CH9SeBz1 
2>CH-CHi 
HO2C 
Et3N 
00 > 
R
1 
Bz1SCH 2. 
C=CH / 2 
HO2C 
RR
3 
\C(0)R4 
Bz1Se\ ,C(0)R4 
tR CHR' /, 2 3 
C=C" 
Na0Me• 
H, =C" 
"NH(0)Me 
0 
1.Na/NH (2.) 
3 > 
2.Fe3+ ,02 
H
+ ,PH 1 
SeCH 2CH\ 
CO - 2 2 
> -> 506 
238 
alkene product ref. 
ionic additions (base catalysed  
Bz1SeH: 
CO2  H Et3  N /   
Me C= 
, 
2 \t02H Et2T1H - 
, 
1.Na/NH3 (2.)b  - CH 1 .5 . 
	> --CH-CHJOnH] -CO > 2 . 02 ._ 1 c .c 
 CH3 2 
570 
= H,H,H,Me; Me,H,H,H; H4H,Me,H; Me,Me,H,Me 572 
H,H,H,H 516 
/H 
g\C
°2
H 
pirridine> 
5b, 12 hr. 
Bz1SeCH CHCO H 573 
PhSeH: 
R R, 
H' 'CO2R 
R ,R2 ,R3 = 
Na0Me(Et) › 
Ft' Ii 
PhSeCK. H.00 R 
2 3 
2 
 
H,H,H; H,Me,H; H,Me,Me 
CO2 ' ' H H H .; CO2 " Et H Et 
 
574 
Table 5.2: Addition of selenolsa to alkenes. 
aunder ionic conditions the selenol is deprotonated. 
to cleave the benzyl group. 
Table 5.3: Addition of selenolsa to alkynes. 
ref. productsb 
111 
>=CHR9 
PhSe ` 
alkyne  
ionic additions (base catalysed)  
Et 0 
PhSeH 2  
R.CECR 2 piperidine'
, 
trans R1 ,R2 = H,CO2Me; Ph,CO 2H; H,CH 2OCOMe; CO 2Me,CO 2Me 
R OR2 
PhSe H 
CO2H,pH; C(OH)Me 2 ,Ph 
Et0H > R.CECCO R2 
R=Me 
R=Me 
• sat.Na0Me  u 
Me0H,70°,3hrs: " >=CHR(OH)Me 
PhSe 
cis R=Et,Prn ; cis & 
580 
584 Et20  
3 hr. 
neat > 
EtSeH HCECXEt 
(X=0,S) 
HCECR PhSeCH=CHR 
cis and trans R=Ph 
(also R=5-(2-Me-pyridy1))" 
H 
EtSe XEt 
R
1 , 
(also 4-NO2-PhSeH) 
HCE1-0H 
R2 = PhPh; 
H,H 
1 
:>=CHR, 
PhSe ` 
cis R1' R2  =H,Ph 
trans Rl ' R
2 
 =Ph,Ph; 
(also H,5-(2-Me-pyridyl) d) 
02Et neat > 
ArCH 
SePh 
Ar=Ph; 4-Me0Ph; 2,5-diMe0Ph; 2-Mle0-C 10H 6 
Ar=Phe 
CC14 > u r R
• 	 "2'=(SePh 
R=Ph,COPh, CO E OEt (mainly cis) 
BunCECH 
R
1
CECR 
Et0 CCECAr 
radical additions  
PhSeH EtO2CECAr 
PhSeH HCECR 
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575 
576 
577 
578 
579 
580 
581 
581 
582 
583 
satAa0Et  n. 
'Et0H,120°,20hr> Bu :>=CH 9c + PhSeCH=CHBUn 
PhSe ` 
Na0Me > Ar H 
Me0H 
PhS CO2 
 Et 
Ar=Ph; 4-Me0Ph; 2,5-diMe0-Ph; 2-Me0-C 10H6 
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Table 5.3: Addition of selenolsa to alkynes. 
(cont.) 
a under ionic addition conditions the selenol is deprotonated. 
b stereochemistry is that indicated in the original reference and appears 
to be solvent dependent. 
cappears to be an exception to 1,2-addition. dstereochemistry not 
given under base-catalysed conditions. estereochemistry incorrectly 
assigned 581 i n ref. 582 
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0 
RSe
- HO 
SeR 
C 	CO2H 
SeR 
0 
---> 
RSe 
HO 2 ? 	N x 	H02 
The starting 3-1actones of a-halomalic acids are unknown (although an 
a,t3-dimethy1 substituted analog has been prepaM) 	and are probably 
unstable with respect to the isomers of 2-halobutenedioic acids. 
The related selenol of interest, 2-selenosuccinic acid, XVI, may 
possibly be obtained using this technique. 
HOC 2 	CO„H 
H 2Se 	 4 
or NaHSe 	SeH XVI 
HOC) /CO2H  
SeR 
In this case the starting B-lactone of malic acid is known. 87 	It 
may be noted in passing that this route has not been attempted with 
a-lactones, which could be expected to generate protected, substituted 
a-sel enocarboxyl c acids 
HO 2 
\o • 
R'Se 
R'SeCR2CO2H 
 
ct-Lactones (R=CH 3 , nBu,-(CH 2 ) n -, n=2,3,4,588 Bu t ;589 CF 359 can be 
prepared in high yield photochemically at 77 K, but most polymerise 
above this temperature.588 Their stability can be enhanced electronic-
ally e.g. R=CF3 has a half life of 8 hours at 24 C,590 or sterically, 
e.g. R=Bu t which is stable below -20°C.589 The usual route to these 
a-selenocarboxylic acids would be alkylation of the selenolate HO 2CCR2Se -
formed by in situ reduction of the corresponding diselenides. However, 
in most of the cases above except R=Me 591) the highly substituted 
diselenides are unknown. 
HOCH 2CH 2SeMe 	 593 
HO, 
R—`C.CH SePr (or Ph) 	 594 
R/ 
2 
MeSeH  
PrSeH 
PhSeH >. or 
(CH 30MgSe) 24Me0H 
 
Bz1Se- > 
MeSe- > 
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ref. 
1 H 2  Se 
(HOCH 2 2Se*2 
 
592 
Pr : R 1 ,R2 = Me,Me; Me,H; C1CH 2 ,H; CH 
CH 2=CH,Me; CH 2=CH; H; 
CH 2=CC1 ,H 
Ph: 	R1 ,R2 = Me,Me; Me,H; C1CH ,H 
EL 
1 Na2  Se 
2. [OH] 
(HO CCH CH 2Se+2 	 595 
• Bz1Se ,DM F> Bz1SeCH 2 CH 	H 	 596 
2. H 
1. Bzl Se - ,DMF> 
2. H + 
PhSeT> 
CH 2Se+2 
	
= H,H,H; H,H,Me 	R4=H 
Me,H,H; Me,H 2 OH 
NH 2 
CH—CO 2H 
R =R =R =H, R =NH 1 2 3 	4 	2 
CO2H 1 
CH 2SeBz1 
(HO 2 CCH 
,R R 
MeSeCH 
CH 2 J Se— 2 
CO 2H 
many examples 
597 
598: 
518 
487 
599 
585 
Table 5.4: 	Opening of lactones and epoxides by organoselenium reagents. 
0 
■// 
HOOC COOH CH 2  OH 
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Epoxides can be opened with disulfides to yield protected vicinal 
dithiols,600 but epoxide ring opening with diselenides is unreported. 
0 R 
+ R'SSR' 3  
25°,5-24hr"
, 
 -----\ 
Bu P 
R'S 
SR' + Bu =0 
(R,W=MePh; Ph,Me; Ph,Ph; cyclohexhyl,Ph) 
The epoxides of succinic aciegild 1-propano1 642 
may be suitable starting materials for synthesis of protected SeDMSH 4 
and SeBALH 2 using this method. 
Kataev has selectively added selenophenol to epichlorohydrin, 
without epoxide ring cleavage6,° 3 and this may be a route to a protected 
0 
CH 2 Cl 
PhSeH 
0 
CH 2SePh 
 
form of SeBALH 2 if the product can be subsequently ring opened with a 
second selenol. 
CH 2  SePh 
H C-CH-CH OH 
2/ \ 2 
SeR SePh 
5.2.4 Choice of Protective groups for SeBALH 2  and SeDMSH4  Syntheses  
Choice of protecting groups was based on the review presented 
above, in particular on the widespread use of the benzyl protecting 
group in selenopeptide synthesis and reports of successful syntheses 
of analogous dithiols. Acetyl-protection as a potential route to SeDMSH4 
XVI I 
5.2.5 Selenols from Selenocyanate Hydrolysis  
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synthesis was rejected since selenolacetic acid is not available, but 
the benzoyl group was considered as a possible alternative although 
2,3-bis(benzoylthio)succinic acid is unknown. 
The benzyl group has been successfully used for protection in the 
604 synthesis of BALH 2 . Bis-benzylthiolation can be achieved using 
vicinal dibromides in which the bromide groups are not both primary, e.g. 
2,3-dibromo-2-methyl-l-propanol (cf. page 233 • 497 
 
However, alkylation 
of benzylthiolate with 2,3-dibromo-l-propanol produces the 1,3-bis(benzyl-
thio)-2-propanol as the almost exclusive product, due to rearrangement via 
- an epoxide. 6045 Removal of benzyl groups from 2,3-bis(benzylthio)-1- 
Prbpanol, XVII, and the isomeric 1,3-bis(benzylthio)-2-propanol, XVIII, 
can be achieved by hydrogenolysis 605 or by sodium reduction in liquid 
490,604 ammonia. 2,3-Bis(benzylthio)succinic acid, XV, has been prepared 606 
by Larsson, by addition of benzylthiol to acetylenedicarboxylic acid, 
suggesting the similar use of benzylselenol for synthesis of SeDMSH 4 . 
OH 
1 
H 2C-CH-CH OH WC-CH-CH, 21 
Bz1S SBz1 Bz1S SBZ1 
HO C 
2 \ 
CH-CH 
Bz1S 
CO
2
H 
SBz1 
The hydrolysis of selenocyanates is a well established route to 
monoselenols. Hydrolysis may be achieved in alkaline media (e.g. 
Zn/NaOH 6°7 or KOH/ROH 6°8) , usually producing diselenides during the 
workup. Advantage may be taken of the higher stability of selenols in 
acidic solution by reduction with other reagents, e.g. Zn 6°9 or 
3 ' 
H po
2 
 478,610 Alkylselenocyanates are conveniently prepared by displace-
ment of bromide from alkyl bromides using KSeCN in acetone, and many non- 
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vicinal diselenocyanates have been prepared using this method.
611-14 
Addition of KSeCN to vicinal dibromides leads to the elimination 
of selenium and bromide to produce an olefin%15 except in the case of 
1,2-dibromoethane, where 1,2-diselenocyanatoethane can be isolated as a 
stable crystalline materi al •6134  
A recent report of the addition of thiocyanogen to alkenes (under 
hetero-616 and homolytic 617 conditions) and alkynes 618 (homolytic 
conditions only) shows that vicinal dithiocyanates are formed 
NCS SCN 
R-CEC-R' 
R ,.CH.CH.R 
(SCN) 2 
Selenocyanogen would be required to extend this reaction to selenium 
analogs. Although reported to be isolable as a very unstable solid,619 
it can readily be produced in good yield at -60°C by the action of 
bromine on KSeCN.608 It has been used as a selenocyanating agent for 
N-heterocycles,608 but addition of (SeCN) 2 to alkenes and alkynes does 
not seem to have been reported. Wille has briefly reported on the 
addition of HSeCN to propynal and 3-butynone, 620 e.g. 
0 0 
R.C.CECH + HSeCN ---> R.C.CH=CH.SeCN 
(R=CH 3 ,H) 
These additions are usually prevented by electron withdrawing groups, 
e.g. R.C1, CO2H, CO 2Et, Bu t , and thus the reaction would not seem to be 
appropriate for SeDMSH 4 synthesis. Addition of (SCN) 2 to propargyl or 
vinyl alcohols has not been attempted and these may be possible routes 
to SeBALH 2 as shown: 
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HOCH .C=-CH
2 ( S CN) 2 HOCH 2C(SCN ) =CH(SCN) 
HOCH 2* CH=CH 2 H
OCH
2CH(SCN)CH 2
(SCN) 
KSeCN will also open lactones.to quantitatively produce seleno-
cyanato-carboxylic acids, 596 but epoxides are opened without Se 
inclusion 
621 
5.2.6 Other Methods  
(i) Reduction of Trithiocarbonates and Xanthates to Dithiols  
1,2-Dithiols can be obtained by L1A1H 4 reduction of trithiocarbon-
ates 6220r xanthates (0-alkyldithiocarbonates) or by distillation of 
trithiocarbonates 
> 
C C=S 
	
s/ 
	
SH 
Few organo-triselenocarbonates are known, although the ion has been 
obtained as Ba and K sa1ts 24-5 and these require CSe
2 for their 
preparation e.g. ethylene and methyleTtriselenocarbonatesP 6 
Like their sulfur analogs, 0-alkyldiselenocarbonates RO-CSe 2 
(R=(CH
2 
 ) CH 3  627 n=1,2,3,4,5,7,8,9,11,1t ---
AlP  
) can be prepared similarly n ' 
from CSe 2 and ROH but reductionl of these compounds does not seem to 
have been reported. 
(ii)Conversion of Alcohols tOYSelenoethers  
Displacement of p-toluenesulfonate (tosyl) by benzylselenolate, can 
be used to convert alcohols into protected telenoethers 
 
p-CH C
6 
H SO
2
Cl I 
BZ1Se- R-OH > R-O-S02 
 C6  
 RSeBz1 
from aminoethano19 23 
,s 
H2  NCH 2  CH OH 
S 
LiA1H4  
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•This route has been used for protection of serine and homoserine 
in peptide synthesesin, 511 . with the carboxyl group in serine protected 
by benzyl or 4-NO 2 benzyl before tosylation. Several vicinal dithiols 
have been prepared from vicinal primary diols, but secondary alcoholic 
groups react less favorably. 629 
The tosyl derivative of tartaric acid . may provide a route to 
SeDMSH4' 
but does not appear to have been reported. 
 
HOOC COOH 
CH-CH 
HO OH 
tosyl Cl  
 
HOOC COON 
,/, 
RSe SeR 
  
XV 
(iii) Reduction of Episulfides  
The recent use of 'sulfurated' sodium borohydride, NaBH 2S , to 
convert episulfides to vicinal dithiols has been reported. 63° 
NaBH2S3 LiA1H4 
R.CH—CH.R' > --------> •R.CH-CH-R' 
(R,W=H2OPh) I I 
SH SH 
Selenium reacts with sodium borohydride to form a product suggested 
to be NaBH2 Se3' 631 and thus the reactions below may be possible routes 
to SeBALH 2 and SeDMSH4 
respectively, 
H C CH .CH OH 2 \ y 2 
Se 
NaBH 2Se3 L1A1H4 
H1C-CH-CH2OH 
I 
HSe SeH 
H 2OCN\ //CO2H 2 N\ CO2H 
HC—CH  > 
> 
 
Hse/ 
SeH 
Se 
Although the existence of a few seleniranes has been reported, e.g. 
episelenides of cyclohexane, 1-octene and stilbene,632 they are unstable 
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and cannot be isolated. 
The reaction of selenourea with epoxides, following the procedure 
for the preparation of thiiranes, 633 does not seem to have been 
attempted. 
(iv) Addition of diselenides to alkenes and alkynes  
Kataeva 634  has briefly reported that diselenides (R=W,Et,Ph) 
will add to substituted acetylenes under alkaline conditions. 
H.CEC,R . + RSeSeR 
(R'=H,Ph,5-(2-Me-pyridyl) 
\\C=C(1 
RSe/ , .SeR 
Addition to alkenes does not seem to have been reported. 	Hydrogenation 
of disubstituted alkenes to the alkanes required for SeDMSH 2 and SeBALH 2 
synthesis is likely to be difficult, and would probably result in 
hydrogenolysis of the RSe-protecting groups. 635 Hydrogenation of 
bis(alkylthio)alkenes is not a convenient route to dithiols1 96 
5.3 Attempted Syntheses of SeDMISH4 and SeBALH 
5.3.1 SeDMSH 4 
Reported below are attempts to produce SeDMISH4via precursors 
containing benzoyl or benzyl protecting groups, following the general 
procedure of Owen's DMS14synthesis 550 	(addition of thiolacetic 
acid to acetylenedicarboxylic acid). 	All reactions were performed 
in a nitrogen atmosphere. 	Addition of benzoylselenol to alkenes or 
alkynes has not been reported previously. 	Benzoyl protection of 
thiol-containing peptides has previously been carried out by alkylation 
of the existing thiol into benzoyl chloride. 
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Benzoyl Protection  
Dibenzoyldiselenide, XXI, was prepared by alkylation of ethanolic 
NaSeH (from Se in NaBH
4) and oxidation of the resulting yellow solution 
with air 
C-SeSe-C 
II II 
0 0 
XXI 
The odourless, yellow crystalline material is a convenient source of 
benzoyl selenol. Addition of excess sodium borohydride to an ethanolic 
suspension of XXI under nitrogen caused the solid to dissolve, yielding 
a deep yellow solution. (Reduction of diselenides to selenols usually 
causes the disappearance of the yellow colour due to the diselenide 
chromophore. However, Jensen reports that oily benzoyl selenol is 
yellow in sodium hydroxide solution 558). Filtration of this solution 
under nitrogen into a stoichiometric quantity of acetylenedicarboxylic 
acid in ethylacetate yielded a deep red solution. Dibenzoyldiselenide 
and grey selenium were obtained as the only components of a grey 
precipitate which formed overnight. Dilution of the filtrate with 
water and extraction with ether produced a small amount of diselenide 
from the yellow ether layer. The components of the aqueous phase could 
not be separated; red selenium was produced on acidification and 
evaporation to low volume. 
The expected highly polar dicarboxylic acid product is likely to 
be very difficult to separate, without decomposition, from boric acid 
formed from borohydride oxidation. The acidity of the carboxylic acid 
groups, e.g. DMSH 4 has plc, 2.24(1) and pK2 3.43(1), requires low pH to 
ensure solvent extraction from aqueous systems. The products were too 
polar for alumina or silica column chromatographic separation. Reduction 
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of dibenzoyldiselenide with 50% hypophosphorus acid (H 3P02 ) was complete 
in 5 minutes at 90 0 . Addition of aqueous acetylenedicarboxylic acid 
(1:1 mole ratio) produced a pink solution (and some H 2Se evolution) 
which was filtered from a small amount of unreduced diselenide. 
Addition of water produced a pink precipitate identified as benzoic acid 
(ir, mass spec. identical with authentic benzoic acid) contaminated with 
selenium. 
(ii) Benzyl Protection  
Dibenzyldiselenide, XXII, was produced as a yellow crystalline 
material by the reaction of benzaldehyde and ethanolic NaSeH in the 
presence of morpholine hydrochloride 636 
CH SeSeCH 
XXII 
A preliminary attempt to alkylate meso-2,3-dibromosuccinic acid with 
benzylselenolate in ethanol (from reduction of the diselenide with 
sodium borohydride) produced the diselenide and fumaric acid (by 
comparison with ir spectra of the authentic compound). The compounds 
2-(benzylseleno)fumaric acid, XXIIIb, and 2-(benzylseleno)succinic acid, 
XXIVb, (also produced in this work) were not detected as products. 
(These compounds have several distinctive strong infrared absorptions: 
v C=0 at 1705, 1688 and 1696 cm  The former also_has 
strong v C=C 1670 cm). 
Addition of NaSH to 2,3-dibromosuccinic acid,493 and addition of 
thiols to 2,3 -dihalogenosuccinic acids and esters, 550 is reported to 
produce fumaric acid by trans-elimination of bromide. 
The 1:1 base-catalysed addition of benzylthiol to acetylene- 
HO
2 
Bzl-X CO
2
H 
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dicarboxylic acid, ADCA, has been reported to result in the formation 
of 2-(benzylthio)fumaric acid, XXIIIa!' 37 
XXIII a, X=S 
b, X=Se 
HOC CO2H 
Bzl 
XXIV a, X=S 
b, X=Se 
Addition of two benzylthio groups to ADCA was also achieved, to 
produce the previously mentioned protected DMSH 4 derivative meso-2,3- 
bis(benzylthio)succinic acid, XIX. Reaction conditions can be varied 
to give predominantly the racemic or meso producO 06 The meso-2:1 
adduct also results from addition of benzylthio to the trans-1:1 
adduct, XXIIIaJ538 
Following this approach it was found that the base-catalysed 
addition of benzylselenol to ADCA produced only the new unsaturated 1:1 
adduct, XXIIIb. Benzylselenol was obtained as a foul smelling, colour- 
less oil (bp. 61.0-61.5 ° /8mm) by Painter's Grignard-reagent method. 501 
Using Larsson's procedure, neat benzylselenol was added to one 
equivalent of ADCA dissolved in sodium bicarbonate solution. The 
colourless solution was stirred for 36 hours under nitrogen, then 
extracted with ether to remove any unreacted diselenide. Upon acidi- 
fication with HC1 (Congo red), the yellow product XXIIIb (55%) was 
obtained. Recrystallisation from aqueous ethanol gave XXIIb as bright 
yellow needles, m.p. 180-3 ° (dec.). 
0C H 
1. Bz1Se-/Na0Et 2\ / 
HO C.CEC.009H > C=C 
` 2. H
+ \ 
 
Bz1Se
/ 
CO
2
H 
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An alternative preparative procedure, used by Kataev tor seleno- 
phenol addition reactions, was more rapid and produced the same product. 
The reactants were dissolved in a saturated ethanolic solution of sodium 
ethoxide cooled in ice. After 15 minutes, the thick white suspension 
was diluted with water and worked up as previously to give XXIIIb. 
The previously reported sulfur analog XXIIa, was prepared under 
identical conditions. 
Attempts to obtain the required 2:1 addition product using either 
of these methods (Larsson, Kataev) failed, even with prolonged reaction 
times (1 week). The 1:1 adduct and dibenzyldiselenide were always 
obtained with the usual Workup. Similarly, the Selenol (or benzyl 
thiol) could not be added to the 1:1 adduct. In contrast, reaction of 
benzylthiol with ADCA in 2:1 mole ratio, produced white meso-2,3- 
bis(benzylthio)succinic acid, XIX, which was also synthesised from 
DMSH4 .and benzylchloride. 
Kataev has reported the failure to add a second molecule of seleno-
phenol to 2-(phenylseleno)fumaric acid, 580 which he claims is due to 
"both the low polarisation oUthe double bond, and the fact that it is 
shielded." The use of benzylselenol in place of selenophenol might 
have been expected to reduce these inhibitory effects. 
It was found, however, that Na0Et catalysed addition of benzyi-
Selenol to ADCA produced a pale-yellow precipitate after 63 hours. On 
filtration and rapid washing with ethylacetate, to remove yellow XXIIIb, 
the product was nearly white, but rapidly became bright yellow with the 
evolution of foul-smelling benZylselenol. 
Bz1Se -/Na0Et 
HO ccEcco 2H  63 hrs 
HO2ci
CO2
H - 
Bz1Se SeBz1 
HO 9 C 
-Bz1SeH  
Bz1Se CO 2H 2 
XXIIIb 
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The white product may have been the required 2:1 benzyl protected 
SeDMISH
4' 
but its instability precludes its use to conveniently obtain 
a deprotected product. 
The 
1
H nmr spectra (in acetone-de, ) of XXIIIa and XXIIIb are 
summarised in Table 5.5. 
2-(benzylX)fumaric acid C H 
7.38 
7.39 
CH 
--2 
4.25 
4.23 
4.21 
CH=C CO,H a 
5.1(br) 
5.3(br) 
X=S (this work) 
(ref. 637 ) 
X=Se (this work) 
6.45 
6.50 
6.69 
Table 5.5: Proton chemical shifts for the acids trans-H0 2CC(XCH CeH e )= 
CHCO2 
 H in acetone-d
6 
 (6 ±0.02) aresonances due to 
carboxylate protons and H 20 impurity in solvent. 
The benzylic protons in these compounds are essentially unaffected by 
substitution of sulfur by selenium. This result is somewhat unexpected; , 
and may reflect a balance between differences in inductive and mesomeric 
effects of the chalcogens in these conjugated Systems. In contrast, 
the benzylic protons in dibenzyldiselenide (3.836 An CDC1 3 , this work) 
are deshielded with respect to dibenzyldisulfide (3.516 in CC1 4 ) 63.9 
and shielded with respect to dibenzylditelluride (4.256 in CDC1 3 , this 
work). The methyl protons of dimethyl polysulfides and polyselenides 
show analogous behaviour.639 In addition, the olefinic proton of the 
selenium analog (.6.456) is deshielded With respect to the sulfur deriv-
ative.(6'.696).. This deshielding effect has also been noted in several 
compounds where selenium is part of a conjugated system;640 indicating 
that mesomeric influences may be dominant. 
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Larsson has compared the olefinic proton chemical shifts in D 20 of 
the disodium salts of 2-(benzylthio)fumaric acid (6.246) and 2-(benzylthio) 
maleic acid (5.686) .637 From Table 5.5 it can be seen that the proton 
chemical shifts of XXIIIb are close to those of the trans- sulfur analog, 
supporting the assignment of trans- stereochemistry for XXIIIb. No 
coupling between selenium and the benzylic protons of XXIIIb could be 
177 
observed. Although one-, two- and three-bond H- Se couplings have 
been observed elsewhere
641
, the 
77
Se satellites are of low intensity (7.5% 
natural abundance) and were not detected in any 1 H nmr spectra recorded 
in this work. 
The selenium compound, XXIIIb, is bright yellow and the analogous 
sulfur compound, XXIII6, also synthesised in this study, is light yellow. 
Aqueous alkaline solutions of these compounds are colourless. The near 
ultraviolet absorption spectra of XXIIIa and XXIIIb are shown in Figure 
5.1, It Can be seen that the yellow Colours of these compounds are 
due to tailing of and intense absorption near 300 nm into the visible 
region. 
The expected position of Amax for the n.4ff* transition of the 
unsaturated carboxylic acid chromophore of the sulfur compound can be 
calculated. The position of Amax for simple 8-substituted ci,8-unsatur7 
• ated carboxylic acids is given at 208±5 nm by Nielsen'.642 
\ 
f3 (1\c02H 
It has been reported that carboxyl ate substitution in the s.-.position of 
simple enone chromophores has no effect on the position of X .643 
max 
Similarly, addition of CO2H to c,-unsaturated carboxylic acids does not 
alter the position of Amax of the chromophore, e.g. the a,-unsaturated 
1.0 
Abs 
0.5 
200 400 nm CJ1 c.n 
400 nm 200 
Figure 5.1: Ultraviolet absorptiona of 2-(benzylseleno)fumaric acid and 2-(benzylthio)fumaric acid. 
a
1.0 x 10
-4M solutions at the pH shown, in 1 cm cells. 
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dicarboxylic acids, maleic and fumaric acids, have Amax (6 in water) 
of 210(1.3 x 104 ) and 208(1.4 x 10
4
), respectively 44 
The degree of bathochromic shift caused by an S-alkyl sUbstituent 
can be deduced from the change in Xmax for enones 643 to be ±85 nm. 
The sulfur analog XXIIIa is thus expected to have X max (in water) at 
293 nm (208 + 85). The position of Xmax is found to be 294 nm at pH 
3.7, where the compound is 92% protonated (the hydrolysis constants 
pical , pKa2 have been Measured to be 2.03(1), 4.49(1) for XXIIIa and 
2.01(1), 4.46(1) for XXIIIb at 25° in 0.1M KNO3 ). 
By comparing the spectra for protonated forms of XXIIIa and XXIIIb 
it is clear that substitution of selenium for sulfur causes a batho-
chromiC shift in the 1147r* transition of +12 nm. 
Thus, the contribution to the position of Xmax due to 6-Se-alkyl 
substitution would appear to be t98 nm. 
Bathochromic shifts are often found to be in the order O<S<Se for 
analogous compounds. This may be explained by a hyperconjugative 
mechanism. Thus in compounds XXIIIa and XXIIIb the lower energy for 
n-nr* transition in the selenium analog may be due to stabilisation of a 
charge-separated excited state (in extended conjugation with the a,6 - 
unsaturated system) due to the increased ability of Se to accept a 
delocalised negative charge. 
This possibility has been postulated by Mautner . and co -workers to 
explain the bathochromic trends in compounds containing the selenoamide 
mOietyf.45-7 
Deprotonation Of WIIa and XXII1b causes the 11±7* transition to 
move to higher energy (hypsochromic shift) (Table 6.6). 
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r1.4114 transition energy/kJ mo1 -1  
XXIIIa X=S XXIIIb X=Se 
2(3z1X)C(CO2H)=CH(CO H) 422 407 
2(Bz1X)C(CO2- )=CH(CO2 - ) 405 389 
Table 5.6: a,f3-unsaturated carbonyl transition energy shifts of 
XXIIIa,b on deprotonation of the carboxylate groups. 
The new saturated analog of XXIIIb 2-(benzylseleno)-succinic acid, 
XXIVb was also prepared. Base-catalysed (Na0Et) addition of benzyl- 
selenol to maleic acid, and the usual workup to remove dibenzyldiselenide, 
produced a white product on acidification. Recrystallisation from 
aqueous ethanol produced XXIVb as fine white needles, mp. 185-7°. The 
sulfur analog XXIVa has been previously prepared by Larsson, and was 648 
synthesised in this work using the Na0Et catalysed method. 
Microanalyses for the new compounds XXIIIb and XXIVb are shown 
below. 
found % calc. % 
C H Se C H Se 
2-(benzylseleno)fumaric acid 46.6 3.6 27.8 46.7 3.5 27.7 
2-(benzylseleno)succinic acid 46.0 4.4 27.2 46.0 4.2 27.5 
The 100 MHz proton nmr spectra (in acetone-d6 ) of XXIVa and XXIVb 
are shown in Figures 5.2 and 5.3 respectively. Substitution of Se for 
S has caused the expected small downfield shift (see page 253 ) in the 
singlet resonance of the benzylic protons (4.036 for XXIVa compared with 
4.096 for XXIVb). These values are close to those previously recorded 
HO2 C 2H 
H 	 H 
H 2 - 
-CO2H 
(C113 ) C=0 
0 2C\ ,H 
C 
'CH 2 s a 
/J /2 
SI 	 r— 1 
7 f 6 T 
CO2H 
ii 
8 	 6 
Figure 5. 2: 	100 MHz proton nmr spectrum of 2- (benzyl tnio)succinic acid in acetone-q. 
1-IOC 	CON 2 ( 2 
H 	H 
Se 	H 
HO 2C, ,H 
‘C- 	C-CH 
Se" "CH, 	2 c 
CO H 
Figure 5.3: 	100 MHz proton nmr spectrum of 2-)benzylseleno)succinic acid in acetone-d6. 
for the unsaturated analogs XXIIIa and XXIIIb (page 253 ) In the nmr 
spectrum of XXIVb, 
1 
 H-
77 
 Se coupling was not observed. 
A feature of interest in these spectra is the well-resolved 12 
line-ABX system of methylene (A,B) and methine (X) protons. 
HO,C /CO 2H 
C-- C 
 
Bz1X/f/ Hb 
H x Ha 
The spectra were treated by the method of Garbisch 649 to obtain the 
considered to be negative 50 The numbering of the ABX transitions 
J < O. 
coupling constants J
ax' bx at) 
J and J The geminal coupling, J
ab' 
 was 
shown in Figures 5.2 and 5.3 is the only combination which satisfies the 
intensity and coupling constant relationships required by Garbisch, with 
/equilibrium in acetone-d 6 which/ is rapid on the nnr timescale. The 
treatment of the spectra are summarised in Table 5.7. 
three possible staggered conformations are shown in Figure 5.4. 
ab 
The values for J
ax 
and J derived from second-order 
Both compounds are expected to be in conformational (rotational) 
649 
\ 
*  
bx 
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XBzl• CO12H • 
H x 
I II III 
Figure 5.4: Staggered ,conforMations L f XXIVa and XXIVb. 
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Conformer III is expected to be the least energetically favorable 
due to the interactions of three gauche bulky groups. The magnitude 
of J ax  (10 Hz) requires the exchange-averaged H a-Hb dihedral angle to 
be near 180 0 ,650 which mitigates against a significant population of 
rotamer III. An estimate of the relative populations of rotamers I 
and II can be made using 
Jax and Jbx 651 
(J /J ) - 0.180 
nun _  bx ax  
1 - 0.18 °(Jbx/jax) 
(This relationship assumes Ha-Hx and H b  -Hx  dihedral angles of 65° and 
185° respectively, which seem to be relatively invarient in a range of 
trisubstituted ethanes 651 ). 
nunII X 
XXIVa -17.1 10.9 5.0 0.3 
XXIVb -17.1 10.7 4.5 0.3 
Table 5.7: Coupling constants
b 
obtained from the ABX subspectra of 
XXIVa, XXIVb. 
a
assumed to be <0; 
650 b 
transition frequencies were measured 
with a sweep width of 90 Hz, errors in peak positions of 
±0.2 Hz generate errors of approx. ±0.5 Hz in the coupling 
constants. 
From Table 5.7 it can be seen that conformation II appears to be 
preferred for both compounds, which may reflect a hydrogen bonding 
interaction between gauche carboxyl and X-benzyl groups. 
II 
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5.3.2 SeBALH 2  and related SeDMPH 2 
Baroni 479 has reported that HSe - will displace bromide from 1,3- 
dibromo-2-propanol to form the non-vicinal diselenol 1,3-diseleno-2- 
propanol, XXV, (SeDMPH 2 , bp. 114°/20 mm) which was isolated as the 
Hg(II) complex. It was reported that the free selenol could be 
regenerated by removal of mercury with H 2Se. Baroni did not report 
the preparation of isomeric SeBALH 2 , of interest in this work. 
OH OH 
+ HSe- 
H H C-CH-CH 
Br 
2/ 2 
Br Br HSe SeH 
XXV 
The non-vicinal . dithiol analog, 1,3-dimerCapto 72-propano40MpH 2 , 
has no antidotal activity towards mercury intoxication. In fact, the 
high toxicity of early preparations of BALH2 have been ascribed to 
,DMPH:2  impurities.605 The interest in SeDMPH 2 in this.work derives from - 
the fact that the Hg(II) complex of its dithidl analog: forms a crystalline 
• adduct with pyridine, HgDMP(py). 238 In contrast, HgBAL is insoluble in lt5 
common solvents and can only be obtained as an amorphous polymer (page 53)-. 
A similar alkylation using 1,3-dibromopropane is reported to form the 
disodium salt of 1,3-diselenopropane, which was not isolated but used in 
situ.652 
Attempted syntheses of SeDMPH 2 and of protected SeBALH 2 are reported 
below. 
(i) SeDMPH 2 
Following the principle of Baroni's synthesis, alkylation of alkaline 
ethanolic NaSeH with 1,3-dibromo-2-propanol gave a colourless solution 
containing the disodium salt of SeDMPH 2 . (NaSeH was conveniently.  
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prepared by the action of sodium borohydride on selenium, in contrast to 
Baroni's use of H 2  Se). Acidification of this solution to pH 4-5 
resulted in the evolution of H 2Se . (from Se
'2- 
 impurities) which was 
removed by purging with nitrogen (under slight vacuum) until the effluent 
gas did not darken lead acetate paper (2 hours). Evaporation under 
nitrogen and ether extraction gave An orange oil which could be distilled 
under reduced pressure. The light orange distillate (bp. 79-85°/1.5 mm) 
solidifies at -20 0 , The Raman spectrum of this oil showed no band's in 
the region 2000-2700 cm
-1
. Free selenols have an intense polarised 
Raman band due to ■SeH at 2280-2300 cm-1 which is weak in infrared 
spectra. . Additionally, a weak absorption at 286 cm -1 in the Raman 
spectrum indicated that diselenide was only a minor component. Ali- 
phatic diselenides, RSeSeR, give an intense polarised Raman band at 
233-293 cm 654But65 -1 (R=MeP 3 Bun , 5) which is weak in infrared 
spectra. • No values of vSeSe have been reported for spectra of 1,2- 
diselenocycloalkenes. 
_Mass spectrometry .(Figure 5.54) indicated that the product is 
predominantly a compound with the formula.C 3H60Se (M4- * 137.9603, calc. 
137.9603) with a minor proportion Of 4 less volatile diselenide 
C3H6OSe2 (Figure 5 . .5b). 
The mixture could not be separated by fractional distillation under 
reduced pressure, or chromatographically on alumina, but could be 
partially separated by fractional distillation under high vacuum to give 
two selenium containing fractions, enriched in the first and second 
compounds respectively. 
Cyclic selenides have previously .been prepared as major products 
from non7vicinal dibromides .(Table 5.8). The proton nmr spectrum 
(Figure 5.6) of the mixture, is consistent with the major component 
being selenetan-3-ol, XXVI. The minor component is most likely 1,2- 
R=11 
CO 2H 
2 
- 
Se
2 
 
H 2Se 
Al2 03'  400 > 
selenanes  
R R" 
Br 
R=R 1 =R!'=H 660,664 
(and others) 
seleniranes  
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Ref 
/0\ 1. Ph P=S 3  
• 2. 
C
F
3
CO
2
H > 
RAI 
R = H, R' = Ph, octyl 
632 
selenetanes  
r 
 
' R=R'=H,Me 656-7 
  
H 2C=CH.CH 2Cy/ 
0 
HO rSe 
Cl HO2C CO2H  
electrolysis  
> R=H,R'=OH 
Cl' 
/402H 
H 2 
658 
591 
selenolanes  
tri\/\r-Br 
Co 
659-60 
661 
662 
• (CH 2=CHCH 2 ) 20 
2. tuC1 2/KSeCN/Me0H > CH OMe 
663 
R' 
H 2  Se • :• 
R=R1=R"=H 662. 
Al
2
0
3'
400 0> 
 
H 3CCH=0,H 2Se• Rei,R'=C0
2
tt ' R u =0: 
Et0H,-100' 24 
H 666 
Et0 .2C"\e^CO2Et 
0 
Al Se /Et0H LiA1H 2 3 4  R=Ph,W=H,R"=0 667 
H 3CCO2Na or Al(OPr1)3> R,R 1 various,R"=0H,H 668-9 
Table 5.8: Previously reported monoselenoalkanes. a 
a many of these compounds undergo addition reactions with halogens to 
produce 1,1'-dihalogeno- and ring-substituted products but these are not 
considered here. Similarly, many 1,1-dioxides are known. 
R" R" 
> 
R"=H 
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ref 
diselenolanes  
R' 
diselenanes  
X=SeCN,R=R'=H 614,656,670,672 
X=SeCN,R=Me,R'=Me 
X=Br,R=Me,R'=Ph 
X=Br,R=H,W=CO 2H 
H X=SeBz1,R=H,R'=CO, ) c 	672 X=C1,R=RI=CH 2OH 
R".=CO 2Et,X=SeCN,R=R 1 =H 	872 
R=H 	659,673-4 
R=C0 H 484,591 
Table 5.9: 	Previously reported 1,2-diselenocycloalkenes. 
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diselenolan-4-ol, XXVII. It is to be expected that these compounds 
would have very similar physical properties, which is consistent with 
difficulties experienced with their attempted separation. 
The selenetane seems to be unusual in that the four-membered ring 
is only mono-substituted, all others repotted to date being at least 
disubttituted. The carboxylic acid analog Of the 1,2-diselenolane 
has been prepared by Fredga-. 481.1 (Table 5.9) - . 
In the 70 eV mass spectrum of XXVI (Figure 5.5a), the molecular 
ion (m/e 138) is not the base peak, but is in fact the second most 
intense peak. This is indicative of fairly high thermal stability of 
the compound, since thermally labile organoselenium compounds rarely 
show an intense molecular ion. In addition, no peaks due to poly- 
. selenide fragments are observed, consistent with high thermal stability 75 
The mass spectrum-of selenetane has not been reported, but that of 
thietan-3-ol has recently been recorded 676and has the most intense 
peaks all containing sulfur at m/e 46 [CH 2S+ :], 61 [C 2H 5S+ '] and 90(M4- ..) 
.[C3H60S :]. Similar fragmentations are shown in the mass spectrum of 
XXVI at m/e 94 (bate peak) [CH 2Se+ ] 109 . [C2H and 13801+ 1 
[C3F1 605 4. ]: 
The mass spectrUm of less volatile XXVII (Figure 5.5h) shows the 
parent peak at M/e 58 (M-C 3H60) -/- * and the expected Se 2 fragments at m/e 
218(M *) and 160 [8e ]. Mass spectra of substituted 1,2-diselenolanes 
have not been previously reported for comparison. 
• After the completion of this work, the first reported preparation 
of selenetan-3-ol appearee68 The product was made in 50% yield by 
electrolysis of an electrolyte containing allyl chloride, epichlorohydrin 
and selenium metal. • The diselenolane XXVII has not previously been 
reported. 
100 
Figure 5.5a: 	Low resolution 70 eV mass spectrum of XXVI. 
94 
CH 2  Se+ 
I % 	. 
OH 
Se 
138 
M -CHO 
HOSe 
92 
43 
7 
90 136 
134 
1 100 
I 	I 
300 m/e 
28 
200 
J 
100 
Figure 5.5b: 	Low resolution 700 eV, mass spectrum of XXVII. 
I% 58 
OH 
28 
43 
Se 2
+ 
18 
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The proton nmr spectrum of XXVI in CDC1 3 is shown in Figure 5.6. 
Apart from a minor impurity at 1.336 (m, 0.4H), the spectrum can be 
interpreted in a first-order fashion as two triplets centred at 3.126 
(2H) and 3.376 (2H) respectively, corresponding to two sets of axial 
and equatorial protons, each of which is coupled to the proton geminal 
to the hydroxyl group, giving rise to a quintet (1H) centred at 4.856. 
Selenetane has a similar methylene proton multiplet at 3.20 77 The 
D20 exchangeable OH proton appears as a broad signal centred at 1.456 
(1H). Satellites due to 
2
J(
1
H-
77
Se) cannot be observed. 
The proton nmr spectrum of the sulfur analog, thietan-3-ol, has recently 
been interpreted 78 and is apparently consistent with the expected 
saddle-conformation of the four-membered ring having an equilibrium 
saddle angle of 140-150 0 . Details of the nmr spectrum of this compound 
are not available, as the original Russian paper is unavailable in 
Tasmania. 
The closely related compound 3-acetylthietane has been mentioned 
in an nmr study of thietene-1,1-dioxides 79 The axial and equatorial 
methylene protons are reported as a multiplet 333 Hz downfield from TMS 
in CC1 4 (5.556 on the 60 MHz instrument) which differs somewhat from 
the value of 4.356 found here for selenetan-3-ol. The positions of 
a-methylene proton resonances were not recorded in the abovementioned 
studyP9 
A complete description of the proton nmr spectrum of selenetan-3-ol 
involves treatment of an A2B2X spin system. The two pairs of axial and 
equatorial protons are magnetically non-equivalent due to long range 
spin coupling and the occurrence of conformational equilibria shown 
below: 
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Figure 5.7: High resolution (60 MHz) proton nmr spectrum of 
3-chlorothietane, taken from reference 679 . 
a) A2
B
2
(methylene), and b) X(methine) subspectra. 
Chemical shifts (6) were calculated from the frequencies (Hz) 
downfield from TMS, as shown. 
HO Ha 
HO 
	> HO 
Such a treatment has been carried out for 3-ch1orothietane 8° 
and sixty-four lines of the A2B 2X system identified (Figure 5.7). 
At lower resolution, such as that under which the spectra were 
recorded in this work, the A 2B 2 sub-spectrum can be considered as 
two asymmetric closely coupled triplets. The X sub-spectrum is a 
quintet. These features appear in the spectrum of selenetan-3-ol 
(Figure 5.6). 
Details of vibrational assignments of spectra of 3-substituted 
thietanes do not seem to have been published, although a small diagram 
of the infrared spectrum of thietan-3-ol is available 81 which is 
similar to that of XXVI. 	The vibrational spectra of thietan 82-ghd 
of selenetane 68 ave been assigned. The infrared spectrum of XXVI 
can be tentatively assigned by comparison with those of 1,3-disubstituted 
2-propanolsand selenetane 686and is shown in Table 5.10 below. 
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XXVI a selenetane 686 assignment 
3150-3550s,vbr H-bonded v0H 
2995m 3008 sym vCHa 
2960vs,sh 2967,2963 asym vCH(3 
2935m and 2900vs,sh 2939,2908 sym vCH(3 
2830w,sh 2850 
1700vw 
1625w 
1436s 1486 SCHa 
1410s 1457,144 (SCHp, 
•1320m 1291 CH (3 wag 
1270w 1228,1197 CHa wag 
1160s 1172 TCHI3 
•1120s 1133 TCHa 
1000vs 993 60H and TCHa 
976vw,sh 980 PCHa 
928m 939 in plane ring 
'breathing' 
891m 902 PCHa 
868m 833 pCK 
810w 792 vCC 
650w • 	 645 vCC 
570vw 570 asym vCSe 
402w 418 sym vCSe 
Table 5.10: 
	
Tentative infrared band assignment of selenetan-3-ol 
XXVI by comparison with the spectrum of selenetane 
(ref.686 neat liquid sample). 
aneat liquid sample. 
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Because 1,3-diseleno-2-propanol could not be isolated directly from 
the alkylation of NaSeH with 1,3-dibromo-2-propanol, Baroni's method of 
isolation, as an insoluble mercury(II) compleX 4,78 was attempted. 
Addition of methanolic Hg(CN) 2 to the ethanolic solution containing the 
disodium salt of SeDMPH 2 
(see page 262) produces a light-yellow powder, 
HgSeDMP, in quantitative yield (based on ,selenium used). X-ray powder 
diffraction showed this compound to be amorphous, similar to its sulfur 
analog 238 (Chapter 4), but unlike its sulfur analog, it is insoluble in 
pyridine. OH 
OH 
Hg(CN)2 r  > Se Se--Hg-Se S g- 
Me0H 
in 
OH 
Passage of hydrogen sulfide through a methanolic suspension of 
HgSeDMP produced no darkening due to the formation of mercuric sulfide. 
Addition of solid sodium sulfide to this H 25-saturated suspension 
•
1 
produced immediate darkening. During precipitation of HgS, small 
samples . of the supernatant solution were tested under nitrogen with 
aqueous ferric chloride. Selenols, like thiols, give deep blue colours 
with this test 98 No free selenol was detected. After stirring for 
12 hours, black HgS was removed by filtration through acid-washed sand, 
under nitrogen. The orange filtrate was evaporated under reduced 
• nitrogen pressure to give an orange oil, found to be mainly selenetan- - 
ol, XXVI, containing some 1,2-diselenolan-4-ol, XXVII. 
Although Baroni precipitated HgSe with hydrogen selenide it is 
likely that the product he obtained was seleneten-3-ol and not the 
desired vicinal diselenol. Baroni's 'yellow' oil has bp. 114°/20 MM479 
which would correspond to approximately 80 0/3.5 mm, close to the bp. of 
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XXVI (79-85°/3.5 mm) using the usual bp.-pressure nomograms. 687 
An alternative synthetic route to SeDMP was attempted. A small 
scale attempt to prepare 1,3-diselenocyanato-2-propanol by refluxing 
the dibromide with two equivalents of KSeCN in methanol, produced an 
orange oil after evaporation and ether extraction under nitrogen. High 
vacuum fractional distillation afforded two fractions. The first, 
minor, fraction (bp. 50-53°/0.01 mm) showed no infrared absorption in 
the region expected for vCEN of selenocyanates e.g. 2150 cm 
several a,i3-alkoxyselenocyanates;588 and was discarded. 
OH 
CH 2  -CH-CH I 	1 
NCSe SeCN . 
XXVIII 
The second major fraction (bp. 60-75°/0.01 mm) showed intense infrared 
absorption at 2135 cm
-1 
consistent with the presence of selenocyanate. 
In addition, the remainder of the infrared spectrum was very similar to 
that of 1,3-dibromopropanol. Extensive hydroxyl hydrogen bonding was 
indicated by a strong, broad absorption at 3100-3600 cm -1 . Mass 
spectrometry (Figure 5.8) indicated a parent ion containing one atom of 
both bromine and selenium in its parent ion m/e 243, consistent with the 
formula C4H 6BrN0Se(M
+ 
242
.
8814, calc. 242.8796). The expected 
patterns of isotopic peaks in fragments containing Br 2 , BrSe and 
Se 2 are shown in Figure 5.9. • The parent ion in Figure 5.8 clearly • 
contains the BrSe.fragment. The product is probably 1-bromo-3- 
selenocyanato-2-propanol, XXIX. 
300 m/e 
100 43 
29 
27 
57 
.111 	II 
121 
Figure 5.8: Low resolution 70 eV mass spectrum of 1-bromo-3-selenocyanato-2-propanol, XXIX. 
94 
80 
11111 	Ii I 
200 
243 C4 H 6  BrNOSe 
	LI 	
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Figure 5.9: Isotopic patterns for Br 2 , BrSe and Se 2 isotopic fragments. 
The presence of a minor component of diselenide was indicated by a very 
weak isotopic cluster at m/e 444, containing the Se2 fragment, in the 
chemical ionisation mass-spectrum. 
The structure, XXIX, was confirmed by the 1 H nmr spectrum in CDC1 3 
(Figure 5.10). The main features of the spectrum are: 
(i) broad hydroxyl proton resonance at 2.96(IH), which disappears 
with D20 exchange. This type of broad resonance is observed in nmr 
278 
Cr 
- 
czt — 
■-••• 
(=1 
1—• 
>.< 
4— 
0 
s- 
4-J 
(t) 
Pr
ot
o
n  
nm
r  
279 
spectra of 0MPH 2 , BALH 2 and other disubstituted propanols used in this 
work, but the position of resonance is quite variable. 
(ii)a multiplet centred at 4.236(1H), similar to the multiplet 
(quintet, 1H) appearing at 4.036 in the spectrum of 1,3-dibromo-2- 
propanol which is due to H c , geminal to the hydroxyl group. 
(iii)an asymmetric doublet 3.56,3.626(2H), identical to that in 
the spectrum of 1,3-dibromo-2-propanol, due to the protons geminal to 
the bromine, Hd,e , which appear to be magnetically equivalent. The 
coupling
cd 
J J ce is 6 Hz. 
-= 
(iv) three singlet resonances at 3.28, 3.35, 3.386(2H) which must 
be associated with protons H a,b geminal to the selenocyanate. This 
pattern can be rationalised by assigning the central (most intense) 
singlet resonance arbitrarily to H a , which requires J ap0. The outer 
pair of resonances form an asymmetric doublet which is similar to (iii) 
due to Hb , with bd=10 Hz. Satellites due to 
2
J( 1 H-
77
Se) could not be 
observed. 
Two points arise, namely, the lack ofcoupling of H a with Hd , yet 
Jbd=10 Hz and the lack of .geminal coupling between H a and Hb . 
The lack of coupling between Ha and Hd suggests that the dihedral 
angle between these protons Must be near to 90 0 , from consideration of 
the Karplus equation 50 A conformation of XXIX consistent with this 
requirement is Shown in the diagram below, which is a Newman projection 
of the molecule, viewed along the C(SeCN)-C(OH) bond. This conforma- 
tion also accounts for hydrogen bonding between the hydroxyl and one 
selenium Tone pair forming a five-membered ring. Evidence of extensive 
hydrogen bonding is found in the infrared spectrum (page 365) and is 
also consistent with J ad,
L6 Hz since the dihedral, angle between H a and 
Hd is approximately 30 0 P. 5. 0 Additionally, the geometry of the two 
seleniumLlone pairs is suited to donation Of electron density into 
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adjacent H a and H b a-bonds. Such hyperconjugative donation will make 
the geminal coupling constant, J ab'  more positive6.50 Since unperturbed -  
geminal coupling constants are usually negative 650 this accounts for 
J NO in this case. An identical situation, depicted below, is found ab 
650 
in 1,3-dioxolane producing 
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(ii) SeBALH 2 
The failure to obtain non-vicinal SeDMPH 2 did not encourage the 
preparation of vicinal SeBALH 2 by similar routes. Attempted alkylation 
of ethanolic NaSeH by 2,3-dibromo-l-propanol produced a deep red-brown 
solution from which allyl alcohol (detected by gc. retention time 
comparison with an authentic sample) could be extracted. 
- C--CH-CH OH + 2HSe>  H
2
C=CH-CH
2OH + 2Br- + H 2  S + Se 
1 1 
Br Br 
Nucleophilic substitution of vicinal dibromides with thiols has often 
been reported to cause elimination to form an olefin. 
Addition of ethanolic mercuric acetate to the red-brown solution 
precipitated a small quantity of pale-yellow powder, which was insoluble 
in hot pyridine and other common solvents. This complex was not 
identical to HgSeDMP as might have been expected if 2,3-dibromo-l-
propanol was contaminated with a small quantity of the non-vicinal 
isomer. 
- 
• 
Selenocyanation of 2,3-dibromo-l-propanol was not attempted in 
view of the' failure to obtain a diselenocyanate.of SeDMPH 2 . 
Addition of two equivalents of benzylselenol to propargyl alcohol 
dissolved in ethanolic sodium ethoxide solution produced a crystalline 
product after ak hours. This product (probably a 1:1 adduct similar 
to those found during additions to acetylenedicarboxylic acid) was not 
isolated but redissolved to give a red solution overnight. Extraction 
into petroleum ether removed dibenzyldiselenide to leave a red oil which 
decomposed to produce selenium on standing. The products were not 
examined - further in view of difficulties experienced with product. 
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separation from attempted SeDMSH 4 synthesis. Addition of excess 
thiolacetic acid to pent-3-yn-l-ol is reported to produce only a mono-
adduct, 554 due to an inactivating effect of the hydroxyl group e.g. 
hex-l-yne produces both mono- and di- adducts under these conditions 89 
No attempt was made to alkylate sodium benzylselenolate with 2,3- 
dibromo-l-propanol because the analogous thiolate reaction produces the 
rearranged product 1,3-bis(benzylthio)-2-propanol, exclusively
604-5 
(page 244). 
5.4 Conclusions  
Possible methods for the preparation of Se-protected diselenols 
have been reviewed, and several routes to synthesis of protected 
selenium analogs of DMSH 4 and BALH 2 and its isomer DMPH 2 have been 
investigated.. The protected SeDMSH 4 compound, 2,3 7bis(benzylseleno) 
succinic acid could not be obtained in this study. 
Addition of two equivalents of benzylselenolate to acetylene-
dicarboxyliC acid gives only the new 1:1 addition product XXIIIb, in 
contrast to the addition of benzylthiolate where 4 2:1 adduct can be 
Obtained. Similarly, the new saturated analog of XXIIIb, XXIVb was 
obtained by addition of benzylselenolate to maleic acid. Benzylthiolate 
reacts identically. 
Perturbations of the n-*Tr* electronic transition of an a,87unsaturated 
carbonyl chromophote by the benzylselenolate group produces a large batho-
chromic shift which causes XXIVb to appear bright yellow. The analogous 
thioether As pale yellow, consistent with the similar but smaller effect 
of the benzylthiolate group. 
Second-order analysis of the ABX 1 H nmr spectra of XXIVb and its 
sulfur analog showsa preference for a conformation in which one carboxyl , 
group is gauche to the chalcogen. 
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Attempted preparation of SOMPH 2 from 1,3-dibromo-2-propanol leads 
to the cyclic product selenetan-3-ol, only recently reported in the 
literature. The 100 MHz proton nmr spectrum can be interpreted as an incomplere.:iy 
- resolved five spin A2B2X coupled system. Reaction of 1,3-dibromo-2- , 
propanol with two equivalents of KSeCN, resulted in the addition of 
only one selenocyanate group. The new product 1-bromo-3-selenocyanato- 
1 
2-propanol has been characterised by H nmr, ms and ir spectroscopy and 
shows considerable hydrogen bonding between the hydroxyl and seleno-
cyanate groups. 
Attempted preparations of SeBALH 2 by alkylation of NaSeH with 
2,3-dibromo-1-propanol, lead to the expected formation of allyl alcohol 
by elimination of bromide. No characterisable products other than Se 
and dibenzyldiselenide could be isolated from reaction of benzyl-
selenolate with propargyl alcohol. 
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CHAPTER SIX  
POTENTIOMETRIC DETERMINATION OF AQUEOUS FORMATION  
CONSTANTS OF VERY STABLE COMPLEXES  
6.1 Introduction 
The aqueous formation constants of MeHg(II)-thiolate complexes 
had not been extensively studied Until this work, and the work of 
Reid and Rabenstein 302 (Chapter 3). Apparent discrepancies in 
previously reported values for the formation constants of MeHg(II) 
monothiolates, and the need to evaluate the stability of MeHg(II) 
complexes with antidotal vicinal.dithiols led to the determination of 
the constants which have been discussed in Chapter 3. 
In order to compare the formation constants for MeHg(II) with a 
range of monothiols and vicinal dithiols (containing sulfhydryl groups 
with acid dissociation constants in the range 9.0< pK a < 11.5),. a 
method which is able to determine these constants with some precision 
is required. The methods currently available for this requitement 
are based on potentiometric, spectrophotometric and nuclear magnetic 
resonance techniques. ,(Other methods . , e.g. polarography,-solvent 
extraction, ion exchange, etc. are generally less precise and of more 
limited applicability 690). All of these methods depend on the ability 
• to monitor the concentration(s) of one or more equilibrium components 
as the equilibrium position is altered. Each of these techniques has 
been reviewed and extensively used to study solution equilibria 90-1 
The most widely used and the most precise is the potentiometric 
method, which was considered to be best suited to investigation of 
equilibria between MeHg(II) and thiolate ligands in this study. • The 
spectrophotometric method,although it offers a unique advantage of 
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sometimes determining the number of significant equilibrium species, 
was unsuitable because the thiolate ligands and methylmercury(II) ion 
do not have chromophores which are sensitive to equilibrium conditions, 
e.g. pH, and which are readily accessivle in the near UV/visible spectral 
	
, 360 199. g H 337 and 309,360,369) regions. NMR Methods (e.g. 11  L 
have been used extensively to study MeHg(II) and offer the advantage of 
being able to determine the concentrations of species involved in 
microscopic equilibria, e.g. the protonation or complexation of sulfhydryl 
and amino groups of biologically important mercaptoamines can be monitored 
individually. (The technique has been discussed in some detail in 
Chapter 3 of this thesis). 
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6.2 Evaluation of ligand hydrolysis equilibria  
6.2.1 Definition of 'Equilibrium Constants' used in this work  
The term equilibrium constant', used in this work, warrants some 
clarification. 
Consider a simple monoprotic BrOnsted acid dissociation in aqueous 
solution, the equilibrium for which can be written 
HL (ao + nH 20 ;,====e(ao + 
(aq) 
Although all species, HL (a0, L - (ao , (ao, are probably extensively 
solvated, few methods of investigation can distinguish between degrees 
of hydration ., and solvent molecules will not be included in subsequent 
equilibria although it should not be forgotten that they may be involved , 
in primary coordination. In particular, the methylMercury(II) cation 
will be represented by MeHe for brevity, instead of MeHg(OH 2 ) 47 , and 
the proton will be considered:As H i'. In addition, the concentration 
or activity Of water is considered to be constant, at least for dilute . 
solutions. The thermodynamic acid dissociation constant for the above 
equilibrium, which can be related directly to free energy changes, is 
written as Ke . 
{HL} 
where the parentheses 0 indicate activities of the relevant species. 
To determine Ke-, the activities, or at least the activity coefficients, 
y (which relate activity to concentration, e.g. {L - } = y L4L- ] ), of all•
species must be determined. Although yH+ has been extensively studied, 
e.g. for the determination of pH standards, this has only been achieved 
for a limited range of electrolyte conditions. Estimates of mean 
activity coefficients, y±, for electrolyte species other than protons 
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are usually made using empirical relationships between y± and solution 
ionic strength. Table 6.1 shows that these relationships may give 
widely different values for mean molar activity coefficients, especially 
for electrolytes which are not of the 1:1 type, even at the moderate 
ionic strength (0.1M) used in many equilibrium constant studies. 692 
For highly charged ions, e.g. the anion DMS 4 , such calculations of 
activity coefficients are highly tenuous. It is more usual to ignore 
activities of species other than protons by defining 'mixed' or 
operational equilibrium constants. 
{H 4-}[L] 
[HL] 
Proton activities are determined directly from the relationship pH 
-logTH
+
1 after calibration of a glass indicator electrode in solutions 
of known proton activity. The concentrations of other species can be 
determined directly, e.g. spectrophotometrically using the Beer-Lambert-
Bouger relationship between absorbance and concentration, or with other 
potentiometric electrodes calibrated in terms of concentration (very 
rarely available), but are more usually calculated. The mathematical 
evaluation of species concentrations assumes the validity of the 
equilibrium expression, electroneutrality, and mass-balance equations, 
and in this case requires two independent measurements of pH from 
different equilibrium solutions. The abovementioned equations can be 
solved for [L -] and [HL]. It is usual to over-determine these equations, 
i.e. obtain many more experimental observations than there are unknowns, 
and use least-squares or other multiparametric curve- fitting. 
procedures to obtain [1.-] and [HL] (page 306). It should be noted that 
[H ] is required in the mass-balance and electroneutrality expressions, 
still necessitating an empirical estimate for yH+. It has been 
Model 2 3 4 6 8 9 12 16 
Debye-HUckel 0.6890 0.4747 0.3271 0.2254 0.1070 0.0508 0.0350 0.0114 0.0026 
Guntelberg 0.7535 0.5678 0.4278 0.3224 0.1830 0.1039 0.0783 0.0335 0.0108 
Davies 0.7715 0.5952 0.4592 0.3542 0.2108 0.1255 0.0968 0.0444 0.0157 
Scatchard 0.7767 0.6033 0.4686 0.3460 0.2196 0.1325 0.1029 0.0482 0.0176 
Bjerrum 0.7623 0.6526 0.5900 0.5498 0.5012 0.4731 0.4630 0.4418 0.4249 
Comments 
log y± 
may be extended to take into 
account ionic 'size' 
logy± = -z+z_ Air/(1+Bain 
log y± = - z+ z_ AM/(1+)7) 
may be extended by consider-
ing a constant ionic size of 
3A°. 
log y± = -z+z_A47(1+3B4) 
log y± = -z+z_A47(1+1/7) 
+0.2Az+z_I 
log y± = -z+z_Ail/(1+1.54) 
may be extended by consider-
ing a temperature dependent 
demoninator 
log y± = -z+z_AIIT/(1+4.5Bin 
log y± = -z+z_Air/(1+Ba B 
takes into account ion pairing 
if ion diameter is less than 
aB . 
Table 6.1: 	Theoretical mean activity coefficients at 25°C and 0.1M Ionic Strength 692 
2TrN 	e 	1
- 0.5116 dm Y2  mol - 	at 25° 
1000 	1n10.K2 	7 2 
1/2 
8TrN 1 	e 	1 	0.3292 x 10-8 m
3 
cm mo -1/2 at 25° 
11000j 	k ir2 T 1/2d12 	* 
z z e 2 ea - 	
+ - 	= 3.58 x 10 -8 cm at 25° 
2 e kT 
Table 6.1: 	Theoretical mean activity coefficients at 25°C and 0.1M Ionic Strength. 692 
(cont.) 
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indicated by Bates, 93 that Km has the disadvantage that it reflects 
small changes in ionic environment via ail but neglects interionic 
effect on ions other than H
+
. 
The third form of equilibrium constant is used in this work and 
101  
tabulated extensively elsewhere: --,694 
 
ine concentration or stoichiometric 
constant, KC , is defined as 
[e][L- ] 
[HL] 
In this case, it is necessary toevaluate hydrogen ion concentration, 
[el instead of activity, e.g. using a glass-electrode calibrated in 
terms of proton concentration by the methods described in Section 6. 
The concentrations of ligand species can be measured as for Km (rarely) 
or calculated by least-squares procedures. Stoichiometric constants 
are used throughout this work unless otherwise stated, and can be 
written for more complex metal-ligand-proton equilibria in an identical 
fashion to those above. 
For example, the formation equilibrium of the complex 
, (MeHg)m I i (SR)sHilwould be written in terms of components MeHg , n- 
and e: 
mMeHg+ + i1 + 811Sn- + i (SR) s Hh 
with an overall stoichiometric equilibrium constant, 
[(MeHgm) I i (SR) sHill 
[MeHg+] n [I
- i i [Rsn-
]8
[H+p 
It has been found that mixed iodide-thiolate species are not formed in 
this study (page g7 ), and so the iodide subscript has been omitted from 
the MeHg(II)-thiolate constants recorded in Chapter 3. (However, for 
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data input,to the computer program MINIQUAD 81 all component subscripts 
are required). 
In addition, hydroxo complexes will be described with h < 0, e g. 
(MeHg) 20H+ will have 
[(MeHg) 2 )H 4 ] 
207 1 [meHg+ ] 2 [H+ ]-2 
It should therefore be emphasised that O's of complexes involving 
hydroxide, are not formal formation constants, but can be related to 
these by the autoprotolysis constant of water, K, since, for example: 
8(actual formation) 
(MeHg) 20e) 
20-1 (‹)-1 
I I 
This practice is widely used in the stability constant literature, and 
is used here for consistency. Equilibrium constants, such as B 
can be evaluated from pH titration data in acid solution, without 
- recourse to experimental values of Kw whereas the corresponding •actual 
formation constant requires accurate values for Kvci in order to evaluate 
[OH], contributing additional uncertainty. 
6.2.2 Calibration of glass-electrodes as [e] probes  
When a glass-electrode assembly is calibrated using a primary 
standard buffer, pH(s), and then transferred to a measurement solution, 
the pH reading corresponding to H is related to [H] s of the buffer 
by the defined relationship 695 
(6.1) (E -E') + (E.' - 
-log
[
H
+
] 1 = pHs 	s j 
2.303 RT/F 
js 	log yHi., 
The measured pH can be related to [H] only if (i) liquid junction 
potentials for the buffer, E js , and test solution, Ej ', are either 
negligible or identical, and (i ) the activity coefficient y H+' can 
joH ‹I [H+] 
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be accurately calculated or measured in both solutions. Since the 
test solution and primary buffers are of totally different ionic 
composition, e.g. the NBS standard buffers commonly used for calibra-
tion, 0.05m potassium hydrogen phthalate and 0.01m sodium tetraborate, 
have ionic strengths 0.053M and 0.02M respectively, it is most unlikely 
that either condition can be fulfilled. 
It is therefore necessary to calibrate the glass-electrode assembly 
as a H -concentration probe, in the ionic medium to be used as measure-
ment solution.696 This is done by noting that the emf of the electrode 
varies linearly with log[H ]in acidic solutions as follows: 
(6.2A) 
E= 
meter 
where the term E° includes the standard potentials of reference and 
glass half-cells, the asymmetry potential of the glass electrode, and 
activity coefficient terms which are assumed to remain constant during 
an experimental titration. The term j H [H ]accounts for the fact that 
the liquid junction potential varies with [H ] at low pH (i.e. the 
glass-electrode becomes 'non-linear' at low pH). 
A similar expression can be written to calibrate the glass-electrode 
in alkaline conditions. 
(6.2B) 
meter 
= E°OH  ' + RTF- 
where E° H  accounts for the glass-electrode asymmetry potential (which O 
is observed to differ in acid and alkaline solutions by up to 2 mV) 
and j oli accounts for non-linearity at high pH (assuming the electrode 
has negligible 'sodium error' which is true for modern high resistance 
glass-electrodes). 
Since the emf of the electrode assembly can usually be determined 
with a precision of 0.1 mV using commercially available pH-meters, the 
+ (RTF-1 in 10)log[H ] + 
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pH range with which j H and joH are negligible (i.e. the electrode 
response is linear) can be calculated. In titrations of the highest 
precision, additional small corrections to the liquid junction potential 
of the form 4L- ' EL2- [HL- 3 li L2- have been used.697 Typical values 
for jH are shown in Table 6.2. Less information is available for j oH , 
but it is generally considered to be smaller in magnitude than jH , and 
of opposite sign. 
x/M1 (j /[H / ]/mV pH at which j = 0.1 mV ref. 
3.0 16.5 2.2 698 
1.0 63 2.8 698 
0.1 440 3.6 699 
Table 6.2: Acid region non-linear corrections, j H for cells of 
the type Nal' (x-h M), H+ (h,M), C104- (xM) 1 NaC104 (xM) 
It can be seen from this table that even in the least linear case (0.1M 
NaC104 ), the glass-electrode behaves linearly (within 0.1 mV or 
0.002 pH) as a concentration probe above pH 3.6 and since the effect 
is smaller in alkaline solution, below pH 10.4. From preliminary 
titrations of 0.1M KNO
3 
 (or 0.1M KOH) with 0.1M HNO
3 
 in this study, it 
has been found that the value of jjH ]is approximately 200 mV, giving 
electrode linearity in the range 3.3< pH < 10.7. 
At the concentrations of metal and ligand solutions used in this 
work, it has rarely been necessary to use pH values below 3.0, and so 
non-linearity corrections are not needed. However, several ligands 
of interest, especially vicinal dithiols, have thiol acid dissociation 
constants pKA > 10, necessitating titration to pH 11 . , where some non-
linearity correction is necessary. This will be treated in Section 6. 
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The calibration parameters E°A, j H and E°H 
 OH1" i Kw c are usually U' -  
obtained from preliminary titrations of either standardised strong 
acid with strong base, or ionic medium with acid or base, and fitting 
the emf versus [e] data manually or by non-linear least-squares 
procedures. 7°° The non-linearity terms 
•only on ionic medium, whereas E0, ' EoOH l vary somewhat day-to-day. 
H  
Trends in these latter values may be used to monitor the condition of 
the glass-electrode assembly. In addition, it should be noted that 
values of K  the ionic medium of interest can be evaluated since 
2.303RTF-1 = pK. In this work, pKtpci has been determined at 25 ° 
(0.1 KNO3) to be 13.74 ± 0.02 from eight such titrations, using a 
variety of glass and reference electrode systems. 
Measurements of K: and the quotient of activity coefficients and 
water activity, yH Y OH  RH 2  Oh can be used to calculate values of the 
concentration ionic product of water, K. Such values have been 
tabulated by Sweeton, Mesmer and Baes 701  (Kis Qw in their terminology) 
using the activity quotient obtained from Harned and Owen in alkali 
metal halide solutions.702 The quotient does not seem to have been 
reported for KNO3 solutions. 
KNO3 solutions, at 25°, pKw 
density Of water 997.048 kg 
Assuming identical behaviour in MC1 and 
= 13.781 ± 0.006 ,) 7a0n1d the 
-3 
m at this temperature7,qm the molar scale 
used in this work 
PK  = 13.784 ± 0.006 
which is in good agreement with the value found in this study. 
An alternative procedure which avoids preliminary titrations, 
considers the terms E°'' E° OH ' j H  and j OH  as parameters to be refined 
•
H'
simultaneously with the equilibrium constants, etc., in the ligand 
hydrolysis constant determination. The extra parameters of course 
joH Kw seem to be dependent 
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necessitate the accumulation of additional titration data, but this 
approach has been used successfully for high precision potentiometric 
evaluation of acid dissociation constants of multiprotic acids and 
bases 704-6  The implementation of this method by the program TITRAT 
derived for such purposes in this work will be described in Section 
6.2.5 
The TITRAT program assumes a glass-electrode-reference electrode 
response Of the type 695 '707-9 
(6.3) 
- log[H
+
] = oHmeter correction 
If activity coefficients are considered to be invariant, as in this 
work in 0.1 M KNO3 ionic background, this can be written 
(6.4) 
- log[e] = pH meter 
PHcal 
where PHcal  incorporates terms for standard electrode potentials of 
glass and reference half-cells, glass-electrode asymmetry potential 
and proton activity. It can be seen to be analogous to the expression 
used previously (equation 6.1 ) for calibration in terms of [H f] using 
electrode emf readings 
(6.5) 
meter 
RTF- 1n10 
+ 
RTF 1n10 
The first term is exactly pH meter • The correction term in this case 
accounts for non-linearity of the electrode system in acid solution 
(page 292), which normally can be neglected in the range 3 < pH.< 10. 
It is of interest that this.relationship is identical to that used by 
VanUitert and Haas 710and Agrawal 711 to calibrate glass-electrodes in 
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mixed-solvents, so that TITRAT can be used under these conditions. It 
should be noted that neglect of non-linearity is not essential, and an 
[H i] dependent term could be included on the right hand side of equation 
6. and the coefficient treated as a titration parameter, accessible 
from low pH titration data. 
The term pH cal  simply calibrates a pHmeter in terms of hydrogen ion 
concentration, and can be refined from titration data at pH < 4 using 
TITRAT. In this work, the pH meter was standardised daily (at least) 
with three NBS primary buffers t in order to monitor the linearity of 
the electrode, and to make values of pH cal comparable on a day-to-day 
basis, although this is not strictly necessary. Values for pH cal 
evaluated by TITRAT from many titrations fall within the range 4.04 to 
-0.08 pH units. This is in excellent agreement with similar ValUeS 695 f 70779 
found elsewhere using electrodes standardised in a similar manner, and 
the uncertainty in pH cal , ±0.02 units, is Of the tame Order as the 
uncertainty in NBS buffers. 
Hydroxide concentration is calculated in TITRAT by defining K = 
[H
+
][0H - ]. Values of in the titration medium can be evaluated from 
E° 1 and E 01 H  terms as described previously (page 294), but it is H O 
convenient to treat K c as a titration parameter accessible from titration 
data at high pH. 
It has been found in this work that titration regions above pH 10 
cannot be fitted satisfactorily with TITRAT using the value p< = 13.74(2) 
found by prior experiment (page 294). This is due to non-linearity of 
the glass-electrode system described by jOH </[H+] term (page 293) above 
pH 10.7, which has not been taken into account in the pH calibration 
t0.025 equimolal phosphate pH(s) 6.865, 0.01m phthalate, pH(s) 4.008 
and 0.01m carbonate/bicarbonate, pH(s) 10.012, page 305. 
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equation 6. . It has been found however, that refinement of 1( 11 
satisfactorily fits titration data in this region, with refined values 
of p< lying in the range 13.82 < pK < 13.90 for many titrations. 
Refinement of Kw is tantamount to inclusion of an alkaline 
non-linearity coefficient similar to j oH . Since the absolute value of 
pK is not of intrinsic value for this work, this calibration procedure 
was considered to be totally satisfactory, and has been used to deter-
mine values of pKa > 10 for thiols, in good agreement with previously 
• reported values (Section 3.3.2). It should be noted however, that the 
value for j oH could be treated as a TITRAT parameter (similar to j H 
mentioned previously) if the value of pic i has been determined independ- 
ently. (Attempted simultaneous evaluation of jand ‹, as parameters 
OH 
would be unwise since these variables are perfectly correlated 
6.2.3 Titration assembly  
The titration cell used in this work is based on the water-jacketed 
cell described by Perrin7 12 in which the glass and reference electrodes 
are thermostatted for their entire lengths to avoid thermal gradients 
which cause pH drifts. The double-walled vessel, shown in Figure 6.1, 
was maintained at a constant temperature of 25.00±0.02° by circulation 
of water through the jacket from a large water bath, which also contained 
buffer solutions and volumetric glassware kept at this temperature. 
(The water bath Beckman thermometer was calibrated against a second 
thermometer which in turn had been calibrated to within ±0.005° using 
a Pt-resistance thermometer). The cell could be hermetically sealed 
by a Teflon stopper holding the glass and reference electrodes, thermo-
meter, nitrogen-inlet and outlet tubes, two titrant delivery tubes, 
and which had provision for an additional two electrodes. The vessel 
was mounted atop a magnetic stirrer and thermally insulated from it by 
a 
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b d 
Figure 6.1: Magnetically stirred double-wall titration cell with 
capacity 30-100 mL. 
a circulating water for temperature control (±0.02'), 1 nitrogen 
inlet capillary and c outlet tube, titrant delivery capillary, 
e Philips GAT130 (or GA110) glass electrode, f Philips R44 
glass-sleeve double-junction calomel reference electrode, g poly- 
ethylene tubing connecting the inner half cell of h (saturated KC1) 
to outside the cell, h filling hole for the outer half-cell of f (1M 
KNO3 ) ' i tight fitting Teflon stopper which contains capped holes 
for additional electrodes and j thermometer (0.010). 
299 
a ceramic tile and the water jacket of the cell. High purity nitrogen 
qD which had been passed througha column containing Carbasorb (to 
0 
remove CO2 ) and 4 A molecular sieves, was presaturated by bubbling 
through 200 cm3  of 0.1M KNO 3 held in the circulating water bath, before 
passage through the cell. A drawn-out piece Of glass tubing (0.5 mm 
i.d.) was found to be more suitable than a glass frit for this purpose 
because the latter, although more dispersive, invariably caused a 
coating of fine bubbles on the glass-electrode bulb causing pH 
instability. 
Preliminary work was done using combination,glass-Ag/AgCl 
electrodes, primarily as. a space-saving device, however, these were 
found to be unsatisfactory in solutions containing both methylmercuric 
ion and some dithiols (particularly DMSH4 ). Erratic behaviour, 
characterised by large drifts (>1 pH unit) from Calibration during a 
titration lasting several, hours, could not be ascribed Solely to 
MeHgC1 formation at the glass-sinter liquid junction, since methyl-
mercuric solutions alone (up to 0.01M) behaved satisfactorily under 
similar titration conditions (e.g. for evaluation of MeHg(II) hydrolysis 
constants). Some evidence for chloride complexation was found in more 
dilute solutions due to leakage of the saturated Kci filling Solution. 
The reason for erratic behaviour in the presence of DMSH 4 is not 
completely understood. It was considered that perhaps H 2S, known to 
be formed as a ,decomposition product of DMSH4 in alkaline solutions, 
might be responsible by diffusion through the reference half-tell filling' 
hole, thereby altering the Ag/AgC1 reference potential. Venting this 
filling hole outside the cell by insertiOn'Of tightly fitting Teflon 
tubing was not successful in eliminating the effect, however it was 
considered that this precaution was advantageous in protecting the long 
term stability of the reference half-cell, particularly in titrations 
/ (ci II -ci I )Pi iz i 
RI i ' 
X ( 
IPI -IPII 	= F -c. : 
1,I
)p 
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involving volatile thiols, and was maintained throughout all subsequent 
titrations (including the eventual use of separate calomel reference 
electrodes),. The use of separate glass (or Ag/AgC1) reference elec-
trodes.eliminated hysteresis problems, which may have been due to the 
close proximity of the combination electrode glass-bulb and liquid 
Junction frit. A double junction (glass-sleeve) calomel reference 
electrode with saturated KC1 in the inner cell, and 1M KNO 3 in the 
outer junction, was finally used to prevent chloride diffusion into 
the.titration solution. 
An important consideration when using potentiometric methods is 
the stability of liquid junction potentials in the electrode chain. 
Potentiometric cells of highest stabilityllust incorporate no liquid 
. junction, e.g. use of Ag/AgCl: reference electrodes, or incorporate a 
liquid junction whose magnitude is .small (for high precision) and 
remains constant. . 
The magnitude of the diffusion potential due to the double liquid 
junction for the Cell,. C below. 
.1 	 II 	 III 
Hg,Hg2 C1 2 ,KC1(sat.4.2M)IIKNO3(1M)iltest-solution,KNO3(0.1M),e(hM)1Ag/AgC1 
glass 
can be evaluated from potentials tp .1 -ti 11 and.tp 11 - using Henderson's - 
solution to the Nernst-Planck equation7D if mobilities, p i , of the 
species with charge z 1 and cOncentration c 1 	c i,II' in the two 
solutions, are known. For example, the diffusion potential of the 
liquid junction qq- is given approximately by 
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The mobilities of background electrolyte species K
+
, NO3- and highly 
mobile H+ , OH will dominate in this expression. 
Ionic mobilities can be derived from transport numbers and used 
to calculate estimates of liquid junction potentialsip 1 -p 11 and 
for varying test-solution pH. These are given in Table 6.3. 
pH 114111 /m 	1 4 111 /mV 
1.5 2.50 
2 2.50 
3 2.50 
4 2.50 
5 2.50 
6 2.50 
7.88 
1.57 
-1.58 
-1.92 
-1.96 
-1.96 
10.38 
4.07 
0,92 
0.58 
0.54 
0.54 
Table 6.3: Estimated liquid junction potentials at various pH 
values for cell C employing a double-junction calomel 
reference electrode. 
aCalculated using 7o2pur 1.0383p_+ U 
' . NO3- = 
0•971611 K+, independent of pH. 
b
Calculated using 79tH+ = 4.882pNO3 	
4 p + = 1.029 - . K NO3 
It can clearly be seen that high proton mobility contributes dominantly 
to high liquid junction potentials at pH values below 3-4. A similar 
effect can be shown to be due to high hydroxide mobility, above pH 
10-11. Together with high . and moderate resistance glass-electrodes 
(Philips GA110 (200-3000 and GAT130 (15-4014)) the double-junction 
reference electrode reliably provided rapid pH response, and good pH 
stability (e.g. pH(s) 6.865 NBS buffer is stable to within 0.005 units 
over periods of 48 hours) The major cause of pH drift seemed' to be 
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loss of 1M KNO3 junction solution from the glass-sleeve double-junction 
reference electrode (capacity % 3mL). 
The stability of the double-junction electrode assembly is 
presumably due to the constancy of the glass-sleeve junction 714 and 
low liquid junction potential, and is quite adequate for potentiometric 
work of this nature. The use of unwieldy Wilhelm salt-bridges and 
massive calomel electrodes can only be justified when high precision 
emf measurements (e.g. 0.01 m1/3 15are required over long titration 
periods. No differences in stability could be unambiguously attributed 
to the use of moderate resistance (15-400 instead of high resistance 
(200-3000 glass electrodes. 
Titrant solutions  
Titrations were performed with potassium hydroxide solutions 
prepared from commercially available ampoules (Merck Titrisol and 
diluted to nominally 0.1M using freshly deionised water. These 
solutions were stored in one litre KOH-leached amber borosilicate 
glass vessels connected directly to the automatic dispensing valve 
of a Dosimat Model E535 autoburette and protected from atmospheric 
CO2 with Carbasorb . A second titrant solution of 0.1M HNO 3 
prepared from AR (conc.) HNO 3 was prepared and stored similarly, but 
without CO 2 protection. Preliminary work using KOH solutions prepared 
by the tedious ion exchange method of Albert and Serjeant 716 showed 
that solutions prepared from commercial ampoules were of identical 
quality. The presence of weakly acidic impurities (mainly carbonate) 
was periodically monitored when the solutions were standardised against 
potassium hydrogen phthalate (dried 120 0 , nominally 100.0±0.2%). 
Titration procedure  
Prior to each titration, the asymmetry-potential control of the 
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pH-meter was set using the NBS pH 6.865 phosphate buffer previously 
maintained at 25.00 0 . (The iso-potential point of the meter was pre- 
set to 6.865). When the pH of this buffer was constant for at least 
15 minutes the 'slope' of the electrode assembly was set by standardisa-
tion in the pH 4.00 phthalate buffer. Finally, as an additional check 
on buffer conditions and electrode linearity, the pH 10.012 carbonate 
buffer was tested. The measured pH of this buffer was always within 
the range 10.002-10.012. (The three buffers described above are not 
perfectly internally consistent, in particular, the carbonate buffer 
is reported to give an operational pH of 10.002 69 . 
The electrode assembly was finally rinsed several times with 
deionised water (kept at 25.00° to reduce thermal shock) and blotted 
dry with clean tissue (not wiped, to avoid static electricity transfer 
to the high resistance bulb which takes some time to dissipate 717 ). 
The titration vessel was quickly dried with clean tissue, the appropriate 
mass of twice recrystallised KNO 3 added together with magnetic stirrer 
bar, the titration solution added using calibrated glassware, and 
electrodesreplaced. Nitrogen purging and magnetic stirring were 
maintained for at least 15 minutes for the electrodes to reattain thermal 
equilibrium and for removal of dissolved oxygen. 
The delivery capillary of the automatic burette was inserted to 
well below the surface of the titration solution. The tip of the glass 
capillary (0.1 mm i.d.) was not inverted to minimise titration diffusion, 
as reported elsewhere. 718 The hydrostatic head of titrant (from 
titrant reservoir to delivery tip) was 5-10 cm, and titrant diffusion 
Was estimated to be less than 0.001 mL/10 minutes by monitoring the pH 
at the unbuffered endpoint of a strong acid/strong base titration. 
This diffusion rate produces no detectable change of pH in moderately 
buffered titration regions. 
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Small volumes of titrant were added using the automatic burette 
in the 0.01 mL 'step' mode while the solution was stirred magnetically 
and with nitrogen. Stirring was then stopped and nitrogen passed 
over the solution surface until the pH showed less than 0.001 units 
change per minute. Maintenance of pH equilibrium was at first monitored 
with the output of the pH meter connected to a chart recorder (10 mV full 
scale) and subsequently with the device described in Appendix 6.1. 
Some confusion appears in the literature over the decision to 
record equilibrium pH values in stirred or unstirred solutions, even in 
work covering high precision pH measurements. In cells containing 
liquid junctions the liquid junction potential can show significant 
stirring effects. 717 In order to maintain a constant liquid junction 
potential throughout a long titration, it is necessary in these cases 
to ensure a constant stirring speed. In this work, it was felt that 
a 'zero' stirring speed could be maintained most precisely, even though 
attainment of equilibrium may be slightly slower in this case. 
Titration data in this region invariably required inordinately 
long equilibrium times (>30 minutes) even when the titrant delivery 
capillary was removed (to eliminate titrant diffusion) and the vessel 
maintained under a static nitrogen atmosphere. In addition, it is to 
be expected that the pH of this region is determined by the presence 
of minor amounts of weakly acidic and basic impurities, e.g. dissolved 
• CO2' bo ron and aluminium-containing anions leached from the glass 
vessel etc. Ciavatta has shown that very small amounts (<1 mole) 
of these products are inevitably present, even under the most rigorous 
titration conditions?-9 We have found in this work, by refinement of 
the total proton concentration, H tot , in these titrations, that H tot is 
always 1-4 pmole greater than expected from analytical 14 + concentrations. 
This behaviour is reflected by 0.001-0.004 mL equivalent point systematic 
305 
errors, consistent with the above impurities (page 302). For these 
reasons data in this region, unless buffered by the system under 
investigation (rarely), have not been included for refinement of 
equilibrium constants. 
pH(t) buffers  
The choice of pH(s) values for standard buffers varies on a nation-
wide basis, according to national definitions of the pH scale. Composi- 
tions of buffer solutions are not universal g. potassium 
hydrogen phthalate studies are prepared as 0.05 molal (10.12 g per 1000 
mL solution at 25°) with pH(s) at 25° 4.004 (U.S.A.), 4.01 (Hungary), 
4.01 (Poland), 4.008 (U.S.S.R.), or 0.05 molar (10.21 g/1000 ml at 25°) 
with ph(s) at 25° 4.008 (Germany), 4.01 (Japan), 4.005 (U.K., defines 
pH scale) . 
Although variations between scales are small, they are not immeasur-
able in the pH-meters capable of 0.001 pH resolution. The recently 
recommended IUPAC values for standard pH buffers at 25°C have been used 
in this. work. They are pH(s) 4.008 for 0.05 molal potassium hydrogen 
phthalate - (10.12 g/1000 mL at 25°), ph(s) 6.865 for 0.025 equimolal 
potassium dihydrogen,orthophosphate (3.39g) and disodium hydrogen ortho-
phosphate (3.53g/1000 mL at 25°). 
To extend the calibrated pH range of the glass electrode to high 
pH, the NBS 0.01 equimolal sodium carbonate (2.640g Na 2CO3 and 2.092g 
NaCO3/1000M1 at 25° ) was used. The highest pH buffer recommended by 
IUPAC ie. 0.01 molal sodium tetraborate decahydrate, pH(S)=9.180 7. 21 
Preliminary work with Na 2B407 .10H 20 as an acidimetric standard indicated 
that our product was partially dehydrated. Although the dilution effect 
of this buffer is sma11, 693it was found to be more convenient to use the 
carbonate-bicarbonate buffer for which high purity reagents were available. 
306 
6:24 Available computer programs for evaluation of ligand-hydrolysis  
equilibria  
Acid dissociation constants for mono- or diprotic ligands of known 
purity can be obtained from potentiometric data by manual calculation, 
e.g. using well-established methods, even under circumstances where two 
acidic groups dissociate simultaneously.716 For more complex multi- 
protic ligands, the deprotonation equilibria are best evaluated using 
least-squares data fitting, and many simple computer programs are 
available for this task of calculating only the acid-dissociation 
constants from potentiometric data. Such programs require that the 
concentrations of ligands and titrant be known precisely, electrode 
calibration factors (e.g. E°,' . 
m 
j. PHcal  etc., page 291) be determined ' 
before the titration and assumed to remain applicable during the 
titration, and for weakly basic ligands the value of K be known for 
the appropriate conditions under study. It is often inconvenient or 
impossible to satisfy all of these requirements simultaneously, parti- 
cularly for high precision titrations. Electrode calibrations may 
change on transfer from calibrant solution (e.g. standard buffers or 
strong acid/base titration, page 292) to measuring solution, the purity 
of readily oxidisable ligands (e.g. thiols used in this work) is often 
not 100% and the ligands may decompose significantly if kept in solution, 
even for short periods before titration etc. An acidic ligand solution 
may be dilute or may involve overlapping buffer regions so that equivalent 
points cannot readily be detected by the usual means. In these circum- 
stances it is convenient to use least-squares procedures to obtain values 
for electrode-calibration constants, concentration of ligand, etc., from 
the same data used to evaluate the ligand hydrolysis constants, albeit 
at necessarily reduced precision since extra parameters are being 
extracted from the data. Situations may also arise where mixtures of 
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multiprotic ligands with similar acidity constants are titrated, e.g. 
HL in the presence of CO 32- impurity. Least-squares procedures have 
been used to treat such multi-protolyte equilibria. The few 
published multiparametric curve-fitting programs which achieve some 
or all of these ends, have been reviewed elsewhere. 690,722-5 
Although multiparametric curve-fitting procedures are widely used 
in chemistry and other fields, the use of correct weighting of data is 
often overlooked, giving rise to incorrect estimates of fitted-model 
parameters. 726-8 
Similarly, conventional least-squares curve-fitting approaches 
almost invariably assume that random errors reside with only one of 
the experimental variables. In a two variable case, e.g. titration 
curves consisting of pairs of (titrant volume, pH) data, the values of 
titrant volume are usually considered to be totally reliable whereas the 
measured pH values incorporate some random error. In many modern 
titration systems, including the system used in this work, this is not 
the case. Specifically, the automatic syringe type burette used in this 
work of capacity 5 mL is reproducible to within 0.001 mL, hence titres 
of 0.5 and 5.0 mL incorporate uncertainties of 0.2 and 0.02%respectively. 
The measured pH can often be recorded to a precision, in buffered regions, 
of 0.001 pH units over the entire pH range, corresponding to a constant 
relative error of 0.1% in [e] (or, if pH is considered to be a variable, 
rather than [e], 0.05% and 0.01% at pH 2 and 10 respectively). 
Extremely high precision titrations can be performed with precision 
of 0.01 mV in glass electrode emf 715 (0.0002 pH units) and l0  in 
0.5 mL titres.729 It can clearly be seen that both experimental variables 
carry comparable uncertainties, and hence normal least-squares methods 
should not be applied. The use of 'rigorous' least-squares techniques 
are therefore necessary, and these have been described generally elsewhere, 
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but seem to have been used infrequently in the potentiometric field. 
The rigorous least-squares approach has been applied to straight-line 
fitting of variables with correction errors, and used to obtain forma-. 
tion constants of diprotic acids and mononuclear metal-ligand complexes 
ML and ML
2'
70° A computer program using this approach, RIGREG, has 
been written by this author and used to calculate diprotic acid disso-
ciation constants for evaluation of the general acid-base titration 
program TITRAT, described below. 
The only computer program for treatment of ligand hydrolysis 
constants using rigorous least-squares approach, of which this author 
is aware, is TITRA, described by Schwartz and Gelb. 706 A copy 
of this program was kindly made available by one of the authors (LMS) 
and was used in the initial stages of this study. 
The original interactive program has been made more efficient in 
terms of convergence properties and running time, and generalised to 
treat the titration of any number of multiprotic acids or bases, and to 
extract any titration parameter by rigorous least-squares curve-fitting. 
6.2.5 TITRAT and related programs for treatment of titrations of  
mixtures of multiprotic acids and bases  
TITRAT is an interactive computer program which has been written 
in OS/8 Basic for implementation on a Digital PDP8E minicomputer with 
12K available core memory for array storage etc. The program uses an 
iterative non-linear least-squares algorithm to fit experimental data 
from an aqueous titration of a mixture of BrOnsted acids or bases by a 
strong monofunctional acid or base, and refine simultaneously any number 
of titration parameters described in the model below. The procedure 
is statistically rigorous, using a weighting scheme which accounts for 
statistical uncertainties in both pH and titrant volume. The statis- 
tical procedure is based on that in the program TITRA 706 but the 
[H 
9- qk-j 
K4 
k 
[Fi g -0 1 
n -j 
k k k 
][H
+
H 
(n k-pk+q k -h) 2 
1+ 
(n -p k+q k-j+1) 2 
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refinement algorithm has been generalised to cope with (theoretically) 
any number of acids or bases and has much more efficient convergence 
properties than TITRA. 
The aqueous solution model considers that a number of N protolytic 
bases, the k
th 
of which is 
[H B] 
-nk pk 
have been added to an initial solution volume, 1/ 0 mL and the mixture 
titrated with strong monofunctional acid or base, of molarity, F. In 
the above generalised species, the charge, n, of the ionic species 
involved in protonation or deprotonation which was initially added to 
the titration system, may be negative, e.g. K-E [H 2PO4 ] - or positive, e.g. 
[NHO +Cl or zero, e.g. [H 2 succinate]° . The number of displaceable 
protons of the general ampholyte is p. It is assumed further that the 
ampholyte can accept a maximum number of protons, q, described as its 
functionality. 
The concentration of the i th-protonated form of the k
th 
 base is 
(n
k
-p
k 
+
k
) 
[H. B] 
 
. . . 
For the 
t  
j dissociation of the base: 
Hq +1 B 
(n k-p k + q k-j + 1) 
H + H B kk 
 - + 
cik - J 
  
the stepwise thermodynamic equilibrium constant can be written 
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The mean activity coefficient term simplifies so that 
-2(n6 -pk+q k-j)-1 
= -iu+) • 1+ r` 
" 
-2(n i,-p k+q k-j)-1 
or e = K. • y+ 	" 
J k J k 
The (q k-j) th overall dissociation of the fully protonated form of k th 
base 
k
- p
k
-q
k 
H B 
n -p 6 A-j 
(q k j)H + H.B N 
qk 
has the overall thermodynamic equilibrium constant 
(q u -j) 
_ 
{Hj
B k k N 
{H B 
T} 
qk 
The (q k-j)
th 
 overall dissociation can be expressed as a sum of (q -j) 
consecutive stepwise dissociations, with thermodynamic stepwise 
equilibria constants as shown 
n u -p u +q k 
H B '•'" H 
qk qk-1 
n k -p k+q,-1 
H 
e- 
K
1 
q k-1 
• 
k -POlk -1 n k-p k+ 
+ H
+ e- 
K2k 
k -2 
• n
k
-p
k
+j+1 n k -p k+j 
+ 
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Hence B,  
e-
= K, K 9 ...K, with analogous relationships holding 
4 k-° 'k k  
•for mixed constants V : 
q k 
(3' . = K' . 
clk -3 
 
1 k 2 k clk-J 
(q,-j) 
[H.B ] -(e} K 
EH B 
qk 
so that the concentration of the general 3 
.th 
-protonated form of the k th 
base can be written in terms of the fully (q
th
k ) protonated form: 
... (K' l K; lc, 4 ) 
1 1( `k. nu-pl,+qk 
[H.B
nk-pk+j
] = .1. 
DI 1 k- 
• [H B " " 1 
qk 
J 
J  
We can now consider the N mass-balance equations for the N bases in the 
mixture. Consider that N
k 
mmoles of k
th 
base was added initially to 
the V
o 
mL titration solution, i.e. the k
th 
analytical concentration is 
N k/Vo .lesftertheadditionof v i .hfl strong monofunctional titrant 
(completely dissociated) of normality F, we have N equations of the form: 
qk 
= (Vo + v i ) [H. B
n
k
-p
k 
i=0 Jk 
k=1 ..,N 
n 6 - 
= (V
o 
+ v
i 
[H
qk
B " 
q (K' K' ..K' .) +q k . 1
k 2k ' qk - J ] I 
j=0 	{H + 1 
Similarly, we have the electroneutrality expression at the i
th 
titration 
point: 
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N q k 
[OW] 1 + (U+-1.1- ) + 1 1 ( 
k=1 j=o 
= 0 
n-p 6+j 
-p +j)[H .B "
c 
 " 
P= 
lk j=o  
q k K6
k
Ki
k 
	vi 
k 
where the terms U
+ 
and U represent concentration sums of all singly 
charged countercations and counteranions, other than H i. and OH - , 
respectively. These compounds come from titrant K(OH) or H
+
(NO 
-
) 
3 
and initial forms of base M  B
n+
). 
-"k Pk 
If the titrant is strong base, U 4"-U - - 
If the titrant is strong acid, U -1.-U - 
v.F- 1 n N 
k=1 k k 
V +v. 
o 
-v 4 F- 	n i,N u 
' k=1 " " 
 
V +v. 
0 1 
By analogy with Schwartz and Gelb, we write 
and 
q k (n k -pk+j)K;) Ki 	_ 4 
= 	k k 	4k  
j=o 
{e}cik-j 
It should be noted in passing that a minor error seems to have appeared 
in the paper by these authors7 °6 On p.1574 of their paper, they write 
(in the nomenclature used here) 
1  
= 1 + 
G 1 {H -1- } 
9- 4a. K1 K2  
G 1 G21H
+
1
2 
• 	 e- 	2K.Tkei K 1 
and P 2 - 	, {H} 
 + 
G 1 G2{e} 
9 where G,
I 
 = Y 'FY 'H .HR- wi th YH 2 R=1 G . 
1 
and G2  = YH+YR2-/7HR- 
The term yH + should not appear in the expressions for G 1 and G 2 . 
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The N mass-balance equations of the i th titration point become: 
n u -p,+q u 
N k  = (Vo  + v.) [H B " P
k 
 
+k) P
lk o 
and the electroneutrality expression becomes 
n -p +q 
 
[e]i - [OH - ] i + 1 B k k k i p u+ 
k=1 qk 
J 2
k 
-U- 0 
Therefore the electroneutrality expression can be written: 
1(1 1 Voili ) P i2 k 	Vo+vi 
	 l k 1 k=1  
- 0 
±v.F- N 
- [OH - 
N 	Nk 
Thus the volume of titrant can be simply expressed in terms of pH 
kIl 	P I 	nk k Vo ( 
 
- [OH]1) 
±F - ([1-1 -F ] i - [OW]) 
This surprisingly simple relationship is exact, requires no assumptions 
and can be used to calculate the titration curve for complex mixtures 
• of bases. The volume of titrant is calculated for a given pH rather 
than the classical treatment which would calculate [e] for a given 
titrant volume by solution of a high order polynomial in [e]. This 
approach has been used to calculate complex titration curves with hand-
held calculators. 
The expression of N i is a generalised version of that given by 
Schwartz and Gelb for the rhodizonic acid (H 2B) system7 06 We define the 
'condition function', F i , similar to that used by Deming 730 
'13
2k 
F. = 
"k 
k=1 r k 2 
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v i 
 
     
     
±F - ([H] 1 -[OW]) 
For rigorous least-squares curve-fitting, we are required to minimise 
the weighted sum-of-squares, S, over all N titration points: 
= i1 [Wx. (PH calc - y 
	
PH i W . (vcalc-v i )2] i 
where the weighting factors W , W are inversely proportion to a 
 
• • x Y i 
priori variance estimates of the pH i and v i measurements. 
SinceF is a non-linear function of most of the titration parameters i 
K. , F, Nk etc., the calculation procedure requires an iterative approach. 
We have used a Gauss-Newton procedure, which requires values of the 
partial derivatives of F. with respect to each parameter, and those with 
respect to pH i and v i . Although the algebra for derivation of these 
derivatives is tedious, the use of analytical expressions, rather than 
numerical estimates of the partial derivates, results in much faster 
program operation (a comparison between TITRAT and TITRA showed speed 
improvements of an order of magnitude in some systems). 
Expressions for derivatives used in TITRAT are given below for 
completion: 
DF 
k=1 
2 k 
P
lk 	
N k + Vo ([11 /I i -E0H - ] i ) 
 
[±F - ([e] i 4OH - ] i )] 
Dv. 
 _ 1 
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3 	E P Fi 2 k 
3Nk 
= 	p---- 	nk 	/ [±F-([11 +] ( [0H - ] i ) 1 k 
k= 1 ,.. .,N 
-1 _  • [OH - ] . _ + - ([H+],-[OH] 1 ) [ V0 + (F i + 1 )] 
	
N k 	DP 	a W. 1 	k 1 _ 	
Pi 
2k _ f } P 1 	e- 	P 2 	e aK. k aK. k aK. ik 	±F - (II +) -[OH - ] i ) • 	• 11 i 	k 	J k J k 
where ..K' 	) qk-1 
and 
DPi k _ 	1 qk-jk e-   (K' K' 	.K' 	) 
Jk 	K. 	
k=o 	qc-32, 	1 k  2 ' {H} K K. qk -1 
aF. ap. 
TIF31,7 lTca i 
- in 10 
 
{(V0+v i )( [ 1-1 1 ]+[0H -]) 
±F•- UH /1 1 40H - 
 
  
DP 2 	a P1 k 
-5TRT P .5TITT 2  + {1-1 4 } k=1 " 
 
 
p 2 1 
3P2
k q k ( qk-j)(nk-P k+j)  1 k 	q k-3 where {H} j=o 	fey 	
• 
1 k-- 
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DP 
q k (q -j) 
a 
2 k _ -1 k  • K' K' athl 	1, 2 nd q {H} j=0 H+ 1 q k-i K k 
The values of [H
+
I. used in the equations above must be obtained 
by choosing an appropriate glass-electrode calibration expression. 
In this case, the operational definition of pH becomes 
-log{e} -log[e]Ye 
PHmeas PH cal 
The proton activity coefficient can be evaluated by empirical relation-
ships, e.g. Debye-Huckel etc. as discussed previously (page 287) and is 
the method used by Schwartz and Gelb. 706 Activity coefficients of all 
other species can be evaluated similarly for titrations at low ionic 
•strength where the component activities are expected to change during the 
titration. Under these conditions, TITRAT equilibrium constants are 
thermodynamic constants. The original version TITRA, has been shown 
to generate highly accurate values for e using this method. TITRAT 
• has the facility to calculate activity coefficients at each titration 
point, by evaluating ionic strength and using the Debye-Huckel expression 
for y±, or to fix activity coefficients to unity, in cases where constant 
ionic strength titrations are performed. The latter case is applicable 
to this study, in which all titrations were carried out in 0.1M KNO 3 or 
0.1M KI media. Under these conditions, the operational definition of 
pH becomes 
= -log[H+] 
PHmeas 
 pH 
which has been shown previously (page 293) to apply in the range 3 < pH 
< 11, and TITRAT equilibrium constants are consequently stoichiometric 
constants. The variable pH cal can be determined by prior experiment 
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(page 296) or can be treated as a parameter by TITRAT. The latter 
alternative is used in this work, since small daily variations in 
electrode calibration are conveniently taken into account. Values of 
PHcal in 0.1M KI or KNO 3 at 25° using the Philips GA110 glass-electrode/ 
R44 (sat. KC1,1M KNO 3) double junction reference electrode, invariably 
lie in the range -0.04 to -0.08 units when refined by TITRAT from data 
below pH 4, in good agreement with directly determined values. 
To evaluate [OH - ], the expression K  felf0H - 1 = [e][0H- ]yH+y H- 
is used. For fixed activity coefficients, this simplifies to K = 
[e][0H- ]. Values for Kvci can be determined by prior experiment or 
treated as a titration parameter at high pH (page 294). Since the 
operational definition of pH involves no non-linearity terms, and since 
many titrations in this study are performed up to pH 11, where non-
linearity becomes measurable (page 293), the value of 'Ktc41 ' is always 
treated as a parameter in these titrations. This has been shown to 
be equivalent to 'calibrating' the electrode at high pH, by evaluation 
of a non-linearity term such as j oH KIC4/[e] 'Kvc,/ , /[e] (page 292). 
It should be noted that, in principle, any glass-electrode calibra-
tion expression e.g. for using electrode emf rather than pH, could be 
incorporated into TITRAT, and the appropriate calibration 'constants' 
treated as parameters. Calibration expressions of the form E = E° + 
+ c + 
log[H ].-j OH Kw/[H ] have been treated by other multiparametric curve-fitting 
programs (non-rigorous) in this way, and reliable values of the parameters 
obtained. 704-5 
6.3 Evaluation of formation constants of stable complexes  
6.3.1 H
+
- competition method for obtaining aqueous stability  
constants 
In this section potentiometric methods for evaluation of equilibrium 
constants in a system containing hydrolysable methylmercuric ion and 
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and basic ligand, L n- , will be considered. Measurement of [H+] under 
different equilibrium 'conditions can be used to evaluate the concentra-
tions of the equilibrium components, usually using a priori assumptions 
about the existence of various MeHgL species (however see page 31 9 for 
recent methods which are model independent). Such an experiment can 
be carried out in several ways. The change in pH (hence in [H f] if 
the electrode is calibrated correctly, page 295) can be measured as a 
function of total ligand concentration, or alternatively the pH can be 
monitored as a solution containing constant total MeHg(II) and ligand 
concentrations is titrated with acid of alkali. 
The latter method, used in this work and widely elsewhere, relies 
on the existence of competition between protons and methylmercuric ions 
for basic ligands, e.g. the following equilibria should co-exist betWeen 
MeHg+ and L 2- (considering only 1:1 MeHgL complexes). 
H
+ H+ 
HL- H 2L 
MeHg0H 
(MeHg) 2 
 
tleHg+ 11 MeHg+ 
MeHgL--,---- MeHgLH 
 
The concentrations of components MeHg
+
, L
2- 
(and hence all complex 
species incorporating these components) will be changed to new (unknown) 
values if protons are added (e.g. by HL or HNO 3 ) or removed (e.g. by 
KOH) from this system. The new [e] can be measured and the procedure 
repeated to give a set of (volume of titrant, [e]) data pairs which 
can be treated by least-squares methods to be described in Section 6. 
to obtain the equilibrium constants for the system described above. 
This H - competition method can be used for many equilibrium systems, 
and has been used in this work to evaluate equilibrium constants for 
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multiprotic thiol dissociation (Section3.3.2), MeHg(II) hydrolysis 
(Section3.2.1), and MeHg(II) association with chloride and iodide 
(Section3.2.1). 
A powerful series of variations of a general method for evaluating 
equilibrium constants by potentiometric titration has received some 
attention in recent literature.
731-9 	
The general method, originating 
from the work of Osterberg, Sarkar and Kruck, exploits the differential 
properties of component mass balance equations, derived from the Gibbs-
Duhem equation, to enable calculation of free metal and ligand concentra- 
tions from measurement of [H
+
] only. Values of [H
+
] are usually 
measured in a series of solutions of constant metal, or ligand concentra- 
tion (Cm ,CL ). Values of [L] can be obtained via differential relation- 
ships such as 
  
lo [1-1 4-] 
j g CH  dlog[H - ]1 } 
C ,[H 
log[H1 
' L 
[1..] log 	= 
  
A - similar relationship holds for [M]. The integration and differentia- 
tion requirements of constant Cm ,C L ,[H+ etc. require data of utmost 
 
precision,
731-5  
wnich seems to have limited the technique to date. 
Despite the stringent requirements of the technique, it has been 
successfully applied to the study of several ternary (M-L-H) 735-6 
and quaternary (M-L-C-H) 732 systems. A very simple recent theoretical 
•approach involves repeated dilution of an initial metal-ligand-proton 
system with pure solvent, but does not seem to have been applied to 
practical systems. 739 
A singular advantage of these methods lies in the fact that free 
component concentrations can be evaluated without a priori knowledge of 
equilibria involved, i.e. they are model independent. 
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For routine application of this general method, automated 
gravimetric titration techniques seem to be necessary to obtain 
data of adequate precision. For this reason the method was not used 
in this study, although it would seem to be applicable to the study 
of MeHg-thiolate-iodide-proton equilibria (Section 3.3.1). 
An inherent limitation for evaluation of metal-ligand equilibrium 
constants by the H i-- competition method lies in the assumption that 
changing [e] can significantly alter the position of metal-ligand 
equilibria. The method cannot be used to evaluate systems in which 
neither metal or ligand is hydrolysable or, more important in this 
study, in which metal-ligand complexation is so strong that the 
changing [e] does not affect complex dissociation. The latter 
situation occurs for methylmercury(II)-thiolate complexation. Proton 
nmr studies have shown that MeHg(II)-monothiolate complexes do not 
detectably dissociate in the range 1 < pH < 13, i.e. protons (even at 
[e] = 0.1M) cannot compete with thiolate for MeHg + , and hydroxide 
(even at [0H - ] = 0.1M) cannot compete with thiolate for MeHg + . When 
such stable systems are titrated with acid or base, the pH only 
reflects changes in protonation of ligand sites not involved in MeHg- 
binding. An example of this effect is shown in Figure 6.2 for the 
methylmercury(II)-mercaptoacetate system. The solid curves have been 
calculated using the assumptions that only the species shown in Table 
6.4 exist in solution (see also page 103for discussion of this system). 
Values for stability constants of hydrolysed MeHg(II) and protonated 
ligand species were determined independently. The titration 
data shown in Figure 6.2 can be treated as a simple monoprotic acid HL, 
due to the carboxylate group of the complex, with acid dissociation 
constant pl(ca = 3.757(6), reflecting the lack of MeHg - thiolate dissociation. 
The data are seen to be very insensitive to changes in the stability 
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1.000 vol. KOH/mL 
13H 
10 
Figure 6.2: Calculateda and experimental titration curves for the 
methylmercury(II)-mercaptoacetate system in the absence 
of iodide. 
a 
Using COMIXH with species formation constants shown in Table 6.4. 
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constant for Melg-thiolate interaction. 
Species log (formation constants) used for  
calculated curves  
A B C 
MeHg0Ha -4.607 -4.607 -4.607 
(MeHg) 200a -2.234 -2.234 -2.234 
HSCH 2CO2
-b 	
10.157 10.157 10.157 
HSCH 2CO2Hb 13.710 13.710 13.710 
MeHgSCH 2CO2- 10.000 14.000 16.000 
MeHgSCH 2CO2Hc 13.757 17.757 19.757 
Table 6.4: 
 
Equilibrium data used by COMIXH to calculate solid curves 
in Figure 6.2. 
alog 1310-1 = -4.607 and log B .20-1 = -2.234 are not true 
formation constants (page 64). 
b
Table 3.6 (page 90). 
athis complex has pK c = 3.757 for carboxylate deprotonation 
a 
(Table 3.8, page 98). 
Attempts to extract log 13 110 (for formation of MeHgSCH 2CO21 from the 
titration data would be fruitless, since any value between 14 and 16 
will fit the experimental data satisfactorily. Unfortunately, the 
indiscrete use of sophisticated least-squares programs such as those 
described in Section 6.3.3 will generate values of log f3. 110 etc. for 
high stability constants to which no useful meaning can be ascribed. 
Although it should be possible to calculate model-independent values of 
'secondary' variables such as the average number of ligands L 2 bound 
to MeHg(II), 7, and thereby use only data for which 7 < 1 to obtain 
f3110 for example, this approach does not seem to have been widely used for 
ternary [MLH] systems. For the situation of inadequate ecompetition, 
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values of !would not deviate significantly from 1 (i.e. complex 
MeHgL is undissociated) within the accessible range 2 < pH < 12. 
6.3.2 Evaluation of high stability constants for MeHg-thiolate  
complexes  
In the situations where 14 4-- competition is ineffective, stability 
constants for high stability complexes can be obtained indirectly. 
By analogy to H - competition, addition of a second metal ion which 
competes with MeHg(II) for ligand could be used. This approach has 
been used to investigate transition-metal complexation with EDTA, 
using Ng
2+ 
as competing meta1. 740 An alternative approach, used here, 
is to use a second ligand, which competes with thiolate for protons 
and MeHg(II). Chloride, for example, has been used to obtain log 
a4 = 63 for Pd(CN) 42 formation, by competition with cyanide 741 in the 
equilibria: 
Pd(CN) 4 + nC1 -----m-Pd(CN) 4_ nCl n2- + nCN- 
Since the formation constants of Pd(C1)
n
(n-2)- 
complexes can-be . 
determined. using H
+
- competition, these can be used, , together with 
values of the competition equilibrium constants, to evaluate a 4 - for the 
formation of Pd(CN)
4
2-
. 
Schwarzenbach and Schellenberg 305 have used iodide competition 
to obtain values of formation constants for MeHg(II) with glutathione 
and mercaptoethanol. This work has extended their method to other 
monothiols by evaluating the equilibrium constants for the competition: 
MeHgSR + I -=#===MeNgI + SR- 
• The effectiveness of this approach can perhaps best be seen by re-
appraisal of the MeHg(II)-mercaptoacetate system (Figure 6.3) in the 
presence of 0.1M KI. The calculated titration curves assume the same 
'pH 
10 
2 
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Figure 6.3: Calculated' and experimental titration curves for the 
methylmercury(II)-mercaptoacetate system in the presence of 0.1M KI. 
aUsin-g COMIXH with species formation constants shown in Table 6.4 and 
log 13(MeHgI) = 8.500. The complex MeHgSCH 2CO2H has pKca = 3.757 for 
carboxylate deprotonation (Table 3.8, page 90 ). 
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species as those in Figure 6.2, but in addition, include log 8(MeHgI) = 
8.500. It can be seen that the titration data are best fitted using 
log= 16.932 and are much more sensitive to values of log 
.110 .110 
than the titration performed in absence of iodine. Methylmercury(II)- 
monothiolate stability constants obtained by this method, are discussed 
in Section 3.3. 
It has been found in this work that the complexes formed between 
MeHg(II) and the vicinal dithiols BALH 2 and Unithiol are too stable 
even for iodide competition to be used effectively to determine the 
formation constants for 1:1 interaction (page138 ). Treatment of 
these systems, using mercaptoethanol as a competing ligand, has been 
discussed previously (page 139). 
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6.3.3. Computer programs for the evaluation of metal-ligand stability  
constants  
Except for the simplest mononuclear systems of metal-ligand 
complexes, evaluation of species formation constants is almost exclu-
sively performed nowadays by computer programs using multiparametric 
curve fitting techniques. Several such programs have been described 
to date, and their advantages and idiosyncracies reviewed. Four of 
these have achieved dominant use, due to their wide areas of applicability 
and ready availability. Sillen's LETAGRO[742was the original in the 
field and is still the most comprehensive (versions are available for 
treatment of heterogeneous systems, with spectrophotometric, potentio-
metric, coulometric data), but is not widely used outside Scandinavian 
743 
circles. The program SCOGS by Perrin and Sayce is still widely used, 
and has been used to refine the formation constants of some MeHg(II)- 
thiol-iodide systems in this study. The main competitor with SCOGS 
is Vacca and Gans' MINIQUAD.—"—Teveral versions of this program have 
evolved since its inception (1974) and it is now widely used. It has 
been found elsewhere, and in this work, that MINIQUAD is much faster 
than SCOGS in refinement of many equilibriumsystems and has in 
consequence been used nearly exclusively in this study. The most 
recent program of which this author is aware is DALSFEK, which is 
unique in being able to simultaneously treat spectrophotometric and 
potentiometric data7 46 Copies of DALSFEK were only recently available, 690 
and so this program has not been used in this study. 
All current programs refine initial estimates of complex species 
formation constants, by iteratively solving the appropriate system of 
component mass-balance equations described below. It must be 
emphasised that these procedures require an a priori description of 
the equilibrium species which are expected to be sufficient to describe 
tThe version used here was kindly provided by Dr. R.N. Sylva (Australian 
Atomic Energy Commission).747 
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the relevant equilibrium system under study. The programs, as yet, 
are not able to determine the nature of the species present, or even 
their number. The decision remains with the chemist, who must 
subjectively consider the relative chemical and statistical virtues 
of the computer generated fits to his experimental data, calculated 
with different proposed equilibrium models. 
We write the overall formation equilibrium of the complex species 
MmL h from its components M,L,H as follows: 
MM I- 11_ -I- hi-l:,--=---%.• MmLiFlh 
with overall stoichiometric formation constant 
[MmL LH] 
mih 	CM]m[L] l [H]h 
The three mass balance equations for conservation of M,L,H can be 
written in terms of all N supposed species 
m. 	1 4 	h. 
mlh MT 	[M] + 	m. 	[M] 1 [L] I [H] 1 i=1 
LT = [L] + Z. 8mlh L rm, 1[L] 
4 
.[H] 
4 
i 
M 	1 	114 
[H] 	f h i 8m1 [M] 14  [1.] I4  [H] 
i=1 
These equations can of course be generalised to any number of components, 
e.g. in this study it has been necessary to consider four components 
simultaneously: MeHg + , I - , thiolate and e; or MeHg + , dithiolate, 
thiolate and H
+
. 
It may be informative to mention that it has been shown that it 
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is not compulsory to consider the 'free' or uncomplexed species M,L,H 
as components7 48 All equilibria could equally well be written in terms 
of formation from the complex species MLH for example, in which case 
MLH may be considered as a component and Ws changed accordingly. 
This technique has been used in this study to evaluate equilibrium 
constants for the addition of a second MeHg(II) group to the 1:1 MeHg(II) 
complex of L-cysteine (pagelll ). In this case, the complex 
MeHgSCH 2CH(NH 2)CO 2- was considered as a component or 'ligand' which 
could be further protonated or coordinated to MeHg + . 
A significant weakness of MINIQUAD, and of all similar currently 
available programs of which this author is aware, becomes evident with 
the relatively simple MeHg(II)-thiolate systems studied here. Such 
programs refine values of overall formation constants, e.g. for the 
simple MeHg(II)-mercaptoacetate system described previously (page 320), 
these are 8 110 and a 	- 111' 
MeHg+ + -SCH CO2 - + MeHgSCH 2CO2H 
13111 
[MeHg41[-SCH2CO2-][e] 
The first constant indicates the affinity of MeHg + for the deprotonated 
sulfhydryl group of the ligand. The second reflects not only protonation 
of the carboxylate group of the MeHg(II)-thiolate complex, but also the 
affinity of MeHg
+ 
for the deprotonated sulfhydryl group. Thus the two 
constants are highly correlated and simultaneous refinement of them by 
SCOGS or by several versions of MINIQUAD, has been found here to be slow. 
In several of the other MeHg(II)-thiolate systems, described in Chapter 
3, which have two or three acidic groups involved in proton association 
in addition to the sulfhydryl group involved in MeHg(II) complexation, 
[MeHgSCH 2CO 2 - ] 
MeHg+ + - SCH 2CO2- -7,==r1MeHgSCH2CO2 
110 + - 
[MeHg ][ SCH 2CO 2 ] 
[MeHgSCH 2CO2H] 
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correlation between overall formation constants has been found to be 
extreme. Simultaneous refinement of these constants, using data over 
a wide pH-range, often fails (except with very good initial estimates) 
or at best is very slow. 
In a chemical sense, a set of overall constants, e.g. 110 and 3111 
above, contains redundant information, i.e. fi ll excludes a component due 
to MeHg(II)-thiolate association, namely 
log 13111 = log no + pq(CO 2H) 
The proton dissociation constant, pq, for the carboxylate group of the 
MeHg(II)-thiolate complex can be obtained from highly correlated fi lo and 
(Table 3.8) (3111 
thus: pq(CO2H) = 20.689(11)- 16.932(12) = 3•757(6) t 
An identical value 3,78(2) has been found by titrating the solid proton-
ated complex in the absence of iodide and treating the complex as a 
simple monoprotic acid (page 98 ). 
The problem of correlation would be alleviated if refinement of 
stepwise stability constants, e.g. fi lo and pre could be achieved. 
Surprisingly however, general programs do not seem to be available for 
this purpose. The major programming problem would seem to be the 
difficulty of defining a general system of equilibrium equations such as 
those described on page 327 in terms of stepwise constants. Although the 
t
As 8.110 and  8.111 are correlated, the standard deviations, a, (in paren- 
 
theses) are correlated. The standard deviations of pK must be determined 
a 
using the general relationship for correlated variables a,b: 749 
a 2 = 4. G 2 	2 , a , 
a±b - a b 'ab 
The correlation coefficient, dab , is obtained from the non-linear least-
squares procedure. 
330 
term 'stepwise' has been used here to describe successive protonation 
equilibria, it could equally well apply to successive metal or ligand 
association, requiring a different set of equilibrium equations. Thus 
it would appear that programs would need to be specific to the equilibrium 
system at hand, and as such, would have limited general appeal. 
Specific programs have been written elsewhere when high correlations 
1 1 ... 
'between overall constants is a problem 750 and the mathematical treatment 
of highly correlated multiparametric functions has been elucidated by 
Sillen. 751 
6.4 Display of titration data and species distributions  
As described in the previous section, the somponent mass-balance 
equations in complex equilibirum systems can be used to evaluate 
equilibrium constants by treating them as unknowns in a multiparametric 
least-squares refinement. In this situation, it is necessary to 
measure at least one of the component concentrations in order to solve 
the set of non-linear equations. (Concentrations of components, other 
than those measured, are also treated as unknowns and iteratively refined.) 
In order to.efficiently display the contents of such an equilibrium 
system it is usual to draw the concentrations of the participating species 
as a function of an experimental variable, e.g. volume of base added or pH 
etc. so long as the equilibrium constants have been established. To this 
author's knowledge there are two generally published computer programs for 
this purpose: COMIC (Concentrations in Mixtures of Metal Ions and Complexing 
S pecies) by Perrin and Sayce 752 and HALTAFALL by Sillen's group. 753  
The latter program is very comprehensive and can. account for heterogeneous: 
as well as homogeneous systems in the gas, liquid and solid phases. Its 
main drawback is due to its generality inasmuch as data input is extremely 
tedious and the program is large and is therefore necessarily implemented 
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on large computers. COMICS on the other hand is much smaller (and thus 
less general) and can only handle homogeneous equilibria, but was 
admirably suited to implementation on the departmental Digital PDP8/e 
minicomputer. 
Experience with the original COMICS indicated that it was abysmally 
slow to solve the non-linear mass-balance equations (for a given pH 
value) for many of the more complex MeHg(II)-thiolate equilibria 
described in Chapter 3. Since the production of a species distribution 
diagram may require the solution of these equations at 50-200 pH values 
in succession, a more efficient algorithm was devised and incorporated 
into the new program COMIX. 
6.4.1 COMIX 
The major problem with COMICS seems to be due to the use of 
numerical differention in the Gauss-Newton iterative procedure. The 
mass-balance equation can, however, be analytically differentiated with 
respect to the component concentrations. It has been found here that 
the use of analytical expressions for these derivatives, increased the 
efficiency of COMICS by an order of magnitude, at least. 
The advantages of analytical derivatives in equilibrium calculations 
was noted independently elsewhere
754 
and the program MINIQUAD (and 
earlier versions) uses analytical derivatives to refine overall formation 
constants. 
A further difficulty encountered with COMICS was that the iteratively 
calculated values of some component concentrations occasionally converged 
to negative values. To prevent against this occurrence, component 
concentrations were restrained to be positive by rewriting the mass-
balance equations in terms of ln[M] etc., rather than [M] as shown 
below for the simple system containing metal, ligand and protons: 
Mtot - [M] - mi 
i=1 
m 	1. 	•h . 
[M] 1 EL] 1 [H] 1 
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To solve the system of two non-linear equations (one in [M] above, 
and the analogous one in [L]) by the Gauss-Newton iterative method, it 
is necessary to write the left-hand side of this equation as the 
function F, and obtain the derivatives 3F/[M] and aF/a[L]. 
If the mass-balance equation in [M] is logarithmically transformed, 
it becomes 
=Mtot -expOnDID-277/.(3.exp(m.ln[M]+I.1n[L] + h. ln[H]) 
i=1 
The transformed ligand mass-balance equation is analogous and both 
equations are readily differentiated with respect to 1n[M] and ln[L]. 
The program COMIX using this new logarithm (analytical derivatives and 
logarithmic variables) has been used to efficiently calculate all the 
species distributions shown in this thesis, and draw them on a Hewlett-
Packard HP7221A plotter. 
6.4.2 COMIXH  
A closely similar procedure can be applied to the calculation of a 
hypothetical 'titration' curve, given the total concentrations of all 
components and all equilibrium constants which define the system. 748 
However, this situation differs from that described above for the 
calculation of species distributions, in that [e] is now no longer 
known, but needs to be treated as an unknown in the mass-balance 
equations (now three: in ln[M], m[L] and ln[H]). 
A computer program, COMIXH, has been written as a modified version 
of COMIX, in order to calculate and draw the titration curves shown in 
Chapter 3. A listing of COMIXH, which contains all the essential 
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features of the COMIX algorithm, has been included as Appendix 2. 
6.5 Appendix. A simple device for monitoring attainment of pH- 
equilibrium  
Some modern pH-meters incorporate a facility to indicate when a 
pH (or mV) reading is 'stable' according to the manufacturer's criteria. 
The Model 701A Orion pH-meter used in this study does not have this 
facility, and the use of a chart-recorder connected to the 10 mV analog 
output of the pH-meter, is one means of monitoring attainment of 
equilibrium. 
Figure 6.4 describes a simple electronic device which can be 
attached to the 31/2 digit BCD output of the Model 701A meter, and which 
generates a visible or audible alarm when the digital display remains 
unchanged for a predetermined length of time. The device was designed 
to detect stability of the least significant digit (lsd) for periods of 
30s to 5 minutes, by monitoring the two least significant bits (lsb's) 
of the lsd. The particular time period can be varied by the operator 
to suit titration conditions. The device ignores one digit oscillations 
of the lsd (digital 'noise') by logically combining the lsb of the 
second least significant digit with the lsd input. 
In principle, most devices with continuous BCD output could be 
monitored for stability with this circuit. The audible/visible alarms 
could easily be replaced by triggers for automatic DH-orintout or 
activation of an automatic burette etc.. allowina inclusion of the 
device in a fully automated ootentiometric data acquisition system. 
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Figure 6.4: Circuit diagram for a device for testing for pH-stability. 
335 
CHAPTER SEVEN  
EXPERIMENTAL  
Microanalyses were carried out by the Australian Microanalytical 
Service, Melbourne, on samples dried over P 205 at room temperature 
unless otherwise stated. Melting points were determined with a 
Reichart Thermo apparatus and stereomicroscope, and are uncorrected. 
The 100 MHz proton magnetic resonance (
1
H nmr) spectra were 
recorded with a JEOL-JNM-4H-100 spectrometer by Mr. R.R. Thomas in 
this Department. Tetramethylsilane (TMS) was used as an internal 
standard. Chemical shifts (0 are given in parts per million relative 
to TMS, coupling constants were measured directly from spectra recorded 
with a sweep width of 900 Hz and are reliable to ±1 Hz unless otherwise 
stated. Resonances are described as singlets(s), doublets(d), 
triplets(t), quartets(q), or as multiplets(m). Spectra were obtained 
at a temperature of 15° 
Infrared spectra (4000-400 cm
-1
) were recorded in Nujol or hexa-
chlorobutadiene mulls (unless otherwise stated) between KBr plates with 
a Perkin-Elmer 577 spectrometer. Far infrared spectra were recorded 
-1 
with a Perkin-Elmer 577 spectrometer (600-200 cm ) or Perkin-Elmer 180 
-1 
spectrometer (500-100 cm , Monash University, Melbourne) as Nujol mulls 
between polyethylene plates. Unless otherwise stated, spectra were 
obtained at room temperature. 
• Raman spectra were obtained from samples in sealed capillaries with 
a Cary 82 Laser Raman spectrometer using Ar + 514.5 nm radiation (60-100 
mW at sample) unless otherwise stated. For some samples, particularly 
those containing selenium, it was necessary to use a Coherent Radiation 
Model 190 dye laser (Rhodamine 6G) as the exciting source to prevent 
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sample decomposition or minimise sample fluorescence. For some samples, 
it was further necessary to defocus the incident laser beam by sample 
spinning, and for Hg(SeCH 2CO2H) 2 it was necessary to cool the sample to 
10 K with a Cryodyne Model 21 cryostat. 
-1 
Maximum errors are considered to be ±4 am for both i.r. and Raman 
spectra. The ultraviolet absorption spectra were obtained on a Cary 17 
spectrophotometer, using 1 cm quartz cells. 
Mass spectra were obtained with a Vacuum General Micromass 7070F 
spectrometer using the direct insertion technique, with electron beam 
energy 70 ev. Peaks of more than 10% base-peak intensity are reported 
in descending m/e order. High resolution accurate mass measurements 
were obtained on this instrument using electron impact ionisation unless 
otherwise stated. 
Debye-Scherrer X-ray powder diffraction patterns were recorded 
photographically from finely ground samples contained in sealed Lindemann 
0 
capillaries using Ni-filtered CuKa (X = 1.5418 A) or Mn-filtered FeKa 
0 
(X = 1.9373 A) radiation. Automatically recorded powder diffraction 
patterns were obtained from some samples using a Philips diffractometer 
and ratemeter with Ni-filtered CuKa radiation. These patterns were 
calibrated with the 2e = 56.12° line of silicon. 
7.1 General reagents  
Ethanol (95%) was used with no further purification. Benzene, 
chloroform and acetone (AR grade) were used as received. 
Pyridine and 4-methylpyridine were refluxed and distilled from 
potassium hydroxide before Use. 
Methylmercuric nitrate for synthetic studies was prepared by 
metathesis of silver'nitrate and a slight excess of methylmercuric iodide 
(Alfa-Ventron) in water. The filtrate was evaporated to give a 
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colorless crystalline product which was stored over P 205 . 
Solutions of methylmercuric nitrate, free of mercuric ion, were 
prepared for potentiometric studies. Preparation and analysis of 
these solutions for MeHg(II) and H 4 content are recorded on page Z. 
Mercuric salts HgC1 2 (B.D.H. Ltd.), Hg(0 2CMe) 2 (Ajax Chemicals 
Ltd.), and Hg(CN) 2 (May and Baker Ltd.) were used as received. 
Crystalline thiols were used as received and stored under nitrogen 
over P205 : meso-2,3-dimercaptosuccinic acid and 2-mercaptosuccinic acid 
(Aldrich Chemical Co., Inc.), 2,3-dimercapto-l-propanesulfonate, sodium 
salt (Heyl and Co. Chem.-Pharm. Fabrik.,), reduced glutathione (Sigma 
Chemical Co.), L-cysteine, DL-homocysteine, N-Acetyl-DL-penicillamine 
(Koch-Light Laboratories Ltd.) and DL-penicillamine (Ega-Chemie). 
Thiocholine perchlorate was a gift from P. Guerney, University of New 
South Wales. 
Liquid thiols: 2-mercaptoethanol (Koch-Light), 1,3-dimercapto-2- 
propanol, 2,3-dimercapto-l-propanol (Aldrich) were fractionally 
distilled under reduced nitrogen pressure and stored under nitrogen at 
-20 0 . Mercaptoacetic acid (Aldrich) was treated similarly after 
azeotropic distillation from benzene. 
The purity of the thiols used in potentiometric titration studies 
was determined alkalimetrically prior to each titration, and are 
recorded in Chapter 3. Melting and boiling points are recorded in 
that chapter together with proton dissociation constants of the thiols. 
7.2 General procedures used in organoselenium preparations 
The offensive odours of many organoselenium reagents are legend, 
and all selenium chemistry was performed in an efficient fumehood. 
Much of the problem is due to relatively small amounts of volatile 
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impurities which may be formed during the preparative reactions, 
especially hydrogen selenide. All reactions were performed under a 
slow stream of nitrogen after rigorous nitrogen purging of apparatus 
to remove oxygen. The effluent nitrogen was passed through at least 
one trap containing 50% aqueous sodium hydroxide (to form NaSeH) and 
then into a lead acetate solution. All glassware, used gloves, etc. 
were decontaminated by soaking in 10% aqueous sodium hypochlorite 
solution which converts offensive selenols etc. into odourless, non-
volatile, oxidised products. 
Many of the organoselenium preparations make use of an ethanolic 
solution of sodium hydrogenselenide, NaSeH. This reagent is very 
conveniently produced using the method of Klayman and Griffin 487 by 
reacting finely ground grey selenium, which had been stored over P 205 , 
with sodium borohydride in 95% ethanol until a nearly colourless solution 
is obtained. These authors describe the addition of ethanol to the 
mixture of solid selenium and NaBH 4* 	This reaction was found to be 
extremely vigorous on a moderate scale with the rapid evolution of 
considerable quantities of hydrogen, and required careful cooling in 
ice to moderate the reaction. Some H 2  Se is produced, especially in the 
initial stages of ethanol addition. It was subsequently found that 
addition of an ethanolic sodium borohydride solution to a vigorously 
stirred slurry of grey selenium in ethanol, contained in a 3-necked flask 
equipped with nitrogen inlet, double surface reflux condenser and pressure-
equalised dropping funnel, was a much more controllable and cleaner, if 
slightly longer, procedure. The purity of sodium borohydride used in 
this work was found to be quite variable, despite storage in tightly 
closed containers. This seemed to be due to some decomposition to sodium 
carbonate, which was difficult to dissolve in ethanol. As a consequence, 
it was invariably necessary to add small quantities of solid NaBH4.to  
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the final NaSeH solution to achieve total reduction of red diselenide, 
Se
2
2-
' 
to colorless HSe - . 
The use of 95% ethanol in this procedure produces some H 2Se due to 
the reaction of selenium and sodium borohydride with water impurity, 
however this was a minor inconvenience since efficient traps were used 
and substitution with absolute ethanol was not considered warranted. 
After reaction (e.g. alkylation) with the ethanolic NaSeH solution 
the reactant mixture was often acidified with glacial acetic acid to 
pH 4 (tested with indicating paper) in order to ensure that any derived 
selenol product was fully protonated, and to facilitate subsequent ether 
extraction. This procedure also protonates any anionic selenide impurity 
and excess NaSeH to H 2Se, and decomposes excess sodium borohydride to 
hydrogen. Dissolved H 2Se was removed before further workup by vigorously 
bubbling nitrogen through the reactant mixture. Simultaneously reducing 
the pressure inside the apparatus by slight water-pump aspiration aided 
H 2Se removal. Absence of hydrogen selenide was confirmed by testing the 
effluent nitrogen with lead-acetate paper until no darkening (PbSe) 
occurred. The resultant mixture, often containing small amounts of 
undissolved grey selenium, was most conveniently filtered in a static 
nitrogen atmosphere through a pressure-equalised sinter containing a bed 
of acid-washed sand. 
Subsequent reduction of solvent volume was performed on a BUchi 
evaporator under water-pump vacuum, with nitrogen purging to restore 
atmospheric pressure. Solvent extraction was performed using peroxide- 
free ether in nitrogen purged separating funnels to avoid spurious 
_oxidation of products. 
These experimental details are not repeated in specific preparations, 
except where significant deviations were required. 
7,3 Preparation of complexes [M0Hg(II) and 	Hg2+]of dithiols and  
model thiols  
(meso-2,3-dimercaptobutanedioato)bis[methylmercury(II)], (MeHg) 2DMSH 2 
A filtered solution of MeHgNO3 (0.445 g, 1-60 mmol) in 15 mL Et0H 
was rinsed into 20 mL ethanolic solution of meso-2,3-dimercaptosuccinic 
acid, with 5 ml Et0H. Evaporation of the clear solution deposits 
(MeHg) 2DMSH 2 as very small needles which were collected by filtration 
at low volume and dried in VaCud. The analysis of this product is 
shown in Table 2.2, page 38. 
Infrared absorption: 3070w,sh, 2980m,br, 1677vs, 1422s, 1311s and 1290w,sh, 
1219vw, 1188 and 1176s, 950m, 785m, 686m, 632m, 530w,sh, 537m, 433m, 352s, 
279m, 226w. 
Raman bands: (below 1200 cm -1 , sample decomposes): 1195m, 1075vw, 974vw, 
822s, 782vw, 708vw,sh and 675s, 550s and 535vw,sh, 391w, 358m, 320vw,sh and 
309m. 
'H nmr (D 20, pH = 7-8) &(CH3Hg) -3.00 (dioxane = 10.0), 1 2J( I H- 199Hg)1 = 
172.0 Hz. 
po1y-imeso-2,3-dimercaptobutanedioato)mercury(II) dihydrate, Hg(DMSH 2 )- H 20 
An ethanolic (20 mL) solution of meso-2,3-dimercaptosuccinic acid 
(0.092 g, 0.50 mmol) was added with stirring to mercuric chloride (o.272 g, 
1.0 mmol) in 10 ml Et0H. The slightly cloudy solution was filtered and 
evaporated to give a white powder at low volume. The product was 
collected, washed with acetone and dried in vacuo. 	Yield 0.13 g (68%). 
The analysis shown in Table 2.4, page 49 is consistent with a 
dihydrate. 
Infrared absorption: 3200-3600m,vbr, 2900w, 1710s,br, 1565w, 1360m,br, 
1290w,br, 1220w,br, 1170vw,sh, 800vw, 389m, 306vw, 216w, 180vw. 
This sample gives an unusable Raman spectrum. 
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(2,3-dimercapto-l-propanesu1fonato)bis[methy1mercury(II)], sodium salt,  
MeHgSCH 2CH(SHgMe)CH 2S03Na, NaL(MeHg) 2U11 
A solution of MeHgNO3 (1.36 g, 4.91 mmol) in methanol (10 mL) was 
filtered into a stirred methanolic solution of Unithiol (0.545 g, 2.46 mmol) 
containing 2.5 mL 2M NaOH. When approximately one-third of the MeHgNO 3 
was added, cloudiness persisted. The slightly cloudy solution was 
filtered and the filtrate evaporated to low volume. Fine microcrystals 
were collected by filtration and dried over P 205 (the product seems to be 
hygroscopic). 
The analysis of anhydrous Na[(MeHg) 2UT] is shown in Table 2.2, page 38. 
Infrared absorption: 3200-3650w,br, 1632w, 1187m,br, 1054vs, 967w, 892w, 
854vw, 838m, 783s.br . 724m, 660w, 586m, 526m, 4552, 412vw, 333w,br. 
Raman bands (below 1200 cm  1184m, 1057w, 780w, 713w, 655vw, 
585vw, 531s, 329m,br. 
H nmr (D20, pH = 6.2) 6(CH3Hg) -2.80 (dioxane = 10.0), I 2  J( 1  H- 199  Hg)I 
171.0 Hz. 
po1y-(2,3-dimercapto-l-propaneSU1fOnatO)mercurate(1-), sodium salt,  
— Na[Hg(UT)]  
Unithiol (1.30 g, 5,68 mmol) was dissolved in water (10 mL) and 
partially neutralised with NaOH (5.16 mL 2M, 110:3 mmol). To this solution 
was added 10 ml aqueous solution of mercuric acetate (1.65A, 5.16 mmol) 
in portions with stirring, waiting for the white precipitate to dissolve 
before the next addition. The slightly brown solution was filtered and 
evaporated to low volume but no crystallisation occurred. A very small 
amount of residue was removed by filtration, ad ethanol added to 
precipitate a white powder which was filtered with difficulty. Drying 
in vacuo over P20 5 yielded a slightly sticky product which appeared 
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somewhat heterogeneous and consequently was not analysed. Theproduct 
is probably hygroscopic like the bis(methylmercury) complex and the 
free ligand. 
Infrared absorption: 3100-3600m,vbr, 1675m, 1283vw.sh , 1265vw,sh, 
1200s,vbr and 1130w,sh, 1050s and 1028w,sh, 970w, 892vw, 853vw, 785vw, 
580w and 540vw, 360w,sh. 
Raman bands (below 1200 cm  poor quality spectrum): 1063w, 790w, 
700vw,br, 632vw, 578vw, 510vw,br, 316s,br. 
2-mercaptobutanedioato(methyl)mercury(II), MeHg[SCH(CO 2H)CH 2 (gO2H)] 
A solution of MeHgNO 3 (0.91 g, 3.26 mmol) in 5 mL acetone was 
filtered into an acetone (5 mL) solution of 2-mercaptosuccinic acid 
(0.488 g, 3.25 mmol) and 1 mL water. The clear solution was evaporated 
under nitrogen and colorless needles were collected by filtration at low 
volume, washed with acetone and dried in vacuo. The filtrate deposited 
more crystals on further evaporation. Total yield 0.97 g (82%). 
The analysis of this product is shown in Table 2.2, page 38. 
Infrared absorption: 1705w,sh and 1680vs, 1410w, 1310m,brand 1260vw,sh, 
1218vw, 1192m, 1178m and 1160vw,sh, 1054vw, 962m and 945w,sh, 780m, 673m, 
617m, 539m and 524vw,sh, 448m,br, 377vw,sh and 361m, 296s,br. 
Raman bands: 2985w,br, 2915s, 1635w, 14302, 1265vw, 1193s, 955w, 782w, 
710vw, 677w, 620w, 550vs and 526 vw,sh, 420vw, 362m, 298s, 215w, 147m,sh 
and 147m, 
(D20, pH =5.2) 2988m, 2927s, 2874m, 1415w, 1318vw, 1191s, 1025vw, 950 vw,br, 
547vs, 365m. 
1
H nmr (D20, pH = 5.2) 6(CH3Hg) -2.99 (dioxane = 10.0), 2 - 199H)I = 
173.4 Hz. 
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Attempted preparation of bis(2-mercaptobutanedioato)mercury(II)  
Addition of mercuric acetate (3.28 g, 10.3 mmol) in 15 mL water to a 
solution of 2-mercaptosuccinic acid (3.09 g, 20.6 mmol) gave a clear 
solution which deposited white microcrystals at very low volume but 
which rapidly turned black and obviously decomposed. 
(1-methyl-3,4-dimercapto)bis[methylmercury(II)]  
An aqueous (5 mL) solution of MeHgNO 3 (1_30 g, 4.70 mmol) was added 
with stirring to toluene-3,4-dithiol (0.442 g, 2.83 mmol) in 5 ml warm 
water containing NaOH (3.266 g, 6.6 mmol). (The dithiol melts at room 
temperature, making weighing difficult). The resultant oily mixture 
was stirred with ethanol (5 mL) and separated into a gum and white 
precipitate which was collected by filtration after 2 hr. The crude 
product was dissolved in 30 mL hot toluene and the solution filtered 
to remove some yellow residue. The filtrate deposited a white powder 
overnight which was collected and dried in air. 
The analysis of this product is shown in Table 2.2, page 38. 
Infrared absorption: 1594w, 1308vw, 1256w, 1210w, 1175vw,br, 1105w, 
1029m, 871 and 858m, 808s, 770m, 685w, 549w, 528w, 354w, 335w, 273m,br. 
Raman bands: 3042w, 2913m, 1608m, 1575w, 1472w, 1397w, 1290 and 1275w, 
1229m, 1200m, 1126s, 1050m, 887w, 689w, 650vw,br, 526vs, 470w, 447w, 
415w, 370 and 357m, 337w, 300vw, 263m. 
[N,N,NtrimethylaminoethylMerCaptO(Methyl)Mercury(II)] perchlorate  
.Methylmercuric nitrate (0.66 . g, 2.38 mmol) in 1 ml water was added 
to thiocholine perchlorate dissolved in hot water (5 mL). Within two 
minutes, on cooling, the solution deposits colorless crystals which 
were collected by careful Buchner filtration on a small paper and dried 
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over P 205 . (CAUTION - perchlorate salts of sulfur-containing 
compounds are potentially explosive. The crystals were collected 
using a polyethylene 'spatula' to prevent scratching.) 
Yield 0.73 g (71%), mp. 163-5°. 
The analysis of this product is shown in Table 2.2, page 38. 
Infrared absorption: 3040w, 2000w, 1492w and 1475m, 1418m, 1343w, 
1186m, 1085vs,br, 1008m, 966m, 942w, 892m 774 and 764m, 727w, 621vs, 
542m, 454w, 381vw, 359m, 329s, 287w. 
Raman bands: 3040m, 2985m and 2940w, 2909m, 1452w, 1405vw, 1181s, 1090w,br, 
970w, 943vw,sh and 931vs, 908w, 894w, 772m, 725w, 621w, 542vs, 500vw, 
478w, 331s. 
H nmr (P20): d(CH3Hg) -2.97 Cdioxane = 10.0 , 
2
J 
199
Hg)I = 169.6 Hz. 
1 
• 4,4'-dimercapto-N-methy1piperidine hydrate  
This intermediate was prepare according to the method of Barrera and 
Lyle406 for subsequent reduction to 4-mercapto-N-methylpiperidine. 
N-methyl-4-piperidone (14.2 g, 125 mmol, bp. 56-8°/10 mm) was 
dissolved in 100 mL toproponol. Hydrogen sulfide t (CAUTION) was 
passed from a Kipp's generator at 2 bubbles/sec through the Pri OH 
solution cooled in ice which deposited white crystals of the product 
after 31/2 hrs. The crystalline product was collected after 8 hours by 
filtration and washed with cold Pr i OH (3 x 5 mL). On standing at -20° 
for 48 hrs, the filtrate deposited a second crop of product which was 
combined with the first. Total yield 20.32 g (90%), mp. fu54° (dec.) 
m it. 406 48-501.  
tEffluent H2S was trapped in 10% CuSO4 in 0.3N HC1. The H2S has a distinct 
tendency to suc back into the reaction vessel. 
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4-mercapto-N-methylp1peridine  
4,4'-Dimercapto-N-methylpiperidine hydrate (10.7 g, 59 mmol) was 
suspended in 27 mL isopropanol and added in small portions to a stirred 
suspension of sodium borohydride (3.55 g 94 mmol) in 27 mL Pri OH 
under nitrogen. The mixture was cooled in ice to moderate the exothermic 
reaction (evolution of H 2St). After 30 min additional stirring, more 
Pri OH was added (20 mL) and the stirred pale yellow mixture heated on a 
water bath at 58° for 2 hrs. The solution was then acidified (Congo 
Red) by dropwise addition of ethanolic HC1 (12.7M, CAUTION H 2 evolution) 
to decompose excess borohydride, and diluted with water (20 mL) to dissolve 
inorganic salts. After the addition of solid KOH to pH 12, the aqueous 
solution was extracted with ether (4 x 35 mL). 
The combined ether extracts were dried over magnesium sulfate then 
evaporated by flash rotary distillation under nitrogen to yield a 
slightly cloudy colorless oil which was fractionally distilled, bp. 
31.5-2°/1 mm [lit. 406 62°/0.8 mm]. The oil freezes to a colorless 
crystalline solid, mp.7-9°. 
• 
Mass spectrum: M  130.0684; calc. for C6H 13NS = 130.0690. 
The acid dissociation constants of the N-protonated form of this 
thiol are recorded in Table 3.6, page 91. 
[4-mercapto-N-methylpiperidinium(Methyl)mercury(II)] nitrate  
4-Mercapto-N-methylpiperidine (0.207 g, 1.59 mmol) was added by 
syringe to a stirred aqueous (5 mL),solution of MeHgNO 3 (0.445 g, 1.60 
mmol). The clear, colorless solution was evaporated to low volume 
and the resulting colorless crystals collected on a sinter, washed with 
tEffluent H2S was trapped in 10% CuSO4 in 0.3N HC1. The H25 has a distinct 
tendency to suc'back into the reaction vessel. 
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7.4 Preparation of selenium cOmpounds and complexes (and S-analogs)  
Diselenides R
2  Se (R=Me,Et)  —2 
The diselenides R2Se2 (R=Me,Et) were prepared by the alkylation of 
Na2Se2 in liquid ammonia by the alkyl iodides. 755-6 Preparation of 
dimethyl diselenide will be described in detail. 
Thinly sliced metallic sodium (3.26g, 140 mmol) was dissolved in 
approx. 150 mL liquid ammonia which had been previously dried over 
sodium and distilled into the 500 mL 3-necked reaction vessel via an 
acetone-dry ice condenser. Addition of small quantities of grey 
selenium (total 11.5g, 140 mmol) produced a color change from deep blue, 
though red brown to dark green. Methyl iodide (25g, 180 mmol) was 
added dropwise at a rate sufficient to dissolve the yellow Me3SeI which 
formed. Water (50 ml) was added after evaporation of the ammonia at 
room temperature, and the deep crimson oil extracted with ether (4 x 
50 m1). The combined yellow extracts were dried (CaCl 2 ), evaporated 
4nd fractionally distilled in vacuo to give Me 2Se2 as a putrid orange 
oil, bp. 42-44°/8-9 mm. [lit. 757 43-4915mm]. 
Diethyl diselenide was prepared similarly (using ethyl iodide) as a 
putrid orange oil, bp. 68-70°/9-10 mm [lit.
757 
74-5°/14 mm]. 
catena-Bis(p-methaneselenolato)mercury(II), Hg(SeMe) 2 
Excess metallic mercury was stirred with Me2Se 2 (2.81g, 15 mmol) in 
pyridine (50 mL) for 2 days. The resulting black suspension was 
extracted with hot pyridine until the extract was colorless (200 mL). 
The black mercuric selenide and finely divided metallic mercury were 
removed by filtration through cellulose powder and a fine sinter under 
slight positive pressure (CAUTION). 
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Yellow leaflets of Hg(SeMe) 2 formed on cooling (5.28g, 90%), mp. 
119°(dec.). Infrared absorption: 2925vw, 2915vw, 1414m, 1253s, 900w,sh, 
890s, 578 and 570w, 161vs,b, 151vs,b, 134vs,b, 103m. 
Raman bands (spinning cup): 2995 and 21988m, 2927m, 2913s, 1415w, 1262m, 
898 and 890w, 576w,sh and 570s, 182vw,sh, 158m, 131vs, 112W. 
The analysis of Hg(SeMe) 2 is shown in Table 4.1, page 174. 
Bis(ethaneselenolato)mercury(II), Hg(SeEt) 2 
Excess metallic mercury was stirred with Et 2Se2 mL, unweighed 
because of stench) in chloroform (50 mL) for 1 day. The yellow powder 
which formed was dissolved by addition of hot chloroform (100 mL), and 
metallic mercury removed by decantation and filtration through a fine 
sinter under slight positive pressure (CAUTION). Chloroform was 
removed under vacuum, and the yellow powder recrystallised from pyridine 
to form yellow crystalline or glassy Hg(SeEt) 2 , mp. 72°(dec.). 
Infrared absorption: 2945m, 2905m, 2865m, 1441s and 1425sh, 1372s, 1221vs, 
1041m, 750m, 570w,sh, 555m, 291w, 198w, 175vs,b, 150vs,vb, 130 vs, 110vs,b. 
Raman bands: (red excitation, spinning capillary) 2950 and 2933w, 2913m, 
2857w, 1442 and 1424w, 1370vw, 1217s, 1041w, 991w, 963w, 745vw, 550m, 
298w, 131vs. 
The analysis of Hg(SeEt) 2 is shown in Table 4.1, page 174. 
cyclo-Tetrakis4chloro-p-ethaneselenolato-pyridinemercury(II)],  
[EtSeHgCl(py)]4 
Mercuric chloride (0.59g, 2.18 mmol) in 5 mL pyridine was added to 
bis(ethaneselenolato)mercury(II) (0.91g, 2.18 mmol) dissolved in 10 mL 
warm pyridine, and the mixture filtered to remove a small amount of 
unreacted Hg(SeEt) 2 after 10 minutes. 
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Addition of 15 ml Et0H and evaporation overnight yields small, 
colorless prisms (1.18g, 64% as EtSeHgCl.py). 
Small colorless prismatic crystals, suitable for crystallographic 
investigation (page 202) were deposited after 1 hour which were collected 
by filtration. The crystals showed negligible weight loss at room 
temperature over 36 hrs. 
EtSeHgCl.py (C7H 10C1NSeHg) requires: C 19.9, H 2.38, N3.31, Hg 47.4%; 
found C 20.2, H 2.46, N 3.50, Hg 47.4%. 
Infrared absorption: 3080vw, 3055w, 3025w, 2990vw, 2950w, 2915w, 2860w, 
1592m, 1428m, 1449s and 1449s, 1420w,sh, 1325m, 1232, 1222 w,sh and 
1222m, 1207m, 1070w, 1062 and 1059m, 1081m 1004s, 961w, 763s, 710s, 
621m, 565vw,sh and 544m, 408m, 212s(br), 179s(br), 156m. 
The compound rapidly loses pyridine and decomposes in the Raman 
laser-beam. 
•  tert-Butyl selenol  
An ethereal solution of Bu tSeH was prepared by the Grignard route 
to Bu tSH. 452 
A Grignard solution of tert-butylmagnesium chloride was prepared 
by the dropwise addition of tBuCl (8.98g, 97 mmol, distilled, bp.50.5-51° 
and stored over K2CO3 at -20°) to activated magnesium t (3.62g, 149 mmol). 
The reaction was initiated by adding approx. 3 mL tBuCl to the 
magnesium under 15 ml sodium-dried diethyl ether after warming the 
magnesium with a single iodine crystal in the oven-dried 250 mL three- 
tA large portion of magnesium turnings was rinsed successively with four 
portions of 0.5% HC1, freshly deionised water (until pH q ,5) ethanol and 
acetone, then dried over CaC1 9 under nitrogen. The turnings were stored 
in a tightly stoppered contaiher containing a few crystals of iodine. 
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necked flask. The subsequent rate of addition of tBuCl (dissolved 
in 50 ml ether) was sufficient to maintain gentle ether reflux. 
Powdered grey selenium (3.83g, 49 mmol) was added slowly to the 
grey suspension over 30 min. with vigorous mechanical stirring and after 
a further 30 min., ether (50 mL) was added. After standing for 12 hr 
under nitrogen, the solution was cooled in ice, and ice-cold water (50 
mL) then sulfuric acid (150 mL, 2.5M) were added slowly over a period 
of two hours. Only a small amount of unreacted selenium remained 
undissolved. The ether layer was separated and combined with an 
ether extract (50 mL) of the aqueous layer. The combined colorless 
extracts (100 mL) were dried over sodium sulfate and stored at -20 0  
until use. This solution remained colorless (free of Bu t2Se2 ) under 
these conditions for 30 months. 
Bis(tert4outaneselenolatO)MerCury(II), Hg(SeBu t ) 2 
A portion of the ether extract from the preparation of Bu tSeH 
(80 mL) was distilled into a stirred solution of mercuric cyanide 
(6.12g, 24 mmol) in methanol (50 mL). The slightly brown precipitate 
was collected •(Whatman No.1), dissolved in boiling chloroform (250 mL), 
and on cooling, white, hairlike needles of Hg(SeBu t ) 2 were collected on 
a coarse sinter, nip. 145 (dec.). 
Infrared absorption: 2965m, 2925w, 2880w, 2815vw,sh, 1458sh and 1450m, 
1389w, 1365s, 1148s, 1023m, 514m, 397m, 296w, 270w, 135vs. 
Raman bands: (yellow excitation, below 1200 cm  1147m, 1027w, 
805w, 519s, 299m, 272w, 139vs,b. 
The analysis of Hg(SeBu t ) 2 is shown in Table 4.1, page 174. 
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1,30,3-Di-1j-chloro-2,4-dichloro-1,20,4;2,3;3,4-tetrakis-
p-1,1'-di-methylethaneselenolato-2,4-bis(pyridine)-  
quadro-tetramercury(II), [Bu tSeHgCl(py) 0. 04 
Mercuric chloride (0.106g, 0.39 mmol) dissolved in 1 ml pyridine was 
added to a stirred solution of bis(tert-butylselenolato)mercury(II) 
(0.185g, 0.39 mmol) suspended in 14 mL pyridine. Stirring for three 
minutes resulted in a clear, colorless solution which deposits a grey 
crystalline product at low volume. This product was redissolved in 
pyridine (10 mL), 10 ml Et0H added, and the solution filtered to remove 
a small amount of grey material. Evaporation deposits smell prismatic 
crystals which rapidly darken if kept exposed to the atmosphere. A 
single crystal of this product was suitable for crystallographic invest-
igation (jage 195) and was mounted in a Lindemann capillary while still 
wet with pyridine. 
Insufficient sample was availabe for spectral characterisation. 
tert-Butaneselenolato(methyl)mercury(II), MeHgSeBu t  
A portion of the ether extract from the preparation of Bu tSeH ( ,20 
mL, page 348) was distilled into an ice-cold solution of MeHg0H 
[prepared from MeHgNO 3 (o.927g, 3.34 mmol) and NaOH (3mL 2M, 6 mon] 
in 40 mL methanol. Water (10 mL) was added, and after standing for 
12 hr, the solution was filtered through a sinter containing cellulose 
powder. The sinter was rinsed with 20 mL Me0H and the combined aqueous 
MOH solutions extracted with hexane (2 x 25m1). Additional NaOH 
(3 mL 2M) and water (10 mL) were added to the aqueous layer which was 
extracted again with hexane (3 x 25 mL). The hexane extracts were taken 
to dryness under low vacuum ('25 mm) at 0°C. The crude white solid was 
purified by sublimation (50-60 0/15 mm), mp. 57-8.5° (sealed capillary). 
MeHgSeBut (C 5 1-1 12HgSe) requires: C 17.1, H 3.44, Hg 57.0%; 
found: C 17.0, H 3.50, Hg 57.0%. 
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Infrared absorption: 2970 and 2950vw, 2930w, 2885w, 2855w, 1465s,sh and -• 
1450w, 1361m, 1172w, 1148s, 1020w, 756m, 521m, 290w, 194s. 
Raman bands: (below 600 cm  526m, 302m, 200s, 142 and 127m. 
'H nmr (CDC1 3 ): 6 0.85 [3H,'CH3Hg(II)], 1.65 [9H, C(C) 3], 1 2J('H-
199Hg)1 146.8 Hz (see Figure 3.34, page 168): 
• tert-Butanethiolato(methyl)mercury(II), MeHgSBu t  
MeHgSBu t was prepared in a similar manner to the selenium analog 
but using Bu tSH, and pentane as the extractant. mp. 40-2° (sealed 
capillary, sublimes 40°/25 mm) [lit. 250b 41-2° (sublimes 28940 mm)]. 
Infrared absorption: 2970 and 2960vw, 2937 and 2920vw, 2890w, 2857w, 
1470w and 1454m, 1363s, 1152s, 821vw, 766m,br, 581w, 532m, 428m, 383m, 
352m, 305w, 234m, 130m. 
Raman bands: 2972m, 2958 and 2950m, 2932w, 2910vs, 2888s, 2795vw, 2769w, 
2707w, 1456 and 1438m, 1212m, 1180vs, 1150w, 1028vw, 932vw, 822s, 586s, 
536vs, 432m, 390s, 368m, 228s, 147m,br. 
'H nmr (CDC1 3 ): 6 0.78 E3H, CH3Hg(II)], 1.51 [9H, C(C) 3], 1 2JOH-
199Hg)1=150.1 Hz, [lit. 250b (CDC1 3) 0.77, 1.48, 150.2]. 
Bis(phenylmethyl)diselenide,(PhCH 2Se) 2 [Dibenzyldiselenide] 
Dibenzyldiselenide was prepared by the selenation of benzaldehyde 
in the presence of morpholine hydrochloride t . Morpholine hydrochloride 
(6.20 g, 50 mmol) was added in one portion to a nearly colourless ethanolic 
solution of NaHSe (prepared from 4.74 g, 60 mmol Se, page 338). 
Benzaldehyde (5.00 g, 47 mmol) was added in one portion to the resultant 
tMorpholine hydrochloride was obtained by protonation of morpholine 
(100 g, 1.15 mole) dissolved in 100 mL ethanol, by ethanolic HC1 (12.7M, 
prepared by the addition of HC1 to conc. H2SO4).7'8 
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white suspension, and the mixture heated to reflux on a water bath for 
1 hr then cooled in ice. Red polyselenide impurities were reduced 
with small portions of solid NaBH4 to produce a yellow solution. 
Addition of ice-cold water (100 mL) precipitated the yellow product 
which was collected by filtration and rapidly washed with water to 
remove easily oxidised selenol impurities which otherwise rapidly 
decompose in air to red Se. The yellow powder NO g crude) was 
recrystallised from ethanol. 
The product was used as a source of benzylselenolate anion, but 
subsequent preparation of benzylselenol was more convenient for this 
purpose. 
Phervimethaheelehol, PhCH2SeH Denzylselenoll 
Benzylselenol was prepared by Painter's Grignard method
501 
from 
benzylmagnesium chloride (prepared from 24.3 g Mg, 1 mole and freshly 
distilled benzylchloride, 115 g, 1 mole, bp. 61.0-61.5°/8mm) and selenium 
(78.98 g, I mole) by the same method as for tBuSeM9C1 (page 349). 
Gaseous HC1 (prepared from 53.5 g NH 4C1 and conc. H 2SO4 759) was 
passed over the ether solution with vigorous stirring. An appreciable 
quantity of H2Se evolved and trapped in 50% sodium hypochlorite solution. 
Water (250 ml) was slowly added (CAUTION - vigorous decomposition) 
followed by an additional 80 ml conc. HC1 in 250 ml water. The combined 
aqueous/ether layers (1000 mL) were filtered (gravity only) into a 1L 
separating funnel and separated. The ether layer was dried over sodium 
sulfate, filtered, and evaporated to yield 120 mL yellow oil. Fractional 
distillation under nitrogen yielded q.50 mL colorless oil, bp. 67-8°/2 mm 
[lit. 
501 
 100-5°/20 mm]. 
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Bis(phenylmethylselenolato)merCury(II), Hg(SeCH 2Ph) 2 
Benzylselenol (5.96 g, 35 mmol) was added with magnetic stirring to 
mercuric cyanide (4.95 g, 19 mmol) in 25 ml methanol, under nitrogen. 
The immediately precipitated yellow product was collected by filtration 
and washed with Me0H (5 x 5 mL). Portions of the crude product were 
recrystallisedfrom benzene or chloroform to yield bright yellow, 
crystalline Hg(SeCH 2Ph) 2 , mp. 111°(dec.). 
Infrared absorption: 3020vw, 1598vw, 1492m, 1175m, 1062w, 1028w, 907w, 
827s, 757s, 694s, 598s, 549m, 449m, 328vw, 236w, 158s,br. 
Raman bands: (spinning cup below 1700 am-1 only) 1603m, 1219m 1177m, 
1002m, 605m, 232w, 149s. 
The analysis of Hg(SeCH 2ph) 2 is shown in Table 4.1, page 174. 
Bis(phenylmethylthiolato)mercury(II), Hg(SCH 2Ph) 2 
This compound was prepared in quantitiative yield in an identical 
manner to Hg(SeCH 2Ph) 2 as a white microcrystalline product, mp. 115-7°. 
Infrared absorption: 3050 and 3020vw, 1490m, 1460m, 1442m, 1229m, 1195vw, 
1151vw, 1065w, 1028m 910vw, 760w, 690vs, 620w, 565m, 472m, 381s, 352vw, 
325vw, 246w. 
Raman bands: 3050s, 2936m, 1602s, k230s, 1430vw, 1230s, 1202w, 1160w, 
1021w, 1004s, 810w, 767m, 688m, 627w, 566w, 476vw, 385vw,sh, 356s, 327vw,sh, 
244m, 107s. 
Phenylmethanethiolato(methyl)mercury(II), MeHgSCH 2Ph 
Benzylthiol (0.25 g, 2.2 mmol) was added by syringe, under nitrogen, 
to MeHgNO 3 (0.60 g, 2.2 mmol) in 5 ml Me0H. After one minute, a 
transitory cloudiness disappearedto give two clear phases. 
Water (5 mL) was added and the cloudy mixture extracted with 
pentane (4 x 10 mL). The pentane extracts were dried by passage through 
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a microcolumn of silica t , then evaporated to dryness under nitrogen to 
yield 0.25 g (34%) of colorless oil. The product smells of BzSH 
impurity confirmed by the Raman spectrum. 
Infrared absorption: 3090vw, 3065w, 3030m, 3000vw,sh, 2915m, 2860vw, 
2400vw, 1738vw, 1601w, 1494m, 1453m, 1382s,br, 1233m, 1202w, 1183w, 
1157w, 1069m, 1029w, 912w, 828m, 767s, 700s, 680m, 566m, 538m, 476w, 
346m. 
Raman bands: 2055s, 2925w,sh, 2913s,(2580w) , 1601m, 1233s, 1203m, 
1179s, 1030m, 1004vs, 804m, 770m, 702vs,sh and 684m, 621w, 565vw,sh and 
540vs, 477w, 365vw,sh and 342s, 277w. 
Phenylmethaneselenolato(methyl)mercury(II), MeNgSeCH 2Ph 
This compound was prepared in a similar manner to MeHgSCH 2Ph, using 
benzylselenol (0.30 g, 1.7 mmol) and extracting with carbon tetrachloride. 
The silica microcolumn drying step was omitted as significant losses of 
sulfur analog appeared to be due to this procedure. 
Infrared absorption: 3085vw, 3065w, 3038m, 3000w,sh, 2940w,sh and 2910m, 
2400w, 1600m, 1495s, 1464m, 1385vs, 1174m, 1030w, 913w, 829m, 760s, 699s, 
600m, 551w, 528m, 447w. 
The complex decomposes in the Raman laser-beam. 
The crude product (0.58 g, 88%) was pumped under high vacuum (21 mm) 
to remove solvents, excess selenol and water, but still smelled of Bu tSeH, 
and was consequently not analysed. 
Diselenodiacetic acid, (SeCH 2CO2H) 2 
Selenocyanatoacetic acid, NCSeCH 2CO2H, 759 was prepared by displacement 
tpreviously dried at 250 0 . 
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of bromide from bromoacetic acid (9.57 g, 69 mmol) dissolved in 50 mL dry 
acetone. Potassium selenocyanate (9.95 g, 69 mmol) dissolved in 100 mL 
dry acetone was added dropwise with magnetic stirring to this solution 
cooled in ice. The precipitated KBr (light purple due to Se impurities) 
was removed by filtration under slight positive pressure (CAUTION). 
Acetone was removed by rotary evaporation of the nearly colorless 
filtrate, to leave a pale yellow oil. Acid hydrolysis of the oil by 
refluxing 21/2 hrs with 100 mL 1M HC1 produced a deep yellow-orange 
solution which was allowed to stand overnight, exposed to the atmosphere, 
but in the dark. This solution was extracted with ether (5 x 50 mL) 
then with ethyl acetate (2 x 50 mL). The combined extracts were 
evaporated and the yellow residue dissolved in 50 ml ethyl acetate. 
Addition of 1 00 mi. benzene and cooling produced (SeCH 2CO2H) 2 as light 
yellow crystals (7.72 g, 53%), mp. 93-5° [lit. 759 101°]. 
Bis(selenoacetato)mercury(II), Hg(SeCH 2CO2H12 
Diselenodiacetic acid (0.64 g, 2.3 mool) was dissolved in 20 mL 
water and the pH lowered to 1.5 with 2.5 M H 2SO4 . Excess metallic 
mercury was added and the yellow mixture immediately turned brown, 
changing to yellow on stirring overnight. The metallic mercury was 
removed by dissolving the yellow precipitate with saturated NaHCO 3 
solution followed by rapid filtration into 2.5M H 2SO4 (the dianion is 
unstable in alkaline solution). This procedure was repeated until the 
filtrate was clear yellow (twice), and the reprecipitated yellow powder 
filtered with some difficulty. 
Infrared absorption: 2700-3300s,br, 2525w, 2515w, 1692s, 1612w, 1452s 
and 1394vw,sh, 1301vw,sh and 1275vs, 1172m, 930m and 911w,sh, 854vw, 
713vw, 649m, 521vw, 446m and 433w,sh, 241s and 222m. 
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Raman bands (orange excitation at 10K, below 350 cm -1 only because of 
sloping background): 313m, 284s, 224m, 192s, 172m. 
Bis(mercaptoacetato)mercury(rr), Hg(SCH 2CO2H)2 
Mercuric chloride (0.272 g, 1.00 mmol) in 5 ml Et0H was added with 
stirring to mercaptoacetic acid (0.187 g, 2.03 mmol) in 25 mL water 
containing 1 mL 5M HNO 3 . Glistening, white plates were precipitated 
and were collected by filtration and dried in vacuo. 	Yield 0.255 g 
(67%). 
The analysis of Hg(SCH 2CO2H) 2 is shown in Table 2.4, page 49. 
Infrared absorption: 2800-3300m,vbr, 2960w, 2915w, 1713s, 1688s, 1418m, 
1382w, 1305s, 1238vw, 1202s, 1170w, 898m, 862w,br, 787m, 677m, 552m, 
464w,sh, 446s,br, 379s, 351w, 226s, 155m. 
Raman bands (below 1700 cm  1650vw, 1395w, 1215w, 920w and 
900vw,sh, 795m, 670vw, 435w 370w,sh and 347s, 235m, 177w, 142vw. 
[bis(mercaptoacetato)mercurate(2-1)],dipotassium salt, K 2[Hg(SCH 2CO2 ) .1 
Bis(mercaptoacetato)mercury(II) (3.65 g, 9.5 mmol) was suspended in 
50 mL N2-bubbled water and dissolved by the addition of KOH (1.06 g, 
19.0 mmol). The solution was filtered and evaporated in a nitrogen- 
filled CaC1 2 dessicator to give a grey powder. The powder was dissolved 
in 70 mL hot water containing a small amount of activated charcoal, 
filtered and cooled. The resulting white microcrystalline precipitate was 
filtered off, washed with ethanol and dried in vacuo over CaC1 2 . 
The analysis of this product is shown in Table 2.4 page 49. 
Infrared absorption: 2900-3600vs,vbr, 2895vw, 1572s, 1382s, 1228m, 1216m, 
1160, 919w, 894m, 769m, 678 and 670w, 550m, 431s, 355s, 321w, 235w. 
Raman bands (yellow excitation, below 800 cm  710m, 437w, 417w, 
360w, 328vs 241w (in H 20, pH 6.3, below 400 cm  336vs,p. 
Acetato(methaneselenolato)mercury(II), MeSeHg0 2CMe 
Bis(methaneselenolato)mercury(II) (0.120 g, 0.34 mmol) was added to 
•a solution of mercuric acetate (0.107 g, 0.34 mmol) in 5 mL water 
• containing 3 mL Et0H. After 15 min the colorless solution was filtered 
to remove a small amount of unreacted Hg(SeMe) 2 . The filtrate deposited 
colorless crystals on slow evaporation which were collected (0.193 g, 
81%) and dried over P 205 . 
MeSeHg02CMe (C3HSO2SeHg) requires C 10.2, H 1.71, Hg 56.7%; 
found: C 10.2, H 1.75, Hg 56.5%. 
Infrared absorption: 2995vw, 2955w,sh, 2925w, 2857w, 1535s, 1410m,sh and 
1392s, 1339m, 1282m, 1040w, 1008m, 931 and 923m, 661s, 611m, 474m, 218s, 
182m, 134s and 114m,sh. 
Raman bands (below 2200 cm  1535vw,br, 1400vw, 1334vw, 1279vw, 
923w, 663vw, 613vw, 574m, 480w, 230vw,sh, 197 and 182s, 143s. 
Selenoacetato(methyl)mercury(II), MeHgSeCH 2CO2H_ 
Diselenodiacetic acid (.0.388 g, 1.40 mmol) was dissolved in ammonium 
hydroxide solution (10 mL 2M) under nitrogen. Rongalite t (0.237 g, 1.54 
mmol) was added in one portion with magnetic stirring, and very small 
additional portions added until the initial yellow solution remained 
colorless for 5 min. 
Methylmercuric nitrate (0.78 g, 2.81 mmol) dissolved in 5 mL 
deaerated water was added, followed by immediate acidification (Congo 
Red) with 5M HNO 3 . The deposited white shiny leaflets were collected 
t
Rongalite = 'sodium formaldehyde hydrosulfite', HOCH 2S02Na.2H 20, was 
obtained from Fluka AG, Buchs. 
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on a sinter (#4) and briefly washed with dilute HNO 3 , then a few drops 
of ethanol and dried in vacuo. 	Yield 0.65 g (67%). Attempted 
recrystallisation from ethanol resulted in deposition of grey Se. 
The product is photosensitive and was stored at -20 0 . 
MeHgSeCH2CO2H (C3H602SeHg) requtres : C 10.2 H 1.68, Hg 56.7, Se 22.3%; 
found: C 9.9, H 1.68, Hg 56.7, Se 22.1%. 
Infrared absorption: 2995vw, 2955w,sh, 2925w, 2857vw, 1530s,br, 1410w,sh 
and 1395s, 1339m, 1282m, 1040w, 1008m, 931 and 923m, 661s, 611w, 474w, 
218s,br, 182m, 134s,br, 114w,sh. 
Raman bands (below 1600 only): 1535vw br, 1402vw,br, 1334vw, 1279vw, 
1006vw, 923w, 663vw, 613vw, 574m, 480w, 230vw sh, 197s,sh, 182m, 143s. 
Mercaptoacetato(methyl)mercury(II), MeHgSCH 2q02H._ 
Mercaptoacetic acid (0.172 g, 1.86 mmol) was added to methylmercuric 
nitrate (0.517 g, 1.86 mmol) in 15 ml water with stirring. An additional 
5 ml water was added to clarify the slightly cloudy mixture which was 
filtered and allowed to evaporate. Fine colorless needles were collected 
after 20 hr. The analysis of this product is given in TAble 2.2, page 
38. 
Infrared absorption: 2985w, 2940vw, 2910m, 1702s, 1440m, 1412w,sh, 
1390 and 1375m, 1282m, 1185 and 1179s, 900 and 870m, 778 and 769 m, 
722w,sh, 654 and 627m, 550 and 529w, 477m, 426m, 334 and 318m, 243w. 
Raman bands: 2991m, 2932m, 2916vs, 1188m, 910vw, 793w, 676m, 580w, 
538vs, 329s, 265vw, 180w, 153m, 138m. 
(in D20, pH = 5.6): 2983m, 2921s, 2870m, 1450w, 1392w, 1334w, 1189s, 
1017w, 932w, 831m, 779w, 546vs, 500vw, 351m. 
1 H nmr (D20, pH = 5.6) s -2.98 relative to dioxane = 10.0, I 2J( 1 199Hg)I 
= 170.5 Hz. 
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Bis(2-hydroxyethyl)diselenide, (HOCH 2CH2Se) 2 
Rongalite (19.7 g, 128 mmol) and sodium hydroxide (12.6 g, 315 mmol) 
were dissolved in 250 mL water under nitrogen. This solution was added 
in one portion to grey selenium (25.2 g 319 mmol) in a 1L 3-necked 
flask and the mixture stirred and heated on a boiling water bath to 
dissolve Se (3 hrs). Freshly distilled 2-chloroethanol, bp. 176-7° 
(26.3 g, 327 mmol) was added dropwise with stirring to the deep red 
Na2Se2 solution. When N95% of the halide was added, an orange oil 
separated which was decanted and dissolved in acetone after cooling to 
room temperature. The aqueous phase was extracted with chloroform 
until the extracts were light yellow. The combined acetone and chloroform 
extracts were evaporated to dryness, then pumped at high vacuum (0.1 mm) 
to remove water. Yield of crude oil 26.2 g (83%) which was fractionally 
distilled, bp. 152-60°/0.05-0.2 mm [lit. 755 169-79°/1.6-4 mm]. , 
Surprisingly, the diselenide is odorless. 
,Attempted isolation of 2-hydroxylethaneselenol, HOCH 2CH 2SeH 
Bis(2-hydroxyethyl)diselenide (8.78 g, 35 mmol) was dissolved in 
30 mL sodium-dried ether, and cooled to -30° with dry ice/acetone. 
Sodium-dried liquid ammonia was condensed into this solution (N130 mL) 
under a slight flow of nitrogen. Metallic sodium was added as a solution 
in liquid ammonia (using a refluxing condenser-thimble arrangement 
described in reference 756) until a blue color persisted for 5 min. 
At this stage the mixture turned whte and cloudy. The ammonia 
was evaporated under nitrogen and 10 mL deaerated water added dropwise 
to the residue followed by conc. HC1 (CAUTION - vigorous) until pH 3-4. 
The white oily residue (NH 4CL) was pumped (N4 mm) in warm water (<55°) 
to remove water, HC1, etc., then at higher vacuum (0.1-0.2 mm) with 
361 
warming to 60°. A colorless oil was condensed in a cold trap (-15°) 
0 
Addition of freshly dried 5A molecular sieves to the oil under nitrogen 
resulted in gas evolution and complete decomposition overnight. 
(2-phenylmethylseleno)butanedioic acid  
Bis(phenylmethyl)diselenide (0.655 g, 1.93 mmol) was dissolved in 
20 mL Et0H and just reduced with small additions of solid NaBH4 under 
nitrogen. A solution of cis-2-butenedioid acid (maleic acid, 0.456 g, 
3.93mmol) in 20 mL Et0H containing NaOH (0.3 g, 7.5 mnol) was added by 
syringe to the solution of selenolate. The nearly colorless solution 
was stirred for 2 hr at 50° and separated into two phases. The bottom 
layer was separated and acidified with conc. HC1 (5 mL). The resultant 
white precipitate was collected by filtration and washed with 10% HC1. 
Yield 0.54 g (48%), rap. 169-71 0 . 
PhCH 2SeCH(CO2H)CH 2CO2H (C il H 1204Se): requires C 46.0, H 4.21, Se 27.5%; 
found C 46.0, H 4.39 Se 27.2%. 
Infrared absorption: 2600-3300s,br, 1690vs, 1494m, 1415s 1319m, 1235m, 
1198m, 1065m, 918m,br, 854w, 811vw, 758s, 699s. 
'H nmr (acetone-d6 ; Figure 5.3 page 259) 
7.35 (m, 5H, C6H5 ), 4.7 (br, 2H COii), 4.15 (s, 2H, CH2Se), 3.75 (q, 1H, 
CHCO2H), 2.85 (m, 2H, CH2CO2H). See Table 5.7, page 261 for coupling 
.constants. 
• 
Mass spectrum: M+ = 287.9904; calc. 287.9898 
(2-phenylmethylmercapto)butanedioic acid  
This compound was prepared by base-catalysed addition of benzylthiol 
(2.22 g, 17.9 mmol) to the sodium salt of maleic acid (2.08 g, 17.9 msol) 
in an identical manner to the selenium analog nip. 173-5°. 
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Infrared absorption: 2600-3300 m,vbr, 1710 and 1692s, 1495w, 1434m, 
1410m, 1352vw, 1321m, 1240s, 1206 and 1198m, 1177w, 1081m, 999w, 921m and 
714,sh, 853w, 837vw, 771w, 718 and 710m, 672w. 
1 H nmr (acetone-d 6 ; Figure 5.2 page 258): 
6 7.39 (m, 5H, C6L15), 4.2 (br, 2H, CO 2H), 4.03 (s, 2H, CLI2Se), 3.17 (q, 
1H, CHCO2H), 2.80 (m, 2H, CH2CO2H). See Table 5.7, page 261, for coupling 
constants. 
Mass spectrum: 11  240.0420; ca;c. 240.0456. 
trans-(2-phenylmethylseleno)butenedioic acid  
Acetylenedicarboxylic acid t (0.99 g,'8.7 mmol) was dissolved in 
15 mL 1M NaOH, the pH of this solution adjusted with HC1 until just 
alkaline (pH el,8) and solid sodium carbonate (1.84 g, 17 mmol) added. 
This solution was deaerated by nitrogen bubbling for 15 min then 
added by syringe to neat benzylselenol (1.49 g, 8.7 mmol) under nitrogen. 
After stirring for 40 hr, the mixture was extracted with ether (25 mL) 
and the aqueous phase acidified with conc. HC1 (Congo REd). The bright 
yellow precipitate was collected by filtrat , and recrystallised from 
ethanol as bright yellow needles. Yield 2.09 g (84%), mp. 180-3° (dec.). 
PhCH 2SeC(CO 2H):CHCO2H (C 1 11-1 1004Se) requires: C 46.7, H 3.53, Se 27.7%; 
found: C 46.6, H 3.59, Se 27.8%. 
Infrared absorption: 2600-3400s,vbr, 1695w,sh, 1670s, 1557m, 1493m, 
1453w, 1414s, 1312m, 1266s, 1231s, 1173w, 1060w, 1028w, 952w, 916w, 888 
and 875m, 861m, 778w, 764m, 743w, 695s, 656w, 617w. 
1 H nmr (acetone-d 6 ): 6 7.38 (m, 5H, C61:15 ) 6.45 (s, 1H, CH=C), 5.1 (br, 
tAcetylenedicarboxylic acid was prepared form the dipotassium salt by 
acidification with sulfuric acid and extraction with ether.761 
2H, CO 2H), 4.25 (s, 2H, Cy). 
Mass spectrum: M
+. 
= 285.9794; calc. 285.9744. 
trans-(2-phenylmethylmercapto)butenedioic acid  
This compound was prepared in 78% yield by the base-catalysed 
addition of benzylthiolate •to acetylenedicarboxylic acid in an identical 
manner to the selenium analog. 
The product was recrystallised as pale yellow crystals from Et0H, 
mp. 151-2°. 
Infrared absorption: 2500-3300m,vbr, 1706 and 1674vs, 1560m, 1497w, 
1416m, 1326 m and 1313w, sh, 1270m, 1238 and 1232s, 1070w, 1048m, 1028w, 
957w, 920w, 890m,br, 857m, 783m, 752m, 729m, 710w and 699m. 
1 H nmr (acetone-d6 ) = cS 7.39 (im, 5H, C 6H5 ), 6.69 (s, 1H, CH=C), 5.3 
(br, 2H, CO 2H), 4.21 (s, 2H, C). 
Mass spectrum: M  238.0306, calc. 238.0300. 
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Attempted preparations of 1,3-diseleno-2-propanol (SeDMPH 2 ) 
1,3-dibromo-2-propanol was prepared for these reactions by hydro-
bromination of epibromohydrin.
762 
Hydrobromic acid (38 mL 46-48% w/v, 
0.342 mole) was added dropwise over a period of 30 minutes to epibromo-
hydrin (Fluka, 41.55 g, 0.303 mole) in 40 ml ethanol at 70-75°, with 
magnetic stirring. After stirring for a further 30 minutes at 60-70°, 
the solution was cooled to room temperature and ethanol removed under 
reduced pressure. The yellow oily residue was stirred with ether 
(300 mL) and washed successively with H 20 (3 x 100 mL), 1% w/v sodium 
bicarbonate solution (3 x 80 mL), then H 20 (3 x 100 mL). The dried 
(MgSO4 ) ether extract was evaporated and vacuum distilled to give the 
product as a colourless oil (51-55%) bp. 77-80°/4mm (lit. 762 82°/6 mm). 
The product darkens in amber glass at room temperature and was redistilled 
before use. 
(i) Selenocyanation of 1,3-dibromo-2-propanol  
Potassium selenocyanate (1.715 g, 119 mmole) dissolved in 10 mL dry 
methanol was added to 1,3-dibromo-2-propanol (1.270 g, 58.3 mmole) under 
nitrogen and the resulting red solution refluxed for 30 minutes. 
Silica TLC showed no change in product distribution after this 
time. The reaction mixture was diluted with water (20 mL) and extracted 
with ether (3 x 30 mL) under nitrogen. The dried (Na2SO4) ether extracts 
were evaporated under nitrogen to yield a dark yellow oil (1.14 g) having 
-1 
intense infrared absorption (2135 cm ) due to selenocyanate. This oil 
could be separated by Ggel-Rohr distillation, giving two fractions. 
The first, bp. 50-53°/0.01 mm, showed no absorption due to CEN in the 
infrared spectrum, and was discarded. The second, bp. 60-75°/0.01 mm, 
-1 
has v CEN 2135 cm and was identified as 1-bromo-3-selenocyanato-2- 
propanol. 
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Infrared absorption: 
3390 vs(br,OH), 3010 vw, 2955 w, 2880 w, 2135 s(vCEN), 1694 m(br), 
1610 vw, br, 1418 s and 1400 sh, 1300 vw, 1274w, 1232m, 1210m, 
1170 w, 1147 w, 1074 m, 1046 m, 1020 s, 966 w, 926 vw, 905 vw, 855 sh 
and 836 w, 697 w, sh and 670 m, 582 w, 520 w and 498 w. 
H nmr (6CDC1 3 ) - seepage 
2.9(br,1H,CO2H); 3.28, 3.38(d, 1H, H a ); 3.35(s, 1H, Hb ); 3.56, 
3.62(d, 2H, 2H d); 4.23(m, 1H, H e). 
Mass spectrum - see page 
M
+. 
accurate mass 242.8814, C 4H6BrNOSe requires 242.8796. 
(ii) Alkylation of NaSeH with 1,3-dibromo-2-propanol  
A solution of 1,3-dibromo-2-propanol (38.35 g, 176 mmole) in 
ethanol (20 mL) was added dropwise to a light grey ethanolic solution 
of NaSeH (300 mL containing 25.3 g, 320 mmole Se). After 1 hour, small 
portions of solid sodium borohydride were added to produce an orange 
solution (which could be decolourised in subsequent preparations by 
addition of further small amounts of solid NaBH 4 ) and a white precipitate 
(NaBr, H 3803 ). The solution was cooled in ice, and glacial acetic acid 
(26 mL) added with vigorous nitrogen bubbling to expel H 2Se after warming 
to room temperature. (A prior attempt to steam-distil the reaction 
products at this stage produced large quantities of red selenium and 
much H
2
Se). The mixture was filtered, evaporated to low volume, and 
the resultant orange slurry shaken with ether and refiltered. Evaporation 
of the ether extract produced an orange oil which could be distilled under 
reduced pressure to give an orange oil, bp. 79-85°/3.5 mm (11.49 g), 
containing some unreacted 1,3-dibromo-2-propanol (nmr). 
366 
The crude oil was fractionally distilled (4gel-Rohr) to give two 
fractions. The first (bath temp. 60-3/4 mm) was mainly selenetan-3-ol. 
Infrared absorption: 3100-3800vs,vbr, 3005w, 2948m, 1655w,sh and 1610s, 
1635w, 1445s and 1418m, 1322m, 1270w,br, 1165m, 1124m, 1050s,br, 980w,sh, 
898m, 869m, 813w, 710w,sh, 680w,sh and 655m. 
'H nmr (CDC1 3 ): 4.85 (q, 1H, CHOH), 4.23 (br, 1H, OH), 3.38 and 3.15 
(d.t. 4H, SeCH2 ). See Figure 5.6, page 270. 
Mass spectrum: (Figure 5.5a, page 267) M 4- = 137.9603; calc. 137.9603). 
The higher boiling fraction gave a less well resolved nmr spectrum. 
The mass spectrum of the major component in this fraction is shown in 
Figure 5.5b, page 268. 
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APPENDIX 1  
Conference poster-paper PI-1, presented at the 10th annual 
meeting of the RACI Division of Coordination and Metal-Organic 
Chemistry (COMO-10), Queenstown, New Zealand, May 11-14, 1981. 
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AQUEOUS SOLUTION EQUILIBRIA FOR MeHgII WITH ANTIDOTES FOR 
MERCURY POISONING 
A.P. Arnold and A.J. Canty, Chemistry Department, University of 
Tasmania, Hobart, Australia. 
The classical antidote for heavy metal poisoning, British Anti-Lewisite (I, 
2,3-dimerCapto-l-propanol) is ineffective for MeHgII poisoning in mammals. 
Administration of T increases the amount of mercury in the brain, contrary to 
the requirements of an effective Antidote. - In vitroformation of complexes 
such as (MeHg)2BAL I, which are soluble in pyridine but insoluble in aqueous 
'systems, may be relevant to the suggested lipid solubility of Such species 
in vivo-. 	A . successful MeHg antidote (animal testing only) is meso-2,1-, 
dimercaptosuccinic acid (II, DMSA) which is tar less toxic than I and may be. 
administered orally. 
In view of the close structural relationships between land II, we have 
investigated the aqueous solution equilibria in, systems containing MeHgII with 
'these dithiols, as well as with thiol ligands such as 2,1-dimercapto-l-propana. 
sulfonate-Na+ .H20 (III, Unithiol), 2-mercaptoSUccinic acid (IV) and mercapto7 
atetic acid (V). 	Thiols II-V are expected to form MeHg // complexes which are 
deprotonated at physiological pH, thus minimising lipid solubility and enhancing 
•the possibility of renal . excretion. 
Solid MeHe /  complexes have been obtained with I-V. IR and Raman evidence . 
support the expected unifunctional MeHg/I with linear Me-Hg-S coordination, e.g. 
• (HO2C)(MeHgS)CHCH(SHgMe)(CO2H) for II. 
PotentiOmetric titration studies using a modified version of MINIQUAD, 4 show 
high formation constants, as expected for 'soft' MeHg/I with 'soft' thiol donors. 
Under condition used in animal studies of II with MeHg I/ poisoning, ([DMSA] 
>100 [MeHe / ])i'the predominant species at pH ‘,7 is likely to be (-02C)(MeHgS). 
CHCH(SH)(CO27).as shown in the species distribution diagram-, This is consistent 
with efficient elimination of MeHg /I as a Water soluble complex via the kidneys • 
After administration of 
pH 
1. A.J. Canty and R. Kishimoto, Inorg. Chim: Acta, 24, 109 (1977). 
2. M. Berlin, L.-G. Jerksell and G. Nordberg, ACta Pharmacol. Toxicol., 23, 
312 (1965). 
3., 	See, for example; J. Aaseth and E.A..H. Friedheim, Acta Pharmacol. Toxicol., 
42, 248 (1978). 
4. R.N. Sylva and M.R. Davidson,  J.C.S. (Dalton), 465 (1979) and ref. therein. 
5. Using model conditions of 10- r mole,MeHei and 5 x 10'6 mole DMSA in 10 ml 
• aqueous volume. 	Species with two MeHgn per dithiol ligand are unimportant 
• under these conditions (less than 1% total MeHg1/). 
APPENDIX 2  
Computer program COMIXH. 
Written in Algol/8 (a compact implementation of Algol 60 for the 
Chemistry Department's PDP8/e computer) and incorporating plotting 
routines to suit the Chemistry Department's HP7221A plotter. 
The data input formed is described in the initial comments to 
the program. 
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'BEGIN 'CUMMENT' PROGRAM COMIXH SIMULATES TITRATION CURVE.GIVEN EXPTL. 
DATA AND APPROPRIATE FORMATION CONSTANTS. 
THIS VERSION INCORPORATES A GAUSS-NEWTON PROCEDURE 
FOR ITERATIVE SOLUTION OF THE NON-LINEAR EQUATIONS FOR 
FREE-LIGAND.METAL AND PROTON CONCENTRATIONS. 
FREE COMPONENT CONCENTRATIONS HAVE BEEN CONSTRAINED 
TO BE POSITIVE BY LOGARITHMIC TRANSFORMATION. 
THE PROGRAM WAS WRITTEN IN ALGOL/8 BY ALAN ARNOLD 
FOR USE ON THE ,CHEMISTRY DEPARTMENT'S PDPEIE 
COMPUTER.PLOTTING ROUTINES ARE DESIGNED FOR USE 
WITH THE HP722IA PLOTTER.; 
'COMMENT' INPUT DATA IN THE FOLLOWING FORMAT: 
1.TITLE OF EXPT.,BETWEEN QUOTATION MARKS(') 
2.NUMBER OF COMPONENTS (MAX.4) 
3.NUMBER OF COMPLEXES (MAX.20) 
4.DATA FOR EACH COMPLEX SPECIES: 
-NO.MOLECULES EACH COMPONENT 
-LOG.OF CUMULATIVE STOICHIOMETRIC ASSOCIATION CONSTANT 
5.DATA FOR EACH COMPONENT (SAME ORDER AS 2) 
-INITIAL MMOLES 
-CONCENTRATION IN TITRANT(M) 
-ESTIMATE OF INITIAL CONCENTRATION (M) 
6.INITIAL VOLUME (ML.) 
7.NUMBER OF TITRATION POINTS(MAX.80) 
B.PHCAL SUCH THAT -LOGEH+]=PH(EXPTL.)+PHCAL 
9.TITRATION DATA IN PAIRS OF VOL(ML.).PH(EXPTL.); 
'REAL"ARRAY' 	VOL,PH[0:80),BETAC1:203. 
TITCONC.TOT,MMOLES.LNFREE.INITCONCC1: 4 ] , HC 1 : 80,0 : 10] ; 
'PEAL" 	HX.V,VINC,MAXX,MAXY,MINX.MINY,VINIT.VTOT , 
LrBrTrFOPHCAL; 	 - 
'1NTEAEk: 	NC,NDATA,NrIPT.I.J,KrINDEX,MAXIT,PEN,TTY.COMPl.COMP2; 
'1, 00LEAN' SINGUL,SUPLAB; 
'INTEOER"ARkAY' 011:4.1:20];  
'PROCEDURE' SIMUL(N,X0rAPEPS);'VALUE' N.EPS; 
'COMMENT' GAUSS-JORDAN SOLUTION OF N EQUATIONS OF AUGMENTED MATPIF.A 
USING MAXIMUM-PIVOT STRATEGY. 
REF..APPLIED NUMERICAL METHODS',CARNAHAN ET.AL .,P289i 
'INTEGER' Ni'REAL"ARRAY . XO,A;'PEAL' [PS; 
'BEGIN! 
'REAL' PIVOTIAIJCK; 
'INTEGER' IrJ.KIISCAN,JSCANTIROWK.JCOLKrIPOWIIJCOLI; 
'INTEGER"ARRAY' IROW.JCOLEO:NCJ; 
'FOR' K:=1 'STEP' 1 'UNTIL' N 'DO' 
'COMMENT' BEGIN ELIMINATION; ' 
'BEGIN' 	PIVOT:=0.0; 
'FOR' I:=1 'STEP' 1 'UNTIL' N 'DO' 
'FOR' J:=1 'STEP' 1 'UNTIL' N 'DO' 
'BEGIN' 
'COMMENT' SCAN FOR INVALID PIVOT-POW SUBSCRIPTS: 
'IF' ti41 'THEN' 
'FOR' ISCAN:=1 'STEP' 1 'UNTIL' 5-1 'DO' 
'FOR' JSCAN:=1 'STEP' 1 'UNTIL' K-1 'DO' 
'IF' I=IROW[ISCAN] 'OR' J=JCOLEJSCAN7 'THEN' 
'GOTO' LOOP; 
'IF' ABS(AEI,JMABS(PIVOT) 'THEN' 
'BEGIN' PIVOT:=AEI,J]; 
IROWEN]:=I;JCOLCK]:=J; 
'END'; 
LOOP: 	'END': 
'IF' ABS(PIVOT) 	EPS 'THEN' 
'BEGIN' 
SINGUL:='TRUE';IPT:=1; 
'GOT' EXIT; 
'END': 
IROWK:=IROWCK);JCOLK:=JCOLEK); 
'COMMENT' NORMALISE PIVOT-ROW ELEMENTS; 
'FOR' J:=1 'STEP' 1 'UNTIL' N+1 '['O' 
ACIROWK+j]:=AEIROWK,J1/PIVOT; 
ACIROWK,JCOLK]:=1.0/PIVOT; 
'COMMENT' CARRY OUT ELIMINATION; 
'FOR' I:=I 'STEP' 1 'UNTIL' N 'DO' 
'BEGIN' AIJCK:=AEIrJCOLK); 
'IF' ISIROWK 'THEN' 
'BEGIN' ACITJCOLK]:=-AIJCK/PIVOT; 
'FOR' J:=1 'STEP' 1 'UNTIL' N+1 'DO' 
'IF' J$JCOLK 'THEN' 
ACI.JJ:=AEI,J]-AIJCK#ACIROWK,JJ; 
'END': 
'END'; 
'END': 
'COMMENT' ORDER SOLUTION ARRAY; 
'FOR' I:=1 'STEP' 1 'UNTIL' N 'DO' 
'BEGIN' IROWI:=IROWEIII; 
JCOLI:=JCOLCii; 
XOEJCOLI]:=ACIROWI.N+11; 
'END'i 
'COMMENT' ARRAY XO CONTAINS THE 'SOLUTION VALUES; 
EXIT: 	'END' OF SIMUL; 
'PROCEDURE' LABEL; 
'COMMENT' TRANSFERS 'LABELS FROM VDU OR DECWRITER TO PLOTTER; 
'BEGIN"IF"NOT' SUPLAB 'THEN' 
'BEGIN' 
REPEAT: TEXT(7,'*SYS:LABELS.DA/2 OPEN FOR 0/P'); 
TEXT(TTY,'PLOT LABEL');TITLE(TTY.3); 
FILE(3); 
'COMMENT' CLOSES LABELS.DA FOR 0/P AND REOPENS FOR I/P: 
TEXT(4,' PLOTTER GET ENTRY PRINT 
TITLE(3,4): 
CHOUT(4.129);TEXT(4.' VDU '); 
TEXT(TTY,'ANOTHER LABEL? (YIN)'); 
'IF' CHIN(TTY)=217 'THEN"GOTO' REPEAT; 
'END': 
'END' OF LABEL; 
'PROCEDURE' TITLE(DEVIN.DEVOUT)i'VALUE' DEVIN.DEVOUT; 
'COMMENT' READS LABELS BETWEEN OUOTAIION MARKS FROM DEVICE IN. 
AND TRANSFERS THEM TO DEVICE OUT 
'INTEGER' DEVIN.DEVOUT: 
'BEGIN' REAL' CHAR:'INTEGER > CASE; 
CASE:=1;'ff' DEVOUT=4 'THEN' CHOUT(4.146); 
'IF' DEVOUT =3 'THEN' CH0UT(DEVOUT,162); 
L: 	CHAR:=CHIN(DEVIN)'IF' CHAR#162 'THEN"GOTO' L; 
'FOR' CHAR:=CHIN(DEVIN) 'WHILE' CHAR*162 'DO' 
'BEGIN' 
'IF' CHAR#163 'THEN' CHOUT(DEVOUT.CHAR) 
'ELSE' 
'BEGIN' CASE:=—CASE; 
'IF' DEVOUT=4 'THEN' CHOUT(4.147—CASE) 
'ELSE' CHOUT(DEVOUT.CHAR); 
'END'; 
'END': 
'IF' DEVOUT =3 'THEN' CHOUT(DEVOUT.162); 
'END' OF TITLE; 
PROCEDURE' - PAIR(X,Y); 
'COMMENT' OUTPUTS PAIR OF CO—ORDINATES TO PLOTTER; 
'VALUE' X.Y; 'REAL'X,Y; 
'DEGIN' PRINT(4.5.1,X);TEXT(4,'.'); 
PRINT(4,5,11, Y);TEXT(4.' *Pi 
'END' OF PAIR;  
'PROCEDURE' ITERATE; 
— COMMENT' GAUSS—NEWTON ITERATIVE ROUTINE FOR PARAMETER SHIFTS.WITH 
CONCENTRATIONS RESTRAINED TO BE POSITIVE ,BY LOGARITHMIC' 
TRANSFORMATION I.E. THE UNKNOWNS ARE LNFRELIII 
*** A HIGHLY MODIFIED VERSION OF COGS ##4, ■ 
'BEGIN' 
'REAL' ARRAY' A011:NC:1:NC+1 .1.X0EI:NCl:CCI:N]: 
'INTEGER' 	NIT.I.J.K; 
NIT: =0 
'COMMENT' CALCULATE SPECIES CONCENTRATIONS; 
LOOP: 	'FOR' J:=1 'STEP' 1 'UNTIL' N 'DO' 
'BEGIN' 
CEJ]:=BETACJ1; 
'FOR' I:=1 'STEP' 1 'UNTIL' NC 'DIY 
CCJ]:=CEMOEI.A*LNFREECII; 
CIA:=EXP(CCJI); 
'END'; 
NIT:=NIT+1; 
'IF' NIT <MAXIT 'THEN' 
'BEGIN' 
'COMMENT' CALCULATE ELEMENTS OF FIRST NC COLUMNS OF A. 
WHICH IS THE AUGMENTED JACOBIAN(SYMMETRICAL); 
'FOR' I:=1 'STEP' 1 'UNTIL' NC 'DO' 
'BEGIN' AOEIPNC4-1]:=EXP(LNFREEEI3)—TOTEI3; 
'FOR' J:=1 'STEP' 1 'UNTIL' NC 'DO' AOEI,J]:=0.0; 
XOEI]:=0.0; 
'FOR' J:=1 'STEP' 1 'UNTIL' I 'DO' 
'BEGIN' 
'FOR: K:= I 'STEP' 1 'UNTIL' N 'DO' 
AOCI.J]:=A0[I.J]-1411I00*OCJ.K3*CCK]; 
AOEIFJ]:= 
'IF' I=J 'THEN' —EXP(LNFREEEJ])—AOCI,J1 
'ELSE' —A0EI,J3; 
'END'; 
• 'COMMENT' CALCULATE ELEMENTS OF LAST COLUMN OF AO; 
• 'FOR' K: ,=1 'STEP' 1 'UNTIL' N 'DO ; 
AOEI,NC+11:=A0[I.NC+1]+OCI.K3*CEK1; 
'END': 
'FOR' I:=1 'STEP' 1 'UNTIL' NC 'DO' 
'FOR' J:=I+1 'STEP' 1 'UNTIL' NC 'DO' AOEI,J]:=AOCJ:IJ; 
'REAL' PROCEDURE' SCALE(X.OFFSET.VAR.MAXVAR.MINVAR); 	 SINGUL:='FALSE'; 
'COMMENT' SCALES X FOR PLOTTER; 	 : 
'VALUE' X,OFFSET.VAR,MAXVAR.MINVAR; 	 SIMUL(NC,X0.A0.1.0E-600)1 
'REAL' X.OFFSET,VAR,MAXVAR.MINVAR; 'IF' NCIT' SINGUL 'THEN' 
'BEGIN' 	 'BEGIN' COMMENT' UPDATE LNFREECII UNTIL CONVERGENT; 
SCALE:=OFFSET+(VAR-2.0*OFFSET)*(X—MINVAR)/(MAXVAR—MINVAR); 	 'FOR' I:=1 'STEP' 1 'UNTIL' NC 'DO' 
END' OF SCALE; 	 LNFREECI]:=X0EIl+LNFREECI]; 
'FOR' I:=1 'STEP' I 'UNTIL' NC 'DO' 
'IF' ABS(X0EI3) >0.002 'THEN' GOTO' LOOP: 
IPT:=IPT•1; 
'END'; 	 TsO 
'END';'COMMENT' IPT NOT RESET IF NOT CONVERGENT; 	 I IND 
WRITE(TTY.NIT);TEXT(TTY."); 
'IF' NIT=MAXIT 'THEN' 
TEXT(TTY.'ITERATION DID NOT CONVERGE*); 
''IF' SINGUL 'THEN' TEXT(TTY.'rMATRIX SINGULAR*) . ; 
'END' LOF PROCEDURE •ITERATE; 
'PKOCEPURE 	TRINI ■ DEV.N.-M.X); 
'VALVE' DEV.K.M.',.; 'INTEGER' DEV,NrMi 'REAL' X: 
'COMMENT: vRiNrs <X:,- IN FORMAT (-) NNN.MMM: 
'INTEGER . V.E..1,Y; 'REAL' ZT 
'RROCEDURI' 5; 
Y:=ENTIER(Z): 
CHOUT(DEVr176+Y): Z:=Z-Yi 
'END': 
.":=10*ABS(X)+5/10 -Mi V:=0: 
'FOR' Z:=0.1* -Z 'WHILE' Z>=1 'DO' V:=V-1-1: 
'IF' V>N1-M 'THEN' RWRITE(DEV.X) 'ELSE' 
'BEGIN' 'IF' kr,W 'THEN' 
'BEGIN' Z:=Z-0.5/10 - (V+M); 
M:=N+M-Vi N:=V; I:=1; 
Z:=Z+0.5/10 - (V+11): 
'IF' Z>=I 'THEN' 
'BEGIN' V:=Vili N:=1,14-1; 
M=M-1; Z:=0.1*Zi 
'END' FIXING ROUNDING: . 
'END' FIXING OVERFLOW; 
'FOR' K:=V+1 'STEP' 1 'UNTIL' N 'DO' CHOUT(DEV7160); 
CHOUT(DEV.'IF' X<0 'THEN' 173 'ELSE' 160); 
'FOR' K:=1 'STEP' 1 'UNTIL' V 'DO' Si 
'IF' M>0 'OR' I=1 'THEN' CHOUT(DEV,174); 
'FOR' K:=1 'STEP' 1 'UNTIL' M 'DO' Si 
'END' FORMATTED OUTPUT; 
'END' PRINT; 
'PROCEDURE' PLOT; 
'COMMENT' PLOTS AXES AND EXPERIMENTAL TITRATION POINTS (CIRCLED); 
-'BEGIN' REAL' X.YrYSTEPFXSTEP; 
'INTEGER' 1,PiPEN: 
SKIP(TTY): 
TEXT(TTY.**** LOAD NEW PLOTTER PAPER...*)iSKIP(TTY); 
TEXT(TTYr*PEN NUMBER FOR AXES= ')iPEN:=READ(TTY)iSKIP(TTY); 
TEXT(TTY,'PLOTTING SPEED (CM/SEC)= ');P:=READITTY):SKIP(TTY)i 
TEXT(TTY,'SUPPRESS AXES LABELS (Y/N)'); 
SUPLAB:='IF' CHIN(TTY)=217. 'THEN"TRUE"ELSE"FALSE'i 
SKIPUITY)i 
TEXT(TfY, 	MAXX:');MAXX:=READ(TTY):SKIP(TTY); 
TEXT(TTY,* MINX:')iMINXI=READ(TTY);SKIP(TTY): 
TEXT(TTY,* . MAXY:*);MAXY:=READ(TTY);SKIP(TTY); 
TEXT(TTY,* MINY:')iMINY:=READ(TTY):SKIP(TTY); 
TEXT(TTY.*NO.VOLUME STEPS FOR PLOTTER ='): 
VINC:=READ(TTY):SKIP(TTY)i 
TEXT(TTYr*MAXIMUM NO.ITERATIONS= *)iMAXITI=READ(TTY); 
SKIP( TTY); 
TEXT(TTY.'INPUT GRID LIMITS: LEFT;');L:=READ(TTY);SKIP(TTY); 
TEXT(TIY,' 	BOTTOM:");B:READ(TTY);SKIP(TTY); 
TEXT(TTY.' RIGHT:fliR:=READ(TTY)iSKIP(TTY); 
TEXT III. TOP:');T:=READ(TTY);SKIP(TTY);  
TEXT(4r * PLOTTER INITIALISE DErINL vELOCITY '):WRITE(40 . ): 
TEXI(4.' DEFINE LIMITS ');PAIR(L , B):PAIK(R.T)i 
'COMMENT' SETS UP 0.025MM GRID:- 
ITX1(4.' DEFINE GRID ')iPAIR(R-L.T-B): 
1EXT(4.' LABEL TERMINATOR '):CHOUT01.129):'COMMENT' CNIL/Ai 
1EXI- (4.' LABEL LCASE ');CHOUT(4.148)i'COMMENT' 
1EXT(4,' LABEL UCASE '):CHOUT(4,146)i'COMMENI . CN1L/P) 
1tXT(4,' LABEL SIZE 100.300); 
TEXT(4,' PEN ');WRITE(4/PEN)i1EXT(4.' MOVE '); 
PAIR(,500,T-8-500);PAIR(500.500):PAIK(K - L - 500.5 00); 
PAIR(R-L•500.T-B-500);PAIR(500)T-B -500): 
XSTEP:=(MAXX-MINX)/10.; 
'FOR' X:=MINXTXSTEP 'STEP' XSIEP 'UNTIL' MAXX-XSTET 	DO' 
'BEGIN' 	TEXT(4,' MOVE '); 
PAIR(5CALE(X,00,R-L,MAXX.MINX:.S00); 
IDRAW 0,'JO IMOVE 0.-250): 
'IF' NO1' SUPLAB 'THEN' BEGIN' 
TEXT(4,' PRINT '): 
CHOUT(4.136);CHOUT(4,136):CHOUT(4.136); 
PRINT(4,1,2,X)iCHOUT(4 , 129): 
'END'; 
'END': 
YSTEP:=(MAXY-MINY)/10.; 	 - 
'FOR' Y:=MINYT-YSTEP 'STEP' .YSTEP 'UNTIL' MAXY-YSTEP 'DO' 
'BEGIN' 	TEXT(4,.' MOVE '): 
PAIR(500,SCALE(Y.500.1-B.MAXY.MINY)); 
TEXT(4,' IDRAW 50r0')i 
TEXT(4,' IMOVE -100,0 ROTATE 90 NOP')) 
'IF' NOT' SUPLAB 'THEN' BEGIN' 
TEXT(A,' PRINT '); 
CHOUT(4,136)iCHOUT(4,136);CHOUT(4 , 136); 
PRINT(4,1,2.Y)iCHOUT(4,129); 
'END': 
TEXT(4,' ROTATE*); 
TEX1(4,' GET SIZE VDU '); 
SKIP(TTY)4 
TEXT(TTY,'PEN NUMBER FOR DATA =');PEN:=READ(TTY): 
SKIP(TTY); 
1EXT(41' PLOTTER PEN *);WRITE(4,PEN); 
'FOR' I:=1 'STEP' 1 'UNTIL' NDATA 'DO' 
'BEGIN' TEXT(4,' MOVE*); 
PAIR(SCALE((MMOLESECOMP1J+VOLEII*TITCONCECOMP11)/ 
(MMOLESECOMP2IFVOLEI1*TITCONC(COMV21) , 
500,R-L.MAXX.MINX). 
	
• 	SCALE(PHLI)7500,T-B.MAXYYMINY)); 
'COMMENT' DRAW CIRCLES 0.02 PH UNITS IN RADIUS; 
TEXT(4,' IMOVE *); 
PATR(0.02*(T-B)/(MAXY -MINY).0); 
TEXT(4,' TURN '); 
RR101- (4.5.1,0.02*(T-B)/(MAXY-MINY)); 
'END': 
TEXT(41' HOP VDU '); 
LABEL; 
'END' OF PLOT; 	 D7=. NJ 
TFX1(11Y.'AIN.N1 	PH(EXPI) NII 	PHICALC)');SKIP(T17); 
'FOR' J:=1 . !: .,1-cp' 1 'UN IL' NDA1A - 1 'DO' 
'BEGIN' INPLX:=0; 
'FOR' V:=VOLCJ11INDEX* 
tVULTJIll-VOLIJ1)/VINC 'WHILE'• V vOL[J+1) 'DU' 
'PEGIN"COMMENT' PH LOOP: 
VTOT:=YINIT4-V4 
'POP' l:=1 'STEP' 1 'UNTIL' NC 'DO' 
TOTE[1:=IMMOLESC114IITCONCEII*V)/VIOT; 
1RIN1(T17,1,3,TOTECOMPU/TOTECUMP21); 
TEXT (111;* 	"); 
PRINICITY,2,3,(PHEJ-M-PHEJ])*INDEX/VINC+PHEA); 
TEXT( TTY.' 	•); 
'COMMENT' INITIALISE FREE COMPONENT CONCENTRATIONS; 
'IF' I11=1 'THEN' 
'DES1N' 	 • • 
'FOR' i:=1 - 'STEP' 1 'uNTIL' NC-1 '['O' 
LNFREEEI]:=LN(INITCONCEI1); 
LNFREE[NC]:=-HX((I'HIJF11-PHLA)*INDEX/vINCEpH(JJ); 
'END' OF FIRST POINT INITIALISATION; 
L9: 	 ITERATE; 
HEJ.INDEX]:=-LNFREEENC7/Hx; 
PRINTITTY,2,3.HCJ.INDEXDiSKIP(TTY); 
INDEX:=INDEX+1; 
'END' OFF1-1 LOOP FOR EACH TITRATION POINT; 
'END' OF TITRATION CURVE; 
SKIP(TTY); 
TEXT(TTy,•PEN NUMBER FOR CALC.CuRVE =*); 
PEN:=READ(TTY);SKIP(TTY.); 
TEXT(4,' PLOTTER PEN ');WRITE(4,PEN);TEXT(4,' MOVE •); 
SKIP(TTY); 
'FOR' J:=1 'STEP' 1 'UNTIL' NDATA-1 'DO' 
'BEGIN' INDEX:=0; 
'FOR' V:=VOLEJ]+INDEX*(WOL[J+1]-VOLEJ))/VINC 
'WHILE' V<VOL[J+1] 'DO' 
'BEGIN' 
PAIR(SCALE((MMOLESECOMP1)+V*TITCONCECOMP13) , 
(MMOLESECO7IP2A+V*TITCONCECOMP23), 
500,17-LyMAXX,MINX), 
SCALE(H[J,INDEX3,500,T-B,MAXY,MINY)); 
INDEX:=INDEX4-1; 
'END'; 
'END': 
- TEXT(4.' NOP VDU *); 
SKIP(ITY);SKIP(TTY);SKIP(TTY); 
TEXT(4,' PLOTTER PEN INITIALISE VDU "); 
TEXT(TTYr"....PROGRAM ENDS....'); 
'END' OF PROORAM COMIXH 
1 
• )• . .t IR( I ) ; TEX N I 	 COMIXH.AL: • );FILE( 1) ;  
• 1 , 	 ); 
	
i • • 1117NOCOPY 0111 pufe 	(/N)•); 
IF" CHIN(1)=:!1 7 ' I u 	' 0 'ELSE' 1FSK IP( TTY); 
;4 	;• 	);E:1-.11 - ( II C.: 
ri .1( ilT.• 	L 	11 	IA 	 LOGBETA' ); 
; 	(1(IF 1, 1 
PU01 ■ 3);N:=RE - Ap(); 
1 	U I EF t 'HNift ' N 'DO' 
• P1 ■31N' 	I XIIITY.• 	•); 
'VOR' 	 1 'UNTIL 	NC --qua'. 
'PEGIN' 
HFI.J1: -FOADH);WRITE(TTY;OEI,J7);TEXT(TTYr• 	•); 
'END': 
PEFALJI: RinH(7.);PRINT(TUY;393,BETACJI)1SKIP(TTY); 
BETALJI: , HX*PLTATJ1; 
'END': 
'FOR' I:=1 'SiER' 	'ONIIL' NC 'DO' 
MMOLCSTIA:=RtAD(3); 
MMOLES OF - COMPONENT ')i 
WRITECITY;ti;(11/1(ITY;•='); • 
PRIN1(TIY.1. -.;MMOLESETI); 
TEXT(TTX.•,TITRANT CONC.=*); 
TITCONCLI]:=READ(3)4 
PRINT(IIY.1,5rTITCONCEID;SKIPFTTY); 
INITCONCLIT:=READ(3); 
'END'i 
IPT:=14 
ViNIF:=READ(3)4TEXT(TTYy•INITIAL VOLUME (ML.)='); 
PRINT(TTY,3,3,VINIT)4SKIP(TTY); 
NDATA:=READ(3);PHCAL:=READ(3); 
TEX1;TTY.'PHCAL =')4PRINT(TTY.1,3,PHCAL);SKIP(TTY); 
',KIP(ITY); irxr(lT(. -X-AXIS OF PLOT WILL BE THE RATIO: 
MMOLES COMPONENT (N) / MMOLES COMPONENT (M)'); 
IP(I1Y)4 
IIXF;.11Y.'INPUT N.m:•);cOmPI:=READ(TTy);c0Mp2:=READTTY); 
il [P ,.TTY); 
'FOR' 	'STEP' I 'UNTI.L' NOMA 'DO' 	. 
'PFGIN' 	VOL1JA:=RF6D(3); 
PR1N1TIY.1.3.<MMOLFSCCOMP134-VOLCJ3*TITCONCECOMP13)./ 
(MMOWACUMP214-VOLEJ1*TITCONCECOMP23)); 
ruuji: ,RKAp((4:1111.11:=PHLJ]fPHCAL: 	 • 
TEXT(TTY•• 	•).miNt(TTY.2.3,PHIJ1);SKIP(TTY); 
ND'; 
fi I ;Sk IP( 111>4 
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